"Assay ID - IEDB IRI","Reference - IEDB IRI","Reference - Type","Reference - PMID","Reference - Submission ID","Reference - Authors","Reference - Journal","Reference - Date","Reference - Title","Epitope - IEDB IRI","Epitope - Object Type","Epitope - Name","Epitope - Reference Name","Epitope - Modified residues","Epitope - Modifications","Epitope - Starting Position","Epitope - Ending Position","Epitope - IRI","Epitope - Synonyms","Epitope - Source Molecule","Epitope - Source Molecule IRI","Epitope - Molecule Parent","Epitope - Molecule Parent IRI","Epitope - Source Organism","Epitope - Source Organism IRI","Epitope - Species","Epitope - Species IRI","Epitope - Comments","Related Object - Epitope Relation","Related Object - Object Type","Related Object - Name","Related Object - Starting Position","Related Object - Ending Position","Related Object - IRI","Related Object - Synonyms","Related Object - Source Molecule","Related Object - Source Molecule IRI","Related Object - Molecule Parent","Related Object - Molecule Parent IRI","Related Object - Source Organism","Related Object - Source Organism IRI","Related Object - Species","Related Object - Species IRI","Host - Name","Host - IRI","Host - Geolocation","Host - Geolocation IRI","Host - Sex","Host - Age","Host - MHC Present","1st in vivo Process - Process Type","1st in vivo Process - Disease","1st in vivo Process - Disease IRI","1st in vivo Process - Disease Stage","1st immunogen - Epitope Relation","1st immunogen - Object Type","1st immunogen - Name","1st immunogen - Reference Name","1st immunogen - Starting Position","1st immunogen - Ending Position","1st immunogen - IRI","1st immunogen - Source Molecule","1st immunogen - Source Molecule IRI","1st immunogen - Molecule Parent","1st immunogen - Molecule Parent IRI","1st immunogen - Source Organism","1st immunogen - Source Organism IRI","1st immunogen - Species","1st immunogen - Species IRI","1st immunogen - Adjuvants","1st immunogen - Route","1st immunogen - Dose Schedule","2nd in vivo Process - Process Type","2nd in vivo Process - Disease","2nd in vivo Process - Disease IRI","2nd in vivo Process - Disease Stage","2nd immunogen - Epitope Relation","2nd immunogen - Object Type","2nd immunogen - Name","2nd immunogen - Reference Name","2nd immunogen - Starting Position","2nd immunogen - Ending Position","2nd immunogen - IRI","2nd immunogen - Source Molecule","2nd immunogen - Source Molecule IRI","2nd immunogen - Molecule Parent","2nd immunogen - Molecule Parent IRI","2nd immunogen - Source Organism","2nd immunogen - Source Organism IRI","2nd immunogen - Species","2nd immunogen - Species IRI","2nd immunogen - Adjuvants","2nd immunogen - Route","2nd immunogen - Dose Schedule","Adoptive Transfer - Flag","Adoptive Transfer - Comments","Immunization - Comments","Assay - Location of Assay Data in Reference","Assay - Method","Assay - Response measured","Assay - Units","Assay - IRI","Assay - Qualitative Measure","Assay - Measurement Inequality","Assay - Quantitative measurement","Assay - Number of Subjects Tested","Assay - Number of Subjects Positive","Assay - Response Frequency (%)","Assay - Comments","Assay Antibody - Antibody Source Material","Assay Antibody - Immunoglobulin Domain","Assay Antibody - Purification Status","Assay Antibody - Antibody Name","Assay Antibody - Heavy chain isotype","Assay Antibody - Light chain isotype","Complex - PDB ID","Assay Antigen - Epitope Relation","Assay Antigen - Object Type","Assay Antigen - Name","Assay Antigen - Reference Name","Assay Antigen - Starting Position","Assay Antigen - Ending Position","Assay Antigen - IRI","Assay Antigen - Source Molecule","Assay Antigen - Source Molecule IRI","Assay Antigen - Molecule Parent","Assay Antigen - Molecule Parent IRI","Assay Antigen - Source Organism","Assay Antigen - Source Organism IRI","Assay Antigen - Species","Assay Antigen - Species IRI"
http://www.iedb.org/assay/4603,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2 and figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,14,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1005847,http://www.iedb.org/reference/1000333,Literature,6192445,,"H L Niman; R A Houghten; L E Walker; R A Reisfeld; I A Wilson; J M Hogle; R A Lerner","Proc Natl Acad Sci U S A",1983,"Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.",http://www.iedb.org/epitope/57312,"Linear peptide",SDVWSFGILLWETFSLGASPYPNLSNQQTR,"ST-FeSV v-Fes",,,396,425,,,"Tyrosine-protein kinase transforming protein Fes",http://www.ncbi.nlm.nih.gov/protein/P00543.1,"Tyrosine-protein kinase transforming protein Fes",http://www.uniprot.org/uniprot/P00543,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780,,,,,,,,,,,,,,,,,"Mus musculus 129 GIX+",https://ontology.iedb.org/ontology/ONTIE_0000163,,,,,,"Administration in vivo",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,Epitope,"Linear peptide",SDVWSFGILLWETFSLGASPYPNLSNQQTR,"ST-FeSV v-Fes",396,425,,"Tyrosine-protein kinase transforming protein Fes",http://www.ncbi.nlm.nih.gov/protein/P00543.1,"Tyrosine-protein kinase transforming protein Fes",http://www.uniprot.org/uniprot/P00543,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"2/2 hybribomas that reacted with the peptide in ELISA also reacted with intact protein in western blot.",,,Monoclonal,,IgG,Kappa,,"Source Antigen",Protein,"Tyrosine-protein kinase transforming protein Fes","Tyrosine-protein kinase transforming protein Fes",,,http://www.ncbi.nlm.nih.gov/protein/P00543.1,,,,,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780,"Snyder-Theilen feline sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11780
http://www.iedb.org/assay/1348947,http://www.iedb.org/reference/1003131,Literature,15060075,,"Roshni Sundaram; Marcus P Lynch; Sharad V Rawale; Yiping Sun; Mirdad Kazanji; Pravin T P Kaumaya","J Biol Chem",2004,"De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.",http://www.iedb.org/epitope/36374,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,L1,Acetylation|ACET,347,374,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide was chosen as it corresponds to the central region of the coiled coil segment of GP21 trasmembrane subunit and is involved in the fusion of viral and cellular membranes and syncytia formation between infected cells. When used as an isolated peptide, the C-terminus was also amidated.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"HLVT-1 infected patient's sera is shown to recognize this peptide alone or as part of a construct where this peptide is linked in a 3meric form to facilitate the interaction into a native coiled-coil structure.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,347,374,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1348948,http://www.iedb.org/reference/1003131,Literature,15060075,,"Roshni Sundaram; Marcus P Lynch; Sharad V Rawale; Yiping Sun; Mirdad Kazanji; Pravin T P Kaumaya","J Biol Chem",2004,"De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.",http://www.iedb.org/epitope/36374,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,L1,Acetylation|ACET,347,374,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide was chosen as it corresponds to the central region of the coiled coil segment of GP21 trasmembrane subunit and is involved in the fusion of viral and cellular membranes and syncytia formation between infected cells. When used as an isolated peptide, the C-terminus was also amidated.",,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"6-8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,347,374,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,,"4 doses of 100μg peptide-carrier at weeks 0, 3, 6 and 9.",,,,,,,,,,,,,,,,,,,,,,,N,,"A construct where 3 copies of this peptide are linked via its C-terminus to the ε-NH2 side chain of 3 lysyl residues in a GKGKGKG template was used. The template includes a Thelper epitope from the tetanus toxin, and is acetylated at the N-teminus and amidated at the C-terminus. . ","Fig 8C and 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Mouse antisera was raised to a construct where this peptide is linked in a trimeric form to facilitate the interaction into a native coiled-coil structure. The antisera is shown to recognize the GP21 protein in direct and competition ELISA, as well as in the surface of HTLV-immortalized ACH cells measured by flow cytometry.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1","envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",,,http://www.ncbi.nlm.nih.gov/protein/A45714,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1348949,http://www.iedb.org/reference/1003131,Literature,15060075,,"Roshni Sundaram; Marcus P Lynch; Sharad V Rawale; Yiping Sun; Mirdad Kazanji; Pravin T P Kaumaya","J Biol Chem",2004,"De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.",http://www.iedb.org/epitope/36374,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,L1,Acetylation|ACET,347,374,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide was chosen as it corresponds to the central region of the coiled coil segment of GP21 trasmembrane subunit and is involved in the fusion of viral and cellular membranes and syncytia formation between infected cells. When used as an isolated peptide, the C-terminus was also amidated.",,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"6-8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,347,374,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,,"4 doses of 100μg peptide-carrier at weeks 0, 3, 6 and 9.",,,,,,,,,,,,,,,,,,,,,,,N,,"A construct where 3 copies of this peptide are linked via its C-terminus to the ε-NH2 side chain of 3 lysyl residues in a GKGKGKG template was used. The template includes a Thelper epitope from the tetanus toxin, and is acetylated at the N-teminus and amidated at the C-terminus. . ","Fig 8B","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Mouse antisera was raised to a construct where this peptide is linked in a 3meric form to facilitate the interaction into a native coiled-coil structure. The antisera recongition of the immunogen is inhibited by the isolated peptide in competition ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,347,374,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1348953,http://www.iedb.org/reference/1003131,Literature,15060075,,"Roshni Sundaram; Marcus P Lynch; Sharad V Rawale; Yiping Sun; Mirdad Kazanji; Pravin T P Kaumaya","J Biol Chem",2004,"De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.",http://www.iedb.org/epitope/36374,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,L1,Acetylation|ACET,347,374,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide was chosen as it corresponds to the central region of the coiled coil segment of GP21 trasmembrane subunit and is involved in the fusion of viral and cellular membranes and syncytia formation between infected cells. When used as an isolated peptide, the C-terminus was also amidated.",,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"6-8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide","LHEVDKDISQLTQAIVKNHKNLLKIAQY + ACET(L1)",WCCR2,347,374,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,,"4 doses of 100μg peptide-carrier at weeks 0, 3, 6 and 9.",,,,,,,,,,,,,,,,,,,,,,,N,,"A construct where 3 copies of this peptide are linked via its C-terminus to the ε-NH2 side chain of 3 lysyl residues in a GKGKGKG template was used. The template includes a Thelper epitope from the tetanus toxin, and is acetylated at the N-teminus and amidated at the C-terminus. . ","FIgures 7,9 and 10","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,45,,,,"Mouse antisera was raised to a construct where this peptide is linked in a 3meric form to facilitate the interaction into a native coiled-coil structure. The antisera is shown to recognize whole HTLV-1 lysates in ELISA, and to inhibit syncytia formation in vitro. Purified antibodies from the sera also shows inhibitory activity on syncytia formation.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375457,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/49016,"Linear peptide",PQIPPPYVEPT,"p19 (115-125)",,,115,125,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,Other,Organism,"Human herpesvirus 3 VZV-32","Varicella-zoster virus (VZV)",,,,,,,,"Human herpesvirus 3 VZV-32",http://purl.obolibrary.org/obo/NCBITaxon_154633,"Human alphaherpesvirus 3",http://purl.obolibrary.org/obo/NCBITaxon_10335,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Paired sera from 60 patients showing 4-fold increase in anti-VZV titer were screened for positive PA test reactivity.","Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,13,13,100,"Particle agglutination (PA) titers for all PA-positive anti-VZV sera were completely abolished by the epitope.  Shorter peptides synthesized from this larger peptide failed to inhibited reactivity.",Serum,"Entire Antibody",Polyclonal,"Anti-VZV sera",IgM,,,Epitope,"Linear peptide",PQIPPPYVEPT,"p19 (115-125)",115,125,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375460,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/61294,"Linear peptide",SSPTHDPPDS,"p19 (104-113)",,,104,113,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,Other,Organism,"Human herpesvirus 3 VZV-32","Varicella-zoster virus (VZV)",,,,,,,,"Human herpesvirus 3 VZV-32",http://purl.obolibrary.org/obo/NCBITaxon_154633,"Human alphaherpesvirus 3",http://purl.obolibrary.org/obo/NCBITaxon_10335,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Paired sera from 60 patients showing 4-fold increase in anti-VZV titer were screened for positive PA test reactivity.","Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,13,0,0,"Particle agglutination (PA) titers for all PA-positive anti-VZV sera were unaffected by the epitope.",Serum,"Entire Antibody",Polyclonal,"Anti-VZV sera",IgM,,,Epitope,"Linear peptide",SSPTHDPPDS,"p19 (104-113)",104,113,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375461,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/64022,"Linear peptide",THDPPDSDPQIPP,"p19 (107-119)",,,107,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,Other,Organism,"Human herpesvirus 3 VZV-32","Varicella-zoster virus (VZV)",,,,,,,,"Human herpesvirus 3 VZV-32",http://purl.obolibrary.org/obo/NCBITaxon_154633,"Human alphaherpesvirus 3",http://purl.obolibrary.org/obo/NCBITaxon_10335,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Paired sera from 60 patients showing 4-fold increase in anti-VZV titer were screened for positive PA test reactivity.","Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,13,0,0,"Particle agglutination (PA) titers for all PA-positive anti-VZV sera were unaffected by the epitope.",Serum,"Entire Antibody",Polyclonal,"Anti-VZV sera",IgM,,,Epitope,"Linear peptide",THDPPDSDPQIPP,"p19 (107-119)",107,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375462,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/76264,"Linear peptide",YVEPTAPQVL,"p19 (121-130)",,,121,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,Other,Organism,"Human herpesvirus 3 VZV-32","Varicella-zoster virus (VZV)",,,,,,,,"Human herpesvirus 3 VZV-32",http://purl.obolibrary.org/obo/NCBITaxon_154633,"Human alphaherpesvirus 3",http://purl.obolibrary.org/obo/NCBITaxon_10335,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Paired sera from 60 patients showing 4-fold increase in anti-VZV titer were screened for positive PA test reactivity.","Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,13,0,0,"Particle agglutination (PA) titers for all PA-positive anti-VZV sera were unaffected by the epitope.",Serum,"Entire Antibody",Polyclonal,"Anti-VZV sera",IgM,,,Epitope,"Linear peptide",YVEPTAPQVL,"p19 (121-130)",121,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375464,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/49016,"Linear peptide",PQIPPPYVEPT,"p19 (115-125)",,,115,125,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope was not capable of inhibiting PA reactivity using HTLV-1 antisera.",Serum,"Entire Antibody",Polyclonal,"HTLV-1 antisera",IgM,,,Epitope,"Linear peptide",PQIPPPYVEPT,"p19 (115-125)",115,125,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375465,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/61294,"Linear peptide",SSPTHDPPDS,"p19 (104-113)",,,104,113,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope was not capable of inhibiting PA reactivity using HTLV-1 antisera.",Serum,"Entire Antibody",Polyclonal,"HTLV-1 antisera",IgM,,,Epitope,"Linear peptide",SSPTHDPPDS,"p19 (104-113)",104,113,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375466,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/64022,"Linear peptide",THDPPDSDPQIPP,"p19 (107-119)",,,107,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope was not capable of inhibiting PA reactivity using HTLV-1 antisera.",Serum,"Entire Antibody",Polyclonal,"HTLV-1 antisera",IgM,,,Epitope,"Linear peptide",THDPPDSDPQIPP,"p19 (107-119)",107,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1375467,http://www.iedb.org/reference/1004087,Literature,1279104,,"A Sato; Y Isaka; F Morita; A Ishii; Y Goto; J Imai; H Igarashi; O Yoshie; Y Hinuma","J Gen Virol",1992,"Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.",http://www.iedb.org/epitope/76264,"Linear peptide",YVEPTAPQVL,"p19 (121-130)",,,121,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope was not capable of inhibiting PA reactivity using HTLV-1 antisera.",Serum,"Entire Antibody",Polyclonal,"HTLV-1 antisera",IgM,,,Epitope,"Linear peptide",YVEPTAPQVL,"p19 (121-130)",121,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380952,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antibodies KE36-7 and KE19-1 are IgG1 kappa and IgG1 lamda, respectively.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KE 36-11, KE36-7, KE19-1",IgG3,Kappa,,Epitope,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",184,196,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380954,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/3683,"Linear peptide",APPLLPHSNLDHIL,"env gp46 187-200",,,187,200,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Rattus norvegicus (brown rat)",http://purl.obolibrary.org/obo/NCBITaxon_10116,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/A45714,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibody LAT27 was generated from a rat immunized with env-expressing vaccinia virus.","Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,,,Monoclonal,LAT27,,,,Epitope,"Linear peptide",APPLLPHSNLDHIL,"env gp46 187-200",187,200,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380956,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Table I",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380963,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"env p20E 332-353",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Table I",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"gag p19 100-130",332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380966,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antibody KG 37-3 is IgG (kappa), while others are IgG1 (kappa).","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KG 27-8, KG 33-1, KG 33-6, KG 37-3",IgG1,Kappa,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1380967,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"All mAbs reactive to the epitope specifically bound to native gag p19, p24, p28, and p53 proteins. Antibody KG 37-3 is IgG (kappa), while others are IgG1 (kappa).","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KG 27-8, KG 33-1, KG 33-6, KG 37-3",IgG1,Kappa,,"Source Antigen",Protein,"Pr gag-pro-pol",,,,http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1382712,http://www.iedb.org/reference/1004878,Literature,9238630,,"J R Appel; J Buencamino; R A Houghten; C Pinilla","Mol Divers",1996,"Exploring antibody polyspecificity using synthetic combinatorial libraries.",http://www.iedb.org/epitope/36317,"Linear peptide",LGSGAFGTIYKG,"v-erbB 138-149",,,138,149,,,"Tyrosine-protein kinase transforming protein erbB",http://www.ncbi.nlm.nih.gov/protein/P00535.1,,,"Avian erythroblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11861,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LGSGAFGTIYKG,"v-erbB 138-149",138,149,,"Tyrosine-protein kinase transforming protein erbB",http://www.ncbi.nlm.nih.gov/protein/P00535.1,,,"Avian erythroblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11861,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details of generation of the mAb were not described.","Table 1","inhibition by antigen (~ IC50)","dissociation constant KD",nM,http://purl.obolibrary.org/obo/OBI_0001638,Positive,,1200,,,,"The peptide Ac-YGPIDK-NH2,  identified from a synthetic combinatorial library, competed for binding to the mAb raised to the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,172-12A4,"Heavy Isotype n/s",,,Other,"Linear peptide",YGPIDK,Ac-YGPIDK-NH2,,,,,,,,,,,
http://www.iedb.org/assay/1383004,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",LLNTEPSQLPPTAPPLLPHSNLDHI,"env gp46 175-199",175,199,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383005,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"All mAbs reactive to the epitope specifically bound to native gp46 protein. Antibody KE33-13 is IgG3 (kappa), KE19-1 is IgG1 (lamda), while others are IgG1 (kappa).","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KE19-1, KE27-15, KE33-13, KE36-7, KE36-11",IgG1,Lambda,,"Source Antigen",Protein,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/A45714,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383008,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 3 and page 943","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"All mAbs reactive to the epitope bound the surface of HTLV-1 bearing cells. Antibodies KE-19-1 is IgG1 (lamda), KE27-15 and KE36-7 are IgG1 (kappa), while KE33-13 and KE 36-11 are IgG3 (kappa). . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KE19-1, KE27-15, KE33-13, KE36-7, KE36-11",IgG1,Lambda,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383009,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 3 and page 943","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"All mAbs reactive to the epitope bound the surface of HTLV-1 bearing cells. Antibody KE-37-3- is IgG3, while others are IgG1. . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KG 27-8, KG 33-1, KG 33-6, KG 37-3",IgG1,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383010,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Inhibition of HTLV-1-induced syncytium formation was also observed with polyclonal antibody. . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,KE36-11,IgG3,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383011,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Soluble peptide env gp46 175-199 (FLNTEPSQLPPTAPPLLPHSNLDHI), which contains the epitope, abolished inhibition of HTLV-1-induced syncytium formation by the mAb. . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,KE36-11,IgG3,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383016,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 5","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,"ADCC was observed with polyclonal and monoclonal antibodies. . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,KE36-7,IgG1,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1383017,http://www.iedb.org/reference/1004069,Literature,1378869,,"M Kuroki; M Nakamura; Y Itoyama; Y Tanaka; H Shiraki; E Baba; T Esaki; T Tatsumoto; S Nagafuchi; S Nakano","J Immunol",1992,"Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.",http://www.iedb.org/epitope/48933,"Linear peptide",PPTAPPLLPHSNL,"env gp46 184-196",,,184,196,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope was deduced from antibody binding assays using overlapping oliogpeptides spanning amino acids 175-200.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monoclonal antibodies against HTLV-1 were generated from peripheral blood B lymphocytes obtained from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","Figure 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Soluble peptide env gp46 175-199 (FLNTEPSQLPPTAPPLLPHSNLDHI), which contains the epitope, inhibited ADCC. . ","Purified Immunoglobulin","Entire Antibody",Monoclonal,KE36-7,IgG1,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384330,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/50996,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCGFPF,"HTLV-1 env gp46 136-161",,,136,161,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCGFPF,"HTLV-1 env gp46 136-161",136,161,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384331,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/50996,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCGFPF,"HTLV-1 env gp46 136-161",,,136,161,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCGFPF,"HTLV-1 env gp46 136-161",136,161,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384332,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 env gp46 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,18,100,"CSF was also positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 env gp46 175-199",175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384333,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 env gp46 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,17,100,"CSF was also positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 env gp46 175-199",175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384334,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 env gp46 197-216",,,197,216,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,7,38.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 env gp46 197-216",197,216,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384335,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 env gp46 197-216",,,197,216,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 env gp46 197-216",197,216,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384336,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"HTLV-1 env gp46 213-236",,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,17,94.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"HTLV-1 env gp46 213-236",213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384337,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"HTLV-1 env gp46 213-236",,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,5,29.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"HTLV-1 env gp46 213-236",213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384338,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"HTLV-1 env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,14,77.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"HTLV-1 env gp46 235-254",235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384339,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"HTLV-1 env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,10,58.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"HTLV-1 env gp46 235-254",235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384340,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"HTLV-1 env gp46 253-282",,,253,282,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,17,94.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"HTLV-1 env gp46 253-282",253,282,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384341,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"HTLV-1 env gp46 253-282",,,253,282,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,5,29.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"HTLV-1 env gp46 253-282",253,282,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384344,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"HTLV-1 env p20E 332-353",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,8,44.4,"CSF was also positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"HTLV-1 env p20E 332-353",332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384345,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"HTLV-1 env p20E 332-353",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,"CSF was also negative.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"HTLV-1 env p20E 332-353",332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384346,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/67993,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"HTLV-1 env p20E 350-386",,,350,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,7,38.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"HTLV-1 env p20E 350-386",350,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384347,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/67993,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"HTLV-1 env p20E 350-386",,,350,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,6,35.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"HTLV-1 env p20E 350-386",350,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384350,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"HTLV-1 env p20E 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,18,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"HTLV-1 env p20E 382-403",382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384351,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"HTLV-1 env p20E 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,10,58.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"HTLV-1 env p20E 382-403",382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384354,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/23247,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"HTLV-1 env p20E 426-448",,,426,448,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,12,66.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"HTLV-1 env p20E 426-448",426,448,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384355,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/23247,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"HTLV-1 env p20E 426-448",,,426,448,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"HTLV-1 env p20E 426-448",426,448,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384356,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"HTLV-1 env p20E 458-488",,,438,468,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"35-65 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from patients with HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,8,44.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"HTLV-1 env p20E 458-488",438,468,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1384357,http://www.iedb.org/reference/1004937,Literature,1955565,,"M Nakamura; M Kuroki; J Kira; Y Itoyama; H Shiraki; N Kuroda; Y Washitani; S Nakano; S Nagafuchi; K Anzai","J Neuroimmunol",1991,"Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"HTLV-1 env p20E 458-488",,,438,468,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"28-92 years",,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 carriers without HTLV-1 associated myelopathy (HAM)/tropical spastic paraparesis (TSP).","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"HTLV-1 env p20E 458-488",438,468,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1386134,http://www.iedb.org/reference/1004077,Literature,1372329,,"M Nakamura; Y Itoyama; M Kuroki; S Nakano; S Kondoh; S Nagafuchi; J Kira; I Ichinose; K Mitsugi; K Anzai","J Neuroimmunol",1992,"Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 (235-254)",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Ten patients with HTLV-1-associated myelopathy/tropical spastic paraparesis(HAM/TSP), nine patients with non-HAM/TSP, HTLV-1 carriers and eight seronegative healthy controls were used as the source of PBMCs. B lymphocytes were enriched from the peripheral blood of HAM/TSP patients. EBV-transformed B lymphocytes that were shown to react with the HTLV-1 gag-env hybrid protein were then used to generate the mAb F31.1 by fusion with a human-mouse heteromyeloma cell line.","Text page 41.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"B lymphocytes were enriched from the peripheral blood of HAM/TSP patients. EBV-transformed B lymphocytes that reacted with the HTLV-1 gag-env hybrid protein were then used to generate the mAb F31.1 by fusion with a human-mouse heteromyeloma cell line.  This mAb was shown to specifically bind the epitope in ELISA format.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F31.1,IgG1,Kappa,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 (235-254)",235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1386137,http://www.iedb.org/reference/1004077,Literature,1372329,,"M Nakamura; Y Itoyama; M Kuroki; S Nakano; S Kondoh; S Nagafuchi; J Kira; I Ichinose; K Mitsugi; K Anzai","J Neuroimmunol",1992,"Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 (235-254)",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Ten patients with HTLV-1-associated myelopathy/tropical spastic paraparesis(HAM/TSP), nine patients with non-HAM/TSP, HTLV-1 carriers and eight seronegative healthy controls were used as the source of PBMCs.  B lymphocytes were enriched from the peripheral blood of HAM/TSP patients. EBV-transformed B lymphocytes that were shown to react with the HTLV-1 gag-env hybrid protein were then used to generate the mAb F31.1 by fusion with a human-mouse heteromyeloma cell line.","Figures 4 and 5","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"B lymphocytes were enriched from the peripheral blood of HAM/TSP patients. EBV-transformed B lymphocytes that reacted with the HTLV-1 gag-env hybrid protein were then used to generate the mAb F31.1 by fusion with a human-mouse heteromyeloma cell line.  Epitope specificity against p235-254 was demonstrated using ELISA.  The epitope-specific mAb was then shown to bind the surface of HTLV-1-infected cells by flow cytometry.  MAb F31.1 was also found to bind specifically to the 46kDa moiety in lysates from HTLV-1-infected MT-2 cells by Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F31.1,IgG1,Kappa,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1422416,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/55707,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",,,64,73,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1422417,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/55707,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",,,64,73,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1422418,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1422419,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1422420,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1422421,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434599,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The anti-peptide sera inhibited BLV-induced polykaryocytosis. The anti-peptide sera neutralized vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434600,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/55707,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",,,64,73,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The anti-peptide sera inhibited BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434601,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not inhibit BLV-induced polykaryocytosis. The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434603,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/55707,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",,,64,73,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434648,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/15315,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",,,71,90,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not inhibit BLV-induced polykaryocytosis. The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434651,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/15315,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",,,71,90,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434653,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/15315,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",,,71,90,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"BLV pp51 38-57",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434654,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434658,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434659,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434660,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/67318,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",,,74,83,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",74,83,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",74,83,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434661,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/67318,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",,,74,83,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",74,83,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434663,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/67318,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",,,74,83,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",74,83,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not inhibit BLV-induced polykaryocytosis. The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434666,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6865,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",,,114,123,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",114,123,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",114,123,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434667,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6865,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",,,114,123,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",114,123,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434668,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6865,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",,,114,123,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",114,123,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434672,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/50183,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",,,115,124,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",115,124,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434675,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/50183,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",,,115,124,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",115,124,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not inhibit BLV-induced polykaryocytosis. The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434677,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/50183,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",,,115,124,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",115,124,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",115,124,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434678,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/68617,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",,,117,136,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",117,136,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434680,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/68617,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",,,117,136,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",117,136,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434682,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/68617,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",,,117,136,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",117,136,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",117,136,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434684,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434685,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434687,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The anti-peptide sera inhibited BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434689,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434700,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/57961,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",,,104,123,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",104,123,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434701,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/57961,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",,,104,123,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",104,123,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434703,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/57961,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",,,104,123,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",104,123,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",104,123,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434706,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434707,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not inhibit BLV-induced polykaryocytosis. The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434711,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434712,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/65113,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",,,124,143,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",124,143,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434714,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/65113,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",,,124,143,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",124,143,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",124,143,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434715,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/65113,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",,,124,143,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",124,143,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434718,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434719,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434723,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434724,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434725,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434728,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434730,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434733,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434735,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434738,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",,,282,301,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434739,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",,,282,301,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1434740,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",,,282,301,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"The anti-peptide sera did not neutralize vesicular stomatitis virus (VSV)-BLV pseudotypes. The anti-peptide sera did not inhibit BLV-induced polykaryocytosis.",Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1463888,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/47201,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",,,111,130,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 antibody-positive sera (n=15) were from a performance panel that included asymptomatic donors and from donors (n=37) from regions of Africa and West Indies.","Figures 2, 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,48,92.3,"Sera from 48 of 52 HTLV-1 antibody-positive donors reacted with the epitope. The epitope inhibited the binding of the sera to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",111,130,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463889,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/47201,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",,,111,130,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-2 antibody-positive sera (n=22) were from a performance panel that included asymptomatic donors.","Figure 4, Text page 1483","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,18,2,11.1,"The epitope competed with MA2 peptide (PSPEAHVPPPYVEPTTTQCF) from HTLV-2 gag protein for binding to HTLV-II seropositive sera from 2 of 18 donors that cross-reacted with the epitope in a direct ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",111,130,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463891,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/49455,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",,,117,136,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-2 antibody-positive sera (n=22) were from a performance panel that included asymptomatic donors.","Figures 2, 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,22,21,95.5,"Sera from 21 of 22 HTLV-2 antibody-positive donors reacted with the epitope. The epitope inhibited the binding of the sera to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",117,136,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463892,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/49455,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",,,117,136,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 antibody-positive sera (n=15) were from a performance panel that included asymptomatic donors and from donors (n=37) from regions of Africa and the West Indies.","Figure 4, Text page 1483","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,11,1,9.1,"The epitope competed with MA1 peptide (PDSDPQIPPPYVEPTAPQVL) from HTLV-1 gag protein for binding to HTLV-1 seropositive sera from 1 of 11 donors that cross-reacted with the epitope in a direct ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",117,136,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463900,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/49455,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",,,117,136,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 antibody-positive sera (n=15) were from a performance panel that included asymptomatic donors and from donors (n=37) from regions of Africa and the West Indies.","Text page 1482",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,12,23.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSPEAHVPPPYVEPTTTQCF,"MA2 peptide (116-135)",117,136,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463903,http://www.iedb.org/reference/1006419,Literature,8314990,,"J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis","J Clin Microbiol",1993,"Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.",http://www.iedb.org/epitope/47201,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",,,111,130,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-2 antibody-positive sera (n=22) were from a performance panel that included asymptomatic donors.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,22,18,81.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDSDPQIPPPYVEPTAPQVL,"MA1 peptide (111-130)",111,130,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P14076.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463912,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",,,191,214,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 52 HTLV-1 seropositive donors. Twenty of 52 were confirmed HTLV-1 positive by PCR. Of these 13 had either ALT or HAM/TSP syndrome and the other 7 were asymptomatic blood donors.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,48,92.3,"Sera from 0 of 21 normal donors reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",191,214,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463913,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",,,191,214,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 35 HTLV-2 seropositive donors confirmed positive by PCR. The donors were mostly intravenous drug users.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,35,3,8.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",191,214,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463914,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 35 HTLV-2 seropositive donors confirmed positive by PCR. The donors were mostly intravenous drug users.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,35,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463915,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 52 HTLV-1 seropositive donors. Twenty of 52 were confirmed HTLV-1 positive by PCR. Of these 13 had either ALT or HAM/TSP syndrome and the other 7 were asymptomatic blood donors.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,52,100,"Sera from 0 of 21 normal donors reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463917,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",,,191,214,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human immunodeficiency virus infectious disease",http://purl.obolibrary.org/obo/DOID_526,Chronic,"Taxonomic Sibling",Organism,"Human immunodeficiency virus 1 (human immunodeficiency virus 1 HIV-1)",HIV-1,,,,,,,,"Human immunodeficiency virus 1",http://purl.obolibrary.org/obo/NCBITaxon_11676,"Human immunodeficiency virus 1",http://purl.obolibrary.org/obo/NCBITaxon_11676,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 28 HIV seropositive donors. Of these 10 were asymptomatic and 18 had AIDS.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,28,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"HTLV-1 peptide Env-1 (191-214)",191,214,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463918,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human immunodeficiency virus infectious disease",http://purl.obolibrary.org/obo/DOID_526,Chronic,"Taxonomic Sibling",Organism,"Human immunodeficiency virus 1 (human immunodeficiency virus 1 HIV-1)",HIV-1,,,,,,,,"Human immunodeficiency virus 1",http://purl.obolibrary.org/obo/NCBITaxon_11676,"Human immunodeficiency virus 1",http://purl.obolibrary.org/obo/NCBITaxon_11676,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 28 HIV seropositive donors. Of these 10 were asymptomatic and 18 had AIDS.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,28,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463920,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/68842,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"HTLV-2 peptide Env-2 (187-210)",,,187,210,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 52 HTLV-1 seropositive donors. Twenty of 52 were confirmed HTLV-1 positive by PCR. Of these 13 had either ALT or HAM/TSP syndrome and the other 7 were asymptomatic blood donors.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,49,94.2,"Sera from 0 of 21 normal donors reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"HTLV-2 peptide Env-2 (187-210)",187,210,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463921,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/68842,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"HTLV-2 peptide Env-2 (187-210)",,,187,210,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 35 HTLV-2 seropositive donors confirmed positive by PCR. The donors were mostly intravenous drug users.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,35,27,77.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"HTLV-2 peptide Env-2 (187-210)",187,210,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463925,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/65667,"Linear peptide",TPNISIPQQTSSRTILF,"HTLV-2 peptide Env-6 (238-254)",,,238,254,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 52 HTLV-1 seropositive donors. Twenty of 52 were confirmed HTLV-1 positive by PCR. Of these 13 had either ALT or HAM/TSP syndrome and the other 7 were asymptomatic blood donors.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,12,23.1,"Sera from 0 of 21 normal donors reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPNISIPQQTSSRTILF,"HTLV-2 peptide Env-6 (238-254)",238,254,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463926,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/65667,"Linear peptide",TPNISIPQQTSSRTILF,"HTLV-2 peptide Env-6 (238-254)",,,238,254,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 35 HTLV-2 seropositive donors confirmed positive by PCR. The donors were mostly intravenous drug users.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,35,2,5.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPNISIPQQTSSRTILF,"HTLV-2 peptide Env-6 (238-254)",238,254,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463934,http://www.iedb.org/reference/1006246,Literature,1984475,,"R B Lal; D L Rudolph; M D Lairmore; R F Khabbaz; M Garfield; J E Coligan; T M Folks","J Infect Dis",1991,"Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope effectively competed with HTLV-1 protein for binding to HTLV-1 antisera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"HTLV-1 peptide Env-5 (242-257)",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463945,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/46085,"Linear peptide",NTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTL,"gp46 peptide env-1 (177-213)",,,177,213,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,11,11,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTL,"gp46 peptide env-1 (177-213)",177,213,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463946,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/46085,"Linear peptide",NTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTL,"gp46 peptide env-1 (177-213)",,,177,213,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,7,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTL,"gp46 peptide env-1 (177-213)",177,213,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463957,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/66188,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide env-2 (173-209)",,,173,209,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,11,2,18.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide env-2 (173-209)",173,209,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463958,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/66188,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide env-2 (173-209)",,,173,209,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,7,6,85.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide env-2 (173-209)",173,209,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1463960,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/45728,"Linear peptide",NRRGLDLLFWEQGGLCKALQEQCRF,"gp46 transmembrane peptide (378-402)",,,378,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,11,10,90.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRRGLDLLFWEQGGLCKALQEQCRF,"gp46 transmembrane peptide (378-402)",378,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463962,http://www.iedb.org/reference/1006547,Literature,1941526,,"R P Viscidi; P M Hill; S J Li; E H Cerny; D Vlahov; H Farzadegan; N Halsey; G D Kelen; T C Quinn","J Acquir Immune Defic Syndr (1988)",1991,"Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.",http://www.iedb.org/epitope/45728,"Linear peptide",NRRGLDLLFWEQGGLCKALQEQCRF,"gp46 transmembrane peptide (378-402)",,,378,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,7,4,57.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRRGLDLLFWEQGGLCKALQEQCRF,"gp46 transmembrane peptide (378-402)",378,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463990,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/40542,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",,,213,259,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,10,83.3,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",213,259,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463991,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/40542,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",,,213,259,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,1,25,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",213,259,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463992,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/62291,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",,,246,274,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,8,66.7,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",246,274,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463993,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/62291,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",,,246,274,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,1,25,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",246,274,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463994,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/65644,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",,,253,275,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,1,25,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",253,275,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463995,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/65644,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",,,253,275,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,10,83.3,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",253,275,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463996,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/17248,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",,,271,305,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,6,50,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",271,305,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463997,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/17248,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",,,271,305,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,1,25,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",271,305,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463998,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/8545,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",,,197,231,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,8,66.7,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",197,231,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1463999,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/8545,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",,,197,231,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,4,0,0,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",197,231,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464000,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/43449,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",,,329,353,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text page 84",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,4,0,0,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",329,353,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464001,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/43449,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",,,329,353,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 12 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,6,50,"The epitope was identified by screening a yeast display library with rabbit antisera raised against HTLV-1 Tax protein.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",329,353,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464115,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/31664,"Linear peptide",KKPNRQGLGYYSPSYNDP,"gp46 peptide Env 20",,,86,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,82,82.8,"Sera from none of 22 normal blood donors reacted.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KKPNRQGLGYYSPSYNDP,"gp46 petide Env 20",86,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464116,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/31664,"Linear peptide",KKPNRQGLGYYSPSYNDP,"gp46 peptide Env 20",,,86,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 seropositive donors confirmed to be HTLV-1 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,2,8.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KKPNRQGLGYYSPSYNDP,"gp46 petide Env 20",86,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464117,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/66188,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide Env 202",,,173,209,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 seropositive donors confirmed to be HTLV-1 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,6,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 petide Env 202",173,209,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464118,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/66188,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide Env 202",,,173,209,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,94,94.9,"Positive binding was also observed with a shorter fragment of the epitope (residues 187-209) in 28 of 30 HTLV-2 antisera tested. Sera from none of 22 normal blood donors reacted.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKF,"gp46 petide Env 202",173,209,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464119,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/75708,"Linear peptide",YSCMVCVDRSSLSSWHVLYTPNISIPQQTSSRTILFPS,"gp46 peptide Env 203",,,219,256,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Tables 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,75,75.8,"Positive binding was also observed with a shorter fragment of the epitope (residues 232-255) in 3 of 30 HTLV-2 antisera tested. Sera from none of 22 normal blood donors reacted.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YSCMVCVDRSSLSSWHVLYTPNISIPQQTSSRTILFPS,"gp46 petide Env 203",219,256,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464120,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/75708,"Linear peptide",YSCMVCVDRSSLSSWHVLYTPNISIPQQTSSRTILFPS,"gp46 peptide Env 203",,,219,256,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-1 seropositive donors confirmed to be HTLV-1 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,14,58.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YSCMVCVDRSSLSSWHVLYTPNISIPQQTSSRTILFPS,"gp46 petide Env 203",219,256,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464121,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/46375,"Linear peptide",NVFFLLLFSLTHFPLAQ,"gp46 peptide Env 4",,,3,19,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,2,6.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NVFFLLLFSLTHFPLAQ,"gp46 petide Env 4",3,19,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464123,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/67283,"Linear peptide",TWNLDLNSLTTDQRLH,"gp46 peptide Env 7",,,45,60,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TWNLDLNSLTTDQRLH,"gp46 petide Env 7",45,60,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464124,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/76065,"Linear peptide",YTGPVSSPSWKFHSDV,"gp46 peptide Env 21",,,120,135,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,5,16.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTGPVSSPSWKFHSDV,"gp46 petide Env 21",120,135,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464125,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/3702,"Linear peptide",APPSQPFPWTHCYQPRL,"gp46 peptide Env 22",,,261,277,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",APPSQPFPWTHCYQPRL,"gp46 petide Env 22",261,277,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464126,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/51959,"Linear peptide",QPRLQAITTDNCNNSI,"gp46 peptide Env 23",,,274,289,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,2,6.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QPRLQAITTDNCNNSI,"gp46 petide Env 23",274,289,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464127,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/34925,"Linear peptide",LAPVPPPATRRRRAVPI,"gp46 peptide Env 24",,,296,312,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,1,3.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAPVPPPATRRRRAVPI,"gp46 petide Env 24",296,312,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464128,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/24595,"Linear peptide",HQNILRVAQ,"gp21 peptide Env 208",,,361,369,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HQNILRVAQ,"gp21 petide Env 208",361,369,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464129,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/4098,"Linear peptide",AQYAAQNRRGLDLLFW,"gp21 peptide Env 25",,,368,383,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AQYAAQNRRGLDLLFW,"gp21 petide Env 25",368,383,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464130,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/6241,"Linear peptide",CFLNISNTHVSV,"gp21 peptide Env 212",,,397,408,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,2,6.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CFLNISNTHVSV,"gp21 petide Env 212",397,408,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464521,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/8545,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",,,197,231,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,6,37.5,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQLTLQSTNYTCIVCIDR,"gp46 197-231 (peptide Rp-A)",197,231,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464522,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/40542,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",,,213,259,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,12,75,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLSTWHVLYSPNVSVPSSSSTPLLYPS,"gp46 213-259 (peptide Rp-B)",213,259,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464523,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/62291,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",,,246,274,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,7,43.8,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVPSSSSTPLLYPSLALPAPHLTLPFNWT,"gp46 246-274 (peptide Rp-C)",246,274,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464524,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/65644,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",,,253,275,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,9,56.3,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTH,"gp46 253-275 (peptide Rp-D)",253,275,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464525,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/17248,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",,,271,305,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,8,50,"The epitope was identified by screening a yeast display library with HTLV-1 human antisera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FNWTHCFDPQIQAIVSSPCHNSLILPPFSLSPVPT,"gp46 272-305 (peptide Rp-E)",271,305,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464526,http://www.iedb.org/reference/1006321,Literature,7679862,,"N Noraz; S Benichou; P Madaule; P Tiollais; J C Vernant; C Desgranges",Virology,1993,"Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.",http://www.iedb.org/epitope/43449,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",,,329,353,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from 16 asymptomatic HTLV-1 carriers. All sera were immunoadsorbed on Baker's yeast to prevent cross-reactions with yeast components.","Table 2; Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,16,6,37.5,"The epitope was identified by screening a yeast display library with rabbit antisera raised against HTLV-1 Tax protein.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NDHEPQISPGGLEPPSEKHFRETEV,"Tax 329-353 (peptide Rp-F)",329,353,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P03409.2,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1464591,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/68841,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide Env 2",,,187,209,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,28,93.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKF,"gp46 peptide Env 2",187,209,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1464593,http://www.iedb.org/reference/1006638,Literature,1727602,,"R B Lal; D L Rudolph; J E Kaplan; B Hjelle; P H Levine; J E Coligan; R P Viscidi",Virology,1992,"Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.",http://www.iedb.org/epitope/72558,"Linear peptide",WHVLYTPNISIPQQTSSRTILFP,"gp46 peptide Env 204",,,233,255,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HTLV-2 seropositive donors confirmed to be HTLV-2 positive by PCR.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WHVLYTPNISIPQQTSSRTILFP,"gp46 peptide Env 204",233,255,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1465529,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 env gp46 peptide 1",,,33,47,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 env gp46 peptide 1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465530,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 env gp46 peptide 1",,,33,47,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 env gp46 peptide 1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465533,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 env gp46 peptide 4",,,129,149,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 env gp46 peptide 4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465534,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 env gp46 peptide 4",,,129,149,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 env gp46 peptide 4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465535,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 env gp46 peptide 8",,,400,415,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 env gp46 peptide 8",400,415,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465536,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 env gp46 peptide 8",,,400,415,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 env gp46 peptide 8",400,415,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465537,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/47925,"Linear peptide",PILQERPPLENR,"HTLV-1 env gp46 peptide 9",,,411,422,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PILQERPPLENR,"HTLV-1 env gp46 peptide 9",411,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465538,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/47925,"Linear peptide",PILQERPPLENR,"HTLV-1 env gp46 peptide 9",,,411,422,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PILQERPPLENR,"HTLV-1 env gp46 peptide 9",411,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465539,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 env gp46 peptide 2",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 env gp46 peptide 2",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465540,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 env gp46 peptide 2",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 env gp46 peptide 2",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465543,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 env gp46 peptide 3",,,176,189,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) and a tyrosine residue (Y) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 env gp46 peptide 3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465544,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 env gp46 peptide 3",,,176,189,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) and a tyrosine residue (Y) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 env gp46 peptide 3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465545,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 env gp46 peptide 5",,,269,280,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A tyrosine residue (Y) and a cysteine residue (C) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 env gp46 peptide 5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465546,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 env gp46 peptide 5",,,269,280,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A tyrosine residue (Y) and a cysteine residue (C) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 env gp46 peptide 5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465547,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/73327,"Linear peptide",YAAQNRRGLDLLFWEQGGL,"HTLV-1 env gp46 peptide 7",,,374,392,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGL,"HTLV-1 env gp46 peptide 7",374,392,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465548,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/73327,"Linear peptide",YAAQNRRGLDLLFWEQGGL,"HTLV-1 env gp46 peptide 7",,,374,392,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGL,"HTLV-1 env gp46 peptide 7",374,392,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465549,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 env gp46 peptide 10",,,462,480,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 env gp46 peptide 10",462,480,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465550,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 env gp46 peptide 10",,,462,480,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 env gp46 peptide 10",462,480,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465551,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/56614,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 env gp46 peptide 11",,,475,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 env gp46 peptide 11",475,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465552,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/56614,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 env gp46 peptide 11",,,475,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 env gp46 peptide 11",475,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465553,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 env gp46 peptide 6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 env gp46 peptide 6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465554,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 env gp46 peptide 6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 env gp46 peptide 6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465555,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,17,100,"A cysteine residue (C) and a tyrosine residue (Y) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465556,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera (33) from healthy HTLV-1 carriers were from Centers for Disease Control (CDC), Atlanta, GA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A cysteine residue (C) and a tyrosine residue (Y) were added at the N- and C-termini of the peptide antigen, respectively, to facilitate coupling of the peptide to protein carrier (C) and iodination (Y).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465557,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/35174,"Linear peptide",LDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a1",,,196,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,6,35.3,"A tyrosine residue (Y) was added to the C-terminus of the peptide antigen to facilitate iodination.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDHILEPSIPWKSK,"HTLV-1 env gp46 peptide 4a1",196,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465559,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/58669,"Linear peptide",SIPWKSK,"HTLV-1 env gp46 peptide 4a2",,,203,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,"A tyrosine residue (Y) was added to the C-terminus of the peptide antigen to facilitate iodination.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SIPWKSK,"HTLV-1 env gp46 peptide 4a2",203,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465560,http://www.iedb.org/reference/1007138,Literature,1704032,,"S Jacobson; J S Reuben; R D Streilein; T J Palker","J Immunol",1991,"Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.",http://www.iedb.org/epitope/37656,"Linear peptide",LLPHSNLD,"HTLV-1 env gp46 peptide 4b",,,190,197,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antisera were obtained from 17 from patients with HTLV-1-associated myelopathy/tropical spastic paraplegia (HAM/TSP). Ten of these patients were Jamaican.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,9,52.9,"A cysteine residue (C) was added to the C-terminus of the peptide antigen to facilitate coupling of the peptide to carrier protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLD,"HTLV-1 env gp46 peptide 4b",190,197,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465649,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/47863,"Linear peptide",PHYSLIKPESSL,"SP-65 (p21)",,,477,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHYSLIKPESSL,"SP-65 (p21)",477,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465650,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/48778,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",,,296,306,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",296,306,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465651,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465653,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling","Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaRV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403
http://www.iedb.org/assay/1465654,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Baboon endogenous virus (baboon endogenous retrovirus)","Baboon endogenous virus",,,,,,,,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403
http://www.iedb.org/assay/1465655,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Mason-Pfizer monkey virus (Simian Mason-Pfizer type D retrovirus)","Mason-Pfizer monkey virus",,,,,,,,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1465656,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Langur virus","Langur retrovirus",,,,,,,,"Langur virus",http://purl.obolibrary.org/obo/NCBITaxon_363747,"Langur virus",http://purl.obolibrary.org/obo/NCBITaxon_363747
http://www.iedb.org/assay/1465657,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Simian retrovirus 1 (Simian SRV-1 type D retrovirus)","Retrovirus D-Washington",,,,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1465662,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465663,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/52871,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",,,373,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), retrovirus D-Washington (R/D-W), reticuloendotheliosis-associated virus (REV-A) and baboon endogenous virus (BaEV), and BaEV peptide SP-9.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Reticuloendotheliosis virus (Avian reticuloendotheliosis virus)","Reticuloendotheliosis-associated virus",,,,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1465665,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Baboon endogenous virus (baboon endogenous retrovirus)","Baboon endogenous virus",,,,,,,,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403
http://www.iedb.org/assay/1465666,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling","Linear peptide",QYAAQNRRGLDLL,"SP-74 (p21)",373,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465667,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Mason-Pfizer monkey virus (Simian Mason-Pfizer type D retrovirus)","Mason-Pfizer monkey virus",,,,,,,,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1465668,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Langur virus","Langur retrovirus",,,,,,,,"Langur virus",http://purl.obolibrary.org/obo/NCBITaxon_363747,"Langur virus",http://purl.obolibrary.org/obo/NCBITaxon_363747
http://www.iedb.org/assay/1465669,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403
http://www.iedb.org/assay/1465670,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"This epitope sequence was described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described by T.D. Copeland, et al. (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Table II","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies cross-reacted with Mason-Pfizer monkey virus (MPMV), Langur retrovirus (Po-1-Lu), reticuloendotheliosis-associated virus (REV-A) and HTLV-1 peptide SP-74.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Reticuloendotheliosis virus (Avian reticuloendotheliosis virus)","Reticuloendotheliosis-associated virus",,,,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1465675,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/48778,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",,,296,306,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were collected from patients positive to HTLV-1.","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,3,2,66.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",296,306,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465679,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/48778,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",,,296,306,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",296,306,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPFSLSPVPTL,"SP-70 (gp46)",296,306,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465680,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This epitope sequence was described by T.J. Palker, et al. (J Immunol. 1986 Apr 1;136(7):2393-7. [PMID: 2419433]).",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were collected from patients positive to HTLV-1.","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,3,2,66.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465681,http://www.iedb.org/reference/1006817,Literature,2428880,,"T D Copeland; W P Tsai; Y D Kim; S Oroszlan","J Immunol",1986,"Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This epitope sequence was described by T.J. Palker, et al. (J Immunol. 1986 Apr 1;136(7):2393-7. [PMID: 2419433]).",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered s.c. followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1465803,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/48084,"Linear peptide",PKINRSAPEPSL,"SP68 (v-raf)",,,289,300,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PKINRSAPEPSL,"SP68 (v-raf)",289,300,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Similar results were obtained with un-purified sera.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PKINRSAPEPSL,"SP68 (v-raf)",289,300,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465804,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/48084,"Linear peptide",PKINRSAPEPSL,"SP68 (v-raf)",,,289,300,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PKINRSAPEPSL,"SP68 (v-raf)",289,300,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Epitope peptide-affinity purified antibodies weakly immunoprecipitated P75gag-raf fusion protein from virus-transformed cells, but not endogenous Pr65gag.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Murine sarcoma virus 3611","Murine sarcoma virus 3611",,,,,,,,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465805,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/31414,"Linear peptide",KIRPRGQRDSSY,"SP45 (v-raf)",,,4,15,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIRPRGQRDSSY,"SP45 (v-raf)",4,15,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,Results,"western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Similar results were obtained with un-purified sera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KIRPRGQRDSSY,"SP45 (v-raf)",4,15,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465806,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/41103,"Linear peptide",MAPEVIRMQDDNP,"SP46 (v-raf)",,,187,199,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",MAPEVIRMQDDNP,"SP46 (v-raf)",187,199,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,Results,"western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Similar results were obtained with un-purified sera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MAPEVIRMQDDNP,"SP46 (v-raf)",187,199,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465809,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/7180,"Linear peptide",CTLTTSPRLPVF,"SP63 (v-raf)",,,312,323,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CTLTTSPRLPVF,"SP63 (v-raf)",312,323,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,Results,"western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Similar results were obtained with un-purified sera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CTLTTSPRLPVF,"SP63 (v-raf)",312,323,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465811,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/31414,"Linear peptide",KIRPRGQRDSSY,"SP45 (v-raf)",,,4,15,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIRPRGQRDSSY,"SP45 (v-raf)",4,15,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Epitope peptide-affinity purified antibodies effectively immunoprecipitated P75gag-raf fusion protein from virus-transformed cells, but not endogenous Pr65gag.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Murine sarcoma virus 3611","Murine sarcoma virus 3611",,,,,,,,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465812,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/41103,"Linear peptide",MAPEVIRMQDDNP,"SP46 (v-raf)",,,187,199,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",MAPEVIRMQDDNP,"SP46 (v-raf)",187,199,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Epitope peptide-affinity purified antibodies effectively immunoprecipitated P75gag-raf fusion protein from virus-transformed cells, but not endogenous Pr65gag.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Murine sarcoma virus 3611","Murine sarcoma virus 3611",,,,,,,,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465815,http://www.iedb.org/reference/1007158,Literature,2994296,,"A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan",Virology,1985,"Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.",http://www.iedb.org/epitope/7180,"Linear peptide",CTLTTSPRLPVF,"SP63 (v-raf)",,,312,323,,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CTLTTSPRLPVF,"SP63 (v-raf)",312,323,,"Serine/threonine-protein kinase-transforming protein raf",http://www.ncbi.nlm.nih.gov/protein/P00532.1,"Serine/threonine-protein kinase-transforming protein mos",http://www.uniprot.org/uniprot/Q83372,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809,";Freund's complete;Freund's incomplete (IFA);",intradermal,"One dose of 1 mg of peptide-KLH conjugate administered i.d. followed by 4 boosts of 0.2 mg conjugate in IFA at 13 to 15 day intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Epitope peptide-affinity purified antibodies efficiently immunoprecipitated P75gag-raf fusion protein from virus-transformed cells, but not endogenous Pr65gag.","Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Murine sarcoma virus 3611","Murine sarcoma virus 3611",,,,,,,,"Murine sarcoma virus 3611",http://purl.obolibrary.org/obo/NCBITaxon_11812,"Moloney murine sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11809
http://www.iedb.org/assay/1465971,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Baboon endogenous virus strain M7 (Baboon endogenous virus (STRAIN M7))","Baboon endogenous virus strain M7",,,,,,,,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403
http://www.iedb.org/assay/1465974,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The reactivity was weak. Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Moloney murine leukemia virus (Moloney murine leukemia virus M-MuLV)","Moloney murine leukemia virus (Mo-MuLV)",,,,,,,,"Moloney murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11801,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1465975,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Reticuloendotheliosis virus (Avian reticuloendotheliosis virus)","reticuloendotheliosis virus, strain A (REV-A)",,,,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1465976,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline endogenous virus RD114","endogenous feline virus (RD-114)",,,,,,,,"Feline endogenous virus RD114",http://purl.obolibrary.org/obo/NCBITaxon_11767,"Feline endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_11765
http://www.iedb.org/assay/1465977,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Woolly monkey sarcoma virus (Simian sarcoma virus)","simian sarcoma virus (SSAV)",,,,,,,,"Woolly monkey sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11970,"Woolly monkey sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11970
http://www.iedb.org/assay/1465980,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The reactivity was weak. Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline leukemia virus (Feline leukemia provirus)","feline leukemia virus (FeLV)",,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1465981,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Mason-Pfizer monkey virus (Simian Mason-Pfizer type D retrovirus)","Msson-Pfrizer monkey virus (MPMV)",,,,,,,,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1465982,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Squirrel monkey retrovirus","squirrel monkey retrovirus (SMRV)",,,,,,,,"Squirrel monkey retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11856,"Squirrel monkey retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11856
http://www.iedb.org/assay/1465983,http://www.iedb.org/reference/1007156,Literature,3977884,,"T D Copeland; W P Tsai; S Oroszlan","Biochem Biophys Res Commun",1985,"Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins.",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",,,437,449,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,"The epitope is also presents in Moloney murine leukemia virus (Mo-MuLV) p15env.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,"SP-9 (BaEV p20)",437,449,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P10269.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P10269,"Baboon endogenous virus strain M7",http://purl.obolibrary.org/obo/NCBITaxon_11764,"Baboon endogenous virus",http://purl.obolibrary.org/obo/NCBITaxon_196403,";Freund's complete;Freund's incomplete (IFA);",,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibodies bound baboon endogenous virus (BaEV), Moloney murine leukemia virus (Mo-MuLV) and reticuloendotheliosis virus, strain A (REV-A), and crossreacted with endogenous feline virus (RD-114), simian sarcoma virus (SSAV), feline leukemia virus (FeLV), Msson-Pfrizer monkey virus (MPMV), squirrel monkey retrovirus (SMRV) and langur retrovirus (Po-l-Lu).",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Endogenous langur type D retrovirus PO-1-Lu","langur retrovirus (Po-l-Lu)",,,,,,,,"Endogenous langur type D retrovirus PO-1-Lu",http://purl.obolibrary.org/obo/NCBITaxon_240594,"Langur virus",http://purl.obolibrary.org/obo/NCBITaxon_363747
http://www.iedb.org/assay/1466518,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/32811,"Linear peptide",KPNRNGGGYYSASYS,"gp46 (91-105)",,,91,105,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,38,41.8,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O",89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466519,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/47853,"Linear peptide",PHSNLDH,"gp46 (192-198)",,,192,198,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,71,73.2,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466524,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/58883,"Linear peptide",SKLLTL,"gp46 (207-212)",,,208,213,,,"Envelope GLYCOPROTEIN(GP21, GP46) [Human T-cell leukemia virus type I]",http://www.ncbi.nlm.nih.gov/protein/Q9PY03,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,84,86.6,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T",190,212,,"Envelope GLYCOPROTEIN(GP21, GP46) [Human T-cell leukemia virus type I]",http://www.ncbi.nlm.nih.gov/protein/Q9PY03,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466525,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/9951,"Linear peptide",DRASLST,"gp46 (231-237)",,,230,236,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,79,81.4,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",YTCIVCIDRASLSTWHVLYSP,"Peptide C",223,243,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466526,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/48418,"Linear peptide",PLLYPS,"gp46 (255-260)",,,254,259,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,81,89,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V",239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466527,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/28133,"Linear peptide",IQAIVSSP,"gp46 (282-289)",,,281,288,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,54,55.7,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"Peptide B",273,295,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466528,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/22490,"Linear peptide",GSRSRRA,"gp46 (308-314)",,,307,313,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,76,78.4,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"Peptide X",291,313,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466529,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/36373,"Linear peptide",LHEVDKDI,"gp21 (348-355)",,,347,354,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,81,30,37,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,"Peptide AA",345,367,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466530,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/13830,"Linear peptide",EQGGLCKALQ,"gp21 (389-398)",,,388,397,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,57,58.8,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,"Peptide A",381,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466531,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/70858,"Linear peptide",VRYPHYSLIKPESSL,"gp21 (475-489)",,,474,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,65,71.4,"The minimal epitope was deduced by correlating the relative reactivities of individual and adjacent or overlapping peptide.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,"Peptide GG",466,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466534,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/41597,"Linear peptide",MGKFLATLILFFQFCPLILGDYSPSC,"gp46 (1-26)",,,1,26,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGKFLATLILFFQFCPLILGDYSPSC,"gp46 (1-26)",1,26,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466539,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/17755,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,"gp46 (154-176)",,,154,176,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,"gp46 (154-176)",154,176,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466540,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/37886,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"gp46 (163-185)",,,163,185,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"gp46 (163-185)",163,185,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466541,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/75415,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"gp46 (258-280)",,,257,279,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"gp46 (258-280)",257,279,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466542,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/62567,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"gp46 (35-57)",,,35,57,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"gp46 (35-57)",35,57,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466543,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"gp46 (53-75)",,,53,75,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"gp46 (53-75)",53,75,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466544,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/71235,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"gp46 (71-94)",,,71,94,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"gp46 (71-94)",71,94,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466545,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/62700,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"gp46 (103-125)",,,103,125,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"gp46 (103-125)",103,125,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466546,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/47047,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"gp46 (107-129)",,,107,129,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","HTLV- 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"gp46 (107-129)",107,129,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466547,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/18895,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,"gp46 (116-140)",,,116,140,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,"gp46 (116-140)",116,140,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466548,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/50995,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,"gp46 (136-158)",,,136,158,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,"gp46 (136-158)",136,158,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466549,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/48016,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"gp46 (172-194)",,,172,194,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"gp46 (172-194)",172,194,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466550,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/34858,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,"gp46 (261-283)",,,260,282,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,33,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,"gp46 (261-283)",260,282,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466551,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/34862,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,"gp46 (55-77)",,,55,77,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,"gp46 (55-77)",55,77,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466552,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/19192,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,"gp46 (20-40)",,,20,40,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,67,2,3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,"gp46 (20-40)",20,40,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466556,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/55950,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,"gp21 (310-332)",,,309,331,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,"gp21 (310-332)",309,331,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466558,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/18611,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,"gp21 (328-350)",,,327,349,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,"gp21 (328-350)",327,349,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466559,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/30178,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,"gp21 (353-375)",,,352,374,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,"gp21 (353-375)",352,374,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466560,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/69279,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,"gp21 (363-391)",,,362,384,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,11,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,"gp21 (363-391)",362,384,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466561,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/32506,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,"gp21 (363-385)",,,363,385,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,11,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,"gp21 (363-385)",363,385,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466562,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/37441,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,"gp21 (369-391)",,,368,390,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,"gp21 (369-391)",368,390,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466563,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/2838,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,"gp21 (396-418)",,,395,417,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,33,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,"gp21 (396-418)",395,417,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466564,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/6919,"Linear peptide",CRFPNITNSHVPILQERPPLENR,"gp21 (401-423)",,,400,422,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENR,"gp21 (401-423)",400,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466565,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/48309,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,"gp21 (419-441)",,,418,440,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,73,1,1.4,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,"gp21 (419-441)",418,440,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466566,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/72481,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,"gp21 (428-450)",,,427,449,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,"gp21 (428-450)",427,449,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466567,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/60591,"Linear peptide",SQWAREALQTGITLVALLLLVIL,"gp21 (437-459)",,,436,458,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,67,5,7.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SQWAREALQTGITLVALLLLVIL,"gp21 (437-459)",436,458,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466568,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/37899,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,"gp21 (455-477)",,,454,476,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,29,31.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,"gp21 (455-477)",454,476,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466569,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/26833,"Linear peptide",IKKPNRQGLGYYSPSYNDPCSL,"gp46 (85-106)",,,85,106,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,14,58.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IKKPNRQGLGYYSPSYNDPCSL,"gp46 (85-106)",85,106,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466572,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/29081,"Linear peptide",ITSEPTQPPPTSPPLVHDSDLEHV,"gp46 (172-195)",,,172,195,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,23,95.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ITSEPTQPPPTSPPLVHDSDLEHV,"gp46 (172-195)",172,195,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466573,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/48523,"Linear peptide",PLVHDSDLEHVLTPSTSWTTKILK,"gp46 (185-208)",,,185,208,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,23,95.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLVHDSDLEHVLTPSTSWTTKILK,"gp46 (185-208)",185,208,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466574,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/40381,"Linear peptide",LVHDSDLEHVLTPSTSWTTKI,"gp46 (186-206)",,,186,206,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,3,12.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LVHDSDLEHVLTPSTSWTTKI,"gp46 (186-206)",186,206,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466575,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/75707,"Linear peptide",YSCMVCVDRSSLSSWHVLYTP,"gp46 (219-239)",,,219,239,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,2,8.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YSCMVCVDRSSLSSWHVLYTP,"gp46 (219-239)",219,239,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466576,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/45847,"Linear peptide",NSIILPPFSLAPVPPPATRRRRA,"gp46 (287-309)",,,287,309,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,1,4.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NSIILPPFSLAPVPPPATRRRRA,"gp46 (287-309)",287,309,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466578,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/69911,"Linear peptide",VLYTPNISIPEETSSRTILFPSLA,"gp46 (235-258)",,,,,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,24,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VLYTPNISIPEETSSRTILFPSLA,"gp46 (235-258)",,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466579,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/73134,"Linear peptide",WTHCYQPRLQAITTDNCNNSIIL,"gp46 (269-291)",,,269,291,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,24,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WTHCYQPRLQAITTDNCNNSIIL,"gp46 (269-291)",269,291,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466581,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/59270,"Linear peptide",SLLLEVDKDISHLTQAIVKNHQN,"gp21 (341-363)",,,341,363,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,24,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLLEVDKDISHLTQAIVKNHQN,"gp21 (341-363)",341,363,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466582,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/20803,"Linear peptide",GLDLLPWEQGGLCKAIQEQCCFLN,"gp21 (377-400)",,,,,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","Human T-lymphotropic virus 2",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twenty four HTLV-2 antibody-positive sera were obatained from intravenous drug abusers (IVDAs) who were concomitantly infected with HIV-1 (n=6) and from IVDAs who had a single HTLV-2 infection (n=18).","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,4,16.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLPWEQGGLCKAIQEQCCFLN,"gp21 (377-400)",,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466586,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/26833,"Linear peptide",IKKPNRQGLGYYSPSYNDPCSL,"gp46 (85-106)",,,85,106,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IKKPNRQGLGYYSPSYNDPCSL,"gp46 (85-106)",85,106,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466587,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/29081,"Linear peptide",ITSEPTQPPPTSPPLVHDSDLEHV,"gp46 (172-195)",,,172,195,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ITSEPTQPPPTSPPLVHDSDLEHV,"gp46 (172-195)",172,195,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466588,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/48523,"Linear peptide",PLVHDSDLEHVLTPSTSWTTKILK,"gp46 (185-208)",,,185,208,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLVHDSDLEHVLTPSTSWTTKILK,"gp46 (185-208)",185,208,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466589,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/40381,"Linear peptide",LVHDSDLEHVLTPSTSWTTKI,"gp46 (186-206)",,,186,206,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LVHDSDLEHVLTPSTSWTTKI,"gp46 (186-206)",186,206,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466590,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/45847,"Linear peptide",NSIILPPFSLAPVPPPATRRRRA,"gp46 (287-309)",,,287,309,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NSIILPPFSLAPVPPPATRRRRA,"gp46 (287-309)",287,309,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466591,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/69911,"Linear peptide",VLYTPNISIPEETSSRTILFPSLA,"gp46 (235-258)",,,,,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VLYTPNISIPEETSSRTILFPSLA,"gp46 (235-258)",,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466592,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/75707,"Linear peptide",YSCMVCVDRSSLSSWHVLYTP,"gp46 (219-239)",,,219,239,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,11,36.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YSCMVCVDRSSLSSWHVLYTP,"gp46 (219-239)",219,239,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466593,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/73134,"Linear peptide",WTHCYQPRLQAITTDNCNNSIIL,"gp46 (269-291)",,,269,291,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,3,10,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WTHCYQPRLQAITTDNCNNSIIL,"gp46 (269-291)",269,291,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466594,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/59270,"Linear peptide",SLLLEVDKDISHLTQAIVKNHQN,"gp21 (341-363)",,,341,363,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,1,3.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLLEVDKDISHLTQAIVKNHQN,"gp21 (341-363)",341,363,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466595,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/20803,"Linear peptide",GLDLLPWEQGGLCKAIQEQCCFLN,"gp21 (377-400)",,,,,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Text page 5757",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,6,20,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLPWEQGGLCKAIQEQCCFLN,"gp21 (377-400)",,,,"Envelope glycoprotein gp63",https://ontology.iedb.org/ontology/ONTIE_0002504,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1466943,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/48927,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",,,102,115,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",102,115,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the antibodies was previously described by T.D. Copeland, et al (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466944,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/48927,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",,,102,115,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",102,115,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the antibodies was previously described by T.D. Copeland, et al (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Figure 2 and Table II","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope peptide inhibited antisera binding to HTLV-1 proteins bound to plates. Similar results were obtained with immunoprecipitation of the epitope by antisera.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",102,115,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466945,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the antibodies was previously described by T.D. Copeland, et al (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466946,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"One dose of 1 mg of peptide-KLH conjugate administered in CFA followed by 0.1 mg conjugate in IFA at 2 week interval.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the antibodies was previously described by T.D. Copeland, et al (Biochem Biophys Res Commun. 1985 Jan 31;126(2):672-7. [PMID: 3977884]).","Figure 2 and Table II","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope peptide inhibited antisera binding to HTLV-1 proteins bound to plates. Similar results were obtained with immunoprecipitation of the epitope by antisera.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466947,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope peptide inhibited anti-p19 mAb binding to HTLV-1 proteins bound to plates.",,"Entire Antibody",Monoclonal,13B12,IgG1,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466949,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,"The epitope specific anti-p19 mAb binding to HTLV-1 proteins in RIA, IFA with acetone-fixed infected cells, and Western blot.",,"Entire Antibody",Monoclonal,13B12,IgG1,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466951,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",,,120,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 4 and Tables I, II","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,8,88.9,"Similar results were obtained with immunoprecipitation of the epitope by patient sera.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PYVEPTAPQVL,"SP-71 (HTLV-I p19)",120,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466970,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/48927,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",,,102,115,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 4 and Table I","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,2,22.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",102,115,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466971,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/48927,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",,,102,115,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table II",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,"SP-61 (HTLV-I p19)",102,115,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466972,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/21888,"Linear peptide",GQIFSRSASPIPR,"SP-82/SP-84 (HTLV-I p19)",,,2,14,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table I","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,2,22.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GQIFSRSASPIPR,"SP-82/SP-84 (HTLV-I p19)",2,14,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466973,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/21888,"Linear peptide",GQIFSRSASPIPR,"SP-82/SP-84 (HTLV-I p19)",,,2,14,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table II",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GQIFSRSASPIPR,"SP-82/SP-84 (HTLV-I p19)",2,14,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466974,http://www.iedb.org/reference/1007157,Literature,2419433,,"T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes","J Immunol",1986,"C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.",http://www.iedb.org/epitope/56995,"Linear peptide",SASPIPR,"SP-83 (HTLV-I p19)",,,8,14,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table I","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,2,22.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SASPIPR,"SP-83 (HTLV-I p19)",8,14,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1466976,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/30853,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",,,21,28,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466977,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/30853,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",,,21,28,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was weak.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466978,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/30853,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",,,21,28,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Antisera to this epitope did not react with BLV in either ELISA or Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466979,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/30853,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",,,21,28,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466980,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/30853,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",,,21,28,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KFSISIDQ,"BLV gp51 21-28",21,28,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466982,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/6834,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",,,39,48,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466983,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/6834,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",,,39,48,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Antisera to this epitope did not react with BLV in either ELISA or Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466985,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/6834,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",,,39,48,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466986,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/6834,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",,,39,48,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466987,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/6834,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",,,39,48,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CPRSPRYTLD,"BLV gp51 39-48I",39,48,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay. The response was weak.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466988,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/5994,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",,,72,81,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"This is an author-identified variant. This variant maps in blast search to this Genbank sequence of an envelope protein of bovine leukemia virus. Sequence positions differ from the paper.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",72,81,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera to this epitope reacted weakly with BLV in ELISA, but no reactivity was seen in Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466991,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/5994,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",,,72,81,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"This is an author-identified variant. This variant maps in blast search to this Genbank sequence of an envelope protein of bovine leukemia virus. Sequence positions differ from the paper.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",72,81,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay. The response was weak. Direct ELISA against BLV gp51 was also weakly positive.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466992,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/5994,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",,,72,81,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"This is an author-identified variant. This variant maps in blast search to this Genbank sequence of an envelope protein of bovine leukemia virus. Sequence positions differ from the paper.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",72,81,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, this immunization protocol was used with this epitope (unconjugated) mixed with gp51 peptides covering aa 78-92 (unconjugated) and aa 144-157 (conjugated to tetanus toxoid).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong. When unconjugated epitope was part of a cocktail of three epitopes used for immunization, the response to this epitope was weak.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",72,81,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466993,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/5994,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",,,72,81,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"This is an author-identified variant. This variant maps in blast search to this Genbank sequence of an envelope protein of bovine leukemia virus. Sequence positions differ from the paper.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",CAKSPRYTLD,"BLV gp51 39-48II",72,81,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466995,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers. No reactivity was seen in this assay with antisera to this epitope conjugated to either KLH or tetanus toxoid.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466996,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Antisera raised to this epitope conjugated to either KLH or tetanus toxoid did not react with BLV in either ELISA or Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466997,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay. No reactivity was seen in this assay with antisera to this epitope conjugated to either KLH or tetanus toxoid.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466998,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera against this epitope conjugated to KLH had a weak response. Antisera against the epitope conjugated to tetanus toxoid was not reactive.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1466999,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera against this epitope conjugated to KLH had a weak response. Antisera against the epitope conjugated to tetanus toxoid was not reactive.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467001,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/48878,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",,,59,69,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467002,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/48878,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",,,59,69,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Antisera to this epitope did not react with BLV in either ELISA or Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467003,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/48878,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",,,59,69,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467004,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/48878,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",,,59,69,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467005,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/48878,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",,,59,69,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was weak.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",PPPQGRRRFGA,"BLV gp51 59-69",59,69,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467007,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/13743,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",,,78,92,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",78,92,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate immunization, the epitope was cyclized prior to conjugation.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467008,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/13743,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",,,78,92,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",78,92,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate immunization, the epitope was cyclized prior to conjugation.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay. The response was moderate, whether cyclized or linear epitope was used for immunization. Antisera also were positive in direct ELISA against BLV gp51.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467009,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/13743,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",,,78,92,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",78,92,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate immunization, the epitope was cyclized prior to conjugation.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera to this epitope, whether linear or cyclized, reacted strongly with BLV in ELISA but did not react with BLV on Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467010,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/13743,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",,,78,92,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",78,92,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate immunization, the epitope was cyclized prior to conjugation to KLH. In addition, this immunization protocol was used with this epitope (uncyclized and unconjugated) mixed with gp51 peptides covering aa 39-48 (unconjugated) and aa 144-157 (conjugated to tetanus toxoid). The sequence of the aa 39-48 peptide (a BLV gp51 variant described by the authors) was CAKSPRYTLD.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response to this epitope was strong, either using this peptide, cyclized or uncyclized,  conjugated to KLH, or using it unconjugated but in a mixture with two other peptides.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",EPRCPYVGADHFDCP,"BLV gp51 78-92L",78,92,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467018,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47160,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",,,144,155,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was moderate.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467019,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47160,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",,,144,155,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467020,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47160,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",,,144,155,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467022,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47160,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",,,144,155,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera to this epitope reacted weakly to BLV in ELISA, but did not react to BLV on Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467023,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47160,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",,,144,155,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was minimal.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",PDPPQPDFPQLN,"BLV gp51 144-155",144,155,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467025,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47161,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",,,144,157,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",144,157,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay. Antisera generated using KLH-conjugated peptide gave a weak response, but no response was seen using antisera generated agains tetanus-toxoid conjugated peptide. Both antisera reacted with purified gp51 in ELISA.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467026,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47161,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",,,144,157,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",144,157,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera generated  to this epitope conjugated to either KLH or tetanus toxoid reacted with BLV in ELISA but did not react with BLV in Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467028,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47161,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",,,144,157,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",144,157,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid. In addition, this immunization protocol was used with tetanus toxoid-conjugated epitope mixed with unconjugated gp51 peptides covering aa 39-48  and aa 78-92. The sequence of the aa 39-48 peptide (a BLV gp51 variant described by the authors) was CAKSPRYTLD.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera generated using KLH-conjugated epitope had a moderate response to this epitope, whereas antisera using tetanus toxoid conjugated epitope reacted minimally. When the tetanus-toxoid conjugated epitope was used in a mixture with two other peptides, reactivity to the epitope remained minimal.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",144,157,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467029,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/47161,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",,,144,157,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDPPQPDFPQLNSD,"BLV gp51 144-157",144,157,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed. In a separate experiment, immunization was performed with this epitope conjugated to tetanus toxoid.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers. No inhibition was seen using antisera generated against this epitope conjugated to either KLH or tetanus toxoid.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467030,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467032,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467033,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Antisera to this epitope did not react with BLV in either ELISA or Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467034,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was weak.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467035,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 195-205",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467036,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Authors refer to this as a tridecapeptide and sequence shown is thirteen amino acids long. Sequence maps to aa 256-268.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467038,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Authors refer to this as a tridecapeptide and sequence shown is thirteen amino acids long. Sequence maps to aa 256-268.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was moderate.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467039,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Authors refer to this as a tridecapeptide and sequence shown is thirteen amino acids long. Sequence maps to aa 256-268.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467040,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Authors refer to this as a tridecapeptide and sequence shown is thirteen amino acids long. Sequence maps to aa 256-268.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera to this epitope reacted strongly with BLV in both ELISA and Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467041,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Authors refer to this as a tridecapeptide and sequence shown is thirteen amino acids long. Sequence maps to aa 256-268.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 255-268",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467042,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,"Antisera were evaluated for their ability to prevent syncytia formation (cell fusion) by bovine leukemia virus-infected cells in uninfected cell monolayers.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467043,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was strong.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467044,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Antisera were evaluated for their ability to neutralize the plaque-forming activity of vesicular stomatitis virus (VSV)-BLV pseudotypes on indicator cells as described in Zavada et al. (1978) Acta Virol 29:91 [PMID: 169045]. Because VSV is not the source species for the BLV gp51 antigen, this assay is classified as a binding assay.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467045,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Antisera to this epitope reacted weakly to BLV in ELISA, but did not react to BLV on Western blots.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467047,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,"6 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 260-268",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3-4 injections of 500 μg at 2-3 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Adjuvant was switched to incomplete Freund's for subsequent injections when a positive serological reaction was observed.","Table 1 and Figure 2A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was moderate.",Serum,"Entire Antibody",Polyclonal,"Anti-epitope rabbit sera",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467253,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env  191-214",,,191,214,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-cell lymphotrophic virus type 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,42,87.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env  191-214",191,214,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467260,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/59328,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"MTA-1 162-209",,,162,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-cell lymphotrophic virus type 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,48,100,"The epitopes within the peptide recognized by the serum antibodies in HTLV-1 infected individuals have been mapped to PPLLPH (a.a. 188-193) and IPWKSK (a.a. 204-209) (Lipka etal., 1992).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"MTA-1 162-209",162,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467262,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/59328,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"MTA-1 162-209",,,162,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian T-lymphotropic virus 1 (Simian T cell lymphotropic virus type 1)","Simian T-cell lymphotrophic virus type 1",,,,,,,,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monkeys were infected with STLV-1.","Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serologic cross-reactivity was found in 98% of monkeys tested.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"MTA-1 162-209",162,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467264,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env  191-214",,,191,214,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian T-lymphotropic virus 1 (Simian T cell lymphotropic virus type 1)","Simian T-cell lymphotrophic virus type 1",,,,,,,,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monkeys were infected with STLV-1.","Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,54,44,81.5,"Serologic cross-reactivity was found in 81% of monkeys tested.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env  191-214",191,214,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467265,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian T-lymphotropic virus 1 (Simian T cell lymphotropic virus type 1)","Simian T-cell lymphotrophic virus type 1",,,,,,,,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Monkeys were infected with STLV-1.","Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,54,29,53.7,"Serologic cross-reactivity was found in 54% of monkeys tested.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467266,http://www.iedb.org/reference/1006798,Literature,8395074,,"D L Rudolph; J Yee; T Palker; J E Coligan; R B Lal","Res Virol",1993,"Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-cell lymphotrophic virus type 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,47,97.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",242,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1467267,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure are referenced as a manuscript in preparation by H. Saikkou.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope was used in a competitive ELISA to inhibit the binding of mAb 14F10 to BLV virions.",,"Entire Antibody",Monoclonal,"mAb 14F10",IgG,,,Epitope,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",57,67,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467268,http://www.iedb.org/reference/1007164,Literature,2466371,,"D Portetelle; C Dandoy; A Burny; J Zavada; H Siakkou; H Gras-Masse; H Drobecq; A Tartar",Virology,1989,"Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.",http://www.iedb.org/epitope/76471,"Linear peptide",YWPPPQGRRRF,"BLV gp51 57-67",,,57,67,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure are referenced as a manuscript in preparation by H. Saikkou.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Denatured BLV virions were used in a competitive ELISA to inhibit the binding of epitope-specific mAb 14F10 to disrupted BLV virions. The denatured BLV virions were able to inhibit binding, but native BLV was not, suggesting that the epitope is inaccessible on native virions.",,"Entire Antibody",Monoclonal,"mAb 14F10",IgG,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467304,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/55707,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",,,64,73,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRRFGARAMV,"BLV gp51 64-73",64,73,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Disrupted bovine leukemia virions",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467305,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467368,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"BLV gp51 142-161",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467369,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"BLV gp51 177-192",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467370,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"BLV pp51 68-87",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467372,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"BLV gp51 119-132",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467373,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"BLV gp51 168-180",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467374,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,"BLV gp51 169-188",169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Disrupted bovine leukemia virions",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467375,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"BLV gp51 218-237",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467376,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",,,282,301,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"BLV gp51 249-268",282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467380,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/67318,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",,,74,83,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TYDCEPRCPY,"BLV pp51 74-83",74,83,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467381,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/6865,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",,,114,123,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPYVGADRFD,"BLV pp51 81-90",114,123,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467382,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/50183,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",,,115,124,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVGADRFDC,"BLV pp51 82-91",115,124,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467383,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/68617,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",,,117,136,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VGADRFDCPHWDNASQADQG,"BLV pp51 84-103",117,136,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467384,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"BLV pp51 98-117",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467385,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/57961,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",,,104,123,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQCHGIF,"BLV gp51 104-123",104,123,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1467386,http://www.iedb.org/reference/1006126,Literature,7688821,,"I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle","J Virol",1993,"Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.",http://www.iedb.org/epitope/65113,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",,,124,143,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TLTWEIWGYDPLITFSLHKI,"BLV gp51 124-143",124,143,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",intradermal,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was repeatedly injected into rabbits.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,,Polyclonal,,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468374,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",,,33,47,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope polyprotein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP1",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468375,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",,,33,47,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468379,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/73328,"Linear peptide",YAAQNRRGLDLLFWEQGGLC,"HTLV-1 peptide SP7",,,374,393,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGLC,"HTLV-1 peptide SP7",374,393,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGLC,"HTLV-1 peptide SP7",374,393,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468380,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/73328,"Linear peptide",YAAQNRRGLDLLFWEQGGLC,"HTLV-1 peptide SP7",,,374,393,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGLC,"HTLV-1 peptide SP7",374,393,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera bound purified recombinant HTVL-1 gp21 fragment (374-422).",Serum,,Polyclonal,Anti-peptide,,,,"Fragment of Source Antigen","Linear peptide",YAAQNRRGLDLLFWEQGGLCKALQEQCRFPNITNSHVPILQERPPLENR,"HTVL-1 gp21 fragment (374-422)",374,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468381,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 peptide SP8",,,400,415,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 peptide SP8",400,415,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 peptide SP8",400,415,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468382,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 peptide SP8",,,400,415,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 peptide SP8",400,415,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera bound purified recombinant HTVL-1 gp21 fragment (374-422).",Serum,,Polyclonal,Anti-peptide,,,,"Fragment of Source Antigen","Linear peptide",YAAQNRRGLDLLFWEQGGLCKALQEQCRFPNITNSHVPILQERPPLENR,"HTVL-1 gp21 fragment (374-422)",374,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468384,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 peptide SP10",,,462,480,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 peptide SP10",462,480,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Anti-peptide sera did not bind purified HTVL-1 gp63.",Serum,,Polyclonal,Anti-peptide,,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468385,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 peptide SP10",,,462,480,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 peptide SP10",462,480,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1 peptide SP10",462,480,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468387,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",,,129,149,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468388,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",,,129,149,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.","Table 2, Figure 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope polyprotein of HTLV-1. B.",Serum,,Polyclonal,"Anti-peptide SP4",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468389,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47925,"Linear peptide",PILQERPPLENR,"HTLV-1 peptide SP9",,,411,422,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PILQERPPLENR,"HTLV-1 peptide SP9",411,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",PILQERPPLENR,"HTLV-1 peptide SP9",411,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468390,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47925,"Linear peptide",PILQERPPLENR,"HTLV-1 peptide SP9",,,411,422,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PILQERPPLENR,"HTLV-1 peptide SP9",411,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera bound purified recombinant HTVL-1 gp21 fragment (374-422).",Serum,,Polyclonal,Anti-peptide,,,,"Fragment of Source Antigen","Linear peptide",YAAQNRRGLDLLFWEQGGLCKALQEQCRFPNITNSHVPILQERPPLENR,"HTVL-1 gp21 fragment (374-422)",374,422,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468391,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2, Figure 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope protein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP6",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468392,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468393,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/56614,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 peptide SP11",,,475,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 peptide SP11",475,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera bound purified HTVL-1 gp63.",Serum,,Polyclonal,Anti-peptide,,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468394,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/56614,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 peptide SP11",,,475,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 peptide SP11",475,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 peptide SP11",475,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468416,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its N- and C-termini, respectively, to facilitate conjugation to carrier protein and iodination.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its N- and C-termini, respectively, to facilitate conjugation to carrier protein and iodination.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468417,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope polyprotein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP4A",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468418,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",,,176,189,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its N- and C-termini, respectively, to facilitate conjugation to carrier protein and iodination.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its N- and C-termini, respectively, to facilitate conjugation to carrier protein and iodination.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468419,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",,,176,189,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope polyprotein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP3",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468420,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",,,269,280,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its C- and N-termini, respectively, to facilitate conjugation to carrier protein and iodination.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,,,,"Anti-peptide sera did not recognize envelope polyprotein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP5",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468421,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",,,269,280,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its C- and N-termini, respectively, to facilitate conjugation to carrier protein and iodination.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue and a tyrosine (Y) residue at its C- and N-termini, respectively, to facilitate conjugation to carrier protein and iodination.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468434,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized the epitope. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468435,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Table 2",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Anti-peptide sera recognized envelope protein of HTLV-1.",Serum,,Polyclonal,"Anti-peptide SP2",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468507,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38347,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"SP3/4A (176-209)",,,176,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"SP3/4A (176-209)",176,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA with a mixture of peptide-tetanus toxoid conjugate that included this peptide.","Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,2,0,0,"Incubation of the epitope with anti-peptide sera did not result in adsorption of neutralizing antibodies and no inhibition of HTLV-1-induced formation of syncytia.",Serum,,Polyclonal,Anti-peptide,,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"SP3/4A (176-209)",176,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468508,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/31663,"Linear peptide",KKPNRNGGG,"HTLV-1 peptide SP2 (90-98)",,,90,98,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA with a mixture of peptide-tetanus toxoid conjugate that included region 68-107. This region was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Figures 4, 6, 7","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,3,3,100,"Incubation of the epitope with anti-SP2 peptide sera resulted in adsorption of neutralizing antibodies and a reduction in inhibition of HTLV-1-induced formation of syncytia. This minimal epitope was determined by testing overlapping peptide derived from residues 86-107 (PHWTKKPNRNGGGYYSASYSDP) of HTLV-1 envelope polyprotein. Asparagine (N) residues at position 93 and 95 were found to be important for adsorption of all three anti-peptide sera.",Serum,,Polyclonal,"Anti-SP2 peptide",,,,Epitope,"Linear peptide",KKPNRNGGG,"HTLV-1 peptide SP2 (90-98)",90,98,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468512,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA with a mixture of peptide-tetanus toxoid conjugate that included this peptide. The peptide was synthesized to contain an additional cysteine (C) residue at its N-terminus to facilitate conjugation to carrier protein.","Figures 3, 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,2,2,100,"Peptide-specific antibodies, as determined in a competition assay, inhibited HTLV-1-induced formation of syncytia.",Serum,,Polyclonal,Anti-peptide,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468513,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38347,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"SP3/4A (176-209)",,,176,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,"SP3/4A (176-209)",176,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA with a mixture of peptide-tetanus toxoid conjugate that included this peptide.","Figure 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,2,0,0,"Peptide-specific antibodies, as determined in a competition assay, did not inhibit HTLV-1-induced formation of syncytia.",Serum,,Polyclonal,Anti-peptide,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1468521,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/72630,"Linear peptide",WIKKPNRQGLG,"HTLV-2 peptide SP-2.2/8/10 (84-94)",,,84,94,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PHWIKKPNRQGLGYYS,"Peptide DP90 (82-97)",82,97,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.","Figure 8","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Incubation of the epitope with anti-DP90 peptide sera resulted in adsorption of neutralizing antibodies and a reduction in inhibition of HTLV-2-induced formation of syncytia. Residues Q95 and L97were found to be important for adsorption of anti-peptide sera.",Serum,,Polyclonal,"Anti-DP90 peptide",,,,Epitope,"Linear peptide",WIKKPNRQGLG,"HTLV-2 peptide SP-2.2/8/10 (84-94)",84,94,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1468646,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1 Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized the whole bovine leukemia virus. Rabbit anti-epitope sera inhibited the binding of epitope-specific mAb to bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468647,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468648,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized gp51of bovine leukemia virus.","Purified Immunoglobulin",,Monoclonal,E,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468653,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Table 1, Text page 51","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope competed with gp51of bovine leukemia virus and whole virus for binding to the epitope-specific mAb.","Purified Immunoglobulin",,Monoclonal,"E, D, D', A",,,,Epitope,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",142,161,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468654,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/31383,"Linear peptide",KIPDPPQPDFPQLNSDWVPS,"Peptide MCF4",,,142,161,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 3","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-epitope sera inhibited the binding of epitope-specific mAb to bovine leukemia virus.","Purified Immunoglobulin",,Monoclonal,E,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468676,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 2 Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized of bovine leukemia virus. Rabbit anti-epitope sera inhibited the binding of epitope-specific mAb to bovine leukemia virus.","Purified Immunoglobulin",,Monoclonal,"D, D'",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468677,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1 Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized the whole bovine leukemia virus. Rabbit anti-epitope sera inhibited the binding of epitope-specific mAb to bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468678,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope competed with bovine leukemia virus for binding to the epitope-specific mAb.","Purified Immunoglobulin",,Monoclonal,"D, D', A",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468681,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,"Peptide MCF6",251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope polyprotein","envelope polyprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468702,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",,,282,301,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",282,301,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468703,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",,,282,301,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized bovine leukemia virus.","Purified Immunoglobulin",,Monoclonal,A,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468706,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",,,282,301,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope competed with bovine leukemia virus for binding to the epitope-specific mAb.","Purified Immunoglobulin",,Monoclonal,A,,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",282,301,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468707,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",,,282,301,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,"Peptide MCF7",282,301,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized the whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468726,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized gp51 of bovine leukemia virus.","Purified Immunoglobulin",,Monoclonal,B',,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468727,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized subcutaneously and intraperitoneally with whole bovine leukemia virus (BLV) or gp51 of BLV. The first booster dose in NaCl was given 2 weeks later in the same route, while the second booster was given i.p. and intravenously 2 months later. Splenocytes were obtained 4 days after the final injection and used for fusing with myeloma cells.","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope competed with gp51 of bovine leukemia virus for binding to the epitope-specific mAb.","Purified Immunoglobulin",,Monoclonal,B',,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468728,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468729,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,"BLV gp51 (195-205)",195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468731,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/15315,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"Peptide MCF1",,,71,90,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"Peptide MCF1",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein","envelope glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468733,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/15315,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"Peptide MCF1",,,71,90,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FCAKSPRYTLDSVNGYPKIY,"Peptide MCF1",71,90,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABL86339.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468734,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"Peptide MCF3",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"Peptide MCF3",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468735,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/60362,"Linear peptide",SQADQGSFYVNHQILFLHLK,"Peptide MCF3",,,98,117,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQADQGSFYVNHQILFLHLK,"Peptide MCF3",98,117,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468736,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 (256-268)",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 (256-268)",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468737,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 (256-268)",,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,"BLV gp51 (256-268)",256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468738,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"Peptide MCF2",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"Peptide MCF2",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468739,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/18750,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"Peptide MCF2",,,68,87,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GARAMVTYDCEPRCPYVGAD,"Peptide MCF2",68,87,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468740,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"Peptide GX1",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"Peptide GX1",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468741,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/6385,"Linear peptide",CHGIFTLTWEIWGY,"Peptide GX1",,,119,132,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CHGIFTLTWEIWGY,"Peptide GX1",119,132,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468742,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"Peptide GX2",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"Peptide GX2",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468743,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,"Peptide GX2",,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,"Peptide GX2",168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-eptiope sera recognized whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468744,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 (260-268)",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 (260-268)",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize whole bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine leukemia virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1468745,http://www.iedb.org/reference/1007190,Literature,1718088,,"I Callebaut; A Burny; V Krchnák; H Gras-Masse; B Wathelet; D Portetelle",Virology,1991,"Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,"BLV gp51 (260-268)",,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,"BLV gp51 (260-268)",260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 1mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first two injections were in CFA, while the last one was in IFA. Sera were collected 8-12 days after the last injection.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The anti-eptiope sera did not recognize gp51 of bovine leukemia virus.",Serum,,Polyclonal,Anti-epitope,,,,"Source Antigen",Protein,"envelope glycoprotein gp51","envelope glycoprotein gp51",,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1469961,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",,,33,47,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 peptide SP1",33,47,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera recognized purified HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP1",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469962,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 peptide SP2 (86-107)",86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Anti-peptide sera did not recognize purified HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP2",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469963,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",,,176,189,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 peptide SP3",176,189,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera recognized purified HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP3",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469964,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",,,129,149,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 peptide SP4",129,149,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera recognized purified HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP4",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469965,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 peptide SP4A",190,209,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera recognized purified HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP4A",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469966,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",,,269,280,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 peptide SP5",269,280,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Anti-peptide sera did not recognize HTVL-1 envelope polyprotein.",Serum,,Polyclonal,"Anti-peptide SP5",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1469967,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Table 2, Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Anti-peptide sera recognized purified HTVL-1 gp46 and gp63.",Serum,,Polyclonal,"Anti-peptide SP6",,,,"Source Antigen",Protein,"Envelope glycoprotein gp62 precursor","Env polyprotein precursor",,,http://www.ncbi.nlm.nih.gov/protein/P03381.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1470019,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",,,296,312,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were primed with the immunogen in CFA and boosted with the immunogen in IFA on days 14, 21, 28, and 35.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the binding of anti-peptide sera to the epitope.",Serum,,Polyclonal,"Anti-peptide SP6",,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 peptide SP6",296,312,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1470321,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47860,"Linear peptide",PHWIKKPNRQGLGYYS,"HTLV-2 peptide DP90 (82-97)",,,82,97,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWIKKPNRQGLGYYS,"HTLV-2 peptide DP90 (82-97)",82,97,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.","Figure 8","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Incubation of the epitope with anti-DP90 peptide sera resulted in adsorption of neutralizing antibodies and a reduction in inhibition of HTLV-2-induced formation of syncytia. Residues Q95 and L97were found to be important for adsorption of anti-peptide sera.",Serum,,Polyclonal,"Anti-DP90 peptide",,,,Epitope,"Linear peptide",PHWIKKPNRQGLGYYS,"HTLV-2 peptide DP90 (82-97)",82,97,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1470523,http://www.iedb.org/reference/1007191,Literature,1326649,,"T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss","J Virol",1992,"Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.",http://www.iedb.org/epitope/47860,"Linear peptide",PHWIKKPNRQGLGYYS,"HTLV-2 peptide DP90 (82-97)",,,82,97,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWIKKPNRQGLGYYS,"HTLV-2 peptide DP90 (82-97)",82,97,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;Freund's incomplete (IFA);",intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Goat were immunized intramuscularly and subcutaneously in CFA (day 0) and IFA. The peptide was synthesized to contain an additional cysteine (C) residue at its C-terminus to facilitate conjugation to carrier protein.","Figure 8","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Incubation of peptide of HTLV-1 envelope polyprotein (WTKKPNRNGGG) with anti-DP90 peptide sera did not resulted in adsorption of neutralizing antibodies and no reduction in inhibition of HTLV-2-induced formation of syncytia.",Serum,,Polyclonal,"Anti-DP90 peptide",,,,"Taxonomic Sibling","Linear peptide",WTKKPNRNGGG,"HTLV-1 env polyprotein (88-98)",88,98,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1471865,http://www.iedb.org/reference/1006682,Literature,12693813,,"Milenen Hernández Marin; Yadaris Márquez Bocalandro; René Vázquez Vallejo; Chryslaine Rodríguez Tanty; David Higginson Clark; Lilliam Pozo Peña; Carlos Silva León","Prep Biochem Biotechnol",2003,"Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection.",http://www.iedb.org/epitope/48920,"Linear peptide",PPSPEAHVPPPYVEPTTTQ,M1,,,116,134,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus I or II",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,8,28.6,"The peptide did not react with HTLV-II-positive samples, but reacted with 2/6 HTLV-I positive sera and 1/2 HTLV-I/II positive sera. Furthermore, the peptide reacted with 4/7 sera from seropositive Cuban people to HTLV-I and a seropositive sample from Chile. Anti-HTLV-I/II panelPRP-205 (M) (Boston Biomedica Inc) was used.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPSPEAHVPPPYVEPTTTQ,M1,116,134,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1471866,http://www.iedb.org/reference/1006682,Literature,12693813,,"Milenen Hernández Marin; Yadaris Márquez Bocalandro; René Vázquez Vallejo; Chryslaine Rodríguez Tanty; David Higginson Clark; Lilliam Pozo Peña; Carlos Silva León","Prep Biochem Biotechnol",2003,"Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection.",http://www.iedb.org/epitope/51889,"Linear peptide",QPPPTSPPLVHDSDLEHVLTPST,M2,,,178,200,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus I or II",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,9,32.1,"The peptide reacted with 4/9 HTLV-II positive sera, 2/2 HTLV-I/II positive sera, but did not react with HTLV-I positive sera. Also, this peptide reacted with 3/7 sera from seropositive Cuban people to HTLV-I but did not react with a seropositive sample from Chile.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QPPPTSPPLVHDSDLEHVLTPST,M2,178,200,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1471882,http://www.iedb.org/reference/1006585,Literature,11708767,,"M Hernández Marin; P Castellanos Pentón; Y Márquez Bocalandro; L Pozo Peña; J Díaz Navarro; L J González López","Biochem Biophys Res Commun",2001,"Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.",http://www.iedb.org/epitope/73329,"Linear peptide",YAAQNRRGLDLLFWEQGGLCKALQEQC,P7,,,374,400,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-cell lymphotrophic virus type 1 or 2",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,37,13,35.1,"The peptide was utilized to detect 4/8 HTLV-I-positive sera, one HTLV-II-positive serum andtwo HTLV-I/II-positive sera. Furthermore, the peptide detected 4/5 HTLV-I-positive sera from Cuban individuals, and 2/9 HTLV-I-positive samples from Colombia and Chile.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGLCKALQEQC,P7,374,400,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1471883,http://www.iedb.org/reference/1006585,Literature,11708767,,"M Hernández Marin; P Castellanos Pentón; Y Márquez Bocalandro; L Pozo Peña; J Díaz Navarro; L J González López","Biochem Biophys Res Commun",2001,"Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.",http://www.iedb.org/epitope/37659,"Linear peptide",LLPHSNLDHILEPSIPWK,P8,,,190,207,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-cell lymphotrophic virus type 1 or 2",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,37,15,40.5,"The peptide was utilized to detect 5/8 HTLV-I-positive sera and one HTLV-I/II-positive sera. Furthermore, the peptide detected 5/5 HTLV-I-positive sera from Cuban individuals, and 4/9 HTLV-I-positive samples from Colombia and Chile.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWK,P8,190,207,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1473796,http://www.iedb.org/reference/1006748,Literature,16603536,,"Mirdad Kazanji; Jean-Michel Heraud; Fabrice Merien; Claudine Pique; Guy de Thé; Antoine Gessain; Steven Jacobson","J Gen Virol",2006,"Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",,,175,218,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Saimiri sciureus (South American squirrel monkey)",http://purl.obolibrary.org/obo/NCBITaxon_9521,,,M,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",175,218,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was composed of the epitope linked by a four residue turn (GPSL) to the carrier peptide. The first two doses were given at 4 weeks intervals. The third and fourth doses were given at weeks 9 and 16. Sera were collected every  2-3 weeks throughout the study. The carrier was composed of a peptide of measles virus fusion protein. ","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"The antigen was composed of the epitope linked by a four residue turn (GPSL) to the carrier peptide. Similar response was also observed with the assay antigen being the epitope without carrier peptide. The carrier was composed of a peptide of measles virus fusion protein. ",Serum,,Polyclonal,,,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",175,218,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1473810,http://www.iedb.org/reference/1006748,Literature,16603536,,"Mirdad Kazanji; Jean-Michel Heraud; Fabrice Merien; Claudine Pique; Guy de Thé; Antoine Gessain; Steven Jacobson","J Gen Virol",2006,"Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",,,175,218,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Saimiri sciureus (South American squirrel monkey)",http://purl.obolibrary.org/obo/NCBITaxon_9521,,,M,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",175,218,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was composed of the epitope linked by a four residue turn (GPSL) to the carrier peptide. The first two doses were given at 4 weeks intervals. The third and fourth doses were given at weeks 9 and 16. Sera were collected every  2-3 weeks throughout the study. The carrier was composed of a peptide of measles virus fusion protein. ","Figure 1","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,2,2,100,"The anti-epitope sera recognized env polyprotein on the surface of HTLV-1-immortalized cells.",Serum,,Polyclonal,"Anti-gp46 (175-218)",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1473834,http://www.iedb.org/reference/1006748,Literature,16603536,,"Mirdad Kazanji; Jean-Michel Heraud; Fabrice Merien; Claudine Pique; Guy de Thé; Antoine Gessain; Steven Jacobson","J Gen Virol",2006,"Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",,,175,218,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Saimiri sciureus (South American squirrel monkey)",http://purl.obolibrary.org/obo/NCBITaxon_9521,,,M,,,"Administration in vivo to prevent or reduce disease",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV-1 gp46 residues 175-218",175,218,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was composed of the epitope linked by a four residue turn (GPSL) to the carrier peptide. The first two doses were given at 4 weeks intervals. The third and fourth doses were given at weeks 9 and 16. Immunized monkeys were challenged 15 days after the last boost with an intravenous injection of cells from a squirrel monkey HTLV-1-transformed cell line. The carrier was composed of a peptide of measles virus fusion protein. ","Figure 3","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Positive,,,2,2,100,"Five months after the challenge, immunized monkeys had not undergone seroconversion against HTLV-1 antigen.",,,,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1477029,http://www.iedb.org/reference/1006141,Literature,2677406,,"Y M Chen; T H Lee; K P Samuel; A Okayama; N Tachibana; I Miyoshi; T S Papas; M Essex","J Virol",1989,"Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.",http://www.iedb.org/epitope/7612,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,"HTLV-1 gp61 aa 166-201",,,166,201,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope appears in the cited reference Seiki et al. (1983) Proc Natl Acad Sci USA 80:3618 [PMID: 6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients had HTLV-1 positive sera by particle agglutination and immunofluorescence tests.","Table 2 and Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,44,,"Recombinant HTLV-1 env protein consisting of the epitope fused at the amino terminus to a portion of the amino terminus of the Harvey murine sarcoma virus p21 (v-has, also known as v-rasH) was detected by sera from HTLV-1 positive, but otherwise healthy, patients. Sera from 53 of 77 patients with adult T-cell leukemia were also positive.",Serum,"Entire Antibody",Polyclonal,"Patient sera",,,,Epitope,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,"Recombinant protein",166,201,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479525,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/48720,"Linear peptide",PNVSVPSSSSTPLLY,Env-5-1,,,243,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,18,18,100,"Deletion of the C-terminal tyrosine significantly reduced the reactivity of patient's sera, whereas deletion of C-terminal leucine and tyrosine residues completely abolished the bindingof human antibodies, indicating that the C-terminal residues are critical in forming the epitopedetected by antibodies.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PNVSVPSSSSTPLLY,,243,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479531,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,Env-5,,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"Three monthly injections",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The antibodies were affinity purified with the epitope. No reactivity was observed against HTLV-I or II.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479547,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,Env-5,,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"Three monthly injections",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The antibodies were affinity purified with the epitope. No reactivity was observed against HTLV-I or II. The authors also report that rabbit antibodies to the epitope did not inhibit syncytium formation.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479558,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,Env-5,,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"Three monthly injections",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The antibodies were affinity purified with HTLV-I. Reactivity was also observed against HTLV-I and II.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479559,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,Env-5,,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"Three monthly injections",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Negative,,,,,,"The antibodies were affinity purified with the epitope. Reactivity was shown against the MT-2 (HTLV-I-infected) cell line, but not with Mo-T (HTLV-II-infected) cells. The authors also report that rabbit antibodies to the epitope did not inhibit syncytium formation.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479570,http://www.iedb.org/reference/1009953,Literature,1716657,,"R B Lal; D L Rudolph; T J Palker; J E Coligan; T M Folks","J Gen Virol",1991,"A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,Env-5,,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intramuscular,"Three monthly injections",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The antibodies were affinity purified with the epitope. Reactivity was shown against both the precursor envelope protein (gp68) and the processed external glycoprotein (gp46).","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1479651,http://www.iedb.org/reference/1009547,Literature,8911007,,"H Kabeya; K Ohashi; K Ohishi; C Sugimoto; H Amanuma; M Onuma",Vaccine,1996,"An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"Env 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,M,"4-5 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"MAP construct",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intramuscular,"3 doses of peptides (0.5 milligrams of each), administered at 2 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Sheep were immunized with a multiple antigen peptide construct containing a branching lysine core linked to 8 copies of 3 different peptides, including epitope, Helper T-cell peptide, and cytotoxic T-cell peptide (gp51 121-140, GIFTLTWEIWGYDPLITFSL).","Results (page 1119)",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,1,33.3,,Serum,"Entire Antibody",Polyclonal,"Sheep serum",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,,177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1479652,http://www.iedb.org/reference/1009547,Literature,8911007,,"H Kabeya; K Ohashi; K Ohishi; C Sugimoto; H Amanuma; M Onuma",Vaccine,1996,"An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"Env 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,M,"4-5 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intramuscular,"3 doses of 0.5 milligrams of protein, administered at 2 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Freund's complete adjuvant was used for the first and second immunization, and incomplete Freund's adjuvant was used for the last immunization.","Results (page 1119)",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,"Sheep serum",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,,177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1479653,http://www.iedb.org/reference/1009547,Literature,8911007,,"H Kabeya; K Ohashi; K Ohishi; C Sugimoto; H Amanuma; M Onuma",Vaccine,1996,"An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"Env 177-192",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,M,"4-5 months",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"MAP construct",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intramuscular,"3 doses of peptides (0.5 milligrams of each), administered at 2 week intervals.",,,,,,,,,,,,,,,,,,,,,,,N,,"Sheep were immunized with a multiple antigen peptide construct containing a branching lysine core linked to 8 copies of 3 different peptides, including epitope, Helper T-cell peptide, and cytotoxic T-cell peptide (gp51 121-140, GIFTLTWEIWGYDPLITFSL).","Results (page 1119)",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,1,33.3,,Serum,"Entire Antibody",Polyclonal,"Sheep serum",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","BLV Virions",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1480055,http://www.iedb.org/reference/1008790,Literature,6203125,,"J H Nunberg; G Rodgers; J H Gilbert; R M Snead","Proc Natl Acad Sci U S A",1984,"Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70.",http://www.iedb.org/epitope/41608,"Linear peptide",MGPNLVLPDQKPPS,"GA-FeLV-B gp70 (213-226)",,,246,259,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Protein,"gp70 protein","gp85 complex",,,http://www.ncbi.nlm.nih.gov/protein/NP_955581.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with gp85 complex composed of cross-linked gp70 and p15E from FL-74 FeLV.","Figures 2, 3 and text p. 3678","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope of mAb cl.25 was determined by screening a phage library of short random segments of the FeLV-B [Gardner-Arnstein (GA) isolate] envelope gene. The synthetic epitope inhibited the binding of mAb cl.25 to gp70 in an ELISA and prevented mAb cl.25-mediated virus neutralization.","Purified Immunoglobulin","Entire Antibody",Monoclonal,cl.25,IgG,,,Epitope,"Linear peptide",MGPNLVLPDQKPPS,"GA-FeLV-B gp70 (213-226)",246,259,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1480056,http://www.iedb.org/reference/1008790,Literature,6203125,,"J H Nunberg; G Rodgers; J H Gilbert; R M Snead","Proc Natl Acad Sci U S A",1984,"Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70.",http://www.iedb.org/epitope/41608,"Linear peptide",MGPNLVLPDQKPPS,"GA-FeLV-B gp70 (213-226)",,,246,259,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Protein,"gp70 protein","gp85 complex",,,http://www.ncbi.nlm.nih.gov/protein/NP_955581.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with gp85 complex composed of cross-linked gp70 and p15E from FL-74 FeLV.","Text P. 3678",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mAb cl.25 bound to gp70 in an ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,cl.25,IgG,,,"Source Antigen",Protein,"unnamed protein product",gp70,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1480070,http://www.iedb.org/reference/1008790,Literature,6203125,,"J H Nunberg; G Rodgers; J H Gilbert; R M Snead","Proc Natl Acad Sci U S A",1984,"Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70.",http://www.iedb.org/epitope/41608,"Linear peptide",MGPNLVLPDQKPPS,"GA-FeLV-B gp70 (213-226)",,,246,259,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Protein,"gp70 protein","gp85 complex",,,http://www.ncbi.nlm.nih.gov/protein/NP_955581.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with gp85 complex composed of cross-linked gp70 and p15E from FL-74 FeLV.","Text p. 3676","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb cl.25 neutralized most FeLV isolates tested, of all FeLV subgroups. Viruses neutralized include CT600 FeLV-A, CF-927 FeLV-A, GA-FeLV-B, Synder-Theilen FeLV-B,  and CF-927 FeLV-C.  CF-927 FeLV-B was not neutralized.","Purified Immunoglobulin","Entire Antibody",Monoclonal,cl.25,IgG,,,"Source Organism",Organism,"Gardner-Arnstein feline leukemia oncovirus B",GA-FeLV-B,,,,,,,,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1480417,http://www.iedb.org/reference/1012047,Literature,2999520,,"J Blomberg; G Fölsch; I Nilsson; R Fäldt","Leuk Res",1985,"Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors.",http://www.iedb.org/epitope/65423,"Linear peptide",TNSHVPILQERPPLE,"env 406-420",,,406,420,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Japan,http://purl.obolibrary.org/obo/GAZ_00002747,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with adult T-cell leukemia were used.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,21,7,33.3,"Sera from 3 American cases of ATL did not bind to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TNSHVPILQERPPLE,,406,420,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480420,http://www.iedb.org/reference/1012047,Literature,2999520,,"J Blomberg; G Fölsch; I Nilsson; R Fäldt","Leuk Res",1985,"Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors.",http://www.iedb.org/epitope/65423,"Linear peptide",TNSHVPILQERPPLE,"env 406-420",,,406,420,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","rheumatoid arthritis",http://purl.obolibrary.org/obo/DOID_7148,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,26,17,65.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TNSHVPILQERPPLE,,406,420,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480421,http://www.iedb.org/reference/1012047,Literature,2999520,,"J Blomberg; G Fölsch; I Nilsson; R Fäldt","Leuk Res",1985,"Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors.",http://www.iedb.org/epitope/65423,"Linear peptide",TNSHVPILQERPPLE,"env 406-420",,,406,420,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera from multitransfused patients suffering from a variety of nonleukemic disorders were tested.","Figure 3, Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,7,53.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TNSHVPILQERPPLE,,406,420,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (isolate MT-2)",http://purl.obolibrary.org/obo/NCBITaxon_11928,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480510,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/42829,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTK,GH2-K15,,,157,205,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-2 infection by PCR.","Table 2, Figure 2, 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,22,21,95.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTK,,157,205,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480512,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/42829,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTK,GH2-K15,,,157,205,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-1 infection by PCR.","Table 2, Figure 2, 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,10,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTK,,157,205,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480516,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/60186,"Linear peptide",SPPLVHDSDLEHVLTPS,GH2-K34,,,183,199,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-2 infection by PCR.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,6,2,33.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPPLVHDSDLEHVLTPS,,183,199,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480517,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/60186,"Linear peptide",SPPLVHDSDLEHVLTPS,GH2-K34,,,183,199,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-1 infection by PCR.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPPLVHDSDLEHVLTPS,,183,199,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480521,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/42828,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTS,GH2-K16,,,157,183,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-2 infection by PCR.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,6,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTS,,157,183,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480522,http://www.iedb.org/reference/1008250,Literature,1375112,,"K G Hadlock; J J Lipka; T P Chow; S K Foung; G R Reyes",Blood,1992,"Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.",http://www.iedb.org/epitope/42828,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTS,GH2-K16,,,157,183,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera was used from patients that were seropositive and also typed for HTLV-1 infection by PCR.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MTLLVDAPGYDPLWFITSEPTQPPPTS,,157,183,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480594,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"Tax-8 106-125",,,105,124,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,138,66,47.8,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,105,124,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480598,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"Tax-8 106-125",,,105,124,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used.","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive-Low,,,,,,"Preincubation of patient serum samples with the epitope resulted in marginal inhibition in antibody reactivity to the tax protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,105,124,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480602,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"Tax-22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,138,50,36.2,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480605,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"Tax-23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,138,66,47.8,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480616,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"Tax-22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used.","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Preincubation of patient serum samples with the epitope resulted in  inhibition of antibody reactivity to the tax protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480617,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"Tax-24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,138,66,47.8,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480644,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/17535,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,"Tax8II 106-125",,,106,125,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-II were used.","Text p 178",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,,106,125,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480645,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/17535,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,"Tax8II 106-125",,,106,125,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used.","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Preincubation of patient serum samples with the epitope resulted in no inhibition of antibody reactivity to the tax protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,,106,125,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480647,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/76132,"Linear peptide",YTNIPVSILFNKEEADDNGD,"Tax22II 312-331",,,312,331,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used.","Figure 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Preincubation of patient serum samples with the epitope resulted in no inhibition of antibody reactivity to the tax protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YTNIPVSILFNKEEADDNGD,,312,331,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480648,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/76132,"Linear peptide",YTNIPVSILFNKEEADDNGD,"Tax22II 312-331",,,312,331,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-II were used.","Text p 178",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTNIPVSILFNKEEADDNGD,,312,331,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480776,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,SP5,,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 3, 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to compete for binding of the mAb to solid-phase gp46 or to the epitope. The mAb also reacted with the epitope by ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,B53-5,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480805,http://www.iedb.org/reference/1006786,Literature,8645089,,"N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi","Arch Virol",1996,"Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.",http://www.iedb.org/epitope/35937,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",,,80,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",subcutaneous,"[4] doses of [500ug-1mg], administered at intervals of [2] weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first immunization used a 1 mg dose and subsequent ones 500 ug.","Figure 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,3,3,100,"Antibodies raised against the epitope neutralized vesicular stomatitis virus (VSV) pseudotypes carrying HTLV II envelope antigens (including the source antigen).",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Envelope glycoprotein gp63 precursor","HTLV II envelope antigens/VSV pseudotype",,,http://www.ncbi.nlm.nih.gov/protein/P03383.1,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480806,http://www.iedb.org/reference/1006786,Literature,8645089,,"N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi","Arch Virol",1996,"Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.",http://www.iedb.org/epitope/35937,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",,,80,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",subcutaneous,"[4] doses of [500ug-1mg], administered at intervals of [2] weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first immunization used a 1 mg dose and subsequent ones 500 ug.","Text p. 474","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,3,3,100,"Antibodies raised against the epitope neutralized HTLV II by a syncitium inhibition assay.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","HTLV II",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480807,http://www.iedb.org/reference/1006786,Literature,8645089,,"N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi","Arch Virol",1996,"Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.",http://www.iedb.org/epitope/35937,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",,,80,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",subcutaneous,"[4] doses of [500ug-1mg], administered at intervals of [2] weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first immunization used a 1 mg dose and subsequent ones 500 ug.","Text p. 474","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"ELISA showed an increased titre in anti-epitope antibodies in sera from immunized animals.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480808,http://www.iedb.org/reference/1006786,Literature,8645089,,"N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi","Arch Virol",1996,"Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.",http://www.iedb.org/epitope/35937,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",,,80,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",subcutaneous,"[4] doses of [500ug-1mg], administered at intervals of [2] weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first immunization used a 1 mg dose and subsequent ones 500 ug.","Figures 2 and 3","in vivo assay","survival from pathogen challenge",,http://purl.obolibrary.org/obo/OBI_0003468,Positive,,,,,,"Epitope-immunized rabbits that were challenged with HTLV II-infected MOT cells showed lower titers of anti-HTLV II antibodies by particle agglutination test; non-immunized rabbits showed higher titers of anti-HTLV II antibodies. PCR of HTLV II sequences also indicated that virus was present in the non-immunized but not in the immunized animals.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)","HTLV II",,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480809,http://www.iedb.org/reference/1006786,Literature,8645089,,"N Kariya; K Hayashi; H Hoshino; Y Tanaka; T R Koirala; N Ohara; K Miyamoto; T Akagi","Arch Virol",1996,"Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.",http://www.iedb.org/epitope/35937,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",,,80,103,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LFPHWIKKPNRQGLGYYSPSYNDP,"HTLV II env gp46 80-103",80,103,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",subcutaneous,"[4] doses of [500ug-1mg], administered at intervals of [2] weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first immunization used a 1 mg dose and subsequent ones 500 ug.","Text p. 475","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Antibodies raised against the epitope did not react with HTLV II gp 46 by western blot.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Envelope glycoprotein gp63 precursor","HTLV II envelope gp46",,,http://www.ncbi.nlm.nih.gov/protein/P03383.1,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1480932,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Two cell lines were derived from the EBV transformation of peripheral B cells of a patient infected with HTLV-1.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibody(ies) bound the p21 band of HTLV-1.","Culture Supernatant","Entire Antibody",Monoclonal,"6E9, 5G4",IgG,,,"Source Organism",Organism,"Human T-cell lymphotrophic virus type 1 (strain ATK) (Human T-cell leukemia virus type I (strain ATK))",,,,,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480933,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Two cell lines were derived from the EBV transformation of peripheral B cells of a patient infected with HTLV-1.","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,,"Culture Supernatant","Entire Antibody",Monoclonal,"6E9, 5G4",IgG,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1480977,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,26,26,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481094,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,28,28,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481095,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,26,14,53.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481097,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,28,19,67.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481100,http://www.iedb.org/reference/1008202,Literature,7632947,,"K G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; J E Kaplan; R Khabbaz; S K Foung",Blood,1995,"Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.",http://www.iedb.org/epitope/59467,"Linear peptide",SLSPVPTLGSRSRRAVPVAV,1A1B,,,299,318,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3, Text p 1396","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,7,1,14.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLSPVPTLGSRSRRAVPVAV,,299,318,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481255,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"Tax-8 106-125",,,105,124,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,105,124,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481256,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"Tax-22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481257,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"Tax-23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481258,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"Tax-24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481259,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"Tax-8 106-125",,,105,124,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,105,124,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/AAF37566.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481260,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"Tax-22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481261,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"Tax-23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481262,http://www.iedb.org/reference/1006511,Literature,7496941,,"D L Rudolph; J E Coligan; R B Lal","Clin Diagn Lab Immunol",1994,"Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"Tax-24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals previously identified to be infected with HTLV-I were used, 26 had HAM or tropical spastic paraparesis, 46 had adult T-cell leukemia, and 66 were from asymptomatic blood donors.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,,,,"The highest reactivity was in the serum samples from individuals with HAM or tropical spastic paraparesis,  then in the samples from the asymptomatic blood donors and then the adult T-cell leukemia patients.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481643,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env-1 191-214",,,191,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form HTLV-I infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,,191,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481644,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form HTLV-I infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481645,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/68842,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"Env-2 187-209",,,187,210,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form HTLV-II infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,,187,210,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1481646,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/31664,"Linear peptide",KKPNRQGLGYYSPSYNDP,"Env-2 85-102",,,86,103,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form HTLV-II infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KKPNRQGLGYYSPSYNDP,,86,103,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1481647,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"Gag-1a 102-117",,,102,117,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined from HTLV infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481648,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/20199,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,"Gag-1 364-385",,,364,386,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This sequence is present in both HTLV 1 and HTLV 2.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined from HTLV infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples  from 95% of HTLV infected blood donors were positive for the epitope. Minimal reactivity was seen with serum samples identified as HTLV-indeterminate.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,,364,386,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481690,http://www.iedb.org/reference/1008103,Literature,11027594,,"M Hernández; M E Selles; L Pozo Peña; I Gómez; A Melchor","Biochem Biophys Res Commun",2000,"Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.",http://www.iedb.org/epitope/60282,"Linear peptide",SPTHDPPDSDPQIPPPYVEP,M1,,,105,124,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,24,100,"The highest level of response (24/24) was observed when the epitope was linked to peptide M2 (LLPHSNLDHILEPSIPWK), while a lower response (20/24) was observed when the the eptiope was linked to peptide M3 (LLSHSNLDHILEPSIPWK). When the epitope was tested alone, positive reaction was seen in 18/24 sera. Epitope orientation in the chimeric peptide appears to influence antigenicity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPTHDPPDSDPQIPPPYVEP,,105,124,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481692,http://www.iedb.org/reference/1008103,Literature,11027594,,"M Hernández; M E Selles; L Pozo Peña; I Gómez; A Melchor","Biochem Biophys Res Commun",2000,"Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.",http://www.iedb.org/epitope/37659,"Linear peptide",LLPHSNLDHILEPSIPWK,M2,,,190,207,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,24,100,"Reactivity was observed in 22 of 24 sera when the epitope was linked to peptide M1 (SPTHDPPDSDPQIPPPYVEP), while a lower response (12/24) was observed when the the eptiope was tested alone.The same level of reactivity was observed when variant P3S of the epitope was used. Epitope orientation in the chimeric peptide appears to influence antigenicity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWK,,190,207,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481693,http://www.iedb.org/reference/1008103,Literature,11027594,,"M Hernández; M E Selles; L Pozo Peña; I Gómez; A Melchor","Biochem Biophys Res Commun",2000,"Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.",http://www.iedb.org/epitope/60282,"Linear peptide",SPTHDPPDSDPQIPPPYVEP,M1,,,105,124,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,Other,Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,11,0,0,"The epitope was also tested alone and results were considered negative.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPTHDPPDSDPQIPPPYVEP,,105,124,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481695,http://www.iedb.org/reference/1008103,Literature,11027594,,"M Hernández; M E Selles; L Pozo Peña; I Gómez; A Melchor","Biochem Biophys Res Commun",2000,"Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.",http://www.iedb.org/epitope/37659,"Linear peptide",LLPHSNLDHILEPSIPWK,M2,,,190,207,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,Other,Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,11,0,0,"The epitope was also tested alone and results were considered negative.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWK,,190,207,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481733,http://www.iedb.org/reference/1006409,Literature,8586709,,"M Varma; D L Rudolph; M Knuchel; W M Switzer; K G Hadlock; M Velligan; L Chan; S K Foung; R B Lal","J Clin Microbiol",1995,"Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals were used that were PCR-positive for HTVL-1.","Table 1, 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,102,102,100,"Responses were seen with samples from the U.S., Peru, Ghana, and Japan, as well as Brazil, Jamaica, and Melanesia. Minimal response was seen with HTLV indeterminate samples.",Serum,"Entire Antibody",,,,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481735,http://www.iedb.org/reference/1006409,Literature,8586709,,"M Varma; D L Rudolph; M Knuchel; W M Switzer; K G Hadlock; M Velligan; L Chan; S K Foung; R B Lal","J Clin Microbiol",1995,"Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from individuals were used that were PCR-positive for HTVL-2.","Table 1, 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,107,107,100,"Responses were seen with samples form the U.S., Brazil, Panama, Tanzania and Ghana, as well as Mexcico, Seminole Indians, Guayami Indian, Wayuu Indian, and Italy. Minimal response was seen with HTLV indeterminate samples.",Serum,"Entire Antibody",,,,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481742,http://www.iedb.org/reference/1006409,Literature,8586709,,"M Varma; D L Rudolph; M Knuchel; W M Switzer; K G Hadlock; M Velligan; L Chan; S K Foung; R B Lal","J Clin Microbiol",1995,"Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Platyrrhini (New World monkey)",http://purl.obolibrary.org/obo/NCBITaxon_9479,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Simian T-lymphotropic virus 1 (Simian T cell lymphotropic virus type 1)",,,,,,,,,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from monkeys infected with simian t-lymphotropic virus were used.","Text p 3240","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,8,8,100,,Serum,"Entire Antibody",,,,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481815,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"gp46 86-107",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,50,8,16,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481913,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"gp46 86-107",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,27,12,44.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481914,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"gp46 86-107",,,86,107,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,10,2,20,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481918,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 175-199",,,175,199,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,27,27,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481919,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 175-199",,,175,199,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,10,6,60,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481921,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 175-199",,,175,199,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,50,47,94,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481929,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"gp46 239-261",,,239,261,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,27,24,88.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481930,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"gp46 239-261",,,239,261,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,10,7,70,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481932,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"gp46 239-261",,,239,261,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples reactive with HTLV-1 from patients from French Guiana, Martinique, Guadeloupe and Gabon were used.","Table 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,50,37,74,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481967,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/69908,"Linear peptide",VLYSPNVSVPSSSS,"gp46 239-252",,,239,252,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,44,68.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VLYSPNVSVPSSSS,,239,252,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481970,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/46489,"Linear peptide",NVSVPSSSSTPLLY,"gp46 244-P-257",,,244,257,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,41,64.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NVSVPSSSSTPLLY,,244,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481975,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/46488,"Linear peptide",NVSVPSPSSTPLLY,"gp46 244-S-257",,,244,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,43,67.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NVSVPSPSSTPLLY,,244,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481977,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/62290,"Linear peptide",SVPSSSSTPLLYPSLALPAP,"gp46 246-265",,,246,265,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,53,82.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVPSSSSTPLLYPSLALPAP,,246,265,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481978,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/61824,"Linear peptide",STPLLYPSLA,"gp46 252-261",,,252,261,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,60,93.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STPLLYPSLA,,252,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1481979,http://www.iedb.org/reference/1006238,Literature,8798979,,"D Londos-Gagliardi; R Dalibart; S Geoffre; P Dalbon; J F Pouliquen; M C Georges-Courbot; S Sainte-Foie; C Hajjar; A J Georges; J P Moreau; B Guillemain","AIDS Res Hum Retroviruses",1996,"Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.",http://www.iedb.org/epitope/61371,"Linear peptide",SSSTPLLYPSLALPA,"gp46 250-264",,,250,264,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from asymptomatic carriers or  HTLV-1 positive patients with neurological disorders, hematological disorders or sicca syndrome from French Guiana, Martinique, Guadeloupe and Gabon were used.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,64,26,40.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSSTPLLYPSLALPA,,250,264,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482008,http://www.iedb.org/reference/1006721,Literature,8697633,,"H Plotnicky-Gilquin; A Afani; J C Vernant; C Desgranges","Clin Exp Immunol",1996,"Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"peptide 2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 positive patients with TSP or asymptotic carriers were used.","Figure 4","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Negative,,,4,0,0,"Preincubation of the epitope with HTLV-1 infected sera was not able to inhibit complement-dependent  cytotoxicity of MT4 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482009,http://www.iedb.org/reference/1006721,Literature,8697633,,"H Plotnicky-Gilquin; A Afani; J C Vernant; C Desgranges","Clin Exp Immunol",1996,"Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"peptide 4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 positive patients with TSP or asymptotic carriers were used.","Figure 4","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Positive,,,2,1,50,"Preincubation of the epitope with HTLV-1 infected sera was able to inhibit complement-dependent  cytotoxicity of MT4 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482010,http://www.iedb.org/reference/1006721,Literature,8697633,,"H Plotnicky-Gilquin; A Afani; J C Vernant; C Desgranges","Clin Exp Immunol",1996,"Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"peptide 6",,,296,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 positive patients with TSP or asymptotic carriers were used.","Figure 4","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Positive-Low,,,4,1,25,"Preincubation of the epitope with HTLV-1 infected sera was able to slightly inhibit complement-dependent  cytotoxicity of MT4 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,,296,312,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482014,http://www.iedb.org/reference/1006721,Literature,8697633,,"H Plotnicky-Gilquin; A Afani; J C Vernant; C Desgranges","Clin Exp Immunol",1996,"Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"peptide 8",,,400,415,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 positive patients with TSP or asymptotic carriers were used.","Figure 4","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Negative,,,4,0,0,"Preincubation of the epitope with HTLV-1 infected sera was not able to inhibit complement-dependent  cytotoxicity of MT4 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,,400,415,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482200,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Rabbits immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figures 3, 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,12,12,100,"The epitope competes with gp46 of HTLV-1 (residues 165-136) for binding to anti-peptide sera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482202,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Rabbits immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figures 3, 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,12,12,100,"The epitope competed with recombinant envelope protein (residues 165-306) for binding to anti-peptide antibodies.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,ACH-RE3,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482203,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,"100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Mice immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figures 4, 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,9,6,66.7,"The epitope competes with gp46 of HTLV-1 (residues 165-136) for binding to anti-peptide sera.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482205,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,"100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Mice immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figures 4, 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,9,6,66.7,"The epitope competed with recombinant envelope protein (residues 165-306) for binding to anti-peptide antibodies.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,ACH-RE3,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482206,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were boosted boosted twice at 3-week intervals.","Table 2, Text page 1077","in vivo assay","survival from pathogen challenge",,http://purl.obolibrary.org/obo/OBI_0003468,Negative,,,,,,"Rabbits were challenged with HTLV-1-infected cells. Immunized rabbits were not protected from challenged as determined by PCR for presence of virus DNA and by reactivity to HTLV-1 p19 antigen in ELISA.",,,,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482207,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,"100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Mice immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Text page 1075",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,9,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482208,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Rabbits immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Table 1, Text, Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,10,83.3,"Recognition of whole virus in ELISA and of gp46 band in Western blots was detected in peptide-immunized rabbits.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482209,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Rabbits immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figure 7","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive-Low,,,12,12,100,"Anti-peptide antibodies inhibited HTLV-1-mediated cell fusion in syncytia inhibition assay.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482210,http://www.iedb.org/reference/1008106,Literature,11137241,,"M Frangione-Beebe; B Albrecht; N Dakappagari; R T Rose; C L Brooks; S P Schwendeman; M D Lairmore; P T Kaumaya",Vaccine,2000,"Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.",http://www.iedb.org/epitope/16791,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,"HTLV1 gp46 (175-218)",,,175,218,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,F,"8 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTL,,175,218,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,intramuscular,"100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with either the immunogen (peptide) alone, the immunogen and adjuvant or the immunogen encapsulated in biodegradable biosphere of poly(D,L-lactide-co-glycolide). Mice immunized with non-encapsulated immunogen were boosted at 3-week intervals.","Figure 7","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,9,9,100,"Anti-peptide antibodies inhibited HTLV-1-mediated cell fusion in syncytia inhibition assays.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482223,http://www.iedb.org/reference/1006721,Literature,8697633,,"H Plotnicky-Gilquin; A Afani; J C Vernant; C Desgranges","Clin Exp Immunol",1996,"Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"peptide 4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 positive patients with TSP or asymptotic carriers were used.","Figure 4","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Positive,,,2,2,100,"Preincubation of the epitope with HTLV-1 infected sera was able to inhibit complement-dependent  cytotoxicity of MT4 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482262,http://www.iedb.org/reference/1008103,Literature,11027594,,"M Hernández; M E Selles; L Pozo Peña; I Gómez; A Melchor","Biochem Biophys Res Commun",2000,"Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.",http://www.iedb.org/epitope/37794,"Linear peptide",LLSHSNLDHILEPSIPWK,M3,,,190,207,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,24,12,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLSHSNLDHILEPSIPWK,,190,207,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482274,http://www.iedb.org/reference/1008085,Literature,11508771,,"M Frangione-Beebe; R T Rose; P T Kaumaya; S P Schwendeman","J Microencapsul",2001,"Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.",http://www.iedb.org/epitope/16792,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQS,"gp46 (175-218)",,,175,220,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence was provided in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQS,,175,220,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;nor-MDP;,,"1 dose of 1 mg peptide",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized either with peptide encapsulated in biodegradable microspheres in  the presence or absence of adjuvant or with free peptide emulsified in adjuvant. The rabbits immunized with free peptide and adjuvant received a booster dose of 500 micrograms of peptide 10 weeks later.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"The presence of adjuvant did not have any significant effect on the antibody response. Rabbits immunized with the encapsulated peptide showed a slightly delayed response.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQS,,175,220,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482344,http://www.iedb.org/reference/1012100,Literature,3048703,,"H Siomi; H Shida; S H Nam; T Nosaka; M Maki; M Hatanaka",Cell,1988,"Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing.",http://www.iedb.org/epitope/66203,"Linear peptide",TSFPPPSPGPSCPT,"Rex (176-189)",,,176,189,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TSFPPPSPGPSCPT,,176,189,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's adjuvant;",,,,,,,,,,,,,,,,,,,,,,,,,N,,"The anti-peptide serum was generated by repeated injection with the peptide.","Figures 2, 3","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Antibody binding was also detected in Western blot.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"rex protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482352,http://www.iedb.org/reference/1010398,Literature,10516045,,"S Blanchard; T Astier-Gin; B Tallet; D Moynet; D Londos-Gagliardi; B Guillemain","J Virol",1999,"Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"Env (190-199)",,,190,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence was provided in Londos-Gagliardi et al (1990) AIDS Res Hum Retroviruses 15:90-920 [PMID: 10408728].",,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"5 doses of 50 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 3 booster doses were given in IFA on days 15, 36, and 57, while the last booster was given intravenously without adjuvant.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific mAb recognize envelope glycoprotein of HTLV-1.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF2,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482433,http://www.iedb.org/reference/1006296,Literature,11242520,,"B Tallet; T Astier-Gin; D Moynet; D Londos-Gagliardi; B Guillemain","AIDS Res Hum Retroviruses",2001,"Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.",http://www.iedb.org/epitope/77197,"Discontinuous peptide","K39, P265, H290",,,,,,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum from an asymptomatic HTLV-positive patient living in Gabon was used.","Figure 5","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,2,1,50,"Serum from one of two patients infected with HTLV was able to inhibit syncytium formation with wild type but not with mutant env protein containing the 3 point mutations of the epitope. Serum from another patient 2085 sees a different epitope.",Serum,"Entire Antibody",Polyclonal,2555,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482434,http://www.iedb.org/reference/1006296,Literature,11242520,,"B Tallet; T Astier-Gin; D Moynet; D Londos-Gagliardi; B Guillemain","AIDS Res Hum Retroviruses",2001,"Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.",http://www.iedb.org/epitope/77197,"Discontinuous peptide","K39, P265, H290",,,,,,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of autoimmune disease","Sjogren's syndrome",http://purl.obolibrary.org/obo/DOID_12894,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum from a sicca syndrome patient living in West Indies was used.","Figure 6","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Serum from a patient infected with HTLV was able to inhibit syncytium formation with wild type but not with mutant env protein containing the 3 point mutations of the epitope.",Serum,"Entire Antibody",Polyclonal,2555,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482435,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"Env-1 191-214",,,191,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,,191,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482436,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482437,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/68842,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,"Env-2 187-209",,,187,210,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VHDSDLEHVLTPSTSWTTKILKFI,,187,210,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482439,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/31664,"Linear peptide",KKPNRQGLGYYSPSYNDP,"Env-2 85-102",,,86,103,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KKPNRQGLGYYSPSYNDP,,86,103,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482440,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"Gag-1a 102-117",,,102,117,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form HTLV-II infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482441,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"Gag-1a 102-117",,,102,117,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Of serum samples identified as HTLV-indeterminate, 23% of those that gave only p19 Western blot band reacted with the epitope, all other samples has minimal reactivity.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482442,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/20199,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,"Gag-1 364-385",,,364,386,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This sequence is present in both HTLV 1 and HTLV 2.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,,364,386,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482444,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/20199,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,"Gag-1 364-385",,,370,392,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"This sequence is present in both HTLV 1 and HTLV 2.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined from HTLV infected blood donors.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples  from 95% of HTLV infected blood donors were positive for the epitope. Minimal reactivity was seen with serum samples identified as HTLV-indeterminate.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,,370,392,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482445,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/20199,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,"Gag-1 364-385",,,370,392,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"This sequence is present in both HTLV 1 and HTLV 2.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined form patients that reacted to only one of the 3 HTLV proteins tested (p19, p14, or gp46), and were PCR negative for virus.","Figure 2, Text p 546",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,,370,392,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAD34841.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03346,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482520,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Thirty percent of patients with T-LGL reacted with the epitope, as well as 10% of normal controls.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482522,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/50671,"Linear peptide",QEQCRFPNIT,"Peptide 1",,,397,406,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,70,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QEQCRFPNIT,,397,406,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482523,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/45840,"Linear peptide",NSHVSILQER,"Peptide 2",,,407,416,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,70,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NSHVSILQER,,407,416,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482610,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/50672,"Linear peptide",QEQCRFPNITNSHVS,"Peptide 4",,,397,411,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,70,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QEQCRFPNITNSHVS,,397,411,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482632,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/70994,"Linear peptide",VSILQERPPLE,"Peptide 5",,,410,420,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,70,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSILQERPPLE,,410,420,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482639,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/35635,"Linear peptide",LENRVLTGWGLN,"Peptide 6",,,419,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,70,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LENRVLTGWGLN,,419,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482716,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/49201,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,"RTVL gag",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide has 60% homology to C-terminus of both HTLV-1 and HTLV-2 gag.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"serum samples were examined from HTLV infected blood donors.","Text p 547",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples from 88% of HTLV positive patients reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482717,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/49201,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,"RTVL gag",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide has 60% homology to C-terminus of both HTLV-1 and HTLV-2 gag.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"serum samples were examined from HTLV infected blood donors.","Text p 547",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples from 88% of HTLV positive patients reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482718,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/49201,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,"RTVL gag",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide has 60% homology to C-terminus of both HTLV-1 and HTLV-2 gag.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined from patients that reacted to only one fo the 3 HTLV proteins tested (p19, p14 or gp46), and were PCR negative.","Text p 547",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples from 42-46% of HTLV indeterminate patients reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482719,http://www.iedb.org/reference/1009552,Literature,1627806,,"R B Lal; D L Rudolph; J E Coligan; S K Brodine; C R Roberts",Blood,1992,"Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.",http://www.iedb.org/epitope/49201,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,"RTVL gag",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"This peptide has 60% homology to C-terminus of both HTLV-1 and HTLV-2 gag.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were examined from patients that reacted to only one of the 3 HTLV proteins tested (p19, p14 or gp46), and were PCR negative.","Text p 547",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Serum samples from 42-46% of HTLV indeterminate patients reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PRIPPKPCPICVGPHWKSDCPT,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482721,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/48818,"Linear peptide",PPLENRVLTGWGLN,"Peptide 3",,,417,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,70,21,30,"The epitope was determined to be the immunodominant epitope recognized by human sera reactive with the peptide BA21 (env 397-430).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLENRVLTGWGLN,,417,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482857,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus (brown rat)",http://purl.obolibrary.org/obo/NCBITaxon_10116,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization are in Tanaka et al (1991) [PMID: 1711082 ].","Figure 2, 3, 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope-specific mAb was able to bind to phage clones L4-2-11, L4-2-22 and L4-1-22 that displayed the epitope, and the phage clones were able to compete for binding of the mAb to the peptide LPHSNLDHIL . Binding of the mAb to a fusion protein from the phage clones was also shown by Western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Structurally Related","Linear peptide",ILPHSNL,,,,,,,,,,,,
http://www.iedb.org/assay/1482860,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"10 weeks",,"Administration in vivo",,,,"Structurally Related","Linear peptide",TLPHSNL,,,,,,,,,,,,,";Freund's complete;Freund's incomplete (IFA);",intradermal,"4 doses of 1.4 x 10e11 pfu on days 0, 21, 42 and 63",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the epitope expressed in a fusion protein from the phage clone 4-2-22.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,"Epitope-specific antibody was able to bind to a fragment of env protein.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Fragment of Source Antigen","Linear peptide",LPHSNLDHIL,,191,200,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482861,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus (brown rat)",http://purl.obolibrary.org/obo/NCBITaxon_10116,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization are in Tanaka et al (1991) [PMID: 1711082 ].","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind to gp46 (env).","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482863,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus (brown rat)",http://purl.obolibrary.org/obo/NCBITaxon_10116,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization are in Tanaka et al (1991) [PMID: 1711082 ].","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind to HTLV positive cell lysate.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482864,http://www.iedb.org/reference/1012112,Literature,8046543,,"S Hashida; K Hirota; T Kohno; E Ishikawa","J Clin Lab Anal",1994,"Anti-HTLV-I IgG in urine detected by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using a synthetic peptide, Cys-env gp46(188-224), as antigen.",http://www.iedb.org/epitope/48825,"Linear peptide",PPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQSTNYT,"gp46 (188-224)",,,188,224,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"38-69 years",,"Exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Urine samples were from HTLV-1 seropositive subjects.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,31,29,93.5,"A traditional ELISA with HTLV-1 virus and an novel Immune Complex Transfer ELISA with the epitope were compared. The new method had higher sensitivity and specificity than the HTVL-1 ELISA.",Urine,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQSTNYT,,188,224,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482865,http://www.iedb.org/reference/1012107,Literature,8325711,,"N Ohara; K Hayashi; K Takahashi; K Miyamoto; T Akagi","Int J Cancer",1993,"A novel monoclonal antibody specifically reactive with human T-lymphotropic virus type-II (HTLV-II) envelope protein.",http://www.iedb.org/epitope/16317,"Linear peptide",FITSEPTQPPPTSPPLVHDSDLEHVL,"HTLV-2 env (171-196)",,,171,196,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FITSEPTQPPPTSPPLVHDSDLEHVL,,171,196,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice received the first dose of 100 μg of peptide in CFA and 50 μg of peptide in IFA on days 14 and 28. The mice were boosted with 100 μg peptide without adjuvant 3 days prior to isolation of spleen cells for cell fusion.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific mAb recognized gp46 of HTLV-2 lysate by Western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,N5.4.4,IgG1,Kappa,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482866,http://www.iedb.org/reference/1012107,Literature,8325711,,"N Ohara; K Hayashi; K Takahashi; K Miyamoto; T Akagi","Int J Cancer",1993,"A novel monoclonal antibody specifically reactive with human T-lymphotropic virus type-II (HTLV-II) envelope protein.",http://www.iedb.org/epitope/16317,"Linear peptide",FITSEPTQPPPTSPPLVHDSDLEHVL,"HTLV-2 env (171-196)",,,171,196,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FITSEPTQPPPTSPPLVHDSDLEHVL,,171,196,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice received the first dose of 100 μg of peptide in CFA and 50 μg of peptide in IFA on days 14 and 28. The mice were boosted with 100 μg peptide without adjuvant 3 days prior to isolation of spleen cells for cell fusion.","Figures 2, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAb bound to the surface of HTLV-2-producing simian cell line (Si-IIA) cells.  Binding was also observed with indirect immunofluorescence. No binding was detected for HTLV-1-infected cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,N5.4.4,IgG1,Kappa,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482868,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from HAM/TSP patients.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482869,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","systemic lupus erythematosus",http://purl.obolibrary.org/obo/DOID_9074,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from SLE patients.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,31,5,16.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482870,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from MS patients.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,31,7,22.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482871,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were boosted without BSA in IFA.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,"Structurally Related","Linear peptide",PTRAPSGPRPPSRSQAQTPPR,,14,34,,"Putative HTLV-1-related endogenous sequence (p25)",http://www.ncbi.nlm.nih.gov/protein/P13985.1,"Putative HTLV-1-related endogenous sequence",http://www.uniprot.org/uniprot/P13985,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1482872,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were boosted without BSA in IFA.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482883,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"2 doses 2 months apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were immunized i.p with vaccinia-infected cells containing the env gene and then 2 months later were injected i.v. with partially purified gp46 (env) protein.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific mAb was able to recognize gp46 (env) in Western blots of cell lysates.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482885,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"2 doses 2 months apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were immunized i.p with vaccinia-infected cells containing the env gene and then 2 months later were injected i.v. with partially purified gp46 protein.","Figure 2, 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Epitope-specific mAb was able to inhibit HTLV-1 mediated cell fusion in MOLT-4 cells and transformation of human PBLs.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482886,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 positive human sera was used.","Figure 4","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Human sera was able to inhibit the binding of epitope-specific  LAT-27mAb to gp46, indicating that the human sera contained antibodies reactive with this epitope.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482890,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"2 doses 2 months apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were immunized i.p with vaccinia-infected cells containing the env gene and then 2 months later were injected i.v. with partially purified gp46 protein.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope sequence was deduced through study of overlapping peptides.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Fragment of Source Antigen","Linear peptide",PPLLPHSNL,,188,196,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482923,http://www.iedb.org/reference/1010398,Literature,10516045,,"S Blanchard; T Astier-Gin; B Tallet; D Moynet; D Londos-Gagliardi; B Guillemain","J Virol",1999,"Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.",http://www.iedb.org/epitope/77191,"Discontinuous peptide","I173, A187",I173-A187,,,,,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope was mapped by mutation at epitopic residues. I173V and A187T mutations resulted in loss of binding to serum neutralizing antibodies.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482924,http://www.iedb.org/reference/1012113,Literature,1506984,,"T Kohno; I Sakoda; E Ishikawa","J Clin Lab Anal",1992,"Sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for (antihuman T-cell leukemia virus type I) immunoglobulin G in serum using a synthetic peptide, Ala-Cys-Env gp46(237-262), as antigen.",http://www.iedb.org/epitope/72557,"Linear peptide",WHVLYSPNVSVPSSSSTPLLYPSLAL,"gp46 (237-262)",,,237,262,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"16-79 years",,"Exposure without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy subjects from Miyazaki, Japan.","Figure 2, Text page 166",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,126,119,94.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WHVLYSPNVSVPSSSSTPLLYPSLAL,,237,262,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482925,http://www.iedb.org/reference/1012115,Literature,1403331,,"T Kohno; I Sakoda; E Ishikawa","J Clin Lab Anal",1992,"Sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, Cys-env gp46(188-224), as antigen.",http://www.iedb.org/epitope/48825,"Linear peptide",PPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQSTNYT,"gp46 (188-224)",,,188,224,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"16-79 years",,"Exposure without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy subjects from Miyazaki, Japan.","Figure 2, Text page 108",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,277,271,97.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLLPHSNLDHILEPSIPWKSKLLTLVQLTLQSTNYT,,188,224,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482926,http://www.iedb.org/reference/1012116,Literature,1900332,,"T Kohno; I Sakoda; E Ishikawa","J Clin Lab Anal",1991,"Immune complex transfer enzyme immunoassay for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, Env gp46(188-209), as antigen.",http://www.iedb.org/epitope/48824,"Linear peptide",PPLLPHSNLDHILEPSIPWKSK,"gp46 (188-209)",,,188,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"16-79 years",,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy subjects from Miyazaki, Japan.","Figure 7, Text page 36",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,122,99,81.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLLPHSNLDHILEPSIPWKSK,,188,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482927,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"gp 46 190-199",,,190,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses at intervals of 2 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 6","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482931,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"gp 46 190-199",,,190,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses at intervals of 2 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482932,http://www.iedb.org/reference/1012119,Literature,1711082,,"Y Tanaka; L Zeng; H Shiraki; H Shida; H Tozawa","J Immunol",1991,"Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"gp 46 190-199",,,190,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses at intervals of 2 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,4,4,100,"Sera from epitope-immunized rabbits were able to neutralize HTLV-1.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482933,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"10 weeks",,"Administration in vivo",,,,"Structurally Related","Linear peptide",TLPHSNL,,,,,,,,,,,,,";Freund's complete;Freund's incomplete (IFA);",intradermal,"4 doses of 1.4 x 10e11 pfu on days 0, 21, 42 and 63",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the epitope expressed in a fusion protein from the phage clone 4-2-22.","Figure 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Phage clone 4-2-22 which contains the epitope was able to inhibit the binding of monospecific rabbit serum to HTLV-1 positive cells.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Structurally Related","Linear peptide",TLPHSNL,,,,,,,,,,,,
http://www.iedb.org/assay/1482934,http://www.iedb.org/reference/1010183,Literature,11818146,,"Nurjahan Begum; Sankichi Horiuchi; Yuetsu Tanaka; Norio Yamamoto; Kouji Ichiyama; Naoki Yamamoto",Vaccine,2002,"New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"10 weeks",,"Administration in vivo",,,,"Structurally Related","Linear peptide",TLPHSNL,,,,,,,,,,,,,";Freund's complete;Freund's incomplete (IFA);",intradermal,"4 doses of 1.4 x 10e11 pfu on days 0, 21, 42 and 63",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the epitope expressed in a fusion protein from the phage clone 4-2-22.","Figure 6","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Rabbit immune serum to phage-expressing epitope  was able to inhibit HTLV-1 mediated cell fusion.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482943,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/48817,"Linear peptide",PPLENRVLTG,PP10,,,417,426,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Figure 3, 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to compete for the binding of patient serum seropositive for the longer peptide BA21 (QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN ) to BA21 by Western blot, suggesting it is the minimal epitope responsible for seroreactivity against the HTLV-1 p21 env.  Direct biding of the patient's serum to the epitope was also shown by Western blot.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLENRVLTG,,417,426,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482952,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/48308,"Linear peptide",PLENRVLT,P8,,,418,425,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropostive  patients with T cell large granular lymphocyte leukemia were used.","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Direct biding of the patient's serum to the epitope was shown by Western blot, but competition Western with a fragment of the env protein with reactivity to the longer peptide BA21 (QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN) was not successful.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PLENRVLT,,418,425,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482962,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/48816,"Linear peptide",PPLENR,PP6,,,417,422,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"A smaller fragment (PLENR) of the epitope was also negative.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLENR,,417,422,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1482964,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/48815,"Linear peptide",PPLEKRVIT,"HTLV-2 peptide",,,413,421,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Sera from patients reactive with the homologous HTLV-1 env peptide PPLENRVLT did not cross-react with the epitope from HTLV-2.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPLEKRVIT,,413,421,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1482978,http://www.iedb.org/reference/1007995,Literature,15725471,,"Lubomir Sokol; Deepak Agrawal; Thomas P Loughran Jr","Leuk Res",2005,"Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.",http://www.iedb.org/epitope/49418,"Linear peptide",PSLENRVLT,"STLV-1 peptide",,,128,136,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAB52543.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Sera from HTLV seropositive patients with T cell large granular lymphocyte leukemia were used.","Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,"Sera from patients reactive with the homologous HTLV-1 env peptide PPLENRVLT did not cross-react with the epitope from STLV-1.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSLENRVLT,,128,136,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAB52543.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483182,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/54663,"Linear peptide",RLLSPLSPLALTALL,1,,,4,18,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence is from Koralnik et al (1992) Proc Natl Acad Sci USA 89:8813-8817[PMID: 1528897].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RLLSPLSPLALTALL,,4,18,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain KKC at its C-terminus to increase its solubility.","Figure 2, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483184,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/49350,"Linear peptide",PSDVSGLLLRPPPAP,2,,,24,38,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PSDVSGLLLRPPPAP,,24,38,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain an extra Cys residue at its C-terminus.","Table 1, Figures 2, 3",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483185,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/38484,"Linear peptide",LPFQILSGLLFLLFL,3,,,44,58,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPFQILSGLLFLLFL,,44,58,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain KKC at its C-terminus to increase its solubility.","Figure 2, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483186,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/60260,"Linear peptide",SPSLPITMRFPARWRF,4,,,69,84,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPSLPITMRFPARWRF,,69,84,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain KKC at its C-terminus to increase its solubility.","Figure 2, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483187,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/38772,"Linear peptide",LPWRAPSQPAAAFLF,5,,,138,152,,,"pX-rex-orf I {alternatively spliced}",http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPWRAPSQPAAAFLF,,138,152,,"pX-rex-orf I {alternatively spliced}",http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain KKC at its C-terminus to increase its solubility.","Table 1, Figures 2, 3",immunohistochemistry,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001998,Positive,,,2,2,100,"Binding was also observed by Western blotting and immunohistochemistry.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"pX-rex-orf I {alternatively spliced}",,,,http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483188,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/16861,"Linear peptide",FLPWKAPSQP,2043,,,84,93,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLPWKAPSQP,,84,93,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain an extra Cys residue at its C-terminus.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483189,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/16862,"Linear peptide",FLPWRAPSQP,2046,,,137,146,,,"pX-rex-orf I {alternatively spliced}",http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FLPWRAPSQP,,137,146,,"pX-rex-orf I {alternatively spliced}",http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain an extra Cys residue at its C-terminus.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"pX-rex-orf I {alternatively spliced}",,,,http://www.ncbi.nlm.nih.gov/protein/AAB23359.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483190,http://www.iedb.org/reference/1006700,Literature,10936091,,"G A Dekaban; A A Peters; J C Mulloy; J M Johnson; R Trovato; E Rivadeneira; G Franchini",Virology,2000,"The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.",http://www.iedb.org/epitope/55263,"Linear peptide",RPPPAPCL,2047,,,33,40,,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RPPPAPCL,,33,40,,"Accessory protein p12I",http://www.ncbi.nlm.nih.gov/protein/P0C215.1,"Isoform p27I of Accessory protein p12I",http://www.uniprot.org/uniprot/P0CK16-2,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figures 2, 3, 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,2,2,100,"Binding to anti-peptide serum from one rabbit is weak.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p12I",,,,http://www.ncbi.nlm.nih.gov/protein/P0C215.1,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483329,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/29327,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,GD21-I,,,361,404,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum from a patient infected with HTLV 2 with LGL leukemia was used.","Text p 321, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,1,1,100,"The LGL leukemia patient shown to be infected with HTLV-2 reacted to the epitope. Other LGL leukemia patients (37 tested) did not react.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCRFPN,,361,404,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483331,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/29328,"Linear peptide",IVKNHQNILRVAQYAAQNRRGLDLLFWEQGGLCKAIQEQCCFLN,GD21-2,,,357,400,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients infected with HTLV 2 who also had LGL leukemia were used.","Text p 321, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,1,1,100,"A patient infected with HTLV-2 with LGL leukemia reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IVKNHQNILRVAQYAAQNRRGLDLLFWEQGGLCKAIQEQCCFLN,,357,400,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1483332,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/29328,"Linear peptide",IVKNHQNILRVAQYAAQNRRGLDLLFWEQGGLCKAIQEQCCFLN,GD21-2,,,357,400,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera from patients with LGL leukemia were used.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,40,2,5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IVKNHQNILRVAQYAAQNRRGLDLLFWEQGGLCKAIQEQCCFLN,,357,400,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1483333,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Unknown,,,,,,,,,,,,,,,,,,,N,,"Serum from a patient infected with HTLV-2 as well as LGL leukemia was used.","Text p 321","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483334,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"14-88 years",,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","chronic lymphocytic leukemia",http://purl.obolibrary.org/obo/DOID_1040,Chronic,,,,,,,,,,,,,,,,,,,N,,"Sera from patients with LGL leukemia were used. Most of these patients were negative for HTLV 1 and 2 by PCR.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,38,17,44.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483362,http://www.iedb.org/reference/1008063,Literature,12404172,,"Michael C Levin; Sang Min Lee; Yvette Morcos; John Brady; John Stuart","J Infect Dis",2002,"Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax 346-351",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibody(ies) bound HTLV-1 infected Hut cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"Tab169, Tab 170, Tab 171",IgG2a,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483366,http://www.iedb.org/reference/1008063,Literature,12404172,,"Michael C Levin; Sang Min Lee; Yvette Morcos; John Brady; John Stuart","J Infect Dis",2002,"Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax 346-351",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope specific antibody(ies) bound HTLV-1 Tax protein.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"Tab169, Tab 170, Tab 171",IgG2a,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483367,http://www.iedb.org/reference/1008063,Literature,12404172,,"Michael C Levin; Sang Min Lee; Yvette Morcos; John Brady; John Stuart","J Infect Dis",2002,"Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax 346-351",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Table 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to compete for the binding of the antibodies to both Tax protein and HTLV-1 infected Hut cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"Tab169, Tab 170, Tab 171",IgG2a,,,Epitope,"Linear peptide",KHFRETEV,,346,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483368,http://www.iedb.org/reference/1008063,Literature,12404172,,"Michael C Levin; Sang Min Lee; Yvette Morcos; John Brady; John Stuart","J Infect Dis",2002,"Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax 346-351",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Epitope specific antibody(ies) stained human neurons and incubation with the epitope abolished the reactivity.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"Tab169, Tab 170, Tab 171",IgG2a,,,Other,Organism,"Homo sapiens (human)","human neuron",,,,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1483369,http://www.iedb.org/reference/1008063,Literature,12404172,,"Michael C Levin; Sang Min Lee; Yvette Morcos; John Brady; John Stuart","J Infect Dis",2002,"Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax 346-351",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Epitope specific antibody(ies) bound human hnRNP A1 and incubation with the epitope abolished the reactivity.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"Tab169, Tab 170, Tab 171",IgG2a,,,Other,Protein,"Heterogeneous nuclear ribonucleoprotein A1",,,,http://www.ncbi.nlm.nih.gov/protein/P09651.4,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1483457,http://www.iedb.org/reference/1012138,Literature,8445734,,"I J Koralnik; J Fullen; G Franchini","J Virol",1993,"The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.",http://www.iedb.org/epitope/61989,"Linear peptide",STVPYPSTPLLPHPENL,"Peptide B",,,225,241,,,"Accessory protein p30II",http://www.ncbi.nlm.nih.gov/protein/P0C214.1,"Accessory protein p30II",http://www.uniprot.org/uniprot/P0CK17,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",STVPYPSTPLLPHPENL,,225,241,,"Accessory protein p30II",http://www.ncbi.nlm.nih.gov/protein/P0C214.1,"Accessory protein p30II",http://www.uniprot.org/uniprot/P0CK17,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3, 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,,,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p30II",,,,http://www.ncbi.nlm.nih.gov/protein/P0C214.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483458,http://www.iedb.org/reference/1012138,Literature,8445734,,"I J Koralnik; J Fullen; G Franchini","J Virol",1993,"The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.",http://www.iedb.org/epitope/19971,"Linear peptide",GGPRRSRPRLSSSKDSK,"Peptide 6",,,90,106,,,"Accessory protein p30II",http://www.ncbi.nlm.nih.gov/protein/P0C214.1,"Accessory protein p30II",http://www.uniprot.org/uniprot/P0CK17,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Koralnik et al. (1992) Proc Natl Acad Sci USA 89:8813-8817 [1528897].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GGPRRSRPRLSSSKDSK,,90,106,,"Accessory protein p30II",http://www.ncbi.nlm.nih.gov/protein/P0C214.1,"Accessory protein p30II",http://www.uniprot.org/uniprot/P0CK17,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,,,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"Accessory protein p30II",,,,http://www.ncbi.nlm.nih.gov/protein/P0C214.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483702,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,15,46.9,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483720,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"gag p24 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,3,9.4,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had a higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483721,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"gag p24 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,2,6.3,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had a higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483723,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"env gp21 332-352",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,3,9.4,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had a higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,,332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483725,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/67993,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"env gp21 350-386",,,350,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,3,9.4,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had a higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,350,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483726,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"env gp21 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,6,18.8,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483727,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"env gp21 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,15,46.9,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483731,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/19193,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,"env gp46 20-49",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,3,9.4,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483735,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/62567,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"Peptide E (E1)",,,35,57,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M",53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,,35,57,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483739,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483740,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/34862,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,"Peptide F (E3)",,,55,77,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M",53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,,55,77,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483741,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N",71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483742,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/71235,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N (E4)",,,71,94,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M",53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,,71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483743,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/71235,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N (E4)",,,71,94,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O",89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,,71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483744,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483745,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"Peptide G",103,125,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483746,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"Peptide P",107,129,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483747,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N",71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483748,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483749,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"Peptide E",35,57,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483750,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/62700,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"Peptide G (E6)",,,103,125,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O",89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,,103,125,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483751,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/47047,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"Peptide P (E7)",,,107,129,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O",89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,,107,129,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483752,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37886,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"Peptide VH (E8)",,,163,185,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,,163,185,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483753,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/48016,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S (E9)",,,172,194,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,,172,194,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483754,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483755,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"Peptide VH",163,185,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483756,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S",172,194,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483757,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH",190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483758,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T",190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483759,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"Peptide U",208,230,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483760,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483761,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"Peptide VH",163,185,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483762,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S",172,194,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483763,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH",190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483764,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483765,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483766,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"Peptide U",208,230,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483771,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/58884,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"Peptide U (E13)",,,208,230,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T",190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,,208,230,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483772,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/75984,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,"Peptide C (E14)",,,223,243,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V",239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,,223,243,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483773,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/39726,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,"Peptide HC (E15)",,,234,256,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V",239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,,234,256,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483774,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483775,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",YTCIVCIDRASLSTWHVLYSP,"Peptide C",223,243,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483776,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,"Peptide HC",234,256,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483777,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"Peptide W",257,279,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483778,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/75415,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"Peptide W (E17)",,,257,279,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V",239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,,257,279,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483779,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/73133,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"Peptide B (E18)",,,273,295,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB",286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,,273,295,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483780,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483781,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"Peptide B",273,295,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483782,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"Peptide X",291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483784,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/45894,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"Peptide X (E20)",,,291,313,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB",286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,,291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483787,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483788,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"Peptide G",103,125,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483789,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"Peptide P",107,129,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483790,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N",71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483791,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483792,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S",172,194,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483793,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H",176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483794,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T",190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483795,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483796,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"Peptide B",273,295,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAS77581.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483797,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Other Structure from Source Organism","Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"Peptide X",291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483799,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Ascitic Fluid","Entire Antibody",Monoclonal,1C6,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483802,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/48016,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S (E9)",,,172,194,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH",190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Ascitic Fluid","Entire Antibody",Monoclonal,"5B4C6G10, 5B4C6G5",IgG,,,"Other Structure from Source Organism","Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"Peptide N",71,94,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483803,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Ascitic Fluid","Entire Antibody",Monoclonal,"5B4C6G10, 5B4C6G5",IgG,,,"Other Structure from Source Organism","Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"Peptide S",172,194,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483804,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483805,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Binding was also observed by Western blot analysis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483806,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483807,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483808,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Binding was also observed by Western blot analysis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483809,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figures 5, 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Binding was also observed by Western blot analysis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483810,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483811,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483812,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483813,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483814,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483815,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Figure 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483817,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 5","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Similar results were observed for mAbs obtained from the peptide-immunized animals.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483819,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 5","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Similar results were observed for mAbs obtained from the peptide-immunized animals.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483820,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50 μg peptide conjugated to BSA or ovalbumin.","Figure 5","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Similar results were observed for mAbs obtained from the peptide-immunized animals.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483821,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide HH (E11)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figures 5, 6","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAbs recognized antigen exposed on HTLV-1 infected cells (MT4, C91/P).","Ascitic Fluid","Entire Antibody",Monoclonal,"5B2C2C11, 5B2C2F7",IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483822,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figures 5, 6, 4","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAbs recognized antigen exposed on surface of HTLV-1-infected cells (MT4, C91/PL).  Binding was also observed in immunoprecipitation assays.","Ascitic Fluid","Entire Antibody",Monoclonal,4D4,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483838,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific mAbs recognized antigen expressed in transfected COS-1 cells.","Ascitic Fluid","Entire Antibody",Monoclonal,4D4,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483839,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB (E19)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483840,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"Peptide M (E2)",,,53,75,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483841,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"Peptide O (E5)",,,89,110,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483842,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"Peptide H (E10)",,,176,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483843,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"Peptide T (E12)",,,190,212,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483844,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"Peptide V (E16)",,,239,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"2 months",,"Administration in vivo",,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intramuscular,"4 doses of 500 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was covalently linked to BSA or ovalbumin prior to injection. Booster doses were given in IFA.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,"Syncytia formation inhibition was used to assay for neutralizing activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483873,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/64604,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,"env gp46 136-160",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,32,0,0,"HAM/TSP patients with and without high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  no intrathecal antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483874,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"env gp46 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,17,53.1,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483887,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/64604,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,"env gp46 136-160",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,4,12.5,"HAM/TSP patients with and without high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  serum antibodies to the epitope, but not intrathecal antibodies.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483889,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"env gp46 197-216",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,1,3.1,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483890,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"env gp46 213-236",,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,2,6.3,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483891,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,32,0,0,"HAM/TSP patients with and without high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  no intrathecal antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483892,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,6,18.8,"HAM/TSP patients with and without high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  serum antibodies to the epitope, but not intrathecal antibodies.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483893,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"env gp46 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,7,21.9,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483894,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/6215,"Linear peptide",CFDPQIQAIVSSPCHN,"env gp46 277-292",,,276,291,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,9,28.1,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",CFDPQIQAIVSSPCHN,,276,291,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1483895,http://www.iedb.org/reference/1006236,Literature,8937542,,"B Kitze; K Usuku; S Yashiki; S Ijichi; T Fujiyoshi; M Nakamura; S Izumo; M Osame; S Sonoda","Acta Neurol Scand",1996,"Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.",http://www.iedb.org/epitope/47023,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,"env gp46 288-317",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients who had a diagnosis of HAM/TSP were used.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,32,17,53.1,"HAM/TSP patients with high immune response haplotypes (A24Cw7B7DR1DQ5, A2Cw7B7DR1DQ5, A24CwB52DR15DQ6, A11Cw1B54DR1DQ4, A24Cw1B54DR4DQ4) had  higher intrathecal antibodies as well as serum antibodies to the epitope.",Other,"Entire Antibody",Polyclonal,Intrathecal,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484027,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37656,"Linear peptide",LLPHSNLD,"gp46 peptide 190-P-197",,,190,197,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,,190,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope. The epitope was deduced by testing overlapping peptides containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF1,IgG2b,,,Epitope,"Linear peptide",LLPHSNLD,,190,197,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484030,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37656,"Linear peptide",LLPHSNLD,"gp46 peptide 190-P-197",,,190,197,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,,190,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized peptide 190-199 of HTLV-1 strain HS35 (with serine at position 192).  The epitope was deduced by testing overlapping peptides containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF1,IgG2b,,,"Taxonomic Sibling","Linear peptide",LLSHSNLDHI,,190,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484041,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37656,"Linear peptide",LLPHSNLD,"gp46 peptide 190-P-197",,,190,197,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,,190,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAb recognized HTLV-1, but not HTLV-2. The epitope was deduced by testing overlapping peptides containing the epitope. Binding was also observed in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF1,IgG2b,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484043,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37793,"Linear peptide",LLSHSNLDHI,"gp46 peptide 190-S-199",,,190,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/ontology/ONTIE_0000870,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLSHSNLDHI,,190,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/taxon/10001004,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF6,IgG3,,,Epitope,"Linear peptide",LLSHSNLDHI,,190,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/taxon/10001004,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484044,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37793,"Linear peptide",LLSHSNLDHI,"gp46 peptide 190-S-199",,,190,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/ontology/ONTIE_0000870,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLSHSNLDHI,,190,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/taxon/10001004,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized peptide 190-199 of HTLV-1 with proline at position 192.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF6,IgG3,,,"Taxonomic Sibling","Linear peptide",LLPHSNLDHI,,190,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484046,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37793,"Linear peptide",LLSHSNLDHI,"gp46 peptide 190-S-199",,,190,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/ontology/ONTIE_0000870,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLSHSNLDHI,,190,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate) (Strain HS35)",https://ontology.iedb.org/taxon/10001004,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAb recognized HTLV-1, but not HTLV-2. Binding was also observed in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF6,IgG3,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484054,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/46488,"Linear peptide",NVSVPSPSSTPLLY,"gp46 peptide 244-P-257",,,244,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",NVSVPSPSSTPLLY,,244,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific mAbs recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"DB1, VD2",IgG1,,,Epitope,"Linear peptide",NVSVPSPSSTPLLY,,244,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484057,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/46488,"Linear peptide",NVSVPSPSSTPLLY,"gp46 peptide 244-P-257",,,244,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NVSVPSPSSTPLLY,,244,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAbs recognized HTLV-1, but not HTLV-2. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"DB1, VD2",IgG1,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484058,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/62289,"Linear peptide",SVPSSSS,"gp46 peptide 246-S-252",,,246,252,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",NVSVPSSSSTPLLY,,244,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAbs recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"DB5, DB4, DB6",IgG1,,,Epitope,"Linear peptide",SVPSSSS,,246,252,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484059,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/62289,"Linear peptide",SVPSSSS,"gp46 peptide 246-S-252",,,246,252,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",NVSVPSSSSTPLLY,,244,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAbs recognized peptide 244-252 of HTLV-1 strain HS35 (with proline at position 250).","Purified Immunoglobulin","Entire Antibody",Monoclonal,"DB5, DB4",IgG1,,,"Taxonomic Sibling","Linear peptide",NVSVPSPSS,,244,252,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484061,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/62289,"Linear peptide",SVPSSSS,"gp46 peptide 246-S-252",,,246,252,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",NVSVPSSSSTPLLY,,244,257,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAbs recognized HTLV-1, but not HTLV-2. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"DB5, DB4, DB6",IgG1,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484062,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/61824,"Linear peptide",STPLLYPSLA,"gp46 peptide 252-261",,,252,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Taxonomic Child","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAb recognized HTLV-1, but not HTLV-2. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,DF2,IgG1,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484063,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/61824,"Linear peptide",STPLLYPSLA,"gp46 peptide 252-261",,,252,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Taxonomic Child","Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,DF2,IgG1,,,Epitope,"Linear peptide",STPLLYPSLA,,252,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484066,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/38628,"Linear peptide",LPPTAPPLL,"gp46 peptide 183-191",,,183,191,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3, Figure 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific mAb recognized HTLV-1, but not HTLV-2. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,7G5D8,IgG1,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484067,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/38628,"Linear peptide",LPPTAPPLL,"gp46 peptide 183-191",,,183,191,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,7G5D8,IgG1,,,Epitope,"Linear peptide",LPPTAPPLL,,183,191,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484071,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 peptide 175-P-199",,,175,199,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Human T-cell lymphotrophic virus type 1 (strain ATK) (Human T-cell leukemia virus type I (strain ATK))",,,,,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1, Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4F5F6,IgG1,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484073,http://www.iedb.org/reference/1011065,Literature,10408728,,"D Londos-Gagliardi; V Jauvin; M H Armengaut; T Astier-Gin; M Goetz; S Huet; B J Guillemain","AIDS Res Hum Retroviruses",1999,"Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.",http://www.iedb.org/epitope/37656,"Linear peptide",LLPHSNLD,"gp46 peptide 190-P-197",,,190,197,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,,190,199,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses of 50 μg, administered at intervals of 3 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"The first three booster doses were given in IFA at intervals of 3 weeks. The final boost was given intravenously without adjuvant. Immune spleen cells were isolated 5 days after the final boost.","Figure 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Epitope-specific mAb neutralized HTLV-1 in reporter assays and inhibition of syncytium formation assays.","Purified Immunoglobulin","Entire Antibody",Monoclonal,MF1,IgG2b,,,"Taxonomic Parent",Protein,"surface glycoprotein gp46",,,,http://www.ncbi.nlm.nih.gov/protein/AAA87561.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484101,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Table 2, Figures 1, 2","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Binding was also observed in immunofluorescence assays with both live and fixed cells that were infected with HTLV-1and in Western blots.",,"Entire Antibody",Monoclonal,REY7,IgG2,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484108,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Figures 2, 3, Table 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Binding was also observed in indirect immunofluorescence assays with both live and fixed HeLa cells that were infected with recombinant vaccina virus encoding HTLV-1 env and in Western blots. The mAb also recognized the C-terminal fragment (147 residues) of HTLV-1 gp46 in Western blots.",,"Entire Antibody",Monoclonal,REY7,IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484157,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Figure 4","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"The mAb competed with sera from HTLV-1-infected humans for binding to HTLV-1 gp46.",,"Entire Antibody",Monoclonal,REY7,IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484158,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb recognized the epitope.",,"Entire Antibody",Monoclonal,REY7,IgG2,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484161,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Figures 2, 3, Table 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Epitope-specific binding was also observed in indirect immunofluorescence assays with both live and fixed HeLa cells that were infected with recombinant vaccina virus encoding HTLV-1 env and in Western blots. The mAb also recognized the C-terminal fragment (147 residues) of HTLV-1 gp46 in Western blots.",,"Entire Antibody",Monoclonal,MET3,IgG1,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484162,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Figure 4","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Epitope-specific mAb competed with sera from HTLV-1-infected human for binding the gp46.",,"Entire Antibody",Monoclonal,MET3,IgG1,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484163,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Palker et al (1989) J Immunol 142: 971-978 [PMID: 2563272] .",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Table 3","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Epitope-specific mAb recognized the epitope.",,"Entire Antibody",Monoclonal,MET3,IgG1,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484164,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 (253-282)",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Figures 2, 3, Table 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Binding was also observed in indirect immunofluorescence assays with both live and fixed HeLa cells that were infected with recombinant vaccina virus encoding HTLV-1 env and in Western blots. The mAb(s) also recognized the C-terminal fragment (147 residues) of HTLV-1 gp46 in Western blots.",,"Entire Antibody",Monoclonal,"REY11, REY16",IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484165,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 (253-282)",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Figure 4","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"The mAb(s) competed with sera from HTLV-1-infected humans for binding to HTLV-1 gp46.",,"Entire Antibody",Monoclonal,"REY11, REY16",IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484166,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 (253-282)",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus Lewis",https://ontology.iedb.org/ontology/ONTIE_0000568,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intravenous,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were injected with disrupted YB2/0 cells infected with recombinant vaccina virus with HTVL-1 env gene. Two weeks later, the rats were injected with 100 μg recombinant HLTV-1 gp46 containing the C-terminal half 147 residues of gp46.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized the epitope.",,"Entire Antibody",Monoclonal,"REY11, REY16",IgG2,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484177,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Figures 2, 3, Table 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Binding was also observed in indirect immunofluorescence assays with both live and fixed HeLa cells that were infected with recombinant vaccina virus encoding HTLV-1 env and in Western blots. The mAb(s) also recognized the C-terminal fragment (147 residues) of HTLV-1 gp46 in Western blots.",,"Entire Antibody",Monoclonal,REY30,IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484178,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Figure 4","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"The mAb(s) competed with sera from HTLV-1-infected humans for binding to HTLV-1 gp46.",,"Entire Antibody",Monoclonal,REY30,IgG2,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484179,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized the epitope.",,"Entire Antibody",Monoclonal,REY30,IgG2,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,,288,312,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484182,http://www.iedb.org/reference/1012109,Literature,1698731,,"Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa","Int J Cancer",1990,"Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"4 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose of 25 µg was given in IFA. The first two booster doses of 25 µg were given in IFA at 2 and 4 weeks after the first injection. The last boost was given i. v. with 10 µg of gp46.","Table 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Epitope-specific mAb(s) recognized HTLV-2-infected Mo-B cells.",,"Entire Antibody",Monoclonal,REY30,IgG2,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1484193,http://www.iedb.org/reference/1010894,Literature,1582023,,"K Yamada; N Kuroda; Y Washitani; H Shiraki; Y Maeda","Clin Chem",1992,"Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Kuroda et al (1990) Int J Cancer 45: 865-868 [PMID: 2185995].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from a healthy donor from the Fukuoka Red Cross Blood Center (Japan). This donor was tested positive by particle agglutination for anti-HTLV antibodies and by PCR.","Table 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,1,1,100,"Anti-peptide antibodies were detected in an HTLV-1 carrier by direct ELISA and competition ELISA.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484419,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Antibody response was only observed when mice were immunized with the epitope linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Sera from 4 of 5 immunized mice showed binding to the epitope alone (without MVF sequence). Antibody response against the epitope was also observed when mice were immunized with a multi-epitope construct containing the epitope, HTLV-1 peptide SP2 (residues 86-107), tetanus toxin peptide (TT), and measles virus fusion protein peptide (MVF).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484420,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Antibody response was only observed when mice were immunized with the epitope linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence .",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484421,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C3H/He",https://ontology.iedb.org/ontology/ONTIE_0000037,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,5,5,100,"Antibody response was generated when the epitope was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Binding was also observed with the epitope alone (without MVF peptide) as antigen, but the titer was much lower. Antibody response against the epitope was also observed when mice were immunized with a multi-epitope construct containing the epitope, HTLV-1 peptide SP2 (residues 86-107), tetanus toxin peptide (TT), and measles virus fusion protein peptide (MVF).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484422,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C3H/He",https://ontology.iedb.org/ontology/ONTIE_0000037,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,5,5,100,"Antibody response was generated when the epitpe was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484425,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,5,5,100,"Antibody response was generated when the epitope was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Binding was also observed with the epitope alone (without MVF peptide) as antigen, but the titer was much lower. Antibody response against the epitope was also observed when mice were immunized with a multi-epitope construct containing the epitope, HTLV-1 peptide SP2 (residues 86-107), tetanus toxin peptide (TT), and measles virus fusion protein peptide (MVF).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484426,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 2, Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,5,5,100,"Antibody response was generated when the epitpe was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484427,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 3, Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A higher antibody response was generated when the epitope was linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence compared to un-conjugated peptide as immunogen. There was no difference in titers from immunization with epitope-MVF construct and from immunization with mixture of peptides containing the epitope, SP2 peptide (residues 86-107) and SP3 peptide (residues 176-169). Binding was also observed with the epitope alone (without MVF peptide) as antigen, but the titer was much lower.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484428,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"There was no difference in titers from immunization with epitope linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence and from immunization with mixture of peptides containing the epitope, SP2 peptide (residues 86-107) and SP3 peptide (residues 176-169).",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484429,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"A lower response was observed when the antigen was the epitope not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484430,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with a multi-epitope construct containing the epitope, HTLV-1 peptide SP2 (residues 86-107), tetanus toxin peptide (TT), and measles virus fusion protein peptide (MVF). The immunogen was  emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,4,80,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484431,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 9","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Neutralization was determined in syncitium inhibition assay.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484432,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 9","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Neutralization was determined in syncitium inhibition assay.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484433,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"Peptide SP4a",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C3H/He",https://ontology.iedb.org/ontology/ONTIE_0000037,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 9","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Neutralization was determined in syncitium inhibition assay.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484456,http://www.iedb.org/reference/1011274,Literature,9495252,,"M P Grange; A R Rosenberg; P Horal; C Desgranges","Int J Cancer",1998,"Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I).",http://www.iedb.org/epitope/45894,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"Peptide X (E20)",,,291,313,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence in the reference has typos from the original sequence used.  Correct epitope sequence can be found in Horal et al (1991) Proc Natl Acad Sci USA 88:5754-5758 [PMID: 1712105].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"Peptide HB",286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"At least 2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 50μg peptide conjugated to BSA or ovalbumin. Immune spleen cells were isolated 5 days after the final booster dose. Clones were generated by limiting dilution. Antibodies were purified from ascitic fluid or culture supernatant.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,,291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484474,http://www.iedb.org/reference/1012213,Literature,1682432,,"T Kohno; I Sakoda; M Suzuki; A Izumi; E Ishikawa","J Clin Lab Anal",1991,"Immune complex transfer enzyme immunoassay for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, Cys-Gag p19(100-130), as antigen.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"p19 (100-130)",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"16-79 years",,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy subjects in Miyazaki (Japan). Approximately 7% of healthy subjects were HTLV-1 carriers. The sera were tested positive for HTLV-1 in gelatin particle agglutination test.","Figures 2, 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,303,155,51.2,"Antibody reactivity was determined by a novel Immune Complex Transfer Enzyme Immunoassay, which was said to be more sensitive than the conventional ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484475,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"P19 (100-130)",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,94,100,"Reactivity was also observed for a shorter fragment of the epitope (residues 100-119) in 80 of 94 subjects.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484476,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,P24-131,,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,4,4.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484477,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/9652,"Linear peptide",DPILRSLAYSNANKECQKLL,P24-295,,,296,315,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,17,18.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DPILRSLAYSNANKECQKLL,,296,315,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484478,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/64603,"Linear peptide",TKKPNRNGGGYYSASYSDPCSLKCPYL,P46-89,,,89,115,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [PMID: 6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,13,13.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSLKCPYL,,89,115,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484479,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,P46-175,,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,86,91.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484480,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/14645,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,P20-350,,,349,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,7,7.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,349,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484481,http://www.iedb.org/reference/1012214,Literature,2185995,,"N Kuroda; Y Washitani; H Shiraki; H Kiyokawa; M Ohno; H Sato; Y Maeda","Int J Cancer",1990,"Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,P20-458,,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 94 HTLV-1 healthy carriers diagnosed by gelatin particle agglutination assay and indirect immunofluorescence assay.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,94,7,7.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484520,http://www.iedb.org/reference/1010894,Literature,1582023,,"K Yamada; N Kuroda; Y Washitani; H Shiraki; Y Maeda","Clin Chem",1992,"Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (175-199)",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Kuroda et al (1990) Int J Cancer 45: 865-868 [PMID: 2185995].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy donors from the Fukuoka Red Cross Blood Center (Japan). These donors were negative for HTLV-1 by particle agglutination and immunofluorescence assays, Western blots and PCR.","Table 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,1116,2,0.2,"Anti-peptide antibodies were detected by direct ELISA and competition ELISA in 2 negative controls out of 1116 tested.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484524,http://www.iedb.org/reference/1010894,Literature,1582023,,"K Yamada; N Kuroda; Y Washitani; H Shiraki; Y Maeda","Clin Chem",1992,"Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gp19 (100-130)",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Kohno et al (1991) J Clin Lab Anal 5: 307-316 [PMID: 1682432].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from a healthy donor from the Fukuoka Red Cross Blood Center (Japan). This donor was tested positive by particle agglutination for anti-HTLV antibodies and by PCR.","Table 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,1,1,100,"Anti-peptide antibodies were detected in an HTLV-1 carrier by direct ELISA and competition ELISA.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484525,http://www.iedb.org/reference/1010894,Literature,1582023,,"K Yamada; N Kuroda; Y Washitani; H Shiraki; Y Maeda","Clin Chem",1992,"Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gp19 (100-130)",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in Kohno et al (1991) J Clin Lab Anal 5: 307-316 [PMID: 1682432].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples were from healthy donors from the Fukuoka Red Cross Blood Center (Japan). These donors were negative for HTLV-1 by particle agglutination and immunofluorescence assays, Western blots and PCR.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1116,2,0.2,"Anti-peptide antibodies were detected by direct ELISA in 2 negative controls out of 1116 tested.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484538,http://www.iedb.org/reference/1011506,Literature,1360328,,"M D Lairmore; D L Rudolph; B D Roberts; C S Dezzutti; R B Lal","Cancer Lett",1992,"Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence appears in Lal et al (1991) [PMID: 1716657].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses at intervals of 2 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484543,http://www.iedb.org/reference/1011506,Literature,1360328,,"M D Lairmore; D L Rudolph; B D Roberts; C S Dezzutti; R B Lal","Cancer Lett",1992,"Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence appears in Lal et al (1991) [PMID: 1716657].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo to prevent or reduce disease",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses at intervals of 2 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figure 2, 3","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Positive-Low,,,7,1,14.3,"After immunization with the epitope, rabbits were challenged with HTLV-infected cells. Serum samples from 6 of 7 rabbits had reactivity to gag gene products indicating a lack of protection. Six of 7 rabbit PBMC cultures were positive for HTLV, also indicating lack of protection.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1484546,http://www.iedb.org/reference/1011506,Literature,1360328,,"M D Lairmore; D L Rudolph; B D Roberts; C S Dezzutti; R B Lal","Cancer Lett",1992,"Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"Env-5 242-257",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence appears in Lal et al (1991) [PMID: 1716657].",,,,,,,,,,,,,,,,"Mus musculus Nude",https://ontology.iedb.org/ontology/ONTIE_0000546,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Txt p 17",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,10,10,100,"Both nu/nu as well as nu/+ mice responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485060,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,R99,,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLNQTARAFPDCA,,168,180,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-peptide antibodies competed with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485068,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,R21,,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LNQTARAFPDCAICWEPSPP,,169,188,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-peptide antibodies competed with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485069,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,R2659,,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VYNKTISGSGP,,195,205,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-peptide antibodies competed with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485070,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,R93,,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,,251,270,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-peptide antibodies competed with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485071,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/47986,"Linear peptide",PISLVNLSTASSAPPTRVRR,R91,,,282,301,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PISLVNLSTASSAPPTRVRR,,282,301,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Negative,,,,,,"Rabbit anti-peptide antibodies did not compete with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485072,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/61995,"Linear peptide",STVSSAPPTRVRR,R2664,,,256,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",STVSSAPPTRVRR,,256,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Negative,,,,,,"Rabbit anti-peptide antibodies did not compete with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485073,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/56937,"Linear peptide",SAPPTRVRR,R2651,,,260,268,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SAPPTRVRR,,260,268,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",intradermal,"3 doses of 1 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first 2 doses were given in CFA, while the last dose was in IFA.","Table 3, Table 2","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Rabbit anti-peptide antibodies competed with epitope-specific mAb(s) for binding to gp51.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485078,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/72113,"Linear peptide",VYNKTISGSGP,R2659,,,195,205,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B',,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485106,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/45990,"Linear peptide",NSSSFNTTQGWHHPSQRLLF,R93,,,251,270,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"D, D'",,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485108,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/47985,"Linear peptide",PISLVNLSTASS,"mAb epitope A (gp51 249-260)",,,282,293,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,A,,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485209,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/1864,"Linear peptide",AICWEPSPPWAPEILVYNKTISSSGP,"mAb epitope B (gp51 180-205)",,,213,238,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Epitope sequence can be found in Sagata et al (1985) Proc Natl Acad Sci USA 82:677-681 [2983308].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B,,,,"Source Antigen",Protein,"envelope polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1485567,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Table 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485568,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus ICR",https://ontology.iedb.org/ontology/ONTIE_0000526,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with a multi-epitope construct containing the epitope, HTLV-1 peptide SP2 (residues 86-107), tetanus toxin peptide (TT), and measles virus fusion protein peptide (MVF). The immunogen was  emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485569,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Antibody response was only observed when mice were immunized with the epitope linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Sera from 5 of 5 immunized mice showed binding to the epitope alone (without MVF sequence).",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485570,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C3H/He",https://ontology.iedb.org/ontology/ONTIE_0000037,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Antibody response was generated when the epitope was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Binding was also observed with the epitope alone (without MVF peptide) as antigen, but the titer was much lower.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485571,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"2 doses of 100 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 5, Figure 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Antibody response was generated when the epitope was linked or not linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence. Binding was also observed with the epitope alone (without MVF peptide) as antigen, but the titer was much lower.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485572,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"There was no difference in titers from immunization with epitope linked to a peptide (KLLSLIKGVIVHRLEGVEGPSL) containing measles virus fusion protein (MVF) sequence and from immunization with mixture of peptides containing the epitope, SP2 peptide (residues 86-107) and SP3 peptide (residues 176-169).",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKS,,162,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485573,http://www.iedb.org/reference/1008197,Literature,7545241,,"M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya","J Virol",1995,"Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"Peptide SP2",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,"12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,;Other;,subcutaneous,"500 μg, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were immunized with the peptide emulsified in squalene-arlacel supplemented with muramyl dipeptide.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1485999,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/37627,"Linear peptide",LLNQTARAFPDCA,R99,,,168,180,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"A, B, B', D, D'",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1486000,http://www.iedb.org/reference/1008256,Literature,1383413,,"J Ban; S Czene; C Altaner; I Callebaut; V Krchnak; M Merza; A Burny; R Kettmann; D Portetelle","J Gen Virol",1992,"Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.",http://www.iedb.org/epitope/38323,"Linear peptide",LNQTARAFPDCAICWEPSPP,R21,,,169,188,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"2 months",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of 500 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously and intravenously with gp51 or whole BLV particles. The first dose was given in CFA. Two and 4 weeks later, mice were injected with second dose in IFA and a third dose in NaCl. The last dose was given i.p. and i.v. two months later. Spleen cells were isolated 4 days after the last injection.","Tables 3, 2, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific mAb(s) recognized gp51. Binding was also observed in Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"A, B, B', D, D'",,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1486992,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/7611,"Linear peptide",DAPGYDPIWFL,"Env 166-176",,,166,176,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",DAPGYDPIWFL,,166,176,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486993,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/7611,"Linear peptide",DAPGYDPIWFL,"Env 166-176",,,166,176,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",DAPGYDPIWFL,,166,176,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1486994,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/46084,"Linear peptide",NTEPSQLPPTA,"Env 177-187",,,177,187,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",NTEPSQLPPTA,,177,187,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486995,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/62953,"Linear peptide",TAPPLLPHSNLDHILE,"Env 186-201",,,186,201,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",TAPPLLPHSNLDHILE,,186,201,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486996,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/27025,"Linear peptide",ILEPSIPWKSKLLTLV,"Env 199-214",,,199,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",ILEPSIPWKSKLLTLV,,199,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486997,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/29218,"Linear peptide",IVCIDRASLST,"Env 226-236",,,226,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",IVCIDRASLST,,226,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486998,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/70482,"Linear peptide",VPSSSSTPLLY,"Env 247-257",,,247,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",VPSSSSTPLLY,,247,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1486999,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/17247,"Linear peptide",FNWTHCFDPQI,"Env 271-281",,,271,281,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FNWTHCFDPQI,,271,281,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487000,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/60000,"Linear peptide",SPCHNSLILP,"Env 287-296",,,287,296,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPCHNSLILP,,287,296,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487001,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/6469,"Linear peptide",CKALQEQCRFPN,"Env 393-404",,,393,404,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",CKALQEQCRFPN,,393,404,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487002,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/46084,"Linear peptide",NTEPSQLPPTA,"Env 177-187",,,177,187,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",NTEPSQLPPTA,,177,187,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487003,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/62953,"Linear peptide",TAPPLLPHSNLDHILE,"Env 186-201",,,186,201,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",TAPPLLPHSNLDHILE,,186,201,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487004,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/27025,"Linear peptide",ILEPSIPWKSKLLTLV,"Env 199-214",,,199,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",ILEPSIPWKSKLLTLV,,199,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL27482.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487005,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/29218,"Linear peptide",IVCIDRASLST,"Env 226-236",,,226,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",IVCIDRASLST,,226,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487006,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/70482,"Linear peptide",VPSSSSTPLLY,"Env 247-257",,,247,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",VPSSSSTPLLY,,247,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487007,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/17247,"Linear peptide",FNWTHCFDPQI,"Env 271-281",,,271,281,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",FNWTHCFDPQI,,271,281,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487008,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/60000,"Linear peptide",SPCHNSLILP,"Env 287-296",,,287,296,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPCHNSLILP,,287,296,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487009,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/6469,"Linear peptide",CKALQEQCRFPN,"Env 393-404",,,393,404,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",CKALQEQCRFPN,,393,404,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487011,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/7612,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,"Env 166-201",,,166,201,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Human sera were from HTLV-1 carriers from Japan (n=87) and Jamaica (n=46).","Table I","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,133,114,85.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,,166,201,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487012,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/7612,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,"Env 166-201",,,166,201,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,,166,201,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487013,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/7612,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,"Env 166-201",,,166,201,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"Epitope sequence can be found in cited reference: Seiki et al (1983) Proc Natl Acad Sci USA 80:3618-3622 [6304725].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",DAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILE,,166,201,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487018,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/73571,"Linear peptide",YDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKFIQLT,"HTLV-2 RP-B2",,,166,213,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"Epitope sequence can be found in cited reference: Sodroski et al (1984) Science 225: 242 [PMID: 6204380].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from HTLV-2 intravenous drug users from New Orleans.","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,53,48,90.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKFIQLT,,166,213,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487021,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/57119,"Linear peptide",SCMVCVDRSSLSSW,"HTVL-2 env (220-233)",,,220,233,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"Epitope sequence can be found in cited reference: Sodroski et al (1984) Science 225: 242 [PMID: 6204380].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SCMVCVDRSSLSSW,,220,233,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Text page 2372","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1487022,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/57119,"Linear peptide",SCMVCVDRSSLSSW,"HTVL-2 env (220-233)",,,220,233,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"Epitope sequence can be found in cited reference: Sodroski et al (1984) Science 225: 242 [PMID: 6204380].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,"6 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SCMVCVDRSSLSSW,,220,233,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,";Freund's complete;",intradermal,"More than 1 dose of 50 µg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits received booster doses every 3 weeks after the initial injection.","Text page 2372","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1487697,http://www.iedb.org/reference/1010896,Literature,1717557,,"Y M Chen; X Q Zhang; C E Dahl; K P Samuel; R T Schooley; M Essex; T S Papas","J Immunol",1991,"Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.",http://www.iedb.org/epitope/73571,"Linear peptide",YDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKFIQLT,"HTLV-2 RP-B2",,,166,213,,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,"Epitope sequence can be found in cited reference: Sodroski et al (1984) Science 225: 242 [PMID: 6204380].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from HTLV-1 carriers from Japan (n=87) and Jamaica (n=46).","Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,71,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YDPLWFITSEPTQPPPTSPPLVHDSDLEHVLTPSTSWTTKILKFIQLT,,166,213,,"Envelope glycoprotein gp63 precursor",http://www.ncbi.nlm.nih.gov/protein/P03383.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1488452,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/58115,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,V1E1,,,342,363,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.BR",https://ontology.iedb.org/ontology/ONTIE_0000178,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,,342,363,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1488453,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/58115,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,V1E1,,,342,363,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.A(5R)",https://ontology.iedb.org/ontology/ONTIE_0000176,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,,342,363,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1488454,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/38523,"Linear peptide",LPHSNLDHILEPSIPWKSK,V1E8,,,191,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.BR",https://ontology.iedb.org/ontology/ONTIE_0000178,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSK,,191,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1488455,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/38523,"Linear peptide",LPHSNLDHILEPSIPWKSK,V1E8,,,191,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.A(5R)",https://ontology.iedb.org/ontology/ONTIE_0000176,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSK,,191,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1488456,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/18054,"Linear peptide",FTQEVSRLNINLHFSK,V1E10,,,141,156,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.BR",https://ontology.iedb.org/ontology/ONTIE_0000178,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FTQEVSRLNINLHFSK,,141,156,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1488457,http://www.iedb.org/reference/1009959,Literature,2528586,,"A Kurata; T J Palker; R D Streilein; R M Scearce; B F Haynes; J A Berzofsky","J Immunol",1989,"Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.",http://www.iedb.org/epitope/18054,"Linear peptide",FTQEVSRLNINLHFSK,V1E10,,,141,156,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus B10.A(5R)",https://ontology.iedb.org/ontology/ONTIE_0000176,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FTQEVSRLNINLHFSK,,141,156,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",intraperitoneal,"2 doses",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with 10 nmol of peptide in CFA and boosted with 5.6 µg of purified envelope protein in IFA 14 days later. Sera were collected at weekly intervals thereafter.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492046,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 1, 2, Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,39,100,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 45% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492053,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48870,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,"gag p19 100-119",,,100,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,25,25,100,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 13% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,,100,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492054,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48955,"Linear peptide",PPYVEPTAPQVL,"gag p19 119-130",,,119,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,25,19,76,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 7% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",PPYVEPTAPQVL,,119,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492056,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"gag p24 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 20% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492057,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"gag p24 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 10% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492058,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"env gp21 332-352",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 15% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,,332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492059,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/67993,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"env gp21 350-386",,,350,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 15% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,350,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492060,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"env gp21 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 20% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492061,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"env gp21 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 40% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492063,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/19193,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,"env gp46 20-49",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 10% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492065,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/64604,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,"env gp46 136-160",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,,,"Serum and CSF samples from HAM/TSP patients responded weakly to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 5% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492068,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"env gp46 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 50% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492069,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"env gp46 197-216",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 10% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492071,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"env gp46 213-236",,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 10% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492075,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,,,"Serum and CSF samples from HAM/TSP patients responded weakly to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 3% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492078,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"env gp46 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 20% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492084,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/6215,"Linear peptide",CFDPQIQAIVSSPCHN,"env gp46 277-292",,,276,291,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 30% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",CFDPQIQAIVSSPCHN,,276,291,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1492087,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/47023,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,"env gp46 288-317",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.  There was also evidence for intrathecal synthesis which may represent a pathogenic immune response in about 50% of the patients.",Other,"Entire Antibody",Polyclonal,"cerebrospinal fluid",IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1493393,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,"2-3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,,124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,";Freund's complete;",,"2 doses of 100ug administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the epitope alone, the epitope bound to KLH or BSA, or crosslinked peptide.","Figure 2 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,"Immunization with the epitope bound to KLH gave the best response.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Simian retrovirus 1 (Simian SRV-1 type D retrovirus)",SRV-1,,,,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1493397,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,"2-3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,,124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,";Freund's complete;",,"2 doses of 100ug administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the epitope alone, the epitope bound to KLH or BSA, or crosslinked peptide.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,3,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Sibling",Organism,"Simian retrovirus 2 (Simian SRV-2 retrovirus)",SRV-2,,,,,,,,"Simian retrovirus 2",http://purl.obolibrary.org/obo/NCBITaxon_39068,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1493402,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,"2-3 months",,"Administration in vivo",,,,"Source Antigen",Protein,"env polyprotein - simian AIDS retrovirus SRV-1",rEP,,,http://www.ncbi.nlm.nih.gov/protein/VCLJSA,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen resembles a truncated form of SRV-1 native envelope protein with a molecular weight of 52kDa.","Figure 1A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The binding of cross-linked peptide 142-167 with anti-rEP was measured.",Serum,Fab,Polyclonal,,IgG,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,rEP,124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1493611,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,"2-3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,";Freund's complete;",,"2 doses of 100ug administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with peptide 142-167-KLH conjugate, with peptide 142-167-BSA conjugate, with cross-linked peptide 142-167, or with the free peptide 142-167.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"env polyprotein - simian AIDS retrovirus SRV-1",rEP,,,http://www.ncbi.nlm.nih.gov/protein/VCLJSA,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1493642,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"env polyprotein - simian AIDS retrovirus SRV-1","SRV-1 rEP",,,http://www.ncbi.nlm.nih.gov/protein/VCLJSA,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,";Freund's complete;",subcutaneous,"2 doses of 100ug, and 1 dose of 50ug, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the antibody generation were provided by the cited reference Werner et al, Molec Immun. 28(8) 1991 [PMID:1715026].","Figure 1B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The binding of cross-linked (CL) peptide 142-167 with mAb C11B8 was measured.","Purified Immunoglobulin","Entire Antibody",Monoclonal,C11B8,IgG1,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"CL 142-167",124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1494986,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"gag p19 100-130",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 1, 2, Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1494995,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48870,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,"gag p19 100-119",,,100,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 1, 2, Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,25,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,,100,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1494996,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/48955,"Linear peptide",PPYVEPTAPQVL,"gag p19 119-130",,,119,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 1, 2, Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,25,21,84,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPYVEPTAPQVL,,119,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1494998,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"gag p24 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495002,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"gag p24 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495003,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/19891,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,"env gp21 332-352",,,332,353,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDKD,,332,353,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495008,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/67993,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"env gp21 350-386",,,350,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,350,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495009,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"env gp21 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495010,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"env gp21 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495011,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/19193,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,"env gp46 20-49",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPGNPAQPVCS,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495012,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/64604,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,"env gp46 136-160",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPYL,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495019,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"env gp46 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495020,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"env gp46 197-216",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495029,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"env gp46 213-236",,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,213,236,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495030,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"env gp46 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495031,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"env gp46 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495032,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/6215,"Linear peptide",CFDPQIQAIVSSPCHN,"env gp46 277-292",,,276,291,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CFDPQIQAIVSSPCHN,,276,291,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495034,http://www.iedb.org/reference/1006785,Literature,8741079,,"B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame","J Neurol",1996,"Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.",http://www.iedb.org/epitope/47023,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,"env gp46 288-317",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum or CSF samples from patients with tropical spastic paraplegia/HTLV-1-Associated Myelopathy (HAM/TSP).","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,,,"Serum and CSF samples from HAM/TSP patients responded to the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPVPTLGSRRAVPVA,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495576,http://www.iedb.org/reference/1006403,Literature,9609528,,"T P Loughran Jr; K G Hadlock; R Perzova; T C Gentile; Q Yang; S K Foung; B J Poiesz","Br J Haematol",1998,"Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.",http://www.iedb.org/epitope/50673,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,BA21,,,397,430,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera from healthy subjects were used.","Text p 322","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,78,11,14.1,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QEQCRFPNITNSHVSILQERPPLENRVLTGWGLN,,397,430,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1495595,http://www.iedb.org/reference/1008419,Literature,1652065,,"J V Torres; L L Werner; A Malley; E Benjamini","Mol Immunol",1991,"The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).",http://www.iedb.org/epitope/39816,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,"Peptide 142-167",,,124,149,,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,,,,,,,,,,,,,,,,,"Mus musculus BALB/c X A/J",https://ontology.iedb.org/ontology/ONTIE_0000014,,,,"2-3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LTATMIRDKSPSSGDGNVPTILGNNQ,,124,149,,"env polyprotein - simian AIDS retrovirus SRV-1",http://www.ncbi.nlm.nih.gov/protein/VCLJSA,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P04027,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855,";Freund's complete;",,"2 doses of 100ug administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with the epitope alone, the epitope bound to KLH or BSA, or crosslinked peptide.","Figure 2 and Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,3,3,100,"Immunization with the epitope bound to KLH gave the best response.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Simian retrovirus 1 (Simian SRV-1 type D retrovirus)",SRV-1,,,,,,,,"Simian retrovirus 1",http://purl.obolibrary.org/obo/NCBITaxon_11942,"Mason-Pfizer monkey virus",http://purl.obolibrary.org/obo/NCBITaxon_11855
http://www.iedb.org/assay/1498129,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/42289,"Linear peptide",MPKTRRQRTRRARRNRPPTP,G12Rex1,,,1,20,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/CAA61542.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,1,1.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MPKTRRQRTRRARRNRPPTP,,1,20,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/CAA61542.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498143,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/55275,"Linear peptide",RPPTPWPISQDSDRASYMDT,G12Rex2,,,16,35,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,3,5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RPPTPWPISQDSDRASYMDT,,16,35,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498144,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/62650,"Linear peptide",SYMDTPSTCLAIVYRPIGVP,G12Rex3,,,31,50,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,1,1.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYMDTPSTCLAIVYRPIGVP,,31,50,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498145,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/47910,"Linear peptide",PIGVPSQVVYVPPAYIDMPS,G12Rex4,,,46,65,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,9,15,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PIGVPSQVVYVPPAYIDMPS,,46,65,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498146,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/25631,"Linear peptide",IDMPSWPPVQSTSSPGTPSM,G12Rex5,,,61,80,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,7,11.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IDMPSWPPVQSTSSPGTPSM,,61,80,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498147,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/22786,"Linear peptide",GTPSMDALSALLSNTLSLAS,G12Rex6,,,76,95,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,4,6.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GTPSMDALSALLSNTLSLAS,,76,95,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498148,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/39473,"Linear peptide",LSLASPPSPPREPPRPSRSL,G12Rex7,,,91,110,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,4,6.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSLASPPSPPREPPRPSRSL,,91,110,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498149,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/49498,"Linear peptide",PSRSLPLPPLLSPPRFHPPS,G12Rex8,,,106,125,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,1,1.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PSRSLPLPPLLSPPRFHPPS,,106,125,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498150,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/16132,"Linear peptide",FHPPSSNQCESTPPIAMDAW,G12Rex9,,,121,140,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,25,41.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FHPPSSNQCESTPPIAMDAW,,121,140,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498151,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/3069,"Linear peptide",AMDAWNQPSGISSPPSPSLN,G12Rex10,,,136,155,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,2,3.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AMDAWNQPSGISSPPSPSLN,,136,155,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498152,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/60259,"Linear peptide",SPSLNLASVPKTSTPPGEKP,G12Rex11,,,151,170,,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,1,1.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPSLNLASVPKTSTPPGEKP,,151,170,,rex,http://www.ncbi.nlm.nih.gov/protein/AAA45412.1,"Protein Rex",http://www.uniprot.org/uniprot/Q85601,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498161,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/41048,"Linear peptide",MAHFPGFGQSLLYGYPVYVF,G12Tax1,,,1,20,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,6,10,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MAHFPGFGQSLLYGYPVYVF,,1,20,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498162,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/50022,"Linear peptide",PVYVFGDCVQADWCPVSGGL,G12Tax2,,,16,35,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,5,8.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PVYVFGDCVQADWCPVSGGL,,16,35,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498163,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/70950,"Linear peptide",VSGGLCSTRLHRHALLATCP,G12Tax3,,,31,50,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,6,10,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSGGLCSTRLHRHALLATCP,,31,50,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498164,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/34981,"Linear peptide",LATCPEHQLTWDPIDGRVVS,G12Tax4,,,46,65,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,5,8.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LATCPEHQLTWDPIDGRVVS,,46,65,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498165,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/22248,"Linear peptide",GRVVSSPLQYLIPRLPSFPT,G12Tax5,,,61,80,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,60,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GRVVSSPLQYLIPRLPSFPT,,61,80,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498166,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/49366,"Linear peptide",PSFPTQRTSKTLKVLTPPTT,G12Tax6,,,76,95,,,tax,http://www.ncbi.nlm.nih.gov/protein/CAA73490.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,4,6.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PSFPTQRTSKTLKVLTPPTT,,76,95,,tax,http://www.ncbi.nlm.nih.gov/protein/CAA73490.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498167,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/65699,"Linear peptide",TPPTTPVSPKVPPAFFQSMR,G12Tax7,,,91,110,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,6,10,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TPPTTPVSPKVPPAFFQSMR,,91,110,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498168,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/17535,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,G12Tax8,,,106,125,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,14,23.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FQSMRKHTPYRNGCLEPTLG,,106,125,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498169,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/13771,"Linear peptide",EPTLGDQLPSLAFPEPGLRP,G12Tax9,,,121,140,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,60,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EPTLGDQLPSLAFPEPGLRP,,121,140,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498170,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/74479,"Linear peptide",YKMFLHTGAVIVLPEDDLPT,G12Tax14,,,196,215,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,2,3.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YKMFLHTGAVIVLPEDDLPT,,196,215,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498172,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/7822,"Linear peptide",DDLPTTMFQPVRAPCIQTAW,G12Tax15,,,211,230,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,14,23.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DDLPTTMFQPVRAPCIQTAW,,211,230,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498173,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/28234,"Linear peptide",IQTAWCTGLLPYHSILTTPG,G12Tax16,,,226,245,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,60,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IQTAWCTGLLPYHSILTTPG,,226,245,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498174,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/41775,"Linear peptide",MISGPCPKAGQPSLVVQSSL,G12Tax18,,,256,275,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,3,5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MISGPCPKAGQPSLVVQSSL,,256,275,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498175,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/57789,"Linear peptide",SFHNLHLLFDEYTNIPVSIL,G12Tax21,,,301,320,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,2,3.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SFHNLHLLFDEYTNIPVSIL,,301,320,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498176,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/76132,"Linear peptide",YTNIPVSILFNKEEADDNGD,G12Tax22,,,312,331,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,24,40,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YTNIPVSILFNKEEADDNGD,,312,331,,tax,http://www.ncbi.nlm.nih.gov/protein/AAG48731.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498177,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/7833,"Linear peptide",DDNGDRPPEPAAQGESSTQK,G12Tax23,,,327,346,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAA45411.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,22,36.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DDNGDRPPEPAAQGESSTQK,,327,346,,tax,http://www.ncbi.nlm.nih.gov/protein/AAA45411.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1498178,http://www.iedb.org/reference/1012805,Literature,7622904,,"D Pardi; J E Coligan; R B Lal","J Infect Dis",1995,"Mapping of linear epitopes of the regulatory proteins of human T cell lymphotropic virus (HTLV) type II: identification of an HTLV-IIb-restricted epitope.",http://www.iedb.org/epitope/387,"Linear peptide",AAQGESSTQKVRPSHTNNPK,G12Tax24,,,337,356,,,tax,http://www.ncbi.nlm.nih.gov/protein/AAA45411.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Donors were a group of HTLV-2-infected Guaymi Indians.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,60,48,80,"In further studies, it was shown that seroreactivity to the epitope is linked to infection with HTLV-IIb viruses. This is reinforced by the fact that the epitope represents the carboxyl terminus of the extended TaxII protein which is a  region of protein that does not exist in HTLV-IIa viruses. By testing various populations for reactivity with the epitope, it was found that the seropositivity within the US IDU population was low (10%) and closely paralleled the US blood donor population (9.3%). Within the Amerindian populations, the Guaymi had the highest reactivity to the peptide (78.7%), followed by the Wayuu (50%), the Seminole (33.3%), the Navajo and Pueblo (22.8%), and other Southwest Indians (18.2%).",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AAQGESSTQKVRPSHTNNPK,,337,356,,tax,http://www.ncbi.nlm.nih.gov/protein/AAA45411.1,"Protein Tax-2",http://www.uniprot.org/uniprot/P03410,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1501420,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/75278,"Linear peptide",YPEKAVLDEYDYRYNRPK,"PERV Env 417-434",,,444,461,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was shown to block binding of the monoclonal antibody to Env 332-615.","Purified Immunoglobulin","Entire Antibody",Monoclonal,8E10,,,,Epitope,"Linear peptide",YPEKAVLDEYDYRYNRPK,,444,461,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1501426,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/30399,"Linear peptide",KEGGLSVALKEECCFYVDHSG,"PERV Env 517-537",,,517,537,,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Peptide fragments were used in ELISA and competition analysis to deduce the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,7C4,,,,"Fragment of Source Antigen","Linear peptide",ALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLSVALKEECCFYVDHSGAI,,460,539,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1501428,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/75278,"Linear peptide",YPEKAVLDEYDYRYNRPK,"PERV Env 417-434",,,444,461,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb was shown to neutralize porcine endogenous retrovirus infection.","Purified Immunoglobulin","Entire Antibody",Monoclonal,8E10,,,,"Source Organism",Organism,"Porcine endogenous retrovirus A (porcine endogenous retrovirus subclass A)",,,,,,,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1501429,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/30399,"Linear peptide",KEGGLSVALKEECCFYVDHSG,"PERV Env 517-537",,,517,537,,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb was shown to neutralize porcine endogenous retrovirus infection.","Purified Immunoglobulin","Entire Antibody",Monoclonal,7C4,,,,"Source Organism",Organism,"Porcine endogenous retrovirus A (porcine endogenous retrovirus subclass A)",,,,,,,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1501430,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/75278,"Linear peptide",YPEKAVLDEYDYRYNRPK,"PERV Env 417-434",,,444,461,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 6",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"The epitope-specific neutralizing mAb was shown to precipitate intact virions, suggesting that the mAb exerts neutralization activity through direct binding to the Env protein on the virions.","Purified Immunoglobulin","Entire Antibody",Monoclonal,8E10,,,,"Source Organism",Organism,"Porcine endogenous retrovirus A (porcine endogenous retrovirus subclass A)",,,,,,,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1501431,http://www.iedb.org/reference/1006057,Literature,17222436,,"Chen-Yi Chiang; Yun-Ru Pan; Li-Fang Chou; Chih-Yeu Fang; Shih-Rong Wang; Chiou-Ying Yang; Hwan-You Chang",Virology,2007,"Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.",http://www.iedb.org/epitope/30399,"Linear peptide",KEGGLSVALKEECCFYVDHSG,"PERV Env 517-537",,,517,537,,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SGPPYYEGMARGGKFNVTKEHRDQCTWGSQNKLTLTEVSGKGTCIGMVPPSHQHLCNHTEAFNRTSESQYLVPGYDRWWACNTGLTPCVSTLVFNQTKDFCVMVQIVPRVYYYPEKAVLDEYDYRYNRPKREPISLTLAVMLGLGVAAGVGTGTAALITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFNRSPWMTTLLSALTGPLVVL,,332,615,,"transmembrane envelope protein",https://ontology.iedb.org/ontology/ONTIE_0002341,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Details about the immunization protocol were not provided in the manuscript.","Figure 6",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Negative,,,,,,"The epitope-specific neutralizing mAb did not  precipitate intact virions, suggesting that the mAb does not exert neutralization activity through direct binding to the Env protein on the virions.","Purified Immunoglobulin","Entire Antibody",Monoclonal,7C4,,,,"Source Organism",Organism,"Porcine endogenous retrovirus A (porcine endogenous retrovirus subclass A)",,,,,,,,,"Porcine endogenous retrovirus A",http://purl.obolibrary.org/obo/NCBITaxon_194958,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1506506,http://www.iedb.org/reference/1013017,Literature,15223246,,"J Fujimori; I Nakashima; K Fujihara; J Feng; M Yamamoto; N Yamamoto; N Begum; Y Sagara; H Shiraki; Y Shiga; J Onodera; S Sato; S Takase; M Asano; M Endo; Y Itoyama","J Neuroimmunol",2004,"Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.",http://www.iedb.org/epitope/78311,"Linear peptide",WHVLYSP,"gp46 237-243",,,237,243,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HAM/TSP individuals.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,2,2,100,"The epitope competed with a phage containing a mimotope (WHELYSP) of the epitope for binding to serum IgG from HAM/TSP individuals.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WHVLYSP,,237,243,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506508,http://www.iedb.org/reference/1013017,Literature,15223246,,"J Fujimori; I Nakashima; K Fujihara; J Feng; M Yamamoto; N Yamamoto; N Begum; Y Sagara; H Shiraki; Y Shiga; J Onodera; S Sato; S Takase; M Asano; M Endo; Y Itoyama","J Neuroimmunol",2004,"Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.",http://www.iedb.org/epitope/78233,"Linear peptide",PHSNLDHI,"gp46 192-199",,,192,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HAM/TSP individuals.","Figures 2 and 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,2,2,100,"The epitope competed with a phage containing a mimotope (PHTNLDHF) of the epitope for binding to serum IgG from HAM/TSP individuals. Competition was also observed by Western blotting.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHSNLDHI,,192,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506509,http://www.iedb.org/reference/1013017,Literature,15223246,,"J Fujimori; I Nakashima; K Fujihara; J Feng; M Yamamoto; N Yamamoto; N Begum; Y Sagara; H Shiraki; Y Shiga; J Onodera; S Sato; S Takase; M Asano; M Endo; Y Itoyama","J Neuroimmunol",2004,"Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.",http://www.iedb.org/epitope/78195,"Linear peptide",LLYPSLA,"gp46 255-261",,,255,261,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were obtained from HAM/TSP individuals.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,2,0,0,"The epitope did not compete with a phage containing a mimotope of the epitope for binding to serum IgG from HAM/TSP individuals.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLYPSLA,,255,261,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506882,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48870,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,"p19 gag 100-119",,,100,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,,100,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506891,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48955,"Linear peptide",PPYVEPTAPQVL,"p19 gag 119-130",,,119,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPYVEPTAPQVL,,119,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506892,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"p24 gag 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506893,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"p24 gag 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was weakly positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, and negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506894,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78162,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,"gp46 env 20-49",,,20,49,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell lymphotrophic virus type 1 (strain ATK) (Human T-cell leukemia virus type I (strain ATK))",,,,,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,,20,49,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506895,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78280,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,"gp46 env 89-115",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506896,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 env 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506897,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"gp46 env 213-236",,,193,216,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, and highly reactive with sera from patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,193,216,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506898,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 env 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, and was highly reactive with sera from patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506899,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 env 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506900,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78153,"Linear peptide",FDPQIQAIVSSPCHNS,"gp46 env 277-292",,,277,292,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FDPQIQAIVSSPCHNS,,277,292,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506901,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,"gp46 env 288-317",,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,,288,317,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506902,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78166,"Linear peptide",GGITGSMSLASGKSLLHEVDK,"p20E env 332-352",,,332,352,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was weakly positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but highly reactive with sear from patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDK,,332,352,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506903,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/14645,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"p20E env 350-386",,,349,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,349,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506904,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"p20E env 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was weakly positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but showed moderate reactivity with sera from patients with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506905,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78114,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,"p20E env 400-429",,,400,429,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,,400,429,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506906,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/23247,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"p20E env 426-448",,,426,448,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,,426,448,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1506907,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"p20E env 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507461,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78609,"Linear peptide",ANPSPHQVYN,"FeLV-B peptide A (1-10)",,,34,43,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ANPSPHQVYN,Peptide-KLH,34,43,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ANPSPHQVYN,,34,43,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507462,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78819,"Linear peptide",RRWQQRNTPFY,"FeLV-B peptide B (70-80)",,,103,113,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRWQQRNTPFY,Peptide-KLH,103,113,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RRWQQRNTPFY,,103,113,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507463,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78615,"Linear peptide",CPGHANRKQCGG,"FeLV-B peptide C (82-93)",,,115,126,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPGHANRKQCGG,Peptide-KLH,115,126,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPGHANRKQCGG,,115,126,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507464,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78628,"Linear peptide",DQKPPSR,"FeLV-B peptide D (221-227)",,,254,260,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSR,Peptide-KLH,254,260,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DQKPPSR,,254,260,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507465,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78806,"Linear peptide",QSQIESR,"FeLV-B peptide E (228-234)",,,261,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QSQIESR,Peptide-KLH,261,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QSQIESR,,261,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507466,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78629,"Linear peptide",DQKPPSRQSQIESR,"FeLV-B peptide F (221-234)",,,254,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSRQSQIESR,Peptide-KLH,254,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DQKPPSRQSQIESR,,254,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507467,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78836,"Linear peptide",SPKRIGTGDR,"FeLV-B peptide G (267-276)",,,300,309,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPKRIGTGDR,Peptide-KLH,300,309,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPKRIGTGDR,,300,309,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507468,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78895,"Linear peptide",YTHFAKAARFRR,"FeLV-B peptide H (421-432)",,,454,465,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YTHFAKAARFRR,Peptide-KLH,454,465,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTHFAKAARFRR,,454,465,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507469,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78637,"Linear peptide",EKSLTSLSE,"FeLV-B peptide I (490-498)",,,523,531,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSE,Peptide-KLH,523,531,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EKSLTSLSE,,523,531,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507470,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78638,"Linear peptide",EKSLTSLSEVVLQNRRGLD,"FeLV-B peptide J (490-508)",,,523,541,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSEVVLQNRRGLD,Peptide-KLH,523,541,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EKSLTSLSEVVLQNRRGLD,,523,541,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507471,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78707,"Linear peptide",KLRERLKQR,"FeLV-B peptide K (541-549)",,,574,582,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KLRERLKQR,Peptide-KLH,574,582,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KLRERLKQR,,574,582,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507472,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78711,"Linear peptide",KQYDPDRP,"FeLV-B peptide L (622-629)",,,655,662,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQYDPDRP,Peptide-KLH,655,662,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KQYDPDRP,,655,662,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507473,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78668,"Linear peptide",GPNLVLPDQK,"FeLV-A peptide M (205-214)",,,247,256,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPNLVLPDQK,Peptide-KLH,247,256,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPNLVLPDQK,,247,256,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507474,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78667,"Linear peptide",GPKRIRTGDR,"FeLV-A peptide N (247-256)",,,,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPKRIRTGDR,Peptide-KLH,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPKRIRTGDR,,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507475,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78609,"Linear peptide",ANPSPHQVYN,"FeLV-B peptide A (1-10)",,,34,43,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ANPSPHQVYN,Peptide-KLH,34,43,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507477,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78609,"Linear peptide",ANPSPHQVYN,"FeLV-B peptide A (1-10)",,,34,43,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ANPSPHQVYN,Peptide-KLH,34,43,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507478,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78819,"Linear peptide",RRWQQRNTPFY,"FeLV-B peptide B (70-80)",,,103,113,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRWQQRNTPFY,Peptide-KLH,103,113,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507479,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78819,"Linear peptide",RRWQQRNTPFY,"FeLV-B peptide B (70-80)",,,103,113,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RRWQQRNTPFY,Peptide-KLH,103,113,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507480,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78615,"Linear peptide",CPGHANRKQCGG,"FeLV-B peptide C (82-93)",,,115,126,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPGHANRKQCGG,Peptide-KLH,115,126,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507481,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78615,"Linear peptide",CPGHANRKQCGG,"FeLV-B peptide C (82-93)",,,115,126,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPGHANRKQCGG,Peptide-KLH,115,126,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507482,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78628,"Linear peptide",DQKPPSR,"FeLV-B peptide D (221-227)",,,254,260,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSR,Peptide-KLH,254,260,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507483,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78628,"Linear peptide",DQKPPSR,"FeLV-B peptide D (221-227)",,,254,260,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSR,Peptide-KLH,254,260,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507484,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78806,"Linear peptide",QSQIESR,"FeLV-B peptide E (228-234)",,,261,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QSQIESR,Peptide-KLH,261,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507485,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78806,"Linear peptide",QSQIESR,"FeLV-B peptide E (228-234)",,,261,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QSQIESR,Peptide-KLH,261,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507486,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78629,"Linear peptide",DQKPPSRQSQIESR,"FeLV-B peptide F (221-234)",,,254,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSRQSQIESR,Peptide-KLH,254,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507487,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78629,"Linear peptide",DQKPPSRQSQIESR,"FeLV-B peptide F (221-234)",,,254,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSRQSQIESR,Peptide-KLH,254,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507488,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78836,"Linear peptide",SPKRIGTGDR,"FeLV-B peptide G (267-276)",,,300,309,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPKRIGTGDR,Peptide-KLH,300,309,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507489,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78836,"Linear peptide",SPKRIGTGDR,"FeLV-B peptide G (267-276)",,,300,309,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPKRIGTGDR,Peptide-KLH,300,309,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507490,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78895,"Linear peptide",YTHFAKAARFRR,"FeLV-B peptide H (421-432)",,,454,465,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YTHFAKAARFRR,Peptide-KLH,454,465,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507491,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78895,"Linear peptide",YTHFAKAARFRR,"FeLV-B peptide H (421-432)",,,454,465,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YTHFAKAARFRR,Peptide-KLH,454,465,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507492,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78637,"Linear peptide",EKSLTSLSE,"FeLV-B peptide I (490-498)",,,523,531,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSE,Peptide-KLH,523,531,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507493,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78637,"Linear peptide",EKSLTSLSE,"FeLV-B peptide I (490-498)",,,523,531,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSE,Peptide-KLH,523,531,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507494,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78638,"Linear peptide",EKSLTSLSEVVLQNRRGLD,"FeLV-B peptide J (490-508)",,,523,541,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSEVVLQNRRGLD,Peptide-KLH,523,541,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507495,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78638,"Linear peptide",EKSLTSLSEVVLQNRRGLD,"FeLV-B peptide J (490-508)",,,523,541,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSEVVLQNRRGLD,Peptide-KLH,523,541,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,6,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507496,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78707,"Linear peptide",KLRERLKQR,"FeLV-B peptide K (541-549)",,,574,582,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KLRERLKQR,Peptide-KLH,574,582,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507497,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78707,"Linear peptide",KLRERLKQR,"FeLV-B peptide K (541-549)",,,574,582,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KLRERLKQR,Peptide-KLH,574,582,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507498,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78711,"Linear peptide",KQYDPDRP,"FeLV-B peptide L (622-629)",,,655,662,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQYDPDRP,Peptide-KLH,655,662,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507499,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78711,"Linear peptide",KQYDPDRP,"FeLV-B peptide L (622-629)",,,655,662,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQYDPDRP,Peptide-KLH,655,662,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507500,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78668,"Linear peptide",GPNLVLPDQK,"FeLV-A peptide M (205-214)",,,247,256,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPNLVLPDQK,Peptide-KLH,247,256,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"unnamed protein product",gp85,,,http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507501,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78668,"Linear peptide",GPNLVLPDQK,"FeLV-A peptide M (205-214)",,,247,256,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPNLVLPDQK,Peptide-KLH,247,256,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507502,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78667,"Linear peptide",GPKRIRTGDR,"FeLV-A peptide N (247-256)",,,,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPKRIRTGDR,Peptide-KLH,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Protein,"Env polyprotein",gp85,,,https://ontology.iedb.org/ontology/ONTIE_0002571,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507503,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78667,"Linear peptide",GPKRIRTGDR,"FeLV-A peptide N (247-256)",,,,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/ontology/ONTIE_0000987,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",GPKRIRTGDR,Peptide-KLH,,,,"Env polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002571,,,"Feline leukemia virus subtype A",https://ontology.iedb.org/taxon/10001130,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507505,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78615,"Linear peptide",CPGHANRKQCGG,"FeLV-B peptide C (82-93)",,,115,126,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",CPGHANRKQCGG,Peptide-KLH,115,126,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507508,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78628,"Linear peptide",DQKPPSR,"FeLV-B peptide D (221-227)",,,254,260,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSR,Peptide-KLH,254,260,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507509,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78629,"Linear peptide",DQKPPSRQSQIESR,"FeLV-B peptide F (221-234)",,,254,267,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DQKPPSRQSQIESR,Peptide-KLH,254,267,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507510,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78836,"Linear peptide",SPKRIGTGDR,"FeLV-B peptide G (267-276)",,,300,309,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPKRIGTGDR,Peptide-KLH,300,309,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507511,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78638,"Linear peptide",EKSLTSLSEVVLQNRRGLD,"FeLV-B peptide J (490-508)",,,523,541,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKSLTSLSEVVLQNRRGLD,Peptide-KLH,523,541,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507512,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78707,"Linear peptide",KLRERLKQR,"FeLV-B peptide K (541-549)",,,574,582,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KLRERLKQR,Peptide-KLH,574,582,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507513,http://www.iedb.org/reference/1010684,Literature,1689371,,"S Nick; J Klaws; K Friebel; C Birr; G Hunsmann; H Bayer","J Gen Virol",1990,"Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.",http://www.iedb.org/epitope/78711,"Linear peptide",KQYDPDRP,"FeLV-B peptide L (622-629)",,,655,662,,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQYDPDRP,Peptide-KLH,655,662,,"unnamed protein product",http://www.ncbi.nlm.nih.gov/protein/CAA25008.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Gardner-Arnstein feline leukemia oncovirus B",http://purl.obolibrary.org/obo/NCBITaxon_11824,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1507690,http://www.iedb.org/reference/1006399,Literature,9882322,,"K G Hadlock; J Rowe; S K Foung","J Virol",1999,"The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.",http://www.iedb.org/epitope/78192,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQAIVSSPCHNSLI,"HTLV-1 gp46 (260-294)",,,260,294,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Baba et al. (1993) J Immunol 151: 1013-1024 [PMID: 7687611].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in the reference cited: Hadlock et al. (1997) J Virol 71: 5828-5840 [PMID: 9223472]. Peripheral B cells were derived from a patient with HAM/TSP and human hybridomas were produced after activation of the B cells with EBV and electrofusion to heteromyeloma cells.","Figure  2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific HMAb PRH-1 was used to capture HTLV-1 gp46 from lysates of the HTLV-1-infected MT-2 cell line.",,"Entire Antibody",Monoclonal,PRH-1,IgG1,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507691,http://www.iedb.org/reference/1006399,Literature,9882322,,"K G Hadlock; J Rowe; S K Foung","J Virol",1999,"The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.",http://www.iedb.org/epitope/78246,"Linear peptide",PPLLPH,"HTLV-1 gp46 (188-193)",,,188,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Ralston et al. (1989) J Biol Chem 264: 16343-16346 [PMID: 2476442].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Generation of the human monoclonal antibody was previously described in the reference cited: Matsushita et al. (1986) Proc Natl Acad Sci USA 83 2672-2676 [PMID: 2422659]. B cells were isolated from lymph node cells obtained from a serpositive patient with ATL and exposed to EBV (B95-8 strain). The cells were cloned by limiting dilution and the antibody producing clone 0.5 alpha was isolated.","Figure  2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific HMAb 0.5 alpha bound to HTLV-1 gp46 from lysates of the HTLV-1-infected MT-2 cell line.",,"Entire Antibody",Monoclonal,"0.5 alpha",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507693,http://www.iedb.org/reference/1006399,Literature,9882322,,"K G Hadlock; J Rowe; S K Foung","J Virol",1999,"The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 (190-209)",,,190,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Baba et al. (1993) J Immunol 151: 1013-1024 [PMID: 7687611].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-1 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in the reference cited: Papsidero et al. (1992) J Clin Microbiol 30: 351-358 [PMID: 1371516]. Mice were immunized with HTLV-1 protein and boosted with recombinant HTLV-1 envelope proteins.","Figure  2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mouse mAb CLN 68 bound to HTLV-1 gp46 from lysates of the HTLV-1-infected MT-2 cell line.",,"Entire Antibody",Monoclonal,"CLN 68",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507694,http://www.iedb.org/reference/1006399,Literature,9882322,,"K G Hadlock; J Rowe; S K Foung","J Virol",1999,"The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"HTLV-1 gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Baba et al. (1993) J Immunol 151: 1013-1024 [PMID: 7687611].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-1 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in the reference cited: Papsidero et al. (1992) J Clin Microbiol 30: 351-358 [PMID: 1371516]. Mice were immunized with HTLV-1 protein and boosted with recombinant HTLV-1 envelope proteins.","Figure  2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mouse mAb CLN 67 bound to HTLV-1 gp46 from lysates of the HTLV-1-infected MT-2 cell line.",,"Entire Antibody",Monoclonal,"CLN 67",,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507696,http://www.iedb.org/reference/1006399,Literature,9882322,,"K G Hadlock; J Rowe; S K Foung","J Virol",1999,"The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.",http://www.iedb.org/epitope/47022,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRR,"HTLV-1 gp46 (288-312)",,,288,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Baba et al. (1993) J Immunol 151: 1013-1024 [PMID: 7687611].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-1 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in the reference cited: Papsidero et al. (1992) J Clin Microbiol 30: 351-358 [PMID: 1371516]. Mice were immunized with HTLV-1 protein and boosted with recombinant HTLV-1 envelope proteins.","Figure  3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mouse mAb CLN 67 was used to capture HTLV-1 gp46 from lysates of the HTLV-1-infected MT-2 cell line. MAb CLN 67 reduced the binding of human mAb PRH-1, which recognizes residues 260-294, to HTLV-1 gp46.",,"Entire Antibody",Monoclonal,"CLN 67",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1507709,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78462,"Linear peptide",MASVVGWGPHSLHACPALVL,"BLV tax peptide 1 (1-20)",,,1,20,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MASVVGWGPHSLHACPALVL,,1,20,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507710,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78520,"Linear peptide",SLHACPALVLSNDVTIDAWC,"BLV tax peptide 2 (11-30)",,,11,30,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLHACPALVLSNDVTIDAWC,,11,30,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507711,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78523,"Linear peptide",SNDVTIDAWCPLCGPHERLQ,"BLV tax peptide 3 (21-40)",,,21,40,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNDVTIDAWCPLCGPHERLQ,,21,40,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507712,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78484,"Linear peptide",PLCGPHERLQFERIDTTLTC,"BLV tax peptide 4 (31-50)",,,31,50,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PLCGPHERLQFERIDTTLTC,,31,50,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507713,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78380,"Linear peptide",FERIDTTLTCETHRINWTAD,"BLV tax peptide 5 (41-60)",,,41,60,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FERIDTTLTCETHRINWTAD,,41,60,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507714,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78378,"Linear peptide",ETHRINWTADGRPCGLNGTL,"BLV tax peptide 6 (51-70)",,,51,70,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ETHRINWTADGRPCGLNGTL,,51,70,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507715,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78409,"Linear peptide",GRPCGLNGTLFPRLHVSETR,"BLV tax peptide 7 (61-80)",,,61,80,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GRPCGLNGTLFPRLHVSETR,,61,80,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507716,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78387,"Linear peptide",FPRLHVSETRPQGPRRLWIN,"BLV tax peptide 8 (71-90)",,,71,90,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FPRLHVSETRPQGPRRLWIN,,71,90,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507717,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78487,"Linear peptide",PQGPRRLWINCPLPAVRAQ,"BLV tax peptide 9 (81-100)",,,81,99,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PQGPRRLWINCPLPAVRAQ,,81,99,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507718,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78352,"Linear peptide",CPLPAVRAQPGPVSLSPFER,"BLV tax peptide 10 (91-110)",,,91,110,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPLPAVRAQPGPVSLSPFER,,91,110,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507719,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78406,"Linear peptide",GPVSLSPFERSPFQPYQCQL,"BLV tax peptide 11 (101-120)",,,101,120,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPVSLSPFERSPFQPYQCQL,,101,120,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507720,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78525,"Linear peptide",SPFQPYQCQLPSASSDGC,"BLV tax peptide 12 (111-130)",,,111,128,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPFQPYQCQLPSASSDGC,,111,128,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507721,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78489,"Linear peptide",PSASSDGCPIIGHGLLPWNN,"BLV tax peptide 13 (121-140)",,,121,140,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSASSDGCPIIGHGLLPWNN,,121,140,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507722,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78419,"Linear peptide",IGHGLLPWNNLVTHPVLGKV,"BLV tax peptide 14 (131-150)",,,129,148,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IGHGLLPWNNLVTHPVLGKV,,129,148,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507723,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78460,"Linear peptide",LVTHPVLGKVLILNQMANFS,"BLV tax peptide 15 (141-160)",,,139,158,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVTHPVLGKVLILNQMANFS,,139,158,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507724,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78450,"Linear peptide",LILNQMANFSLLPSFDTLLV,"BLV tax peptide 16 (151-170)",,,151,170,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LILNQMANFSLLPSFDTLLV,,151,170,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507725,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/135713,"Linear peptide",LLPSFDTLLVDPLRLSVFA,"BLV tax peptide 17 (161-180)",,,161,179,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPSFDTLLVDPLRLSVFA,,161,179,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507726,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78363,"Linear peptide",DPLRLSVFAPDTRGAIRYLS,"BLV tax peptide 18 (171-190)",,,171,190,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DPLRLSVFAPDTRGAIRYLS,,171,190,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507727,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78366,"Linear peptide",DTRGAIRYLSTLLTLCPATC,"BLV tax peptide 19 (181-200)",,,181,200,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DTRGAIRYLSTLLTLCPATC,,181,200,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507728,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78533,"Linear peptide",TLLTLCPATCILPLGEPFS,"BLV tax peptide 20 (191-210)",,,191,209,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLLTLCPATCILPLGEPFS,,191,209,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507729,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78422,"Linear peptide",ILPLGEPFSPNVPICRFPRD,"BLV tax peptide 21 (201-220)",,,201,220,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ILPLGEPFSPNVPICRFPRD,,201,220,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507730,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78476,"Linear peptide",NVPICRFPRDSNEPPLSEFE,"BLV tax peptide 22 (211-230)",,,211,230,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NVPICRFPRDSNEPPLSEFE,,211,230,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507731,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78524,"Linear peptide",SNEPPLSEFELPPIQTPGLS,"BLV tax peptide 23 (221-240)",,,219,238,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNEPPLSEFELPPIQTPGLS,,219,238,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507732,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78453,"Linear peptide",LPPIQTPGLSWSVPAIDLFL,"BLV tax peptide 24 (231-250)",,,229,248,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPPIQTPGLSWSVPAIDLFL,,229,248,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507733,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78566,"Linear peptide",WSVPAIDLFLTGPPSPCDRL,"BLV tax peptide 25 (241-260)",,,241,260,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WSVPAIDLFLTGPPSPCDRL,,241,260,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507734,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78530,"Linear peptide",TGPPSPCDRLHVWSSPQALQ,"BLV tax peptide 26 (251-270)",,,251,270,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGPPSPCDRLHVWSSPQALQ,,251,270,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507735,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78417,"Linear peptide",HVWSSPQALQRFLHDPTLTW,"BLV tax peptide 27 (261-280)",,,259,278,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HVWSSPQALQRFLHDPTLTW,,259,278,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507736,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78502,"Linear peptide",RFLHDPTLTWSELVASRKIR,"BLV tax peptide 28 (271-290)",,,271,290,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RFLHDPTLTWSELVASRKIR,,271,290,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507737,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78514,"Linear peptide",SELVASRKIRLDSPLKLQLL,"BLV tax peptide 29 (281-300)",,,281,300,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SELVASRKIRLDSPLKLQLL,,281,300,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507738,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78439,"Linear peptide",LDSPLKLQLLENEWLSRLF,"BLV tax peptide 30 (291-309)",,,291,309,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDSPLKLQLLENEWLSRLF,,291,309,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507739,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78462,"Linear peptide",MASVVGWGPHSLHACPALVL,"BLV tax peptide 1 (1-20)",,,1,20,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MASVVGWGPHSLHACPALVL,,1,20,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507740,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78520,"Linear peptide",SLHACPALVLSNDVTIDAWC,"BLV tax peptide 2 (11-30)",,,11,30,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLHACPALVLSNDVTIDAWC,,11,30,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507741,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78523,"Linear peptide",SNDVTIDAWCPLCGPHERLQ,"BLV tax peptide 3 (21-40)",,,21,40,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNDVTIDAWCPLCGPHERLQ,,21,40,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507742,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78484,"Linear peptide",PLCGPHERLQFERIDTTLTC,"BLV tax peptide 4 (31-50)",,,31,50,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PLCGPHERLQFERIDTTLTC,,31,50,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507743,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78380,"Linear peptide",FERIDTTLTCETHRINWTAD,"BLV tax peptide 5 (41-60)",,,41,60,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FERIDTTLTCETHRINWTAD,,41,60,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507744,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78378,"Linear peptide",ETHRINWTADGRPCGLNGTL,"BLV tax peptide 6 (51-70)",,,51,70,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ETHRINWTADGRPCGLNGTL,,51,70,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507745,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78409,"Linear peptide",GRPCGLNGTLFPRLHVSETR,"BLV tax peptide 7 (61-80)",,,61,80,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GRPCGLNGTLFPRLHVSETR,,61,80,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507746,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78387,"Linear peptide",FPRLHVSETRPQGPRRLWIN,"BLV tax peptide 8 (71-90)",,,71,90,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FPRLHVSETRPQGPRRLWIN,,71,90,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507747,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78487,"Linear peptide",PQGPRRLWINCPLPAVRAQ,"BLV tax peptide 9 (81-100)",,,81,99,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PQGPRRLWINCPLPAVRAQ,,81,99,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507748,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78352,"Linear peptide",CPLPAVRAQPGPVSLSPFER,"BLV tax peptide 10 (91-110)",,,91,110,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPLPAVRAQPGPVSLSPFER,,91,110,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507749,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78406,"Linear peptide",GPVSLSPFERSPFQPYQCQL,"BLV tax peptide 11 (101-120)",,,101,120,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPVSLSPFERSPFQPYQCQL,,101,120,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507750,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78525,"Linear peptide",SPFQPYQCQLPSASSDGC,"BLV tax peptide 12 (111-130)",,,111,128,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPFQPYQCQLPSASSDGC,,111,128,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507751,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78489,"Linear peptide",PSASSDGCPIIGHGLLPWNN,"BLV tax peptide 13 (121-140)",,,121,140,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSASSDGCPIIGHGLLPWNN,,121,140,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507752,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78419,"Linear peptide",IGHGLLPWNNLVTHPVLGKV,"BLV tax peptide 14 (131-150)",,,129,148,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IGHGLLPWNNLVTHPVLGKV,,129,148,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507753,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78460,"Linear peptide",LVTHPVLGKVLILNQMANFS,"BLV tax peptide 15 (141-160)",,,139,158,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVTHPVLGKVLILNQMANFS,,139,158,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507754,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78450,"Linear peptide",LILNQMANFSLLPSFDTLLV,"BLV tax peptide 16 (151-170)",,,151,170,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LILNQMANFSLLPSFDTLLV,,151,170,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507755,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/135713,"Linear peptide",LLPSFDTLLVDPLRLSVFA,"BLV tax peptide 17 (161-180)",,,161,179,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPSFDTLLVDPLRLSVFA,,161,179,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507756,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78363,"Linear peptide",DPLRLSVFAPDTRGAIRYLS,"BLV tax peptide 18 (171-190)",,,171,190,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DPLRLSVFAPDTRGAIRYLS,,171,190,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507757,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78366,"Linear peptide",DTRGAIRYLSTLLTLCPATC,"BLV tax peptide 19 (181-200)",,,181,200,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DTRGAIRYLSTLLTLCPATC,,181,200,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507758,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78533,"Linear peptide",TLLTLCPATCILPLGEPFS,"BLV tax peptide 20 (191-210)",,,191,209,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLLTLCPATCILPLGEPFS,,191,209,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507759,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78422,"Linear peptide",ILPLGEPFSPNVPICRFPRD,"BLV tax peptide 21 (201-220)",,,201,220,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ILPLGEPFSPNVPICRFPRD,,201,220,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507760,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78476,"Linear peptide",NVPICRFPRDSNEPPLSEFE,"BLV tax peptide 22 (211-230)",,,211,230,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NVPICRFPRDSNEPPLSEFE,,211,230,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507761,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78524,"Linear peptide",SNEPPLSEFELPPIQTPGLS,"BLV tax peptide 23 (221-240)",,,219,238,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNEPPLSEFELPPIQTPGLS,,219,238,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507762,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78453,"Linear peptide",LPPIQTPGLSWSVPAIDLFL,"BLV tax peptide 24 (231-250)",,,229,248,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPPIQTPGLSWSVPAIDLFL,,229,248,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75213.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507763,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78566,"Linear peptide",WSVPAIDLFLTGPPSPCDRL,"BLV tax peptide 25 (241-260)",,,241,260,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WSVPAIDLFLTGPPSPCDRL,,241,260,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507764,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78530,"Linear peptide",TGPPSPCDRLHVWSSPQALQ,"BLV tax peptide 26 (251-270)",,,251,270,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGPPSPCDRLHVWSSPQALQ,,251,270,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507765,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78417,"Linear peptide",HVWSSPQALQRFLHDPTLTW,"BLV tax peptide 27 (261-280)",,,259,278,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HVWSSPQALQRFLHDPTLTW,,259,278,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABI75217.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507766,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78502,"Linear peptide",RFLHDPTLTWSELVASRKIR,"BLV tax peptide 28 (271-290)",,,271,290,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RFLHDPTLTWSELVASRKIR,,271,290,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507767,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78514,"Linear peptide",SELVASRKIRLDSPLKLQLL,"BLV tax peptide 29 (281-300)",,,281,300,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SELVASRKIRLDSPLKLQLL,,281,300,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1507768,http://www.iedb.org/reference/1009008,Literature,9637294,,"N Sakakibara; H Kabeya; K Ohashi; C Sugimoto; M Onuma","J Vet Med Sci",1998,"Epitope mapping of bovine leukemia virus transactivator protein Tax.",http://www.iedb.org/epitope/78439,"Linear peptide",LDSPLKLQLLENEWLSRLF,"BLV tax peptide 30 (291-309)",,,291,309,,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,"4-5 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"tax protein",taxTRX,,,http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;Freund's incomplete (IFA);",intraepidermal,"20 ug of taxTRX",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDSPLKLQLLENEWLSRLF,,291,309,,"tax protein",http://www.ncbi.nlm.nih.gov/protein/ABS11223.1,p34,http://www.uniprot.org/uniprot/O56232,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1508072,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48870,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,"p19 gag 100-119",,,100,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,,100,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508073,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48870,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,"p19 gag 100-119",,,100,119,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPP,,100,119,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508075,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48955,"Linear peptide",PPYVEPTAPQVL,"p19 gag 119-130",,,119,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPYVEPTAPQVL,,119,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508076,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/48955,"Linear peptide",PPYVEPTAPQVL,"p19 gag 119-130",,,119,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPYVEPTAPQVL,,119,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508077,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"p24 gag 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508078,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/49915,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,"p24 gag 131-160",,,131,160,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVMHPHGAPPNHRPWQMKDLQAIKQEVSQA,,131,160,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/NP_057860.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508079,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"p24 gag 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was weakly positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, and negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508080,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/21061,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,"p24 gag 288-317",,,288,317,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The assay was weakly positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, and negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GLPEGTPKDPILRSLAYSNANKECQKLLQA,,288,317,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508081,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78162,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,"gp46 env 20-49",,,20,49,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell lymphotrophic virus type 1 (strain ATK) (Human T-cell leukemia virus type I (strain ATK))",,,,,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,,20,49,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508082,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78162,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,"gp46 env 20-49",,,20,49,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell lymphotrophic virus type 1 (strain ATK) (Human T-cell leukemia virus type I (strain ATK))",,,,,,,,,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, but negative for patients diagnosed with HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKPCNPAQPVCS,,20,49,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508083,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78280,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,"gp46 env 89-115",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508084,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78280,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,"gp46 env 89-115",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPGSLKCPVY,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508085,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 env 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508086,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"gp46 env 175-199",,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508087,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"gp46 env 213-236",,,193,216,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,193,216,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508088,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,"gp46 env 213-236",,,193,216,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,,193,216,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508089,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 env 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508090,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/62003,"Linear peptide",STWHVLYSPNVSVPSSSSTP,"gp46 env 235-254",,,235,254,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STWHVLYSPNVSVPSSSSTP,,235,254,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508091,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 env 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508092,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/65645,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,"gp46 env 253-282",,,253,282,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPLLYPSLALPAPHLTLPFNWTHCFDPQIQ,,253,282,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508093,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78153,"Linear peptide",FDPQIQAIVSSPCHNS,"gp46 env 277-292",,,277,292,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FDPQIQAIVSSPCHNS,,277,292,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508094,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78153,"Linear peptide",FDPQIQAIVSSPCHNS,"gp46 env 277-292",,,277,292,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FDPQIQAIVSSPCHNS,,277,292,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508095,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,"gp46 env 288-317",,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,,288,317,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508096,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,"gp46 env 288-317",,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,,288,317,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508097,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78166,"Linear peptide",GGITGSMSLASGKSLLHEVDK,"p20E env 332-352",,,332,352,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDK,,332,352,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508098,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78166,"Linear peptide",GGITGSMSLASGKSLLHEVDK,"p20E env 332-352",,,332,352,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGITGSMSLASGKSLLHEVDK,,332,352,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508099,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/14645,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"p20E env 350-386",,,349,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,349,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508100,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/14645,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,"p20E env 350-386",,,349,386,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVDKDISQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLF,,349,386,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508101,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"p20E env 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508102,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/35217,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,"p20E env 382-403",,,382,403,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LDLLFWEQGGLCKALQEQCRFP,,382,403,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508103,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78114,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,"p20E env 400-429",,,400,429,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,,400,429,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508104,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/78114,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,"p20E env 400-429",,,400,429,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENRVLTGWGL,,400,429,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508105,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/23247,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"p20E env 426-448",,,426,448,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,,426,448,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508106,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/23247,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,"p20E env 426-448",,,426,448,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GWGLNWDLGLSQWAREALQTGIT,,426,448,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508107,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"p20E env 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508108,http://www.iedb.org/reference/1006516,Literature,1537894,,"Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda","J Clin Microbiol",1992,"Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.",http://www.iedb.org/epitope/34791,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,"p20E env 458-488",,,458,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for HTLV-1 healthy carriers, and patients diagnosed with ATLL, or HAM.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVRYPHYSLIKPESSL,,458,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508130,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78744,"Linear peptide",MAHFPGFGQSLLFGYPVYVF,"HTLV Tax1 1-20",,,1,20,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MAHFPGFGQSLLFGYPVYVF,,1,20,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508131,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78772,"Linear peptide",PVYVFGDCVQGDWCPISGGL,"HTLV Tax2 16-35",,,16,35,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVYVFGDCVQGDWCPISGGL,,16,35,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508132,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78689,"Linear peptide",ISGGLCSARLHRHALLATCP,"HTLV Tax3 31-50",,,31,50,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,2,6.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISGGLCSARLHRHALLATCP,,31,50,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508133,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78715,"Linear peptide",LATCPEHQITWDPIDGRVIG,"HTLV Tax4 46-65",,,46,65,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,1,3.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LATCPEHQITWDPIDGRVIG,,46,65,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508134,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78671,"Linear peptide",GRVIGSALQFLIPRLPSFPT,"HTLV Tax5 61-80",,,61,80,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GRVIGSALQFLIPRLPSFPT,,61,80,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508135,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78769,"Linear peptide",PSFPTQRTSKTLKVLTPPIT,"HTLV Tax6 76-95",,,76,95,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSFPTQRTSKTLKVLTPPIT,,76,95,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508136,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78862,"Linear peptide",TPPITHTTPNIPPSFLQAMR,"HTLV Tax7 91-110",,,91,110,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPPITHTTPNIPPSFLQAMR,,91,110,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508137,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"HTLV Tax8 106-125",,,106,125,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,19,63.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,106,125,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508138,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78642,"Linear peptide",EPTLGQHLPTLSFPDPGLRP,"HTLV Tax9 121-140",,,121,140,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EPTLGQHLPTLSFPDPGLRP,,121,140,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508139,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78759,"Linear peptide",PGLRPQNLYTLWGGSVVCMY,"HTLV Tax10 136-155",,,136,155,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,3,15.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PGLRPQNLYTLWGGSVVCMY,,136,155,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508140,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78884,"Linear peptide",VVCMYLYQLSPPITWPLLPH,"HTLV Tax11 151-170",,,151,170,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,7,23.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VVCMYLYQLSPPITWPLLPH,,151,170,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508141,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78762,"Linear peptide",PLLPHVIFCHPGQLGAFLTN,"HTLV Tax12 166-185",,,166,185,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,1,5.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PLLPHVIFCHPGQLGAFLTN,,166,185,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508142,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78605,"Linear peptide",AFLTNVPYKRIEELLYKISL,"HTLV Tax13 181-200",,,181,200,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AFLTNVPYKRIEELLYKISL,,181,200,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508143,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78892,"Linear peptide",YKISLTTGALIILPEDCLPT,"HTLV Tax14 196-215",,,196,215,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,1,5.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YKISLTTGALIILPEDCLPT,,196,215,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508144,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78618,"Linear peptide",DCLPTTLFQPARAPVTLTAW,"HTLV Tax15 211-230",,,211,230,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,1,5.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DCLPTTLFQPARAPVTLTAW,,211,230,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508145,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78857,"Linear peptide",TLTAWQNGLLPFHSTLTTPG,"HTLV Tax16 226-245",,,226,245,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,1,5.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLTAWQNGLLPFHSTLTTPG,,226,245,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508146,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78739,"Linear peptide",LTTPGLIWTFTDGTPMISGP,"HTLV Tax17 241-260",,,241,260,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LTTPGLIWTFTDGTPMISGP,,241,260,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508147,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78748,"Linear peptide",MISGPCPKDGQPSLVLQSSS,"HTLV Tax18 256-275",,,256,275,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,1,3.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MISGPCPKDGQPSLVLQSSS,,256,275,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508148,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78732,"Linear peptide",LQSSSFIFHKFQTKAYHPSF,"HTLV Tax19 271-290",,,271,290,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQSSSFIFHKFQTKAYHPSF,,271,290,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508149,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78889,"Linear peptide",YHPSFLLSHGLIQYSSFHSL,"HTLV Tax20 286-305",,,286,305,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YHPSFLLSHGLIQYSSFHSL,,286,305,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508150,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78823,"Linear peptide",SFHSLHLLFEEYTNIPISLL,"HTLV Tax21 301-320",,,301,320,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,30,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SFHSLHLLFEEYTNIPISLL,,301,320,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508151,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"HTLV Tax22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1 and Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,22,73.3,"Serum reactivity to the peptide was shown positive also by competitive inhibition experiments.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508152,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"HTLV Tax23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1 and Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,29,96.7,"Serum reactivity to the peptide was shown positive also by competitive inhibition experiments.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508153,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"HTLV Tax24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1 and Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,29,96.7,"Serum reactivity to the peptide was shown positive also by competitive inhibition experiments.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508186,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78749,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,"HTLV Rex1 1-20",,,1,20,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,63,63.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,,1,20,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508187,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78765,"Linear peptide",PPTPWPTSQGLDRVFFSDTQ,"HTLV Rex2 16-35",,,16,35,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,29,29.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPTPWPTSQGLDRVFFSDTQ,,16,35,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508188,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78656,"Linear peptide",FSDTQSTCLETVYKATGAPS,"HTLV Rex3 31-50",,,31,50,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,15,15.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FSDTQSTCLETVYKATGAPS,,31,50,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508189,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78850,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,"HTLV Rex4 46-65",,,46,65,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,29,29.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,,46,65,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508190,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78883,"Linear peptide",VTPYWPPVQSIRSPGTPSMD,"HTLV Rex5 61-80",,,61,80,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,14,14.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VTPYWPPVQSIRSPGTPSMD,,61,80,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508191,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78863,"Linear peptide",TPSMDALSAQLYSSLSLDSP,"HTLV Rex6 76-95",,,76,95,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,26,26.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPSMDALSAQLYSSLSLDSP,,76,95,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508192,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78833,"Linear peptide",SLDSPPSPPREPLRPSRSLP,"HTLV Rex7 91-110",,,91,110,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,7,7.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLDSPPSPPREPLRPSRSLP,,91,110,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508193,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78840,"Linear peptide",SRSLPRQSLIQPPTFHPPSS,"HTLV Rex8 106-125",,,106,125,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,11,11.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SRSLPRQSLIQPPTFHPPSS,,106,125,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508194,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78680,"Linear peptide",HPPSSRPCANTPPSEMDTWN,"HTLV Rex9 121-140",,,121,140,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,4,4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HPPSSRPCANTPPSEMDTWN,,121,140,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508195,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78746,"Linear peptide",MDTWNPPLGSTSQPCLFQTP,"HTLV Rex10 136-155",,,136,155,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,11,11.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MDTWNPPLGSTSQPCLFQTP,,136,155,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508196,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78723,"Linear peptide",LFQTPDSGPKTCTPSGEAPL,"HTLV Rex11 151-170",,,151,170,,,"Protein Rex",http://www.ncbi.nlm.nih.gov/protein/P0C206.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,12,12.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LFQTPDSGPKTCTPSGEAPL,,151,170,,"Protein Rex",http://www.ncbi.nlm.nih.gov/protein/P0C206.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508197,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78659,"Linear peptide",GEAPLSACTSTSFPPPSPGP,"HTLV Rex12 161-185",,,166,185,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,2,2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GEAPLSACTSTSFPPPSPGP,,166,185,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508198,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78825,"Linear peptide",SFPPPSPGPSCPT,"HTLV Rex13 177-189",,,177,189,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,99,1,1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SFPPPSPGPSCPT,,177,189,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508206,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"HTLV Tax8 106-125",,,106,125,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,27,96.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,106,125,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508207,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"HTLV Tax8 106-125",,,106,125,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,20,41.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,106,125,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508208,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"HTLV Tax8 106-125",,,106,125,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,69,41,59.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,106,125,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508209,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/38810,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,"HTLV Tax8 106-125",,,106,125,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,1,5.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQAMRKYSPFRNGYMEPTLG,,106,125,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508216,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"HTLV Tax22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,21,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508217,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"HTLV Tax22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,2,4.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508218,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"HTLV Tax22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,69,17,24.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508219,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/47984,"Linear peptide",PISLLFNEKEADDNDHEPQI,"HTLV Tax22 316-335",,,316,335,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,19,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PISLLFNEKEADDNDHEPQI,,316,335,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508220,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"HTLV Tax23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,26,92.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508221,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"HTLV Tax23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,5,10.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508222,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"HTLV Tax23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,69,27,39.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508223,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/23722,"Linear peptide",HEPQISPGGLEPPSEKHFRE,"HTLV Tax23 331-350",,,331,350,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,19,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEPQISPGGLEPPSEKHFRE,,331,350,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508224,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"HTLV Tax24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,28,24,85.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508225,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"HTLV Tax24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,48,7,14.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508226,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"HTLV Tax24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3 and Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,69,24,34.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508227,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/60062,"Linear peptide",SPGGLEPPSEKHFRETEV,"HTLV Tax24 336-353",,,336,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-lymphotropic virus 2 (Human T-Cell leukemia virus type 2)",,,,,,,,,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPGGLEPPSEKHFRETEV,,336,353,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508237,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78749,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,"HTLV Rex1 1-20",,,1,20,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,,1,20,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508238,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78749,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,"HTLV Rex1 1-20",,,1,20,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,,1,20,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508239,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78749,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,"HTLV Rex1 1-20",,,1,20,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MPKTRRRPRRSQRKRPPTPW,,1,20,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508241,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78850,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,"HTLV Rex4 46-65",,,46,65,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,,46,65,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508242,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78850,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,"HTLV Rex4 46-65",,,46,65,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,,46,65,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508243,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78850,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,"HTLV Rex4 46-65",,,46,65,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TGAPSLGDYVRPAYIVTPYW,,46,65,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508244,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78863,"Linear peptide",TPSMDALSAQLYSSLSLDSP,"HTLV Rex6 76-95",,,76,95,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPSMDALSAQLYSSLSLDSP,,76,95,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508245,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78863,"Linear peptide",TPSMDALSAQLYSSLSLDSP,"HTLV Rex6 76-95",,,76,95,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPSMDALSAQLYSSLSLDSP,,76,95,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1508246,http://www.iedb.org/reference/1007180,Literature,8158021,,"R B Lal; C Z Giam; J E Coligan; D L Rudolph","J Infect Dis",1994,"Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.",http://www.iedb.org/epitope/78863,"Linear peptide",TPSMDALSAQLYSSLSLDSP,"HTLV Rex6 76-95",,,76,95,,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3C",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TPSMDALSAQLYSSLSLDSP,,76,95,,"rex protein",http://www.ncbi.nlm.nih.gov/protein/AAF71372.1,"Protein Rex",http://www.uniprot.org/uniprot/P0C206,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509223,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78454,"Linear peptide",LPPTAPPLLPHSNLDHILEPSIPW,HTLV-H,,,183,206,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1 and 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for cerebrospinal fluid (CSF) and weakly positive for sera  of patients with tropical spastic paraparesis or ATL. Positive samples were defined as 3 standared deviations of absorbance above the negative controls.",Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPPTAPPLLPHSNLDHILEPSIPW,,183,206,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509225,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78500,"Linear peptide",RASLSTWHVLYSPNVSVPSS,HTLV-C,,,231,250,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for cerebrospinal fluid (CSF) and weakly positive for sera of patients with tropical spastic paraparesis and ATL. Positive samples were defined as 3 standared deviations of absorbance above the negative controls.",Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RASLSTWHVLYSPNVSVPSS,,231,250,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509226,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78425,"Linear peptide",IQAIVSSPCHNSLILPPFSLSPV,HTLV-B,,,281,303,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for cerebrospinal fluid (CSF) and weakly positive for sera  of patients with tropical spastic paraparesis or ATL. Positive samples were defined as 3 standared deviations of absorbance above the negative controls.",Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IQAIVSSPCHNSLILPPFSLSPV,,281,303,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509227,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78492,"Linear peptide",QGGLCKALQEQCRFPNITNSHVP,HTLV-A,,,389,411,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The assay was positive for cerebrospinal fluid (CSF) and weakly positive for sera of patients with tropical spastic paraparesis or ATL. Positive samples were defined as 3 standared deviations of absorbance above the negative controls.",Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QGGLCKALQEQCRFPNITNSHVP,,389,411,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509254,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78486,"Linear peptide",PPPYVEPTAPQVLPVMHPHG,"Gag 1",,,118,137,,,"Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol)",http://www.ncbi.nlm.nih.gov/protein/P14078.3,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate)",http://purl.obolibrary.org/obo/NCBITaxon_11927,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The assay was negative for sera or cerebrospinal fluid (CSF) of patients with tropical spastic paraparesis or ATL. Positive samples were defined as 3 standared deviations of absorbance above the negative controls.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPYVEPTAPQVLPVMHPHG,,118,137,,"Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol)",http://www.ncbi.nlm.nih.gov/protein/P14078.3,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate)",http://purl.obolibrary.org/obo/NCBITaxon_11927,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509377,http://www.iedb.org/reference/1012816,Literature,7545215,,"K R Porter; R L Anthony; A Solihin; C G Hayes","J Med Virol",1995,"Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falciparum antibodies.",http://www.iedb.org/epitope/78478,"Linear peptide",PDSDPQI,"HTLV-I p19 7-mer peptide",,,111,117,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Indonesia,http://purl.obolibrary.org/obo/GAZ_00003727,,,,"Exposure with existing immune reactivity without evidence for disease",,,,Other,Organism,"Plasmodium falciparum (malaria parasite P. falciparum)","P. falciparum",,,,,,,,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-P. falciparum antibody-positive sera from Indonesian population were used.","Table I and figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,31,31,100,"The Indonesian sera showed 100% immunoreactivity to the 10-mer ( HDPPDSDPQI ), 8-mer ( PPDSDPQI ), and 7-mer ( PDSDPQI ) peptides. The 9-mer ( DPPDSDPQI ) and the 6-mer ( DSDPQI ) peptides reacted to 90% and 93% of the Indonesian sera respectively. This indicated that the shortest peptide sequence showing optimum binding was 7-mer peptide. Patients from the Philippines were also positive.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PDSDPQI,,111,117,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509866,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78454,"Linear peptide",LPPTAPPLLPHSNLDHILEPSIPW,HTLV-H,,,183,206,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"No immunization",,,,,,,,,,,,,,,,,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figures 1 and 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPPTAPPLLPHSNLDHILEPSIPW,,183,206,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509871,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78500,"Linear peptide",RASLSTWHVLYSPNVSVPSS,HTLV-C,,,231,250,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"No immunization",,,,,,,,,,,,,,,,,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RASLSTWHVLYSPNVSVPSS,,231,250,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509872,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78425,"Linear peptide",IQAIVSSPCHNSLILPPFSLSPV,HTLV-B,,,281,303,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"No immunization",,,,,,,,,,,,,,,,,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IQAIVSSPCHNSLILPPFSLSPV,,281,303,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509873,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78492,"Linear peptide",QGGLCKALQEQCRFPNITNSHVP,HTLV-A,,,389,411,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"No immunization",,,,,,,,,,,,,,,,,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QGGLCKALQEQCRFPNITNSHVP,,389,411,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell lymphotrophic virus type 1 (strain ATK)",http://purl.obolibrary.org/obo/NCBITaxon_11926,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1509874,http://www.iedb.org/reference/1012263,Literature,1546533,,"J Lycke; O Andersen; B Svennerholm; E Ben-Menachem; P Horal; A Vahlne","Acta Neurol Scand",1992,"Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.",http://www.iedb.org/epitope/78486,"Linear peptide",PPPYVEPTAPQVLPVMHPHG,"Gag 1",,,118,137,,,"Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol)",http://www.ncbi.nlm.nih.gov/protein/P14078.3,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate)",http://purl.obolibrary.org/obo/NCBITaxon_11927,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The sequence is cited in Seiki, M. et al (1983) Proc. Natl. Acad. Sci. U.S.A. 80 (12), 3618-3622 [PMID:6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,"19 to 44 years",,"No immunization",,,,,,,,,,,,,,,,,,,,,,"Occurrence of autoimmune disease","multiple sclerosis",http://purl.obolibrary.org/obo/DOID_2377,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,,Other,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPYVEPTAPQVLPVMHPHG,,118,137,,"Gag-Pro-Pol polyprotein (Pr160Gag-Pro-Pol)",http://www.ncbi.nlm.nih.gov/protein/P14078.3,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell lymphotrophic virus type 1 (Caribbean isolate)",http://purl.obolibrary.org/obo/NCBITaxon_11927,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1513721,http://www.iedb.org/reference/1003598,Literature,8553561,,"S Tanaka; M Mikhailov; P Roy",Virology,1995,"Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.",http://www.iedb.org/epitope/79953,"Linear peptide",NSDWVPSVRSWAL,"BLV gp51 (188-200)",,,188,200,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 8","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The anti-BLV recognized the epitope expressed as part of VP3 protein of Bluetonge virus using baculovirus vector.",Serum,"Entire Antibody",Polyclonal,"Anti-BLV antiserum",,,,Epitope,"Linear peptide",NSDWVPSVRSWAL,,188,200,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/1542378,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94608,"Linear peptide",MGKFLATLILFFQFCPLIFGDYSPSC,"HTLV-I gp46 peptide II(aa1-26)",,,1,26,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,3,23.1,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGKFLATLILFFQFCPLIFGDYSPSC,,1,26,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542423,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/19192,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,"HTLV-I gp46 peptide L(aa20-40)",,,20,40,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,3,23.1,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,,20,40,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542424,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/62567,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"HTLV-I gp46 peptide E(aa35-57)",,,35,57,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,10,76.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,,35,57,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542425,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"HTLV-I gp46 peptide M(aa53-75)",,,53,75,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542426,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/34862,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,"HTLV-I gp46 peptide F(aa55-77)",,,55,77,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,,55,77,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542427,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/71235,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"HTLV-I gp46 peptide N(aa71-94)",,,71,94,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,2,15.4,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,,71,94,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542428,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"HTLV-I gp46 peptide O(aa89-110)",,,89,110,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,12,92.3,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542429,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/62700,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"HTLV-I gp46 peptide G(aa103-125)",,,103,125,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,4,30.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,,103,125,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542430,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/47047,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"HTLV-I gp46 peptide P(aa107-129)",,,107,129,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,,107,129,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542431,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/18895,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,"HTLV-I gp46 peptide D(aa116-140)",,,116,140,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,6,46.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,,116,140,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542432,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/50995,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,"HTLV-I gp46 peptide Q(aa136-158)",,,136,158,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,7,53.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,,136,158,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542433,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/17755,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,"HTLV-I gp46 peptide R(aa154-176)",,,154,176,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,,154,176,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542434,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37886,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"HTLV-I gp46 peptide VH(aa163-185)",,,163,185,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,,163,185,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542435,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/48016,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"HTLV-I gp46 peptide S(aa172-194)",,,172,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,10,76.9,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,,172,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542436,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-I gp46 peptide H(aa176-199)",,,176,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542437,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-I gp46 peptide HH(aa190-209)",,,190,209,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542438,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"HTLV-I gp46 peptide T(aa190-212)",,,190,212,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542439,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/58884,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"HTLV-I gp46 peptide U(aa209-231)",,,208,230,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,,208,230,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542440,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94590,"Linear peptide",LLTLVQLTLQSTNYTCIVCIDRA,"HTLV-I gp46 peptide VC(aa211-233)",,,210,232,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,11,84.6,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLTLVQLTLQSTNYTCIVCIDRA,,210,232,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542441,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/75984,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,"HTLV-I gp46 peptide C(aa224-244)",,,223,243,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,9,69.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,,223,243,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542442,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/39726,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,"HTLV-I gp46 peptide HC(aa235-257)",,,234,256,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,12,92.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,,234,256,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542443,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"HTLV-I gp46 peptide V(aa240-262)",,,239,261,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,12,92.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542444,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/75415,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"HTLV-I gp46 peptide W(aa258-280)",,,257,279,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,,257,279,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542445,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/34858,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,"HTLV-I gp46 peptide VB(aa261-283)",,,260,282,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,8,61.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,,260,282,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542446,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/73133,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"HTLV-I gp46 peptide B(aa274-296)",,,273,295,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,9,69.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,,273,295,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542447,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"HTLV-I gp46 peptide HB(aa287-311)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542448,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/45894,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"HTLV-I gp46 peptide X(aa-292-314)",,,291,313,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,8,61.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,,291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542449,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/55950,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,"HTLV-I gp21 peptide Y(aa310-332)",,,309,331,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,5,38.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,,309,331,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542450,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/18611,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,"HTLV-I gp21 peptide Z(aa328-350)",,,327,349,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,,327,349,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542451,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94690,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,"HTLV-I gp21 peptide AA(aa346-368)",,,345,367,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,13,100,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.  Sera reactivity with the epitope correlated with neutralization titer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,,345,367,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542452,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/30178,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,"HTLV-I gp21 peptide I(aa353-375)",,,352,374,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,6,46.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,,352,374,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542453,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/69279,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,"HTLV-I gp21 peptide J(363-385)",,,362,384,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,8,61.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,,362,384,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542454,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/32506,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,"HTLV-I gp21 peptide BB(aa364-386)",,,363,385,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,10,76.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,,363,385,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542455,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37441,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,"HTLV-I gp21 peptide VA(aa369-391)",,,368,390,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,8,61.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,,368,390,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542456,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94530,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,"HTLV-I gp21 peptide A(aa382-404)",,,381,404,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,11,64.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,,381,404,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542457,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/2838,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,"HTLV-I gp21 peptide HA(aa396-418)",,,395,417,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,2,15.4,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,,395,417,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542458,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/6919,"Linear peptide",CRFPNITNSHVPILQERPPLENR,"HTLV-I gp21 peptide OC(aa401-423)",,,400,422,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENR,,400,422,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542459,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/48309,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,"HTLV-I gp21 peptide DD(aa419-441)",,,418,440,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,9,69.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,,418,440,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542460,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/72481,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,"HTLV-I gp21 peptide K(aa428-450)",,,427,449,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,8,61.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,,427,449,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542461,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/60591,"Linear peptide",SQWAREALQTGITLVALLLLVIL,"HTLV-I gp21 peptide EE(aa437-459)",,,436,458,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,13,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SQWAREALQTGITLVALLLLVIL,,436,458,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542462,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37899,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,"HTLV-I gp21 peptide FF(aa455-477)",,,454,476,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,4,30.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,,454,476,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542463,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94658,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,"HTLV-I gp21 peptide GG(aa467-489)",,,446,468,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,13,9,69.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,,446,468,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542464,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94608,"Linear peptide",MGKFLATLILFFQFCPLIFGDYSPSC,"HTLV-I gp46 peptide II(aa1-26)",,,1,26,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGKFLATLILFFQFCPLIFGDYSPSC,,1,26,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542465,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/19192,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,"HTLV-I gp46 peptide L(aa20-40)",,,20,40,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GDYSPSCCTLTIGVSSYHSKP,,20,40,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542466,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/62567,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,"HTLV-I gp46 peptide E(aa35-57)",,,35,57,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYHSKPCNPAQPVCSWTLDLLAL,,35,57,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542467,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/9157,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,"HTLV-I gp46 peptide M(aa53-75)",,,53,75,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,11,64.7,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DLLALSADQALQPPCPNLVSYSS,,53,75,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542468,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/34862,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,"HTLV-I gp46 peptide F(aa55-77)",,,55,77,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,12,70.6,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALSADQALQPPCPNLVSYSSYH,,55,77,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542469,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/71235,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,"HTLV-I gp46 peptide N(aa71-94)",,,71,94,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSYSSYHATYSLYLFPHWTKKPNR,,71,94,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542470,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"HTLV-I gp46 peptide O(aa89-110)",,,89,110,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,6,35.3,"This peptide is unable to inhibit syncytium formation between HTLV-I positive and HTLV-1 negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542471,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/62700,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,"HTLV-I gp46 peptide G(aa103-125)",,,103,125,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SYSDPCSLKCPYLGCQSWTCPYT,,103,125,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542472,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/47047,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,"HTLV-I gp46 peptide P(aa107-129)",,,107,129,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,13,76.5,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PCSLKCPYLGCQSWTCPYTGAVS,,107,129,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542473,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/18895,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,"HTLV-I gp46 peptide D(aa116-140)",,,116,140,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GCQSWTCPYTGAVSSPYWKFQHDVN,,116,140,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542474,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/50995,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,"HTLV-I gp46 peptide Q(aa136-158)",,,136,158,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QHDVNFTQEVSRLNINLHFSKCG,,136,158,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542475,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/17755,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,"HTLV-I gp46 peptide R(aa154-176)",,,154,176,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FSKCGFPFSLLVDAPGYDPIWFL,,154,176,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542476,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37886,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,"HTLV-I gp46 peptide VH(aa163-185)",,,163,185,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVDAPGYDPIWFLNTEPSQLPP,,163,185,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542477,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/48016,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,"HTLV-I gp46 peptide S(aa172-194)",,,172,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,7,41.2,"This peptide is unable to inhibit syncytium formation between HTLV-I positive and HTLV-1 negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PIWFLNTEPSQLPPTAPPLLPHS,,172,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542478,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-I gp46 peptide H(aa176-199)",,,176,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,13,76.5,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,,176,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542479,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-I gp46 peptide HH(aa190-209)",,,190,209,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,13,76.5,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542480,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"HTLV-I gp46 peptide T(aa190-212)",,,190,212,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,15,88.2,"This peptide is unable to inhibit syncytium formation between HTLV-I positive and HTLV-1 negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,,190,212,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542481,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/58884,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"HTLV-I gp46 peptide U(aa209-231)",,,208,230,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,10,58.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,,208,230,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542482,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94590,"Linear peptide",LLTLVQLTLQSTNYTCIVCIDRA,"HTLV-I gp46 peptide VC(aa211-233)",,,210,232,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,3,17.6,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLTLVQLTLQSTNYTCIVCIDRA,,210,232,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542483,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/75984,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,"HTLV-I gp46 peptide C(aa224-244)",,,223,243,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,,223,243,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542484,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/39726,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,"HTLV-I gp46 peptide HC(aa235-257)",,,234,256,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,6,35.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,,234,256,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542485,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"HTLV-I gp46 peptide V(aa240-262)",,,239,261,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,7,41.2,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,,239,261,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542486,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/75415,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,"HTLV-I gp46 peptide W(aa258-280)",,,257,279,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YPSLALPAPHLTLPFNWTHCFDP,,257,279,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542487,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/34858,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,"HTLV-I gp46 peptide VB(aa261-283)",,,260,282,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LALPAPHLTLPFNWTHCFDPQIQ,,260,282,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542488,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/73133,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"HTLV-I gp46 peptide B(aa274-296)",,,273,295,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,3,17.6,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,,273,295,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542490,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"HTLV-I gp46 peptide HB(aa287-311)",,,286,310,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,7,41.2,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,,286,310,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542491,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/45894,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"HTLV-I gp46 peptide X(aa-292-314)",,,291,313,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,3,17.6,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,,291,313,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542492,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/55950,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,"HTLV-I gp21 peptide Y(aa310-332)",,,309,331,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RSRRAVPVAVWLVSALAMGAGVA,,309,331,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542493,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/18611,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,"HTLV-I gp21 peptide Z(aa328-350)",,,327,349,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GAGVAGGITGSMSLASGKSLLHE,,327,349,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542494,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94690,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,"HTLV-I gp21 peptide AA(aa346-368)",,,345,367,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2, 3, 4, 5, Tables 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,11,64.7,"This peptide was shown to inhibit syncytium formation between HTLV-I positive and HTLV-I negative cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,,345,367,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542495,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/30178,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,"HTLV-I gp21 peptide I(aa353-375)",,,352,374,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KDISQLTQAIVKNHKNLLKIAQY,,352,374,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542496,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/69279,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,"HTLV-I gp21 peptide J(363-385)",,,362,384,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VKNHKNLLKIAQYAAQNRRGLDL,,362,384,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542497,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/32506,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,"HTLV-I gp21 peptide BB(aa364-386)",,,363,385,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KNHKNLLKIAQYAAQNRRGLDLL,,363,385,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542498,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37441,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,"HTLV-I gp21 peptide VA(aa369-391)",,,368,390,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLKIAQYAAQNRRGLDLLFWEQG,,368,390,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542499,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94530,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,"HTLV-I gp21 peptide A(aa382-404)",,,381,404,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,,381,404,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542500,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/2838,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,"HTLV-I gp21 peptide HA(aa396-418)",,,395,417,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ALQEQCRFPNITNSHVPILQERP,,395,417,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542501,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/6919,"Linear peptide",CRFPNITNSHVPILQERPPLENR,"HTLV-I gp21 peptide OC(aa401-423)",,,400,422,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CRFPNITNSHVPILQERPPLENR,,400,422,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542502,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/48309,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,"HTLV-I gp21 peptide DD(aa419-441)",,,418,440,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLENRVLTGWGLNWDLGLSQWAR,,418,440,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542503,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/72481,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,"HTLV-I gp21 peptide K(aa428-450)",,,427,449,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",WGLNWDLGLSQWAREALQTGITL,,427,449,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542504,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/60591,"Linear peptide",SQWAREALQTGITLVALLLLVIL,"HTLV-I gp21 peptide EE(aa437-459)",,,436,458,,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SQWAREALQTGITLVALLLLVIL,,436,458,,"envelope glycoprotein(gp21, gp46) - human T-cell lymphotropic virus type 1",http://www.ncbi.nlm.nih.gov/protein/A45714,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542505,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/37899,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,"HTLV-I gp21 peptide FF(aa455-477)",,,454,476,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLVILAGPCILRQLRHLPSRVRY,,454,476,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1542506,http://www.iedb.org/reference/1006239,Literature,8198868,,"C Desgranges; S Souche; J C Vernant; D Smadja; A Vahlne; P Horal","AIDS Res Hum Retroviruses",1994,"Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.",http://www.iedb.org/epitope/94658,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,"HTLV-I gp21 peptide GG(aa467-489)",,,446,468,,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2, Figures 2 and 3.",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,,446,468,,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/CAA63041.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548836,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/58115,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,"gp21 V1E1",,,342,363,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,10,9,90,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,,342,363,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548838,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/58115,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,"gp21 V1E1",,,342,363,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,4,44.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,,342,363,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548839,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/58115,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,"gp21 V1E1",,,342,363,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SGKSLLHEVDKDISQLTQAIVK,,342,363,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548842,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/8785,"Linear peptide",DISQLTQAIVKNHKNLLK,"gp21 V1E2",,,353,370,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,10,2,20,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DISQLTQAIVKNHKNLLK,,353,370,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548843,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/8785,"Linear peptide",DISQLTQAIVKNHKNLLK,"gp21 V1E2",,,353,370,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DISQLTQAIVKNHKNLLK,,353,370,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548844,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/8785,"Linear peptide",DISQLTQAIVKNHKNLLK,"gp21 V1E2",,,353,370,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DISQLTQAIVKNHKNLLK,,353,370,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548846,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/13831,"Linear peptide",EQGGLCKALQEQCRF,"gp21 V1E4",,,388,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,10,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EQGGLCKALQEQCRF,,388,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548847,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/13831,"Linear peptide",EQGGLCKALQEQCRF,"gp21 V1E4",,,388,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EQGGLCKALQEQCRF,,388,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548848,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/13831,"Linear peptide",EQGGLCKALQEQCRF,"gp21 V1E4",,,388,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EQGGLCKALQEQCRF,,388,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548851,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/34790,"Linear peptide",LAGPCILRQLRHLPSRVR,"gp21 V1E5",,,458,475,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,10,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVR,,458,475,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548852,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/34790,"Linear peptide",LAGPCILRQLRHLPSRVR,"gp21 V1E5",,,458,475,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVR,,458,475,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548853,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/34790,"Linear peptide",LAGPCILRQLRHLPSRVR,"gp21 V1E5",,,458,475,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAGPCILRQLRHLPSRVR,,458,475,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548855,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/20108,"Linear peptide",GGYYSASYSDPCSLK,"gp46 V1E7",,,97,111,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,10,3,30,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGYYSASYSDPCSLK,,97,111,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548856,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/20108,"Linear peptide",GGYYSASYSDPCSLK,"gp46 V1E7",,,97,111,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGYYSASYSDPCSLK,,97,111,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548857,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/20108,"Linear peptide",GGYYSASYSDPCSLK,"gp46 V1E7",,,97,111,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GGYYSASYSDPCSLK,,97,111,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548858,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/85672,"Linear peptide",LPHSLNDHILEPSIPWKSK,"gp46 V1E8",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,10,9,90,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSLNDHILEPSIPWKSK,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548859,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/85672,"Linear peptide",LPHSLNDHILEPSIPWKSK,"gp46 V1E8",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,9,4,44.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSLNDHILEPSIPWKSK,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548860,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/85672,"Linear peptide",LPHSLNDHILEPSIPWKSK,"gp46 V1E8",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSLNDHILEPSIPWKSK,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548950,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/65003,"Linear peptide",TLPFNWTHCFDPQIQAIVS,"gp46 V1E9",,,268,286,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with HAM/TSP were used.","Figure 2, Table III","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,10,8,80,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLPFNWTHCFDPQIQAIVS,,268,286,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548951,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/65003,"Linear peptide",TLPFNWTHCFDPQIQAIVS,"gp46 V1E9",,,268,286,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum samples from patients with ATLL were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,9,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLPFNWTHCFDPQIQAIVS,,268,286,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1548952,http://www.iedb.org/reference/1006518,Literature,1890164,,"H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki","J Clin Immunol",1991,"Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.",http://www.iedb.org/epitope/65003,"Linear peptide",TLPFNWTHCFDPQIQAIVS,"gp46 V1E9",,,268,286,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum samples from HTLV-1 carriers  were used.","Figure 2","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,16,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLPFNWTHCFDPQIQAIVS,,268,286,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1549649,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,1,33.3,"The epitope was synthesized with an irrelevant N-terminal sequence.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,,237,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549650,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,2,66.7,"The epitope was synthesized with an irrelevant N-terminal sequence.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,,237,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549651,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were specific pathogen-free (SPF).","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,3,100,"The epitope was synthesized with an irrelevant N-terminal sequence.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,,237,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549652,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Several peptides containing this minimal epitope sequence were recognized by all the mAbs. For shorter peptides, recognition was lower. Similar results were seen in direct peptide ELISA. The epitope was synthesized with an irrelevant N-terminal sequence.",,"Entire Antibody",Monoclonal,"3-17, 6-15, 11-11-12, 3-3-18 and 8-9-21",IgG1,,,Epitope,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,,237,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549653,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2 and 3","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Epitope-specific mAbs recognize FeLV-infected feline embryo cells. Similar results are seen for recognition of FELV in ELISA.",,"Entire Antibody",Monoclonal,"3-17, 6-15, 11-11-12, 3-3-18 and 8-9-21",IgG1,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549659,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/86247,"Linear peptide",MGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 3",,,237,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Epitope-specific mAbs inhibited FeLV infection of feline embryo cells.",,"Entire Antibody",Monoclonal,"3-17, 6-15, 11-11-12 and 8-9-21",IgG1,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549660,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,"Similar but lower results were obtained when the antigen contains a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549661,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,3,100,"Similar results were obtained when the antigen contains a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549662,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were specific pathogen-free (SPF).","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,3,100,"Similar results were obtained when the antigen contains a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549663,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,"Recognition could not be detected in Western blot. Negative results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549665,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,"Negative results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549667,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,"Similar results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule. Use of ISCOMs or AL(OH)3 as adjuvants was not as effective.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549669,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,"Weaker results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule. Use of ISCOMs or AL(OH)3 as adjuvants was not as effective. The cross-reactivity towards the peptide antigen of epitope-specific sera is suggested to be mediated by the presence of the overlapping region RQSQTGSKVA.",Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",251,272,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549674,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,"Weaker results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule. Use of ISCOMs or AL(OH)3 as adjuvants was not as effective.",Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",260,299,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549679,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,1,1,100,"Negative results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549680,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,1,1,100,"Negative results are obtained when the animals were immunized with a version of this epitope containing a N-terminally coupled myristic acid molecule.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549681,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/89812,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",,,223,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,intramuscular,"3 doses of 50 μg administered at 0, 90 and 155 days",,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with a mixture of 2 peptides, the epitope and an adjacent, non overlapping peptide from the same protein.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"Negative results are seen if the immunization is performed with the epitope not myristilated in ISCOMS or in Al(OH)3 as adjuvants.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,,223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549682,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549683,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,2,66.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549684,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were specific pathogen-free (SPF).","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549685,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,"Same result was obtained by Western blot.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549686,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549687,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",223,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549688,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",251,272,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549689,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",260,299,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549690,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549691,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80400,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 7",,,236,260,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AMGPNLVLPDQKPPSRQSQTGSKVA,,236,260,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,1,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549709,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549710,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,1,33.3,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549711,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were specific pathogen-free (SPF).","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549712,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,1,0,0,"Same result was obtained by Western blot.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549713,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549714,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,"Similar results are obtained in rabbits immunized with a mixture of two myristylated adjacent peptides, each of which overlaps with the epitope at the N- or C-terminus, with ISCOMs at adjuvant. No response is seen with Al(OH)3 as adjuvant.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549715,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,"The cross-reactivity towards the peptide antigen of epitope-specific sera is suggested to be mediated by the presence of the overlapping region RQSQTGSKVA.",Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",223,260,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549716,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",260,299,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549717,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549718,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549719,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figures 4 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,"Same result was obtained by Western blot.",Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549720,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Taxonomic Sibling",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549721,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,1,1,100,"The cross-reactivity of the epitope-specific sera towards the non-overlapping peptide antigen is suggested to be mediated by the presence in both peptides of the triplets MGP and NLV.",Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",223,260,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549722,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Other Structure from Source Organism","Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",251,272,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549723,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549724,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive-Low,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549725,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/87452,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,"Peptide 9",,,276,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTTMGPKRIGTGDRLINLVQGTYL,,276,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,";Freund's complete;",intramuscular,"2 doses of 100 μg  administered at intervals of 13 weeks",,,,,,,,,,,,,,,,,,,,,,,N,,"Boost was performed with IFA as adjuvant. Before the start of the experiments none had antibodies directed to FeLV or to any of the peptides used.","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive-Intermediate,,,1,1,100,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Feline leukemia virus strain A/Glasgow-1 (Feline leukemia virus (strain A/Glasgow-1))",,,,,,,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549731,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80531,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",,,260,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Intermediate,,,3,2,66.7,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,,260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549736,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80531,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",,,260,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,"Taxonomic Parent",Organism,"Feline leukemia virus (Feline leukemia provirus)",,,,,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,,260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549738,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80531,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",,,260,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Feline Leukemia Virus strain FL74",,,,,,,,,"Feline Leukemia Virus strain FL74",https://ontology.iedb.org/taxon/10001147,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were specific pathogen-free (SPF).","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,3,3,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,,260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1549742,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/80531,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,"Peptide 10",,,260,299,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,,260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,intramuscular,"3 doses of 50 μg administered at 0, 90 and 155 days",,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with a mixture of 2 peptides, the epitope and an adjacent, non overlapping peptide from the same protein.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,2,2,100,"Similar weak results are seen if the immunization is performed with the epitope myristilated in ISCOMS or with Al(OH)3 as adjuvant.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ATQRPQTNESAPRSVAPTTMGPKRIGTGDRLINLVQGTYL,,260,299,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1550371,http://www.iedb.org/reference/1013350,Literature,12682272,,"Cyril J Cohen; Offra Sarig; Yoshihisa Yamano; Utano Tomaru; Steven Jacobson; Yoram Reiter","J Immunol",2003,"Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.",http://www.iedb.org/epitope/91065,"Discontinuous peptide","L11, L12, F13, G14, Y15, P16, V17, Y18, V19",Tax11-19,,,,,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Nagai et al. (2001) J Infect Dis 183: 197-205 [PMID: 11120926].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 3, 4 and Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"TCR-like Fab antibodies specific for the HLA-A2/epitope complex were selected from a large human Fab phage library using a single chain construct of HLA-A2 linked to β2m complexed with the epitope. Fabs T3F2 and T3E3 exhibited an apparent binding affinity of 25-30 nM for the HLA-A2/epitope complex.","Purified Immunoglobulin",Fab,"Display Library","T3D4, T3E3, T3F2, T3A4",,,,"Structurally Related","Linear peptide",LLFGYPVYV,"HLA-A2/epitope complex",11,19,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1550373,http://www.iedb.org/reference/1013350,Literature,12682272,,"Cyril J Cohen; Offra Sarig; Yoshihisa Yamano; Utano Tomaru; Steven Jacobson; Yoram Reiter","J Immunol",2003,"Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.",http://www.iedb.org/epitope/91065,"Discontinuous peptide","L11, L12, F13, G14, Y15, P16, V17, Y18, V19",Tax11-19,,,,,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Nagai et al. (2001) J Infect Dis 183: 197-205 [PMID: 11120926].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 5, 6, 8 and Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"TCR-like Fab antibodies specific for the HLA-A2/epitope complex were selected from a large human Fab phage library using a single chain construct of HLA-A2 linked to β2m complexed with the epitope. Fabs T3F2 and T3E3 detected the epitope complexed with HLA-A2 on the surface of APCs pulsed with the epitope, such as murine RMA-S transfected with HLA-A2, HLA-A2+ EBV-transformed B cell line JY, or human HLA-A2+ dendritic cells. Fab tetramers showed 2-log increased staining intensity.","Purified Immunoglobulin",Fab,"Display Library","T3E3, T3F2",,,,"Structurally Related","Linear peptide",LLFGYPVYV,,11,19,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1550374,http://www.iedb.org/reference/1013350,Literature,12682272,,"Cyril J Cohen; Offra Sarig; Yoshihisa Yamano; Utano Tomaru; Steven Jacobson; Yoram Reiter","J Immunol",2003,"Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.",http://www.iedb.org/epitope/91065,"Discontinuous peptide","L11, L12, F13, G14, Y15, P16, V17, Y18, V19",Tax11-19,,,,,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Nagai et al. (2001) J Infect Dis 183: 197-205 [PMID: 11120926].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 7, 9 and Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"TCR-like Fab antibodies specific for the HLA-A2/epitope complex were selected from a large human Fab phage library using a single chain construct of HLA-A2 linked to β2m complexed with the epitope. Fab T3F2 stained HLA-A2+ EBV-transformed B cell line JY transfected with the HTLV-1 Tax gene, as shown by FACS and in situ immunohistochemistry. The authors conclude that Fab T3F2 detected the epitope/HLA-A2 complex after active and naturally occurring endogenous intracellular processing.","Purified Immunoglobulin",Fab,"Display Library",T3F2,,,,"Source Antigen",Protein,"Protein Tax-1",,,,http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1550376,http://www.iedb.org/reference/1013350,Literature,12682272,,"Cyril J Cohen; Offra Sarig; Yoshihisa Yamano; Utano Tomaru; Steven Jacobson; Yoram Reiter","J Immunol",2003,"Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.",http://www.iedb.org/epitope/91065,"Discontinuous peptide","L11, L12, F13, G14, Y15, P16, V17, Y18, V19",Tax11-19,,,,,,,"Protein Tax-1",http://www.ncbi.nlm.nih.gov/protein/P0C213.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is from the reference cited: Nagai et al. (2001) J Infect Dis 183: 197-205 [PMID: 11120926].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 7 and Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"TCR-like Fab antibodies specific for the HLA-A2/epitope complex were selected from a large human Fab phage library using a single chain construct of HLA-A2 linked to β2m complexed with the epitope. Tetrameric Fab T3F2 stained HLA-A2+ human CD4+ T cells infected with HTLV-1. The authors conclude that Fab T3F2 detected the epitope/HLA-A2 complex after active and naturally occurring endogenous intracellular processing.","Purified Immunoglobulin",Fab,"Display Library",T3F2,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1551063,http://www.iedb.org/reference/1006566,Literature,16352628,,"Hiroyuki Kawabata; Atsuko Niwa; Sachiyo Tsuji-Kawahara; Hirohide Uenishi; Norimasa Iwanami; Hideaki Matsukuma; Hiroyuki Abe; Nobutada Tabata; Haruo Matsumura; Masaaki Miyazawa","Int Immunol",2006,"Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.",http://www.iedb.org/epitope/83200,"Linear peptide",HPPSYVYSQFEKSYRHKR,"Env (462-479)",,,462,479,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",HPPSYVYSQFEKSYRHKR,,462,479,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"1 dose of 10 ug",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 7","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"In contrast to the peptide-immunized  wild-type mice, neutralizing IgG titers in CD8-deficient mice were not significantly higher than their IgM titers, suggesting some role of CD8 T cells in facilitating class switching.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1551311,http://www.iedb.org/reference/1011505,Literature,7692683,,"K Weijer; A Pfauth; R van Herwijnen; O Jarrett; R H Meloen; C Tomee; A D Osterhaus",Vaccine,1993,"Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.",http://www.iedb.org/epitope/88141,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,"Peptide 8",,,251,272,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",TVSRQVSTITPPQAMGPNLVLPDQKPPSRQSQTGSKVA,"Peptide 4",223,260,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,;ISCOM;,intramuscular,"3 doses of 50 μg administered at 0, 90 and 155 days",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen preparation consisted of a mixture of two myristylated adjacent peptides, each of which overlaps with the epitope at the N- or C-terminus.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,2,2,100,"Weaker results are seen if the immunization is performed when  the immunogenic peptides are not myristilated or with Al(OH)3 as adjuvant.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RQSQTGSKVATQRPQTNESAPR,,251,272,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08359.1,"Env protein",http://www.uniprot.org/uniprot/D2CNB9,"Feline leukemia virus strain A/Glasgow-1",http://purl.obolibrary.org/obo/NCBITaxon_11769,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1552705,http://www.iedb.org/reference/1006322,Literature,8385083,,"Y Iwahara; T Sawada; H Taguchi; H Hoshino; M Umemoto; H Take; S Foung; I Miyoshi","Jpn J Cancer Res",1993,"Neutralizing antibody to vesicular stomatitis virus (HTLV-I) pseudotype in infants born to seropositive mothers.",http://www.iedb.org/epitope/59328,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,MTA-1,,,162,209,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in  Lipka, JJ. et al. (1992)  J Infect Dis. Feb;165(2):268-72 [PMID: 1370526].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,F,Adult,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,Y,"Trans-placental transfer of antibodies from HTLV-1 seropositive mothers was analyzed.","Sera were collected from 3 infants born to HTLV-1 seropositive mothers.","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Reactivity of antisera against the epitope was seen until at least 6 months after birth. Reactivity to the epitope was also seen without adoptive transfer.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLVDAPGYDPIWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWKSK,,162,209,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1583272,http://www.iedb.org/reference/1013479,Literature,15136590,,"Yoshihisa Yamano; Cyril J Cohen; Norihiro Takenouchi; Karen Yao; Utano Tomaru; Hong-Chuan Li; Yoram Reiter; Steven Jacobson","J Exp Med",2004,"Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.",http://www.iedb.org/epitope/37257,"Linear peptide",LLFGYPVYV,"Tax 11-19",,,11,19,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The Fab Ab specific for the Tax11-19 peptide–HLA-A*0201 complex (TaxA2-Ab) is described in Cohen et al, 2003, J. Immunol. 170:4349–4361 [PMID: 12682272]. They are derived from a naive donor antibody display library.","Figures 1, 2, 5 and 6","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The HLA-peptide complexes were detected with PE-labeled TaxA2-Ab and flow cytometry. The complexes were detected on peptide pulsed HmyA2.1 cells and peptide pulsed CD4+ and CD8+ cells derived from HLA-A2 healthy donors. For HAM/HSP HTLV patients, detection of endogenously processed peptide in complex with HLA-A2 was demonstrated on CD4+ T cells, but not on CD8+ T cells. Flow cytometry assay showed Tax11-19 peptide–HLA-A*201 complexes were preferentially expressed on CD4+ CD25+, CD27-, CD45RO+, CD45RA- cells (that is, in the activated, effector/memory population). The peptide was detected after 24h in vitro culture of the CD4+ cells, but not directly ex-vivo. There was a direct correlation between the level of Tax11-19 peptide–HLA-A*201 complexes detected and HTLV-I proviral DNA load, HTLV-I tax mRNA load, and HTLV Tax11-19 peptide–specific CTL frequencies.","Purified Immunoglobulin",Fab,Polyclonal-Monospecific,TaxA2-Ab,,,,Epitope,"Linear peptide",LLFGYPVYV,,11,19,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1583608,http://www.iedb.org/reference/1010904,Literature,6207538,,"J Suni; A Närvänen; T Wahlström; M Aho; R Pakkanen; A Vaheri; T Copeland; M Cohen; S Oroszlan","Proc Natl Acad Sci U S A",1984,"Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence.",http://www.iedb.org/epitope/92586,"Linear peptide",ENPSQFYERL,Sp23,,,,,,,"retroviral gag protein",https://ontology.iedb.org/ontology/ONTIE_0002179,"Retroviral gag protein",http://www.uniprot.org/uniprot/Q7ZGS4,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ENPSQFYERL,,,,,"retroviral gag protein",https://ontology.iedb.org/ontology/ONTIE_0002179,"Retroviral gag protein",http://www.uniprot.org/uniprot/Q7ZGS4,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug at 2 week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 3, 4, 5, Table 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Rabbit antisera was able to detect a 75 kD band in a Western blot of JEG-3 choriocarcinoma cells, and JAr and BeWo choriocarcinoma cells, but not control fibroblasts. Immunoperoxidase staining of tissue sections with anti-Sp23 gave a strong reaction for the syncytiotrophoblastic cells of all early (",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Human endogenous retrovirus","JEG-3 choriocarcinoma cells, placenta cells",,,,,,,,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827
http://www.iedb.org/assay/1583622,http://www.iedb.org/reference/1010904,Literature,6207538,,"J Suni; A Närvänen; T Wahlström; M Aho; R Pakkanen; A Vaheri; T Copeland; M Cohen; S Oroszlan","Proc Natl Acad Sci U S A",1984,"Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence.",http://www.iedb.org/epitope/92586,"Linear peptide",ENPSQFYERL,Sp23,,,,,,,"retroviral gag protein",https://ontology.iedb.org/ontology/ONTIE_0002179,"Retroviral gag protein",http://www.uniprot.org/uniprot/Q7ZGS4,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"An internal source ID is assigned, because the sequence provided in the reference differs from those found by BLAST.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",ENPSQFYERL,,,,,"retroviral gag protein",https://ontology.iedb.org/ontology/ONTIE_0002179,"Retroviral gag protein",http://www.uniprot.org/uniprot/Q7ZGS4,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,";Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug at 2 week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to inhibit rabbit antiserum binding to JEG-3 choriocarcinoma cells in a Western blot. The epitope was synthesized with an N-terminal Cys.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ENPSQFYERL,,,,,"retroviral gag protein",https://ontology.iedb.org/ontology/ONTIE_0002179,"Retroviral gag protein",http://www.uniprot.org/uniprot/Q7ZGS4,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827,"Human endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11827
http://www.iedb.org/assay/1584130,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,"Peptide 1 gp70 residues 6-12",,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a glutamine residue at its C-terminus to facilitate coupling or labeling. Details of the immunization procedures were described in cited reference: Bayer et al. (1984) EMBO J 3:1925 [PMID: 6479153].","Figure 1","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584135,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,"Peptide 2 gp70 residues 124-131",,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization procedures were described in cited reference: Bayer et al. (1984) EMBO J 3:1925 [PMID: 6479153].","Figure 1","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584136,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,"Peptide 3 gp70 residues 256-262",,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a cysteine residue at its N-terminus to facilitate coupling or labeling. Details of the immunization procedures were described in cited reference: Bayer et al. (1984) EMBO J 3:1925 [PMID: 6479153].","Figure 1","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584137,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,"Peptide 4 gp70 residues 283-290",,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a tyrosine residue at its N-terminus to facilitate coupling or labeling. Details of the immunization procedures were described in cited reference: Bayer et al. (1984) EMBO J 3:1925 [PMID: 6479153].","Figure 1","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Positive,,,3,1,33.3,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584138,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,"Peptide 5 gp70 residues 434-441",,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",intradermal,"2 doses of 1 mg, administered at intervals of 4 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a cysteine residue at its N-terminus to facilitate coupling or labeling. Details of the immunization procedures were described in cited reference: Bayer et al. (1984) EMBO J 3:1925 [PMID: 6479153].","Figure 1","biological activity","complement-dependent cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001641,Positive,,,5,4,80,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584142,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,"Peptide 1 gp70 residues 6-12",,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a glutamine residue at its C-terminus to facilitate coupling or labeling.","Table 1, Text page 519",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,21,9,42.9,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584143,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,"Peptide 1 gp70 residues 6-12",,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a glutamine residue at its C-terminus to facilitate coupling or labeling.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,1,12.5,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"viral envelope protein",gp70,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584146,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,"Peptide 1 gp70 residues 6-12",,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a glutamine residue at its C-terminus to facilitate coupling or labeling.","Table 1","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Negative,,,8,0,0,"The challenge virus was injected 2 weeks after the last immunization.",,,,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584147,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,"Peptide 2 gp70 residues 124-131",,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Text page 519",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,10,10,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584148,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,"Peptide 2 gp70 residues 124-131",,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,4,80,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"viral envelope protein",gp70,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584149,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,"Peptide 2 gp70 residues 124-131",,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","in vivo assay","protection from pathogen challenge",,http://purl.obolibrary.org/obo/OBI_0003465,Positive,,,5,1,20,"The challenge virus was injected 2 weeks after the last immunization.",,,,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584151,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,"Peptide 4 gp70 residues 283-290",,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a tyrosine residue at its N-terminus to facilitate coupling or labeling.","Table 1, Text page 519",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,20,20,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584152,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,"Peptide 4 gp70 residues 283-290",,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a tyrosine residue at its N-terminus to facilitate coupling or labeling.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,7,2,28.6,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"viral envelope protein",gp70,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584153,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,"Peptide 4 gp70 residues 283-290",,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a tyrosine residue at its N-terminus to facilitate coupling or labeling.","Table 1","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Positive,,,7,2,28.6,"The challenge virus was injected 2 weeks after the last immunization.",,,,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584155,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,"Peptide 5 gp70 residues 434-441",,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a cysteine residue at its N-terminus to facilitate coupling or labeling.","Table 1, Text page 519",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,20,17,85,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584156,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,"Peptide 5 gp70 residues 434-441",,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a cysteine residue at its N-terminus to facilitate coupling or labeling.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,7,5,71.4,,Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"viral envelope protein precursor",gp70,,,http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584157,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,"Peptide 5 gp70 residues 434-441",,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a cysteine residue at its N-terminus to facilitate coupling or labeling.","Table 1","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Negative,,,7,0,0,"The challenge virus was injected 2 weeks after the last immunization.",,,,,,,,"Source Organism",Organism,"Friend murine leukemia virus (Friend murine leukemia virus F-MuLV)",,,,,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1584201,http://www.iedb.org/reference/1010417,Literature,2552299,,"S Shoji; O Takenaka; Y Kida; M Matsunaga; M Hayashi; S Horiuchi; Y Kubota","Mol Cell Probes",1989,"A novel antibody against a synthetic NH2-terminal myristoyl glycyl src peptide can detect pp60v-src, the transforming protein of Rous sarcoma virus.",http://www.iedb.org/epitope/94836,"Linear peptide","GSSK + MYRI(G1)","N-terminal src peptide",G1,Myristoylation|MYRI,2,5,,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide","GSSK + MYRI(G1)",,2,5,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,";Freund's complete;Freund's incomplete (IFA);",intradermal,"7 doses of 0.1mg epitope-KLH conjugate on days 0, 10 and weekly thereafter with a final dose in IFA",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to KLH via the C-terminal Lys residue.","Figure 2","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The myristoylated epitope conjugated to KLH or BSA inhibited antisera raised against epitope-KLH from binding to epitope-BSA. The N-Myr-glycine moiety was essential for binding. The myristoylated epitope coupled to tyramine or uncoupled inhibited the antisera from binding to epitope-tyramine.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide","GSSK + MYRI(G1)",,2,5,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886
http://www.iedb.org/assay/1584202,http://www.iedb.org/reference/1010417,Literature,2552299,,"S Shoji; O Takenaka; Y Kida; M Matsunaga; M Hayashi; S Horiuchi; Y Kubota","Mol Cell Probes",1989,"A novel antibody against a synthetic NH2-terminal myristoyl glycyl src peptide can detect pp60v-src, the transforming protein of Rous sarcoma virus.",http://www.iedb.org/epitope/94836,"Linear peptide","GSSK + MYRI(G1)","N-terminal src peptide",G1,Myristoylation|MYRI,2,5,,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide","GSSK + MYRI(G1)",,2,5,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,";Freund's complete;Freund's incomplete (IFA);",intradermal,"7 doses of 0.1mg epitope-KLH conjugate on days 0, 10 and weekly thereafter with a final dose in IFA",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to KLH via the C-terminal Lys residue.","Figures 3 and 4",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"Antisera raised against myristoylated epitope conjugated to KLH immunoprecipitated 60 kDa and 28 kDa proteins from lysates of [3H] myristic acid-labeled tsNy68-transformed CEF. The 60 K protein corresponds to the pp60 v-src protein, as determined by sequencing the radiolabeled N-terminal tryptic peptide of the antibody-bound protein.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"src-p60 phoshoprotein",src,,,http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,,,,,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886
http://www.iedb.org/assay/1584203,http://www.iedb.org/reference/1010417,Literature,2552299,,"S Shoji; O Takenaka; Y Kida; M Matsunaga; M Hayashi; S Horiuchi; Y Kubota","Mol Cell Probes",1989,"A novel antibody against a synthetic NH2-terminal myristoyl glycyl src peptide can detect pp60v-src, the transforming protein of Rous sarcoma virus.",http://www.iedb.org/epitope/94836,"Linear peptide","GSSK + MYRI(G1)","N-terminal src peptide",G1,Myristoylation|MYRI,2,5,,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide","GSSK + MYRI(G1)",,2,5,,"src-p60 phoshoprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42571.1,"Tyrosine-protein kinase transforming protein Src",http://www.uniprot.org/uniprot/P00526,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,";Freund's complete;Freund's incomplete (IFA);",intradermal,"7 doses of 0.1mg epitope-KLH conjugate on days 0, 10 and weekly thereafter with a final dose in IFA",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to KLH via the C-terminal Lys residue.","Figure 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Antisera raised against myristoylated epitope conjugated to KLH immunostained the circumference of RSV-infected cells.","Purified Immunoglobulin","Entire Antibody",Polyclonal-Monospecific,,,,,"Source Organism",Organism,"Rous sarcoma virus (Rous sarcoma virus RSV)",,,,,,,,,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886
http://www.iedb.org/assay/1585906,http://www.iedb.org/reference/1008942,Literature,3469323,,"H Bayer; G Hunsmann","J Gen Virol",1987,"Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,"Peptide 3 gp70 residues 256-262",,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"The epitope sequence is from the cited reference: Bayer et al. (1984) EMBO J 3: 1925 [PMID: 6479153].",,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,,"8-12 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",intraperitoneal,"3 doses using a total of 0.1 mg peptide conjugates, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The peptide was synthesized to contain a glutamine residue at its C-terminus to facilitate coupling or labeling.","Text page 519",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586027,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94967,"Linear peptide",WLGLGGGRVSPPGPECIEKPATERRIDKGEEVGETTVQRDAKM,"p19 97-139",,,97,139,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope sequence was deduced through study of binding of the mAbs to CNBr- and n-chlorosuccinimide-cleaved peptides by Western blot.",,"Entire Antibody",Monoclonal,"2D2, 4C11, 4G9, 5C1, 5H9, 6H12",IgG1,,,"Taxonomic Sibling","Linear peptide",MVLGKSGELKTWGLVLGALKAAREEQVTSEQAKFWLGLGGGRVSPPGPECIEKPATERRTDKGEEVGETTAQRDAKM,,63,139,,"polyprotein I",http://www.ncbi.nlm.nih.gov/protein/AAB31928.1,,,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866
http://www.iedb.org/assay/1586029,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94967,"Linear peptide",WLGLGGGRVSPPGPECIEKPATERRIDKGEEVGETTVQRDAKM,"p19 97-139",,,97,139,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Rous sarcoma virus (Rous sarcoma virus RSV)",,,,,,,,,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAbs were able to bind to p19 by Western blot.",,"Entire Antibody",Monoclonal,"2D2, 4C11, 4G9, 5C1, 5H9, 6H12",IgG1,,,"Taxonomic Sibling",Protein,p110,p19,,,http://www.ncbi.nlm.nih.gov/protein/NP_045935.1,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867
http://www.iedb.org/assay/1586030,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94883,"Linear peptide",MLSLLQKEGLLMSPSDLYSPGSW,"p19 29-51",,,29,51,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope sequence was deduced through study of binding of the mAb to CNBr- and n-chlorosuccinimide-cleaved peptides by Western blot.",,"Entire Antibody",Monoclonal,3C2,IgG1,,,"Taxonomic Sibling","Linear peptide",MVLGKSGELKTWGLVLGALKAAREEQVTSEQAKFWLGLGGGRVSPPGPECIEKPATERRTDKGEEVGETTAQRDAKM,,63,139,,"polyprotein I",http://www.ncbi.nlm.nih.gov/protein/AAB31928.1,,,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866
http://www.iedb.org/assay/1586031,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94883,"Linear peptide",MLSLLQKEGLLMSPSDLYSPGSW,"p19 29-51",,,29,51,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Rous sarcoma virus (Rous sarcoma virus RSV)",,,,,,,,,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind to p19 by Western blot.",,"Entire Antibody",Monoclonal,3C2,IgG1,,,"Taxonomic Sibling",Protein,"polyprotein I",p19,,,http://www.ncbi.nlm.nih.gov/protein/AAB31928.1,,,,,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866
http://www.iedb.org/assay/1586150,http://www.iedb.org/reference/1006545,Literature,1710610,,"Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno","Int J Cancer",1991,"Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.",http://www.iedb.org/epitope/96262,"Linear peptide",EPQISPGGLEPPSEKHFRETEV,"pXD tax1 (339-353)",,,332,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence has been cited in Siki, M. et  al. (1983) Proc Natl Acad Sci U S A. Jun;80(12):3618-22 [PMID: 6304725].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",PX141,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 5ug, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Initial immunization was given i.p. and booster injections were given s.c.","Table 1 and Figures 4 and 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb reacted with HTLV-1-bearing cell lines MT-1, HUT 102, ILT-MOR-II, F-Taj, F-Aki in immunofluorescence. The mAb also reacted with HeLa cells infected with recombinant vaccinia virus WR-40.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"TAXY-6, TAXY-8",IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1586152,http://www.iedb.org/reference/1006545,Literature,1710610,,"Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno","Int J Cancer",1991,"Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.",http://www.iedb.org/epitope/96262,"Linear peptide",EPQISPGGLEPPSEKHFRETEV,"pXD tax1 (339-353)",,,332,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence has been cited in Siki, M. et  al. (1983) Proc Natl Acad Sci U S A. Jun;80(12):3618-22 [PMID: 6304725].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",PX141,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 5ug, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Initial immunization was given i.p. and booster injections were given s.c.","Table 1 and Figures 7 and 8, Table 1 and Figure 7","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Reactivity of the epitope-sprecific mAbs with HeLa cells or MT-2 cells expressing HTLV-1 tax1 as a recombinant protein (pXP141) was measured. The epitope specific mAb TAXY-6 inhibited the binding of monoclonal antibody TAX-7 and Lt4 to the antigen. The epitoie-specific mAb TAXY-8 inhibited the binding of monoclonal antibody TAXY-1 and Lt4 to the antigen, measured bu ELISA. All antibodies were raised against the HTLV-1 tax-1 gene.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"TAXY-6, TAXY-8",IgG,,,"Source Antigen",Protein,"transcriptional activator Tax",PX141,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1586154,http://www.iedb.org/reference/1006545,Literature,1710610,,"Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno","Int J Cancer",1991,"Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.",http://www.iedb.org/epitope/96262,"Linear peptide",EPQISPGGLEPPSEKHFRETEV,"pXD tax1 (339-353)",,,332,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence has been cited in Siki, M. et  al. (1983) Proc Natl Acad Sci U S A. Jun;80(12):3618-22 [PMID: 6304725].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Parent",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 9","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"The epitope-specific mAbs TAXY-6 and TAXY-8 inhibited the binding of the antisera to tax1 in ELISA.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Antigen",Protein,"transcriptional activator Tax",PX141,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1586155,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94927,"Linear peptide",SPSDLYSPGSWDPITAALSQRAM,"p19 41-63",,,41,63,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind to p19 by Western blot.",,"Entire Antibody",Monoclonal,2A7,IgG1,,,"Taxonomic Sibling",Protein,"polyprotein I",p19,,,http://www.ncbi.nlm.nih.gov/protein/AAB31928.1,,,,,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866
http://www.iedb.org/assay/1586156,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94927,"Linear peptide",SPSDLYSPGSWDPITAALSQRAM,"p19 41-63",,,41,63,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1, Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope sequence was deduced through study of binding of the mAb to CNBr- and n-chlorosuccinimide-cleaved peptides by Western blot.",,"Entire Antibody",Monoclonal,2A7,IgG1,,,"Taxonomic Sibling","Linear peptide",MVLGKSGELKTWGLVLGALKAAREEQVTSEQAKFWLGLGGGRVSPPGPECIEKPATERRTDKGEEVGETTAQRDAKM,,63,139,,"polyprotein I",http://www.ncbi.nlm.nih.gov/protein/AAB31928.1,,,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866,"Avian myeloblastosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11866
http://www.iedb.org/assay/1586330,http://www.iedb.org/reference/1006545,Literature,1710610,,"Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno","Int J Cancer",1991,"Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.",http://www.iedb.org/epitope/96262,"Linear peptide",EPQISPGGLEPPSEKHFRETEV,"pXD tax1 (339-353)",,,332,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence has been cited in Siki, M. et  al. (1983) Proc Natl Acad Sci U S A. Jun;80(12):3618-22 [PMID: 6304725].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax",PX141,,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 5ug, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"Initial immunization was given i.p. and booster injections were given s.c.","Figure 6","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb reacted strongly with the 41-kDa protein expressed in chimpanzee ChM114-1 cells, and reacted weakly with a 43-kDa protein expressed in bonnet monkey BM5 and Japanese macaque JM86 cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,TAXY-8,IgG,,,Other,Organism,"Simian T-lymphotropic virus 1 (Simian T cell lymphotropic virus type 1)",STLV-1,,,,,,,,"Simian T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_33747,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1586353,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,pep1,,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (E) was added to the C-terminus to couple the epitope to the carrier protein.","Tables II and III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Anti-epitope sera recognized the epitope by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586354,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,pep1,,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (E) was added to the C-terminus to couple the epitope to the carrier protein.","Tables II and III, Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Anti-epitope sera recognized gp70 by competitive and direct ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586356,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,pep1,,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (E) was added to the C-terminus to couple the epitope to the carrier protein.","Table III","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Anti-epitope sera recognized gp70  from Feline leukemia virus by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Taxonomic Sibling",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA43053.1,,,,,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768,"Feline leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11768
http://www.iedb.org/assay/1586358,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,pep1,,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Anti-gp70 sera did not recognize the epitope. And extra amino acid (E) was added to the C-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586359,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95043,"Linear peptide",SPHQVYN,pep1,,,40,46,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",subcutaneous,"4 doses 3 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization can be found in: Hunsmann et al. Virology. 1981 Sep;113(2):602-12. [PMID: 6943864].","Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Anti-gp70 sera did not recognize the epitope. And extra amino acid (E) was added to the C-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SPHQVYN,,40,46,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586360,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,pep2,,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Anti-gp70 sera did not recognize the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586361,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,pep2,,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",subcutaneous,"4 doses 3 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization can be found in: Hunsmann et al. Virology. 1981 Sep;113(2):602-12. [PMID: 6943864].","Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Anti-gp70 sera did not recognize the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586362,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,pep2,,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Tables II and III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Anti-epitope sera recognized the epitope by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586363,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95040,"Linear peptide",SHRPREAK,pep2,,,158,165,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SHRPREAK,,158,165,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Tables II and III, Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Anti-epitope sera recognized gp70 by competitive and direct ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586365,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,pep3,,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"One of two anti-gp70 sera recognized the epitope. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586366,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,pep3,,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",subcutaneous,"4 doses 3 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization can be found in: Hunsmann et al. Virology. 1981 Sep;113(2):602-12. [PMID: 6943864].","Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"Anti-gp70 sera did not recognize the epitope. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586367,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,pep3,,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Peptide was also conjugated to BSA. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Anti-epitope sera recognized the epitope by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586370,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,pep4,,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"Anti-gp70 sera recognized the epitope by ELISA. And extra amino acid (Y) was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586371,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,pep4,,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",subcutaneous,"4 doses 3 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization can be found in: Hunsmann et al. Virology. 1981 Sep;113(2):602-12. [PMID: 6943864].","Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,2,50,"Two of four anti-gp70 sera recognized the epitope. And extra amino acid (Y) was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586372,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,pep4,,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (Y) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III, Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Anti-epitope sera recognized the epitope by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586373,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95032,"Linear peptide",PAGTGDRL,pep4,,,317,324,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PAGTGDRL,,317,324,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (Y) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III, Figures 3 and 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Anti-epitope sera recognized gp70 by competitive and direct ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586375,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,pep5,,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein precursor",,,,http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"Anti-gp70 sera recognized the epitope. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586376,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,pep5,,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus STU",https://ontology.iedb.org/ontology/ONTIE_0000558,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"viral envelope protein precursor",,,,http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's incomplete (IFA);",subcutaneous,"4 doses 3 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"Details of the immunization can be found in: Hunsmann et al. Virology. 1981 Sep;113(2):602-12. [PMID: 6943864].","Table IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,4,100,"Anti-gp70 sera recognized the epitope. And extra amino acid () was added to the N-terminus to couple the epitope to the carrier protein.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586377,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,pep5,,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"BSA was also used for conjugation. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Anti-epitope sera recognized the epitope by ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586378,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95051,"Linear peptide",YSQFEKSY,pep5,,,468,475,,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YSQFEKSY,,468,475,,"viral envelope protein precursor",http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"BSA was also used for conjugation. And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III, Figures 3 and 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"Anti-epitope sera recognized gp70 by competitive and direct ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"viral envelope protein precursor",,,,http://www.ncbi.nlm.nih.gov/protein/CAA26561.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1586592,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94967,"Linear peptide",WLGLGGGRVSPPGPECIEKPATERRIDKGEEVGETTVQRDAKM,"p19 97-139",,,97,139,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Text p 3177","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAbs were able to bind AMV.",,"Entire Antibody",Monoclonal,"2D2, 4C11, 4G9, 5C1, 5H9, 6H12",IgG1,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867
http://www.iedb.org/assay/1586595,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94883,"Linear peptide",MLSLLQKEGLLMSPSDLYSPGSW,"p19 29-51",,,29,51,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Text p 3177","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind AMV.",,"Entire Antibody",Monoclonal,3C2,IgG1,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867
http://www.iedb.org/assay/1586596,http://www.iedb.org/reference/1011295,Literature,2447226,,"W M Potts; M Olsen; D Boettiger; V M Vogt","J Gen Virol",1987,"Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses.",http://www.iedb.org/epitope/94927,"Linear peptide",SPSDLYSPGSWDPITAALSQRAM,"p19 41-63",,,41,63,,,p19,http://www.ncbi.nlm.nih.gov/protein/NP_955607.1,"Gag-Pol polyprotein",http://www.uniprot.org/uniprot/P03354,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"Rous sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_11886,"The epitope sequence is found in Schwartz et al. (1983) [PMID: 6299578].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Text p 3177","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb was able to bind AMV.",,"Entire Antibody",Monoclonal,2A7,IgG1,,,"Taxonomic Sibling",Organism,"Avian myelocytomatosis virus (Avian myelocytomatosis retrovirus)",,,,,,,,,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867,"Avian myelocytomatosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11867
http://www.iedb.org/assay/1587148,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,36,28,77.8,"Results were expressed as the ratio of duplicate cpm values obtained with experimental HTLV-1 positive sera and normal sera. Ratios equal or greater than 3 were considered positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587150,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"Purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT et al. (1984)  J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figures 2 and 3",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,"The epitope-specific mAb reacted with the antigen in Western blot and Immunoprecipitation.","Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,"Structurally Related",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587151,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"Purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT et al. (1984)  J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb reacted with the antigen in acetone-fixed HUT-1, MT-2, C10MJ, and MJ cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587152,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"Purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT et al. (1984)  J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figure 5","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb reacted with the antigen in viable HUT-1 and MT-2 cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587153,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 8","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,4,4,100,"The epitope-specific mAb 1C11 inhibited the binding of the HTLV-1+ patient sera to the antigen in ELISA and Immonoblot.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,gp46,,,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587154,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"Purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT et al. (1984)  J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figure 8","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the binding of epitope-specific mAb to HTLV-1 gp46.","Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587155,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/71143,"Linear peptide",VSSYHSKPCNPAQPV,"HTLV-1 gp46 1 (33-47)",,,25,39,,,"surface glycoprotein gp46",http://www.ncbi.nlm.nih.gov/protein/AAA87561.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VSSYHSKPCNPAQPV,,25,39,,"surface glycoprotein gp46",http://www.ncbi.nlm.nih.gov/protein/AAA87561.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587156,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/47861,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,"HTLV-1 gp46 2 (86-107)",,,86,107,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"Two sera out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWTKKPNRNGGGYYSASYSDP,,86,107,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587157,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"HTLV-1 gp46 3 (176-149)",,,176,189,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,,176,189,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587158,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"HTLV-1 gp46 4 (129-149)",,,129,149,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,,129,149,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587159,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/38482,"Linear peptide",LPFNWTHCFDPQ,"HTLV-1 gp46 5 (269-280)",,,269,280,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional C-terminal cysteine and N-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPFNWTHCFDPQ,,269,280,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587160,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"HTLV-1 gp46 6 (296-312)",,,296,312,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,35,,,"Results were expressed as the ratio of duplicate cpm values obtained with experimental HTLV-1 positive sera and normal sera. Ratios equal or greater than 3 were considered positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,,296,312,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587161,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/73327,"Linear peptide",YAAQNRRGLDLLFWEQGGL,"HTLV-1 env 7 (374-392)",,,374,392,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional C-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,33,,,"Results were expressed as the ratio of duplicate cpm values obtained with experimental HTLV-1 positive sera and normal sera. Ratios equal or greater than 3 were considered positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YAAQNRRGLDLLFWEQGGL,,374,392,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587162,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"HTLV-1 env 8 (400-415)",,,400,415,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,,400,415,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587163,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/47925,"Linear peptide",PILQERPPLENR,"HTLV-1 env 9 (411-422)",,,411,422,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,,,,"Results were expressed as the ratio of duplicate cpm values obtained with experimental HTLV-1 positive sera and normal sera. Ratios equal or greater than 3 were considered positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PILQERPPLENR,,411,422,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587164,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"HTLV-1  env 10 (462-480)",,,462,480,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Negative,,,,,,"Results were expressed as the ratio of duplicate cpm values obtained with experimental HTLV-1 positive sera and normal sera. Ratios equal or greater than 3 were considered positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,,462,480,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587165,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/56614,"Linear peptide",RYPHYSLIKPESSL,"HTLV-1 env 11(475-488)",,,475,488,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine residue.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-1,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive-Low,,,,,,"One serum out of over 30 tested reacted with the epitope.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RYPHYSLIKPESSL,,475,488,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1587220,http://www.iedb.org/reference/1013409,Literature,8892853,,"J Arp; M LeVatte; J Rowe; S Perkins; E King; C Leystra-Lantz; S K Foung; G A Dekaban","J Virol",1996,"A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.",http://www.iedb.org/epitope/95116,"Linear peptide",LLPHSNLDHILEPSIPWKS,"HTLV-1 gp46 4A (190-209)",,,190,208,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is cited in Palker, TJ. et al. (1989)  J Immunol. Feb 1;142(3):971-8 [PMID: 2563272].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug, administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT. et al (1984) J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figures 2, 4, and 10","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb recognized the HTLV-1 gp46 in Western blot and immunoprecipitatioin. For Western blot analysis, the antigen was expressed in HeLa cells using a recombinant vaccinia virus/T7 polymerase system (vTME-46/vTF-3).","Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,"Source Antigen",Protein,gp46,,,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1588224,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHILEPSIPWKSK,,190,209,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"5 doses of 5mg administered on days 0, 14, 21, 28, and 35.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 9",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,gp46,,,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1588226,http://www.iedb.org/reference/1013597,Literature,2563272,,"T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes","J Immunol",1989,"Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"HTLV-1 gp46 4A (190-209)",,,190,209,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epotipe contained an additional N-terminal cysteine and C-terminal tyrosine residue.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gp46,"Purified gp46",,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 50ug administered at intervals of 1 week.",,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were previously described in Palker, JT et al. (1984)  J Exp Med. Apr 1;159(4):1117-31 [PMID: 6323615].","Figure 9",immunoprecipitation,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001653,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,1C11,IgG,,,"Source Antigen",Protein,gp46,,,,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590065,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96103,"Linear peptide",APPLLPHSNLDHI,SP187-199,,,187,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the mAbs was previously described in the references Kuroki et al, J iimunol 149(3) 1992 [PMID:1378869] and baba et al,  J Immunol 151(2) 1993 [PMID: 7687611].","Figure  1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the binding of the mAbs to HTLV-1 gp46. Additional peptides from gp46 and overlapping the epitope sequence were also positive: SP 185-201, SP181-203, and SP 181-210.","Purified Immunoglobulin","Entire Antibody",Monoclonal,"KE36-11, B44-1, T-2",IgG3,,,Epitope,"Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590083,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96103,"Linear peptide",APPLLPHSNLDHI,SP187-199,,,187,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,MAP181-210,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 500ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with either MAP constructs composed of gp46 peptides containing the epitope sequence (SP 181-203 or SP 181-210) or the gp46 peptide SP 181-203 alone.","Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response to the epitope was greatest when immunization was performed with the gp46 SP181-210 MAP construct.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590084,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96103,"Linear peptide",APPLLPHSNLDHI,SP187-199,,,187,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,MAP181-210,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with MAP constructs composed of gp46 peptides containing the epitope sequence (SP 181-203 or SP 181-210).","Table III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response to the epitope was similar with either MAP construct.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590088,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96914,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,SP181-203,,,181,203,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,,181,203,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with MAP constructs composed of either the epitope or a gp46 peptide containing the epitope sequence (SP 181-210).","Table III",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was similar with either MAP construct.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590090,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96914,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,SP181-203,,,181,203,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,,181,203,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 500ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with either a MAP construct composed of the epitope or the epitope alone.","Table II","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590093,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96914,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,SP181-203,,,181,203,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,,181,203,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table III","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590098,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96914,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,SP181-203,,,181,203,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,,181,203,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 500ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with either MAP constructs composed of the epitope or a gp46 peptide containing the epitope sequence (SP 181-210) or the epitope alone.","Figure  2, Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,9,100,"All responses were positive. Overlapping peptides from gp46 were tested with the greatest response being seen with the epitope as antigen. All responses were positive, however, the response to the epitope-MAP was low.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590107,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96914,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,SP181-203,,,181,203,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,MAP181-210,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"F344, ACI, WKA Lewis, and BN rats were used.","Figure  3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"All animals tested were positive with the best response observed in WKA rats. Overlapping peptides from gp46 were tested with the epitope giving a good response as antigen in F344 and WKA rats.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPS,,181,203,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590129,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96915,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,SP181-210,,,181,210,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 500ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590130,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96915,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,SP181-210,,,181,210,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 500ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table II","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590131,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96915,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,SP181-210,,,181,210,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"F344, Lewis, BN, ACI, and WKA rats were used.","Tables III and IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The response was positive in all rats tested.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590132,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96915,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,SP181-210,,,181,210,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"F344, Lewis, BN, ACI, and WKA rats were used.","Tables III and IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The response was positive in all rats tested.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590133,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96915,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,SP181-210,,,181,210,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,MAP181-210,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"F344, ACI, WKA Lewis, and BN rats were used.","Tables III and IV",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"All animals tested were positive.The response to a smaller gp46 peptide, SP 187-199, was also positive, but the response to the epitope was higher.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1590151,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96593,"Linear peptide",LPHSNLDHIL,SP191-200,,,191,200,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SQLPPTAPPLLPHSNLDHILEPSIPWKSKL,MAP181-210,181,210,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"3 doses of 100ug at two week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"F344, ACI, WKA, Lewis and BN rats were used.","Figure  3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"All animals tested were positive with the best response observed in Lewis and BN rats. Overlapping peptides from gp46 were tested with the epitope giving the best response as antigen in Lewis and BN rats.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHIL,,191,200,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1594225,http://www.iedb.org/reference/1010120,Literature,6479153,,"H Bayer; W Gruber; J Schneider; G Hunsmann","EMBO J",1984,"Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.",http://www.iedb.org/epitope/95034,"Linear peptide",PKPAKSP,pep3,,,290,296,,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PKPAKSP,,290,296,,"viral envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,";Freund's complete;",subcutaneous,"2 doses 4 weeks apart",,,,,,,,,,,,,,,,,,,,,,,N,,"And extra amino acid (C) was added to the N-terminus to couple the epitope to the carrier protein.","Tables II and III, Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"Anti-epitope sera did not recognize gp70 by competitive and direct ELISA.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,"viral envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/CAA84492.1,,,,,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1595554,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,SP5,,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.","Culture Supernatant","Entire Antibody",Monoclonal,B53-5,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595556,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/40541,"Linear peptide",LVQLTLQSTNYTCIVCIDRASLST,SP5,,,213,236,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 2, 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound gp46 by Western blot and ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,B53-5,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595558,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,SP9,,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 3, 4","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to compete for binding of the mAb to solid-phase gp46 or to the epitope. The mAb also reacted with the epitope by ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,B53-4,IgG,,,Epitope,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,,288,317,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595559,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,SP9,,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.","Culture Supernatant","Entire Antibody",Monoclonal,B53-4,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595560,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/78224,"Linear peptide",PCHNSLILPPFSLSPVPTLGSRSRRAVPVA,SP9,,,288,317,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 2, 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound gp46 by Western blot and ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,B53-4,IgG,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAL05538.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595561,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 2, 3, Table 4 and Text p 1018",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mAb bound gp46 by ELISA and Western blot. MAbs were isotype IgG1 (T-1, B1-11) or IgG3 (all others).","Culture Supernatant","Entire Antibody",Monoclonal,"B1-1, B2-1, B42-1-4, B42-2-5, T-1, T-2, B42-1-8, K-3, B44-1, B1-11, B43-1, B44-20, B3-9",IgG,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595562,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 3, 4, Table IV","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope was able to compete for binding of the mAb to solid-phase gp46 or to the epitope. The mAbs also reacted with the epitope by ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,"B1-1, B2-1, B42-1-4, B42-2-5, T-1, T-2, B42-1-8, K-3, B44-1, B1-11, B43-1, B44-20, B3-9, K4-3-6, T-3, L-6, L-10, L-14, K2-4-1, K4-3",IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595563,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,,,175,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1, Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.","Culture Supernatant","Entire Antibody",Monoclonal,"B1-1, B2-1, B42-1-4, B42-2-5, T-1, T-2, B42-1-8, K-3, B44-1, B1-11, B43-1, B44-20, B3-9",IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595615,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96102,"Linear peptide",APPLLPH,"SP3 187-193",,,187,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope sequence was deduced through study of overlapping peptides.","Culture Supernatant","Entire Antibody",Monoclonal,"B42-1-8, K-3",IgG3,,,Epitope,"Linear peptide",APPLLPH,,187,193,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595616,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96102,"Linear peptide",APPLLPH,"SP3 187-193",,,187,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 2 and Text p 1018","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound gp46 by Western blot.","Culture Supernatant","Entire Antibody",Monoclonal,"B42-1-8, K-3",IgG3,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595617,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96102,"Linear peptide",APPLLPH,"SP3 187-193",,,187,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1, Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.","Culture Supernatant","Entire Antibody",Monoclonal,"B42-1-8, K-3",IgG3,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595737,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96102,"Linear peptide",APPLLPH,"SP3 187-193",,,187,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The peptide antigen  was able to compete for binding of the epitope-specific mAb to solid-phase gp46 or to the peptide.","Culture Supernatant","Entire Antibody",Monoclonal,"B42-1-8, K-3",IgG3,,,"Fragment of Source Antigen","Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595738,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"SP3 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 2, Table IV and Text p 1018","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAbs bound gp46 by Western blot and ELISA.  MAbs were isotypes IgG1 (B1-11) and IgG3 (B44-1, B43-1-2, B44-20, B3-9).","Culture Supernatant","Entire Antibody",Monoclonal,"B44-1, B1-11, B43-1-2, B44-20, B3-9",IgG,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595739,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"SP3 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope sequence was deduced through study of overlapping peptides. MAbs were isotypes IgG1 (B1-11) and IgG3 (B44-1, B43-1-2, B44-20, B3-9).","Culture Supernatant","Entire Antibody",Monoclonal,"B44-1, B1-11, B43-1-2, B44-20, B3-9",IgG3,,,Epitope,"Linear peptide",LPHSNL,,191,196,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595740,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"SP3 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1, Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.  MAbs were isotypes IgG1 (B1-11) and IgG3 (B44-1, B43-1-2, B44-20, B3-9).","Culture Supernatant","Entire Antibody",Monoclonal,"B44-1, B1-11, B43-1-2, B44-20, B3-9",IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595741,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"SP3 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Table IV","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The peptide antigen  was able to compete for binding of the epitope-specific mAb to solid-phase gp46 or to the peptide.  MAbs were isotypes IgG1 (B1-11) and IgG3 (B44-1, B43-1-2, B44-20, B3-9).","Culture Supernatant","Entire Antibody",Monoclonal,"B44-1, B1-11, B43-1-2, B44-20, B3-9",IgG3,,,"Fragment of Source Antigen","Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595743,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96367,"Linear peptide",HSNLDHI,"SP3 193-199",,,193,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope sequence was deduced through study of overlapping peptides. The isotypes were IgG1 (T-1) and IgG3 (T-2).","Culture Supernatant","Entire Antibody",Monoclonal,"T-2, T-1",IgG,,,Epitope,"Linear peptide",HSNLDHI,,193,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595744,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96367,"Linear peptide",HSNLDHI,"SP3 193-199",,,193,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figures 2, 3, Table IV and Text p 1018","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound gp46 by Western blot and ELISA.  The isotypes were IgG1 (T-1) and IgG3 (T-2).","Culture Supernatant","Entire Antibody",Monoclonal,"T-2, T-1",IgG,,,"Source Antigen",Protein,"envelope glycoprotein",gp46,,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595745,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96367,"Linear peptide",HSNLDHI,"SP3 193-199",,,193,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The peptide antigen  was able to compete for binding of the epitope-specific mAb to solid-phase gp46 or to the peptide.  The isotypes were IgG1 (T-1) and IgG3 (T-2).","Culture Supernatant","Entire Antibody",Monoclonal,"T-2, T-1",IgG,,,"Fragment of Source Antigen","Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,SP3,175,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595746,http://www.iedb.org/reference/1008238,Literature,7687611,,"E Baba; M Nakamura; Y Tanaka; M Kuroki; Y Itoyama; S Nakano; Y Niho","J Immunol",1993,"Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.",http://www.iedb.org/epitope/96367,"Linear peptide",HSNLDHI,"SP3 193-199",,,193,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"PBMC from patients with HAM/TSP were used to prepare B cells that were then infected with EBV to create monoclonal antibodies.","Figure 1, Table IV","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited HTLV-1-induced syncytium formation.  The isotypes were IgG1 (T-1) and IgG3 (T-2).","Culture Supernatant","Entire Antibody",Monoclonal,"T-2, T-1",IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595747,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96102,"Linear peptide",APPLLPH,SP187-193,,,187,193,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the mAbs was previously described in the references Kuroki et al, J iimunol 149(3) 1992 [PMID:1378869] and baba et al,  J Immunol 151(2) 1993 [PMID: 7687611].","Figure  1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The peptide containing the epitope inhibited the binding of the epitope-specific mAb to HTLV-1 gp46. Additional peptides from gp46 and overlapping the epitope sequence were also positive: SP 185-201, SP181-203, and SP 181-210.","Purified Immunoglobulin","Entire Antibody",Monoclonal,KE36-11,IgG3,,,"Fragment of Source Antigen","Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595753,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,SP191-196,,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the mAbs was previously described in the references Kuroki et al, J iimunol 149(3) 1992 [PMID:1378869] and baba et al,  J Immunol 151(2) 1993 [PMID: 7687611].","Figure  1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The peptide containing the epitope inhibited the binding of the epitope-specific mAb to HTLV-1 gp46. Additional peptides from gp46 and overlapping the epitope sequence were also positive: SP 185-201, SP181-203, and SP 181-210.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B44-1,IgG3,,,"Fragment of Source Antigen","Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1595754,http://www.iedb.org/reference/1006413,Literature,7527817,,"E Baba; M Nakamura; K Ohkuma; J Kira; Y Tanaka; S Nakano; Y Niho","J Immunol",1995,"A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.",http://www.iedb.org/epitope/96367,"Linear peptide",HSNLDHI,SP193-199,,,193,199,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the mAbs was previously described in the references Kuroki et al, J iimunol 149(3) 1992 [PMID:1378869] and baba et al,  J Immunol 151(2) 1993 [PMID: 7687611].","Figure  1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The peptide containing the epitope inhibited the binding of the epitope-specific mAb to HTLV-1 gp46. Additional peptides from gp46 and overlapping the epitope sequence were also positive: SP 185-201, SP181-203, and SP 181-210.","Purified Immunoglobulin","Entire Antibody",Monoclonal,T2,IgG3,,,"Fragment of Source Antigen","Linear peptide",APPLLPHSNLDHI,,187,199,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597613,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98119,"Linear peptide",IPRPPRGLAAHHWLNFLQ,"GAG-T10 (12-29)",,,12,29,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IPRPPRGLAAHHWLNFLQ,,12,29,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597622,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98373,"Linear peptide",QLKKFLKIALETPARI,"GAG-T11 (45-60)",,,45,60,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,18,2,11.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QLKKFLKIALETPARI,,45,60,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597623,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98464,"Linear peptide",SLLPKGYPGRVNEILHILI,"GAG-T12 (70-88)",,,70,88,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLLPKGYPGRVNEILHILI,,70,88,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597624,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98123,"Linear peptide",IQTQAQIPSRPAPPPPS,"GAG-14 (88-102)",,,88,104,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,49,14,28.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IQTQAQIPSRPAPPPPS,,88,104,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597625,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"GAG-1A (102-117)",,,102,117,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,52,46,88.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597626,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/97892,"Linear peptide",APQVLPVMHPHGAPPN,GAG-3,,,126,141,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,52,1,1.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",APQVLPVMHPHGAPPN,,126,141,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597627,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98547,"Linear peptide",TTQCFPILHPPGAPSA,"GAG-15 (132-147)",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TTQCFPILHPPGAPSA,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597628,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98055,"Linear peptide",GAPPNHRPWQMKDLQA,"GAG-T13 (143-158)",,,137,152,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GAPPNHRPWQMKDLQA,,137,152,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597629,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98443,"Linear peptide",SEAETRGITGYNPLA,"GAG-T15 (216-230)",,,210,224,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,49,1,2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SEAETRGITGYNPLA,,210,224,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597630,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98196,"Linear peptide",LAAFSTLPGNTRDPS,"GAG-13 (254-268)",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,7,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LAAFSTLPGNTRDPS,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597631,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98457,"Linear peptide",SILQGLEEPYHAFVE,"GAG-T16 (271-285)",,,265,279,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,18,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SILQGLEEPYHAFVE,,265,279,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597632,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/97918,"Linear peptide",AYSNANKECQKLLQA,"GAG-T17 (308-323)",,,303,317,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,49,2,4.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AYSNANKECQKLLQA,,303,317,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597633,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98108,"Linear peptide",HTNSPLGDMLRACQT,"GAG-T18 (326-340)",,,320,334,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,18,1,5.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HTNSPLGDMLRACQT,,320,334,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597634,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/20199,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,"GAG-10 (370-392)",,,364,386,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,49,26,53.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GHWSRDCTQPRPPPGPCPLCQDP,,364,386,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597635,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98374,"Linear peptide",QLKPPQEEGEPLL,"GAG-12 (400-413)",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,7,1,14.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QLKPPQEEGEPLL,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597636,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/97853,"Linear peptide",ADIPHPKNFIGGEV,"GAG-5 (416-429)",,,416,429,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,52,1,1.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ADIPHPKNFIGGEV,,416,429,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597637,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98159,"Linear peptide",KFLATLILFFQFCPLIFGDYSP,"Env-3 (3-24)",,,3,24,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KFLATLILFFQFCPLIFGDYSP,,3,24,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597641,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98483,"Linear peptide",SSYHSKPCNPAQPVC,"ENV-T26 (33-49)",,,34,48,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSYHSKPCNPAQPVC,,34,48,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597642,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98387,"Linear peptide",QPPCPNLVSYSSYHATYS,"ENV-T27 (64-81)",,,64,81,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,6,17.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QPPCPNLVSYSSYHATYS,,64,81,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597643,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98109,"Linear peptide",HWIKKPNRNGGGYYSASYSD,"ENV-T28 (87-106)",,,87,106,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,10,29.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HWIKKPNRNGGGYYSASYSD,,87,106,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597644,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/76065,"Linear peptide",YTGPVSSPSWKFHSDV,"ENV-21 (124-139)",,,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,4,11.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTGPVSSPSWKFHSDV,,,,,"gag protein",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597645,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/61300,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,"SP-4 (129-149)",,,129,149,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,34,11,32.4,"The epitope contained an additional C-terminal Cys residue.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSPYWKFQHDVNFTQEVSRLN,,129,149,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597646,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/38345,"Linear peptide",LNTEPSQLPPTAPP,"SP-3 (176-189)",,,176,189,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,3,8.8,"The epitope contained an additional N-terminal Cys and C-terminal Tyr residue.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNTEPSQLPPTAPP,,176,189,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597647,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"ENV-1 (191-214)",,,191,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,34,31,91.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,,191,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597648,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/97954,"Linear peptide",DRASLSTWHVLYSPN,"ENV-T29 (230-244)",,,230,244,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,34,17,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DRASLSTWHVLYSPN,,230,244,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597649,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"ENV-5 (242-257)",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,34,34,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597650,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98369,"Linear peptide",QIQAIVSSPCHNSLI,"ENV-T30 (281-295)",,,280,294,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QIQAIVSSPCHNSLI,,280,294,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597654,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/48779,"Linear peptide",PPFSLSPVPTLGSRSRR,"SP-6 (296-312)",,,296,312,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,8,23.5,"The epitope contained an additional N-terminal Cys residue.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPFSLSPVPTLGSRSRR,,296,312,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597655,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98083,"Linear peptide",GVAGGITGSMSLAS,"ENV-T31 (330-343)",,,329,342,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GVAGGITGSMSLAS,,329,342,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597656,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98092,"Linear peptide",HEVDKDISQLTQAIVKNH,"ENV-T32 (349-366)",,,348,365,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,8,23.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HEVDKDISQLTQAIVKNH,,348,365,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04905.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597658,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98222,"Linear peptide",LLKIAQYAAQNRRGL,"ENV-T33 (369-383)",,,368,382,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLKIAQYAAQNRRGL,,368,382,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597659,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98365,"Linear peptide",QGGLCKALQEQCRF,"ENV-T34 (390-403)",,,389,402,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,2,5.9,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QGGLCKALQEQCRF,,389,402,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597660,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/6918,"Linear peptide",CRFPNITNSHVPILQE,"SP-8 (400-415)",,,400,415,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,4,11.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CRFPNITNSHVPILQE,,400,415,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597661,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98013,"Linear peptide",ERPPLENRVLTGWGL,"ENV-T35 (416-430)",,,415,429,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,34,13,38.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ERPPLENRVLTGWGL,,415,429,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597662,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98210,"Linear peptide",LGLSQWAREALQTGI,"ENV-T36 (434-448)",,,433,447,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,34,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LGLSQWAREALQTGI,,433,447,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597663,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/6429,"Linear peptide",CILRQLRHLPSRVRYPHYS,"SP-10 (462-480)",,,462,480,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,34,4,11.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CILRQLRHLPSRVRYPHYS,,462,480,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1597665,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/98435,"Linear peptide",RYPHYSSLIKPESSL,"SP-11 (475-488)",,,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Documented exposure without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 asymptomatic carriers were used in this study.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,34,12,35.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RYPHYSSLIKPESSL,,,,,"Envelope glycoprotein gp62",https://ontology.iedb.org/ontology/ONTIE_0002502,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600870,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"GAG-1A (102-117)",,,102,117,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with HTLV-1 assiciated myelopathy (HAM) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600871,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/48928,"Linear peptide",PPSSPTHDPPDSDPQI,"GAG-1A (102-117)",,,102,117,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with adult T-cell leukemia (ATL) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPSSPTHDPPDSDPQI,,102,117,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600875,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"ENV-1 (191-214)",,,191,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with HTLV-1 assiciated myelopathy (HAM) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,,191,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600876,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/38524,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,"ENV-1 (191-214)",,,191,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with adult T-cell leukemia (ATL) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPHSNLDHILEPSIPWKSKLLTLV,,191,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600877,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"ENV-5 (242-257)",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with HTLV-1 assiciated myelopathy (HAM) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1600878,http://www.iedb.org/reference/1013921,Literature,7680300,,"R B Lal; C Buckner; R F Khabbaz; J E Kaplan; G Reyes; K Hadlock; J Lipka; S K Foung; L Chan; J E Coligan","Clin Immunol Immunopathol",1993,"Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.",http://www.iedb.org/epitope/60170,"Linear peptide",SPNVSVPSSSSTPLLY,"ENV-5 (242-257)",,,242,257,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,"Serum specimens from HTLV-1 seropositive individuals with adult T-cell leukemia (ATL) were used in this study.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPNVSVPSSSSTPLLY,,242,257,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05539.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1664451,http://www.iedb.org/reference/1007092,Literature,1281825,,"J M Davies; S Sonoda; S Yashiki; M Osame; P R Carnegie","J Neuroimmunol",1992,"Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.",http://www.iedb.org/epitope/113401,"Linear peptide",FKLPGLNSR,"HTLV-I 831-839",,,831,839,,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",,"2 doses of 1mg/ml, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to Keyhole limpet haemacyanin (KLH) with ethyldimethylaminop-ropylcarbodiamide.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1664464,http://www.iedb.org/reference/1007092,Literature,1281825,,"J M Davies; S Sonoda; S Yashiki; M Osame; P R Carnegie","J Neuroimmunol",1992,"Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.",http://www.iedb.org/epitope/113401,"Linear peptide",FKLPGLNSR,"HTLV-I 831-839",,,831,839,,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",,"2 doses of 1mg/ml, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to Keyhole limpet haemacyanin (KLH) with ethyldimethylaminop-ropylcarbodiamide.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,"Structurally Related","Linear peptide",FKLGGRDSR,,155,163,,"MBP protein",http://www.ncbi.nlm.nih.gov/protein/AAH08749.3,"Myelin basic protein",http://www.uniprot.org/uniprot/P02686,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1664465,http://www.iedb.org/reference/1007092,Literature,1281825,,"J M Davies; S Sonoda; S Yashiki; M Osame; P R Carnegie","J Neuroimmunol",1992,"Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.",http://www.iedb.org/epitope/113401,"Linear peptide",FKLPGLNSR,"HTLV-I 831-839",,,831,839,,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",,"2 doses of 1mg/ml, administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"The epitope was conjugated to Keyhole limpet haemacyanin (KLH) with ethyldimethylaminop-ropylcarbodiamide.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Other,"Linear peptide",SGKDGHHAA,,54,62,,"Myelin basic protein",http://www.ncbi.nlm.nih.gov/protein/P02687.1,"Myelin basic protein",http://www.uniprot.org/uniprot/P02687,"Bos taurus",http://purl.obolibrary.org/obo/NCBITaxon_9913,"Bos taurus",http://purl.obolibrary.org/obo/NCBITaxon_9913
http://www.iedb.org/assay/1664471,http://www.iedb.org/reference/1007092,Literature,1281825,,"J M Davies; S Sonoda; S Yashiki; M Osame; P R Carnegie","J Neuroimmunol",1992,"Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.",http://www.iedb.org/epitope/113401,"Linear peptide",FKLPGLNSR,"HTLV-I 831-839",,,831,839,,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum were from seven HAM patients and one HTLV-l-positive donor who showed no symptoms.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The HTLV-I-associated myelopathy (HAM) patients' sera showed greater recognition of the epitope than the uninfected sera. The response to the epitope was greater than that to the similar MBP peptide (FKLGGRDSR) and the bovine MBP peptide (SGKDGHHAA).",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1664482,http://www.iedb.org/reference/1007092,Literature,1281825,,"J M Davies; S Sonoda; S Yashiki; M Osame; P R Carnegie","J Neuroimmunol",1992,"Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.",http://www.iedb.org/epitope/113401,"Linear peptide",FKLPGLNSR,"HTLV-I 831-839",,,831,839,,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The uninfected sera showed lower recognition of the epitope than the HTLV-I-associated myelopathy (HAM) patients' sera.  The response to the epitope was greater than that to the similar MBP peptide (FKLGGRDSR) and the bovine MBP peptide (SGKDGHHAA).",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FKLPGLNSR,,831,839,,polymerase,http://www.ncbi.nlm.nih.gov/protein/BAA02931.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691302,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 197 (197-216)",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from surviving animals.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from epitope-immunized, surviving animals reacted with the peptide.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Other Structure from Source Organism","Linear peptide",SIPWKSKLLTLV,"gp46 (203-214)",203,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691341,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 197 (197-216)",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from epitope-immunized, dead animals with hypercalcemia, reacted with the peptide.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Other Structure from Source Organism","Linear peptide",SNLDHILEPSIP,"gp46 (194-205)",194,205,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691342,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 197 (197-216)",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from epitope-immunized, dead animals with hypercalcemia, reacted with the peptide.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Other Structure from Source Organism","Linear peptide",DHILEPSIPWKS,"gp46 (195-206)",197,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691343,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 197 (197-216)",,,197,216,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from epitope-immunized, dead animals with hypercalcemia, reacted with the peptide.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Other Structure from Source Organism","Linear peptide",KLLTLVQLTLQS,"gp46 (209-220)",209,220,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691375,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118146,"Linear peptide",SNLDHILEPSIP,"gp46 (194-205)",,,194,205,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 (197-216)",197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from peptide-immunized, dead animals with hypercalcemia, reacted with the epitope.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Epitope,"Linear peptide",SNLDHILEPSIP,,194,205,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691385,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/117786,"Linear peptide",DHILEPSIPWKS,"gp46 (197-208)",,,197,208,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 (197-216)",197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from epetide-immunized, dead animals with hypercalcemia, reacted with the epitope.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKS,,197,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691386,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/117960,"Linear peptide",KLLTLVQLTLQS,"gp46 (209-220)",,,209,220,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",DHILEPSIPWKSKLLTLVQL,"gp46 (197-216)",197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from dead animals with hypercalcemia.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,"The serum from peptide-immunized, dead animals with hypercalcemia, reacted with the epitope.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Epitope,"Linear peptide",KLLTLVQLTLQS,,209,220,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691387,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118139,"Linear peptide",SIPWKSKLLTLV,"gp46 (203-214)",,,203,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus Japanese white",https://ontology.iedb.org/ontology/ONTIE_0000125,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;",subcutaneous,"3 doses of 0.2 mg, administered s.c at intervals of 7 days, followed by 3 doses of 0.05 mg, administered i.v. at intervals of 7 days.",,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was taken from surviving animals.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The serum from peptide-immunized, surviving animals reacted with the epitope.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Epitope,"Linear peptide",SIPWKSKLLTLV,,203,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691390,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118146,"Linear peptide",SNLDHILEPSIP,"gp46 (194-205)",,,194,205,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNLDHILEPSIP,"gp46 (209-220)",194,205,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691391,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/117786,"Linear peptide",DHILEPSIPWKS,"gp46 (197-208)",,,197,208,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKS,"gp46 (209-220)",197,208,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691392,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/117980,"Linear peptide",LEPSIPWKSKLL,"gp46 (200-211)",,,200,211,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LEPSIPWKSKLL,"gp46 (209-220)",200,211,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691393,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118139,"Linear peptide",SIPWKSKLLTLV,"gp46 (203-214)",,,203,214,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SIPWKSKLLTLV,"gp46 (209-220)",203,214,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691394,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118221,"Linear peptide",WKSKLLTLVQLT,"gp46 (206-217)",,,206,217,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WKSKLLTLVQLT,"gp46 (209-220)",206,217,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1691395,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/117960,"Linear peptide",KLLTLVQLTLQS,"gp46 (209-220)",,,209,220,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from an ATL patient was used in his study. The patient was first diagnosed with chronic ATL in February 2004 and had a crisis in 2006. Hypercalcemia was seen in this patient at the time of crisis in January 2006, and was treated with diuretics.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The strongest reaction was seen in the chronic phase that followed the crisis.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KLLTLVQLTLQS,"gp46 (209-220)",209,220,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1692139,http://www.iedb.org/reference/1014252,Literature,19134004,,"Yasuko Sagara; Yukiko Inoue; Yasuhiro Sagara; Seizaburo Kashiwagi","Cancer Sci",2009,"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.",http://www.iedb.org/epitope/118146,"Linear peptide",SNLDHILEPSIP,"gp46 (194-205)",,,194,205,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAT38829.2,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,N,,"Sera from ATL patients was used in his study.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"Epitope-specific antibodies were purified from ATL patients. These antibodies were able to recognize osteoprotegerin in western blot analysis.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Other,Protein,osteoprotegerin,,,,http://www.ncbi.nlm.nih.gov/protein/AAB53709.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1694495,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118530,"Linear peptide",MVTPVTWMDNPIEVY,"HERV-K10 peptide 1",,,1,15,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MVTPVTWMDNPIEVY,,1,15,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694496,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118515,"Linear peptide",MDNPIEVYVNDSIWV,"HERV-K10 peptide 2",,,7,21,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MDNPIEVYVNDSIWV,,7,21,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694497,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118516,"Linear peptide",MDNPIEVYVNDSVWV,"HERV-K10 peptide 2'",,,8,22,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MDNPIEVYVNDSVWV,,8,22,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694498,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118698,"Linear peptide",YVNDSIWVPGPIDDR,"HERV-K10 peptide 3",,,14,28,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YVNDSIWVPGPIDDR,,14,28,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694499,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118666,"Linear peptide",VPGPIDDRCPAKPEE,"HERV-K10 peptide 4",,,21,35,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VPGPIDDRCPAKPEE,,21,35,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694500,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118667,"Linear peptide",VPGPTDDRCPAKPEE,"HERV-K10 peptide 4'",,,22,36,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VPGPTDDRCPAKPEE,,22,36,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694501,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118577,"Linear peptide",RCPAKPEEEGMMINI,"HERV-K10 peptide 5",,,29,43,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RCPAKPEEEGMMINI,,29,43,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694502,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118318,"Linear peptide",EEGMMINISIGYRYP,"HERV-K10 peptide 6",,,35,49,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EEGMMINISIGYRYP,,35,49,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694503,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118433,"Linear peptide",ISIGYRYPPICLGRA,"HERV-K10 peptide 7",,,42,56,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISIGYRYPPICLGRA,,42,56,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694504,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118432,"Linear peptide",ISIGYHYPPICLGRA,"HERV-K10 peptide 7'",,,43,57,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISIGYHYPPICLGRA,,43,57,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694505,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118555,"Linear peptide",PPICLGRAPGCLMPA,"HERV-K10 peptide 8",,,49,63,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPICLGRAPGCLMPA,,49,63,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694506,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118267,"Linear peptide",APGCLMPAVQNWLVE,"HERV-K10 peptide 9",,,57,71,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",APGCLMPAVQNWLVE,,57,71,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694507,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118278,"Linear peptide",AVQNWLVEVPTVSPI,"HERV-K10 peptide 10",,,63,77,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AVQNWLVEVPTVSPI,,63,77,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694508,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118341,"Linear peptide",EVPTVSPISRFTYHM,"HERV-K10 peptide 11",,,70,84,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVPTVSPISRFTYHM,,70,84,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694509,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118342,"Linear peptide",EVPTVSPNSRFTYHM,"HERV-K10 peptide 11'",,,71,85,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EVPTVSPNSRFTYHM,,71,85,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694510,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118436,"Linear peptide",ISRFTYHMVSGMSLR,"HERV-K10 peptide 12",,,77,91,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISRFTYHMVSGMSLR,,77,91,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694511,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118529,"Linear peptide",MVSGMSLRPRVNYLQ,"HERV-K10 peptide 13",,,84,98,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MVSGMSLRPRVNYLQ,,84,98,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694512,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118587,"Linear peptide",RPRVNYLQDFSYQRS,"HERV-K10 peptide 14",,,91,105,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RPRVNYLQDFSYQRS,,91,105,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694513,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118566,"Linear peptide",QDFSYQRSLKFRPKG,"HERV-K10 peptide 15",,,98,112,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QDFSYQRSLKFRPKG,,98,112,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694514,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118606,"Linear peptide",SLKFRPKGKPCPKEI,"HERV-K10 peptide 16",,,105,119,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLKFRPKGKPCPKEI,,105,119,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694515,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118379,"Linear peptide",GKPCPKEIPKESKNT,"HERV-K10 peptide 17",,,112,126,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKPCPKEIPKESKNT,,112,126,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694516,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3, 4 and 5","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,4,100,"The ELISA results of the epitope correlated strongly with the results of Western blot.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694517,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118420,"Linear peptide",IPKESKNTEVLVWEE,"HERV-K10 peptide 18",,,119,133,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IPKESKNTEVLVWEE,,119,133,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694518,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118421,"Linear peptide",IPKGSKNTEVLVWEE,"HERV-K10 peptide 18'",,,120,134,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,2,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IPKGSKNTEVLVWEE,,120,134,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694519,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118619,"Linear peptide",TEVLVWEECVANSAV,"HERV-K10 peptide 19",,,126,140,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TEVLVWEECVANSAV,,126,140,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ABD29016.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VA7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694520,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118620,"Linear peptide",TEVLVWEECVANSVV,"HERV-K10 peptide 19'",,,127,141,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TEVLVWEECVANSVV,,127,141,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694521,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118315,"Linear peptide",ECVANSVVILQNNEF,"HERV-K10 peptide 20",,,134,148,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune disease of skin and connective tissue",http://purl.obolibrary.org/obo/DOID_0060039,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee. The study population consisted of subjects with SS, SLE, MS and RA patients.   The details were described in the cited reference: Brookes SM et al. 1992, Br J Rheumatol. 31: 735-42. [PMID: 1280512].","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ECVANSVVILQNNEF,,134,148,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694522,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","type 1 diabetes mellitus",http://purl.obolibrary.org/obo/DOID_9744,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,12,6,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694523,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,19,48.7,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694524,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","rheumatoid arthritis",http://purl.obolibrary.org/obo/DOID_7148,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,35,17,48.6,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694525,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","systemic lupus erythematosus",http://purl.obolibrary.org/obo/DOID_9074,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,39,20,51.3,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694526,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","Sjogren's syndrome",http://purl.obolibrary.org/obo/DOID_12894,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,30,15,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1694527,http://www.iedb.org/reference/1013538,Literature,11982593,,"C A Herve; E B Lugli; A Brand; D J Griffiths; P J W Venables","Clin Exp Immunol",2002,"Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.",http://www.iedb.org/epitope/118381,"Linear peptide",GKTCPKEIPKGSKNT,"HERV-K10 peptide 17'",,,113,127,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","autoimmune neuropathy",http://purl.obolibrary.org/obo/DOID_0060499,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The serum samples were from patients attending Charing Cross Hospital and diagnosed according to standard criteria with informed consent and with approval from the local Ethics Committee.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,21,12,57.1,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GKTCPKEIPKGSKNT,,113,127,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAC58457.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VJ7,"Human Endogenous Retrovirus IDDMK1,2-22",http://purl.obolibrary.org/obo/NCBITaxon_64382,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/1702588,http://www.iedb.org/reference/1016153,Literature,15197740,,"Franck Kalume; Sang Min Lee; Yvette Morcos; Joseph C Callaway; Michael C Levin","J Neurosci Res",2004,"Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.",http://www.iedb.org/epitope/31105,"Linear peptide",KHFRETEV,"Tax (346-353)",,,346,353,,,"transcriptional activator Tax",http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,http://www.uniprot.org/uniprot/P14079,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence is found in the cited reference, Levin et al, J Infect Dis. 2002 186:1514 [PMID: 12404172].",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"transcriptional activator Tax","Recombinant Tax protein",,,http://www.ncbi.nlm.nih.gov/protein/AAG31572.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The monoclonal antibody  was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH, from Dr. Beatrice Langton.","Figure 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb was added to primary neuronal cultures and it resulted in decreased neuronal firing. This is attributed to molecular mimicry to hnRNP1 expressed on neurons, as HAM/TSP patients' sera reactive to Tax protein and affinity purified on hnRNP1 caused the same responses.","Purified Immunoglobulin","Entire Antibody",Monoclonal,,,,,"Structurally Related",Protein,"heterogeneous nuclear ribonucleoprotein A1 isoform a",Neurons,,,http://www.ncbi.nlm.nih.gov/protein/NP_002127.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1761169,http://www.iedb.org/reference/1019564,Literature,15894513,,"Peter Gergely Jr; Rudolf Pullmann; Christina Stancato; Laszlo Otvos Jr; Agnes Koncz; Antal Blazsek; Gyula Poor; Kevin E Brown; Paul E Phillips; Andras Perl","Clin Immunol",2005,"Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.",http://www.iedb.org/epitope/127843,"Linear peptide",SVEVRKRRWVTFCSA,"Peptide 54",,,27,41,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/NP_040332.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03332,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","systemic lupus erythematosus",http://purl.obolibrary.org/obo/DOID_9074,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Patients were diagnosed with systemic lupus erythematosus (SLE) according to the American College for Rheumatology (ACR) criteria for a definitive diagnosis of SLE.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVEVRKRRWVTFCSA,,27,41,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/NP_040332.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03332,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1761226,http://www.iedb.org/reference/1019564,Literature,15894513,,"Peter Gergely Jr; Rudolf Pullmann; Christina Stancato; Laszlo Otvos Jr; Agnes Koncz; Antal Blazsek; Gyula Poor; Kevin E Brown; Paul E Phillips; Andras Perl","Clin Immunol",2005,"Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.",http://www.iedb.org/epitope/127843,"Linear peptide",SVEVRKRRWVTFCSA,"Peptide 54",,,27,41,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/NP_040332.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03332,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVEVRKRRWVTFCSA,,27,41,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/NP_040332.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P03332,"Friend murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11795,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1771993,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","rheumatoid arthritis",http://purl.obolibrary.org/obo/DOID_7148,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from patients with rheumatoid arthritis (RA).","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,40,2,5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1771994,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","Sjogren's syndrome",http://purl.obolibrary.org/obo/DOID_12894,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from patients with Sicca syndrome (Sjögren).","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,3,15.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1773310,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from healthy individuals.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,52,2,3.8,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1773312,http://www.iedb.org/reference/1007356,Literature,1280512,,"S M Brookes; Y A Pandolfino; T J Mitchell; P J Venables; W G Shattles; D A Clark; A Entwistle; R N Maini","Br J Rheumatol",1992,"The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease.",http://www.iedb.org/epitope/132011,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,"pHTLV-1 (100-120)",,,100,120,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,"Structurally Related","Linear peptide",PTRAPSGPRPPSRSQAQTPPR,pHRES1/1,14,34,,"Putative HTLV-1-related endogenous sequence (p25)",http://www.ncbi.nlm.nih.gov/protein/P13985.1,"Putative HTLV-1-related endogenous sequence",http://www.uniprot.org/uniprot/P13985,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 μg",,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbits were boosted without BSA in IFA.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPP,,100,120,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784348,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/134411,"Linear peptide",IPP,"HTLV-I p19 (117-119)",,,117,119,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gag,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Spleen cells of a BALB/c mouse hyperimmunized with disrupted HTLV were fused with NS-1 myeloma cells to create hybridomas, which produced the epitope-specific mAb.  Generation of the monoclonal antibody was previously described in the cited reference Robert-Guroff et al., J Exp Med. 1981 Dec 1;154(6):1957-64 [PMID: 6274993].","Figure 3","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,"Epitope-specific mAb bound to the HTLV-1 p19 protein in a direct RIA assay.","Culture Supernatant","Entire Antibody",Monoclonal,12/1-2,IgG,,,"Source Antigen",Protein,gag,"HTLV-1 p19 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784349,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/134412,"Linear peptide",IPPPYV,"HTLV-I p19 (117-122)",,,117,122,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gag,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3","radio immuno assay (RIA)","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001649,Positive,,,,,,"Epitope-specific mAb bound to the HTLV-1 p19 protein in a direct RIA assay.","Culture Supernatant","Entire Antibody",Monoclonal,13B12,IgG,,,"Source Antigen",Protein,gag,"HTLV-1 p19 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784350,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/50180,"Linear peptide",PYVEPTAPQVL,SP-71,,,120,130,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PYVEPTAPQVL,,120,130,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbit antisera raised to the epitope was used.  The details of the immunization procedure were not described.","Figure 3","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Positive,,,,,,"Epitope-specific rabbit antiserum inhibited the binding of HTLV-1 p19 mAb (mAb 12/1-2) to p19 protein.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,gag,"HTLV-1 p19 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784352,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/48927,"Linear peptide",PPSSPTHDPPDSDP,SP-61,,,102,115,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus (rabbit)",http://purl.obolibrary.org/obo/NCBITaxon_9986,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",PPSSPTHDPPDSDP,,102,115,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rabbit antisera raised to the epitope was used.  The details of the immunization procedure were not described.","Figure 3","cross blocking","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001648,Negative,,,,,,"Epitope-specific rabbit antiserum did not inhibit the binding of HTLV-1 p19 mAb (mAb 12/1-2) to p19 protein.",Serum,"Entire Antibody",Polyclonal-Monospecific,,,,,"Source Antigen",Protein,gag,"HTLV-1 p19 protein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784353,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/134411,"Linear peptide",IPP,"HTLV-I p19 (117-119)",,,117,119,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gag,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Spleen cells of a BALB/c mouse hyperimmunized with disrupted HTLV were fused with NS-1 myeloma cells to create hybridomas, which produced the epitope-specific mAb.  Generation of the monoclonal antibody was previously described in the cited reference Robert-Guroff et al., J Exp Med. 1981 Dec 1;154(6):1957-64 [PMID: 6274993].","Figure 4 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specificity of the mAb was deduced from overlapping peptide studies.","Culture Supernatant","Entire Antibody",Monoclonal,12/1-2,IgG,,,"Fragment of Source Antigen","Linear peptide",PQIPPP,,115,120,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784354,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/134412,"Linear peptide",IPPPYV,"HTLV-I p19 (117-122)",,,117,122,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gag,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 4 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Culture Supernatant","Entire Antibody",Monoclonal,13B12,IgG,,,Epitope,"Linear peptide",IPPPYV,,117,122,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1784355,http://www.iedb.org/reference/1020695,Literature,8528727,,"T J Palker; K H Singer; A Vahlne","J Acquir Immune Defic Syndr Hum Retrovirol",1996,"Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.",http://www.iedb.org/epitope/134411,"Linear peptide",IPP,"HTLV-I p19 (117-119)",,,117,119,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P14076,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,gag,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96672.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Spleen cells of a BALB/c mouse hyperimmunized with disrupted HTLV were fused with NS-1 myeloma cells to create hybridomas, which produced the epitope-specific mAb.  Generation of the monoclonal antibody was previously described in the cited reference Robert-Guroff et al., J Exp Med. 1981 Dec 1;154(6):1957-64 [PMID: 6274993].","Table 1, Figures 1 and 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"Immunofluorescence assay and Western blot with the epitope-specific mAb showed similar results.","Culture Supernatant","Entire Antibody",Monoclonal,12/1-2,IgG,,,Other,Protein,keratin,"human thymic epithelium",,,http://www.ncbi.nlm.nih.gov/protein/AAB59562.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1812326,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141760,"Linear peptide",TAPPLLPH,"HTLV-1 peptide 186-193",,,186,193,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 2 and figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb recognized the protein by ELISA but not by Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W185/4,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812327,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141760,"Linear peptide",TAPPLLPH,"HTLV-1 peptide 186-193",,,186,193,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Tables 2 and 5","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 60 ug/ml and inhibited HTLV-1 transformation of normal human T cells at 125 µg/ml.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W185/4,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812330,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb reacted with HTLV-I gp46 glycoprotein by ELISA and Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812331,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Tables 2 and 5","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 5 ug/ml and inhibited HTLV-1 transformation of normal human T cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812332,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb recognized HTLV-1 gp46 fragments containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Fragment of Source Antigen","Linear peptide",PPLLPHSNLD,"HTLV-I gp46 fragment (188-197)",188,197,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812333,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141749,"Linear peptide",SNLDHI,"HTLV-1 peptide 194-199",,,194,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH X LEW",https://ontology.iedb.org/ontology/ONTIE_0001487,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb recognized HTLV-1 gp46 fragments containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F1-194,IgG,,,"Fragment of Source Antigen","Linear peptide",LPHSNLDHIL,"HTLV-I gp46 fragment (191-200)",191,200,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812459,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141760,"Linear peptide",TAPPLLPH,"HTLV-1 peptide 186-193",,,186,193,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb recognized HTLV-1 gp46 fragments containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W185/4,IgG,,,"Fragment of Source Antigen","Linear peptide",PPLLPHSNLD,"HTLV-1 gp46 peptide 188-197",188,197,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812462,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141749,"Linear peptide",SNLDHI,"HTLV-1 peptide 194-199",,,194,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH X LEW",https://ontology.iedb.org/ontology/ONTIE_0001487,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb reacted with HTLV-I gp46 glycoprotein by ELISA and Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F1-194,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812463,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141749,"Linear peptide",SNLDHI,"HTLV-1 peptide 194-199",,,194,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH X LEW",https://ontology.iedb.org/ontology/ONTIE_0001487,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Tables 2 and 5","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 50 µg/ml and inhibited HTLV-1 transformation of normal human T cells at 125 µg/ml.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F1-194,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812469,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141760,"Linear peptide",TAPPLLPH,"HTLV-1 peptide 186-193",,,186,193,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Intermediate,,,,,,"The epitope specific mAb stained only one- to two- thirds of MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W185/4,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812470,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope specific mAb stained almost all MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812471,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141749,"Linear peptide",SNLDHI,"HTLV-1 peptide 194-199",,,194,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH X LEW",https://ontology.iedb.org/ontology/ONTIE_0001487,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the epitope with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope specific mAb stained almost all MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,F1-194,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812480,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141724,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-1 peptide 180-204",,,180,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,,180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812483,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"HTLV-1 peptide 190-199",,,190,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,,Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812484,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141750,"Linear peptide",SNLDHILEPSI,"HTLV-1 peptide 194-204",,,194,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SNLDHILEPSI,,194,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,3,3,100,,Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812485,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141724,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-1 peptide 180-204",,,180,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,,180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Tables 4 and 5","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,4,4,100,"Rabbit antiserum to the epitope neutralized HTLV-I mediated syncytium formation at dilution of 1:8 and inhibited HTLV-I transformation of normal human T cells at 500 µg/ml.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812487,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"HTLV-1 peptide 190-199",,,190,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,2,2,100,"Rabbit antiserum to the epitope completely inhibited HTLV-I mediated syncytium formation at dilution of 1:16.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812488,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141750,"Linear peptide",SNLDHILEPSI,"HTLV-1 peptide 194-204",,,194,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",SNLDHILEPSI,,194,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,3,0,0,"Rabbit antiserum to the epitope did not neutralize HTLV-I mediated syncytium formation at dilution of 1:2.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812490,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141724,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-1 peptide 180-204",,,180,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,,180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,4,4,100,"Rabbits antiserum to the epitope reacted to various peptides on HTLV-I peptide 180-204 (PSQLPPTAPPLLPHSNLDHILEPSI).",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,Epitope,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,,180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812492,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141715,"Linear peptide",NLDHI,"HTLV-1 peptide 195-199",,,195,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SNLDHILEPS,"HTLV-I peptide 194-203",194,203,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2 and text page 6327",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,2,2,100,"The epitope was deduced by testing overlapping fragments.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Fragment of Source Antigen","Linear peptide",NLDHILEPSI,"HTLV-1 fragment (195-204)",195,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812494,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope was deduced.",,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,,190,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,1,1,100,"The epitope was deduced by testing overlapping fragments.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Fragment of Source Antigen","Linear peptide",LLPHSNLDHI,"HTLV-1 fragment (190-199)",190,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812500,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/37657,"Linear peptide",LLPHSNLDHI,"HTLV-1 peptide 190-199",,,190,199,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo to prevent or reduce disease",,,,Epitope,"Linear peptide",LLPHSNLDHI,,190,199,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 6","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0002051,Positive,,,2,2,100,"The epitope protected rabbits from infection with HTLV-I by detection of HTLV-I provirus in PBL samples from HTLV-I-infected rabbits by PCR assay at months 3.",,,,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1812509,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141724,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-1 peptide 180-204",,,180,204,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo to prevent or reduce disease",,,,Epitope,"Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,,180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3 and table 6","in vivo assay","protection from pathogen challenge",,http://purl.obolibrary.org/obo/OBI_0003465,Positive,,,4,4,100,"The epitope protected rabbits from infection with HTLV-I by detection of HTLV-I provirus in PBL samples from HTLV-I-infected rabbits by PCR assay from 3 to 12 months.",,,,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1813592,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141251,"Linear peptide",EPISLTLAVMLGL,"PERV p15E peptide (463-475)",,,463,475,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EPISLTLAVMLGL,,463,475,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813593,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141316,"Linear peptide",ISLTLAVMLGLGV,"PERV p15E peptide (465-477)",,,465,477,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ISLTLAVMLGLGV,,465,477,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813594,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141351,"Linear peptide",LTLAVMLGLGVAA,"PERV p15E peptide (467-479)",,,467,479,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LTLAVMLGLGVAA,,467,479,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813595,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141325,"Linear peptide",LAVMLGLGVAAGV,"PERV p15E peptide (469-481)",,,469,481,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LAVMLGLGVAAGV,,469,481,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813596,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141460,"Linear peptide",VMLGLGVAAGVGT,"PERV p15E peptide (471-483)",,,471,483,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VMLGLGVAAGVGT,,471,483,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813597,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141335,"Linear peptide",LGLGVAAGVGTGT,"PERV p15E peptide (473-485)",,,473,485,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LGLGVAAGVGTGT,,473,485,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813598,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141337,"Linear peptide",LGVAAGVGTGTAA,"PERV p15E peptide (475-487)",,,475,487,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LGVAAGVGTGTAA,,475,487,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813599,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141439,"Linear peptide",VAAGVGTGTAALI,"PERV p15E peptide (477-489)",,,477,489,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VAAGVGTGTAALI,,477,489,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813600,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141205,"Linear peptide",AGVGTGTAALITG,"PERV p15E peptide (479-491)",,,479,491,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AGVGTGTAALITG,,479,491,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813601,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141444,"Linear peptide",VGTGTAALITGPQ,"PERV p15E peptide (481-493)",,,481,493,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VGTGTAALITGPQ,,481,493,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813602,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141429,"Linear peptide",TGTAALITGPQQL,"PERV p15E peptide (483-495)",,,483,495,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TGTAALITGPQQL,,483,495,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813603,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141296,"Linear peptide",GPQQLE,"PERV p15E peptide E1",,,491,496,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope was mapped by using overlapping peptides.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",ALITGPQQLEKGL,,487,499,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813607,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141383,"Linear peptide",QQLEKGLSNLHRI,"PERV p15E peptide (493-505)",,,493,505,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QQLEKGLSNLHRI,,493,505,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813608,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141329,"Linear peptide",LEKGLSNLHRIVT,"PERV p15E peptide (495-507)",,,495,507,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LEKGLSNLHRIVT,,495,507,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813609,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141320,"Linear peptide",KGLSNLHRIVTED,"PERV p15E peptide (497-509)",,,497,509,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KGLSNLHRIVTED,,497,509,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813610,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141349,"Linear peptide",LSNLHRIVTEDLQ,"PERV p15E peptide (499-511)",,,499,511,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSNLHRIVTEDLQ,,499,511,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813611,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141362,"Linear peptide",NLHRIVTEDLQAL,"PERV p15E peptide (501-513)",,,501,513,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NLHRIVTEDLQAL,,501,513,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813612,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141305,"Linear peptide",HRIVTEDLQALEK,"PERV p15E peptide (503-515)",,,503,515,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",HRIVTEDLQALEK,,503,515,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813613,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141317,"Linear peptide",IVTEDLQALEKSV,"PERV p15E peptide (505-517)",,,505,517,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IVTEDLQALEKSV,,505,517,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813614,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141424,"Linear peptide",TEDLQALEKSVSN,"PERV p15E peptide (507-519)",,,507,519,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TEDLQALEKSVSN,,507,519,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813615,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141239,"Linear peptide",DLQALEKSVSNLE,"PERV p15E peptide (509-521)",,,509,521,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DLQALEKSVSNLE,,509,521,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813616,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141376,"Linear peptide",QALEKSVSNLEES,"PERV p15E peptide (511-523)",,,511,523,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QALEKSVSNLEES,,511,523,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813617,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141330,"Linear peptide",LEKSVSNLEESLT,"PERV p15E peptide (513-525)",,,513,525,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LEKSVSNLEESLT,,513,525,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813618,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141322,"Linear peptide",KSVSNLEESLTSL,"PERV p15E peptide (515-527)",,,515,527,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KSVSNLEESLTSL,,515,527,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813619,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141465,"Linear peptide",VSNLEESLTSLSE,"PERV p15E peptide (517-529)",,,517,529,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSNLEESLTSLSE,,517,529,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813620,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141361,"Linear peptide",NLEESLTSLSEVV,"PERV p15E peptide (519-531)",,,519,531,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NLEESLTSLSEVV,,519,531,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813621,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141244,"Linear peptide",EESLTSLSEVVLQ,"PERV p15E peptide (521-533)",,,521,533,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EESLTSLSEVVLQ,,521,533,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813622,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141420,"Linear peptide",SLTSLSEVVLQNR,"PERV p15E peptide (523-535)",,,523,535,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLTSLSEVVLQNR,,523,535,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813623,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141435,"Linear peptide",TSLSEVVLQNRRG,"PERV p15E peptide (525-537)",,,525,537,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TSLSEVVLQNRRG,,525,537,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813624,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141348,"Linear peptide",LSEVVLQNRRGLD,"PERV p15E peptide (527-539)",,,527,539,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSEVVLQNRRGLD,,527,539,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813625,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/14899,"Linear peptide",EVVLQNRRGLDLL,"PERV p15E peptide (529-541)",,,529,541,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EVVLQNRRGLDLL,,529,541,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813626,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141455,"Linear peptide",VLQNRRGLDLLFL,"PERV p15E peptide (531-543)",,,531,543,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VLQNRRGLDLLFL,,531,543,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813627,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141381,"Linear peptide",QNRRGLDLLFLKE,"PERV p15E peptide (533-545)",,,533,545,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QNRRGLDLLFLKE,,533,545,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813628,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141404,"Linear peptide",RRGLDLLFLKEGG,"PERV p15E peptide (535-547)",,,535,547,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RRGLDLLFLKEGG,,535,547,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813629,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141292,"Linear peptide",GLDLLFLKEGGLC,"PERV p15E peptide (537-549)",,,537,549,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLFLKEGGLC,,537,549,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813630,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141238,"Linear peptide",DLLFLKEGGLCVA,"PERV p15E peptide (539-551)",,,539,551,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DLLFLKEGGLCVA,,539,551,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813631,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141333,"Linear peptide",LFLKEGGLCVALK,"PERV p15E peptide (541-553)",,,541,553,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LFLKEGGLCVALK,,541,553,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813632,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141340,"Linear peptide",LKEGGLCVALKEE,"PERV p15E peptide (543-555)",,,543,555,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LKEGGLCVALKEE,,543,555,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813633,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141248,"Linear peptide",EGGLCVALKEECC,"PERV p15E peptide (545-557)",,,545,557,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EGGLCVALKEECC,,545,557,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813634,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141291,"Linear peptide",GLCVALKEECCFY,"PERV p15E peptide (547-559)",,,547,559,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLCVALKEECCFY,,547,559,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813635,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141233,"Linear peptide",CVALKEECCFYVD,"PERV p15E peptide (549-561)",,,549,561,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CVALKEECCFYVD,,549,561,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813636,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141210,"Linear peptide",ALKEECCFYVDHS,"PERV p15E peptide (551-563)",,,551,563,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ALKEECCFYVDHS,,551,563,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813637,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141319,"Linear peptide",KEECCFYVDHSGA,"PERV p15E peptide (553-565)",,,553,565,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",KEECCFYVDHSGA,,553,565,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813638,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141242,"Linear peptide",ECCFYVDHSGAIR,"PERV p15E peptide (555-567)",,,555,567,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ECCFYVDHSGAIR,,555,567,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813639,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141229,"Linear peptide",CFYVDHSGAIRDS,"PERV p15E peptide (557-569)",,,557,569,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",CFYVDHSGAIRDS,,557,569,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813640,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141485,"Linear peptide",YVDHSGAIRDSMS,"PERV p15E peptide (559-571)",,,559,571,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YVDHSGAIRDSMS,,559,571,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813641,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141236,"Linear peptide",DHSGAIRDSMSKL,"PERV p15E peptide (561-573)",,,561,573,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DHSGAIRDSMSKL,,561,573,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813642,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141416,"Linear peptide",SGAIRDSMSKLRE,"PERV p15E peptide (563-575)",,,563,575,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SGAIRDSMSKLRE,,563,575,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813643,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141207,"Linear peptide",AIRDSMSKLRERL,"PERV p15E peptide (565-577)",,,565,577,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AIRDSMSKLRERL,,565,577,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813644,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141389,"Linear peptide",RDSMSKLRERLER,"PERV p15E peptide (567-579)",,,567,579,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RDSMSKLRERLER,,567,579,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813645,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141421,"Linear peptide",SMSKLRERLERRR,"PERV p15E peptide (569-581)",,,569,581,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SMSKLRERLERRR,,569,581,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813646,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141419,"Linear peptide",SKLRERLERRRRE,"PERV p15E peptide (571-583)",,,571,583,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SKLRERLERRRRE,,571,583,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813647,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141345,"Linear peptide",LRERLERRRRERE,"PERV p15E peptide (573-585)",,,573,585,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LRERLERRRRERE,,573,585,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813648,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141254,"Linear peptide",ERLERRRREREAD,"PERV p15E peptide (575-587)",,,575,587,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ERLERRRREREAD,,575,587,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813649,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141331,"Linear peptide",LERRRREREADQG,"PERV p15E peptide (577-589)",,,577,589,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LERRRREREADQG,,577,589,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813650,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141405,"Linear peptide",RRRREREADQGWF,"PERV p15E peptide (579-591)",,,579,591,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RRRREREADQGWF,,579,591,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813651,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141403,"Linear peptide",RREREADQGWFEG,"PERV p15E peptide (581-593)",,,581,593,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RREREADQGWFEG,,581,593,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813652,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141252,"Linear peptide",EREADQGWFEGWF,"PERV p15E peptide (583-595)",,,583,595,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",EREADQGWFEGWF,,583,595,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813653,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141267,"Linear peptide",FEGWFN,"PERV p15E peptide E2",,,591,596,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figures 3 and 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope was mapped by using overlapping peptides.",Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",DQGWFEGWFNRSP,,587,599,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813657,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141301,"Linear peptide",GWFNRSPWMTTLL,"PERV p15E peptide (593-605)",,,593,605,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GWFNRSPWMTTLL,,593,605,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813658,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141273,"Linear peptide",FNRSPWMTTLLSA,"PERV p15E peptide (595-607)",,,595,607,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FNRSPWMTTLLSA,,595,607,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813659,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141406,"Linear peptide",RSPWMTTLLSALT,"PERV p15E peptide (597-609)",,,597,609,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",RSPWMTTLLSALT,,597,609,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813660,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141375,"Linear peptide",PWMTTLLSALTGP,"PERV p15E peptide (599-611)",,,599,611,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PWMTTLLSALTGP,,599,611,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813661,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141357,"Linear peptide",MTTLLSALTGPLV,"PERV p15E peptide (601-613)",,,601,613,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MTTLLSALTGPLV,,601,613,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813662,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141431,"Linear peptide",TLLSALTGPLVVL,"PERV p15E peptide (603-615)",,,603,615,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TLLSALTGPLVVL,,603,615,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813663,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141347,"Linear peptide",LSALTGPLVVLLL,"PERV p15E peptide (605-617)",,,605,617,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSALTGPLVVLLL,,605,617,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813664,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141214,"Linear peptide",ALTGPLVVLLLLL,"PERV p15E peptide (607-619)",,,607,619,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ALTGPLVVLLLLL,,607,619,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813665,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141426,"Linear peptide",TGPLVVLLLLLTV,"PERV p15E peptide (609-621)",,,609,621,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",TGPLVVLLLLLTV,,609,621,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813666,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141370,"Linear peptide",PLVVLLLLLTVGP,"PERV p15E peptide (611-623)",,,611,623,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PLVVLLLLLTVGP,,611,623,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813667,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141467,"Linear peptide",VVLLLLLTVGPCL,"PERV p15E peptide (613-625)",,,613,625,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VVLLLLLTVGPCL,,613,625,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813668,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141343,"Linear peptide",LLLLLTVGPCLIN,"PERV p15E peptide (615-627)",,,615,627,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLLLLTVGPCLIN,,615,627,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813669,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141344,"Linear peptide",LLLTVGPCLINRF,"PERV p15E peptide (617-629)",,,617,629,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LLLTVGPCLINRF,,617,629,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813670,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141352,"Linear peptide",LTVGPCLINRFVA,"PERV p15E peptide (619-631)",,,619,631,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LTVGPCLINRFVA,,619,631,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813671,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141443,"Linear peptide",VGPCLINRFVAFV,"PERV p15E peptide (621-633)",,,621,633,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VGPCLINRFVAFV,,621,633,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813672,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141367,"Linear peptide",PCLINRFVAFVRE,"PERV p15E peptide (623-635)",,,623,635,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PCLINRFVAFVRE,,623,635,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813673,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141339,"Linear peptide",LINRFVAFVRERV,"PERV p15E peptide (625-637)",,,625,637,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LINRFVAFVRERV,,625,637,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813674,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141364,"Linear peptide",NRFVAFVRERVSA,"PERV p15E peptide (627-639)",,,627,639,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",NRFVAFVRERVSA,,627,639,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813675,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141279,"Linear peptide",FVAFVRERVSAVQ,"PERV p15E peptide (629-641)",,,629,641,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FVAFVRERVSAVQ,,629,641,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813676,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141204,"Linear peptide",AFVRERVSAVQIM,"PERV p15E peptide (631-643)",,,631,643,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AFVRERVSAVQIM,,631,643,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813677,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141463,"Linear peptide",VRERVSAVQIMVL,"PERV p15E peptide (633-645)",,,633,645,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VRERVSAVQIMVL,,633,645,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813678,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141258,"Linear peptide",ERVSAVQIMVLRQ,"PERV p15E peptide (635-647)",,,635,647,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ERVSAVQIMVLRQ,,635,647,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813679,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141464,"Linear peptide",VSAVQIMVLRQQY,"PERV p15E peptide (637-649)",,,637,649,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",VSAVQIMVLRQQY,,637,649,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813680,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141223,"Linear peptide",AVQIMVLRQQYQG,"PERV p15E peptide (639-651)",,,639,651,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",AVQIMVLRQQYQG,,639,651,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813681,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141380,"Linear peptide",QIMVLRQQYQGLL,"PERV p15E peptide (641-653)",,,641,653,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QIMVLRQQYQGLL,,641,653,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813682,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141358,"Linear peptide",MVLRQQYQGLLSQ,"PERV p15E peptide (643-655)",,,643,655,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",MVLRQQYQGLLSQ,,643,655,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813683,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141346,"Linear peptide",LRQQYQGLLSQGE,"PERV p15E peptide (645-657)",,,645,657,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LRQQYQGLLSQGE,,645,657,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813684,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141384,"Linear peptide",QQYQGLLSQGETD,"PERV p15E peptide (647-659)",,,647,659,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QQYQGLLSQGETD,,647,659,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813685,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141482,"Linear peptide",YQGLLSQGETDL,"PERV p15E peptide (649-660)",,,649,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",YQGLLSQGETDL,,649,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813686,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141294,"Linear peptide",GLLSQGETDL,"PERV p15E peptide (651-660)",,,651,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLLSQGETDL,,651,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813687,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141350,"Linear peptide",LSQGETDL,"PERV p15E peptide (653-660)",,,653,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LSQGETDL,,653,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813688,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141378,"Linear peptide",QGETDL,"PERV p15E peptide (655-660)",,,655,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QGETDL,,655,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813689,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141259,"Linear peptide",ETDL,"PERV p15E peptide (657-660)",,,657,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",ETDL,,657,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813690,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141237,"Linear peptide",DL,"PERV p15E peptide (659-660)",,,659,660,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Other Structure from Source Organism","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Negative,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",DL,,659,660,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813699,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141296,"Linear peptide",GPQQLE,"PERV p15E peptide E1",,,491,496,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figures 4 and 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the neutralizing activity of the goat p15E-specific antiserum.  The p15E-specific antiserum also reacted with weakly with the epitope in a direct ELISA.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GPQQLE,,491,496,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1813700,http://www.iedb.org/reference/1021430,Literature,12667808,,"Uwe Fiebig; Oliver Stephan; Reinhard Kurth; Joachim Denner",Virology,2003,"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?",http://www.iedb.org/epitope/141267,"Linear peptide",FEGWFN,"PERV p15E peptide E2",,,591,596,,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Capra hircus (domestic goat)",http://purl.obolibrary.org/obo/NCBITaxon_9925,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",LITGPQQLEKGLSNLHRIVTEDLQALEKSVSNLEESLTSLSEVVLQNRRGLDLLFLKEGGLCVALKEECCFYVDHSGAIRDSMSKLRERLERRRREREADQGWFEGWFN,,488,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's adjuvant;",,"2 doses of 0.5 mg fusion protein, administered at weeks 0 and 4.",,,,,,,,,,,,,,,,,,,,,,,N,,"The recombinant ectodomain of p15E (amino acids 488–597) was expressed as a calmodulin binding peptide (CBP) fusion protein in Escherichia coli and used as immunogen. Goats were inoculated twice with the recombinant fusion protein to generate PERV p15E-specific antiserum.","Figures 4 and 5","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the neutralizing activity of the goat p15E-specific antiserum.  The p15E-specific antiserum also reacted with weakly with the epitope in a direct ELISA.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",FEGWFN,,591,596,,env,http://www.ncbi.nlm.nih.gov/protein/CAA72927.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_61673,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1814997,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141605,"Linear peptide",APPLLPHSNL,"HTLV-1 peptide 187-196",,,187,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from mice immunized with the epitope with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,B1E191N43,IgG,,,Epitope,"Linear peptide",APPLLPHSNL,,187,196,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1814998,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141605,"Linear peptide",APPLLPHSNL,"HTLV-1 peptide 187-196",,,187,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from mice immunized with the epitope with Sp2/0-Ag14 cells.","Table 2 and figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb reacted with HTLV-I gp46 glycoprotein by ELISA and Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B1E191N43,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1814999,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141605,"Linear peptide",APPLLPHSNL,"HTLV-1 peptide 187-196",,,187,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from mice immunized with the epitope with Sp2/0-Ag14 cells.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 10 µg/ml.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B1E191N43,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815000,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141605,"Linear peptide",APPLLPHSNL,"HTLV-1 peptide 187-196",,,187,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10^7 L8KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from mice immunized with the epitope with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope specific mAb stained all MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,B1E191N43,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815002,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141761,"Linear peptide",TAPPLLPHSNLD,"HTLV-1 peptide 186-197",,,186,197,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 2 and figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb reacted with gp46 (one of HTLV-1 glycoproteins encoded by env gene) by ELISA and Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/2,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815003,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141761,"Linear peptide",TAPPLLPHSNLD,"HTLV-1 peptide 186-197",,,186,197,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 4 ug/ml.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/2,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815004,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141761,"Linear peptide",TAPPLLPHSNLD,"HTLV-1 peptide 186-197",,,186,197,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/2,IgG,,,Epitope,"Linear peptide",TAPPLLPHSNLD,"HTLV-I gp46 glycoprotein",186,197,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815005,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141761,"Linear peptide",TAPPLLPHSNLD,"HTLV-1 peptide 186-197",,,186,197,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Intermediate,,,,,,"The epitope specific mAb stained only one- to two- thirds of MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/2,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815006,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 2 and figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb recognized the protein by ELISA, but not by Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/7,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815007,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 2","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb completely inhibited HTLV-1 mediated syncytium formation at 200 µg/ml.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/7,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815008,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/7,IgG,,,Epitope,"Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815009,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSQLPPTAPPLLPHSNLDHILEPSI,"HTLV-I peptide 180-204",180,204,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses of 50 µg, administered at intervals of 2 months.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing the spleen cells from rats immunized with the fragment of HTLV-1 gp46 peptide 180-204 with Sp2/0-Ag14 cells.","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive-Low,,,,,,"The epitope specific mAb stained only one-third of MT-2 and ILT-8M2 cells infected by HTLV-I.","Purified Immunoglobulin","Entire Antibody",Monoclonal,W180/7,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815341,http://www.iedb.org/reference/1011496,Literature,7595205,,"R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins","J Exp Med",1995,"A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.",http://www.iedb.org/epitope/135815,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group","alpha-Gal epitope",,,,,http://purl.obolibrary.org/obo/CHEBI_17785,"alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-","env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Normal human serum was tested.","Figure 2","biological activity","antibody activity inhibition",,http://purl.obolibrary.org/obo/OBI_0001705,Positive,,,,,,"Preincubation of human serum with the epitope successfully inhibited retrovirus inactivation (which is a feature of the human serum, in a complement-mediated reaction).",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group",,,,http://purl.obolibrary.org/obo/CHEBI_17785,"env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1815342,http://www.iedb.org/reference/1011496,Literature,7595205,,"R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins","J Exp Med",1995,"A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.",http://www.iedb.org/epitope/135815,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group","alpha-Gal epitope",,,,,http://purl.obolibrary.org/obo/CHEBI_17785,"alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-","env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antibodies to the epitope were affinity purified from normal human serum.","Figures 3 and 8","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Epitope-specific antibodies purified from normal human sera are able to induce inactivation of the virus and to lead to complement-mediated lysis of MLV-producing cell line PA317. Down-regulation of the epitope expression on the cell line and, subsequently, on the retroviral particles lead to enhanced survival.",Serum,"Entire Antibody",Polyclonal-Monospecific,anti-alpha-Gal,,,,"Source Organism",Organism,"Murine leukemia virus (murine leukemia virus MLV)",,,,,,,,,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1815343,http://www.iedb.org/reference/1011496,Literature,7595205,,"R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins","J Exp Med",1995,"A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.",http://www.iedb.org/epitope/135815,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group","alpha-Gal epitope",,,,,http://purl.obolibrary.org/obo/CHEBI_17785,"alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-","env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antibodies to the epitope were affinity purified from normal human serum.","Figure 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"Epitope-specific antibodies purified from normal human sera are able to induce inactivation of the virus.",Serum,"Entire Antibody",Polyclonal-Monospecific,anti-alpha-Gal,,,,"Taxonomic Child",Organism,"Moloney murine leukemia virus (Moloney murine leukemia virus M-MuLV)",,,,,,,,,"Moloney murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11801,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1815345,http://www.iedb.org/reference/1011496,Literature,7595205,,"R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins","J Exp Med",1995,"A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.",http://www.iedb.org/epitope/135815,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group","alpha-Gal epitope",,,,,http://purl.obolibrary.org/obo/CHEBI_17785,"alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-","env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antibodies to the epitope were affinity purified from normal human serum.","Figures 5 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Epitope-specific antibodies purified from normal human sera are able to react in ELISA and Western blot with the env protein obtained from retroviral particles of the amphotropic murine leukemia virus and the ecotropic Moloney murine leukemia virus.",Serum,"Entire Antibody",Polyclonal-Monospecific,anti-alpha-Gal,IgG,,,"Source Antigen",Protein,"env polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,,,,,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1815366,http://www.iedb.org/reference/1011496,Literature,7595205,,"R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins","J Exp Med",1995,"A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.",http://www.iedb.org/epitope/135815,Non-peptidic,"alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc-yl group","alpha-Gal epitope",,,,,http://purl.obolibrary.org/obo/CHEBI_17785,"alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl, alpha-D-Gal(1->3)-beta-D-Gal(1->4)-D-GlcNAc-yl group, alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNHAc-R, alpha-D-galactopyranosyl-(1->3) beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranosyl group, alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R, alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl group, alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R, alpha-D-galactosyl-beta-1,3-D-galactosyl-beta-1,4-N-acetyl-D-glucosaminyl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-Glcp-NAc-yl group, alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNHAc-R, alpha-gal, alpha-Gal trisaccharide, alpha-Gal trisaccharide epitope, alpha-Gal3, alpha-galactosyl epitope, Gal(alpha1->3)-Gal(beta1->4)-GlcNAc-R, Galalpha1-3Galbeta1-4GlcNAc-, Galalpha1-3LacNAc-","env polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA92680.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P03385,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Antibodies to the epitope were affinity purified from normal human serum.","Figures 7","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"Epitope-specific antibodies purified from normal human sera react with the MLV-producing cell line PA317 on FACS.",Serum,"Entire Antibody",Polyclonal-Monospecific,anti-alpha-Gal,,,,"Source Organism",Organism,"Murine leukemia virus (murine leukemia virus MLV)",,,,,,,,,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/1815514,http://www.iedb.org/reference/1021635,Literature,21228129,,"Yuki Nakaya; Shigeki Hoshino; Jiro Yasuda; Takayuki Miyazawa","J Gen Virol",2011,"Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.",http://www.iedb.org/epitope/141523,"Linear peptide",ALEPPHNLPVP,"PERV-B 251-261",,,251,261,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"env protein","recombinant PERV-B",,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's complete;",topical,"4 doses of 50 µg, administered at intervals of 2 weeks, and 1 dose of 25 µg was administered one week after the fourth immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing splenocytes from recombinant PERV-B immunized mice with P3U1 cells.","Figure 1","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope specific mAb recognized PERV-B Env protein by an indirect immunofluorescence assay (IFA) and FACS.","Purified Immunoglobulin","Entire Antibody",Monoclonal,KRT1,IgG,,,"Source Antigen",Protein,"env protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1815516,http://www.iedb.org/reference/1021635,Literature,21228129,,"Yuki Nakaya; Shigeki Hoshino; Jiro Yasuda; Takayuki Miyazawa","J Gen Virol",2011,"Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.",http://www.iedb.org/epitope/141523,"Linear peptide",ALEPPHNLPVP,"PERV-B 251-261",,,251,261,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"env protein","recombinant PERV-B",,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's complete;",topical,"4 doses of 50 µg, administered at intervals of 2 weeks, and 1 dose of 25 µg was administered one week after the fourth immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing splenocytes from recombinant PERV-B immunized mice with P3U1 cells.","Figure 1","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope specific mAb neutralized PERV-B at a higher concentration.","Purified Immunoglobulin","Entire Antibody",Monoclonal,KRT1,IgG,,,"Source Organism",Organism,"Porcine endogenous retrovirus B (porcine endogenous retrovirus subclass B)",PERV-B,,,,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1815518,http://www.iedb.org/reference/1021635,Literature,21228129,,"Yuki Nakaya; Shigeki Hoshino; Jiro Yasuda; Takayuki Miyazawa","J Gen Virol",2011,"Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.",http://www.iedb.org/epitope/141523,"Linear peptide",ALEPPHNLPVP,"PERV-B 251-261",,,251,261,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"env protein","recombinant PERV-B",,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's complete;",topical,"4 doses of 50 µg, administered at intervals of 2 weeks, and 1 dose of 25 µg was administered one week after the fourth immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing splenocytes from recombinant PERV-B immunized mice with P3U1 cells.","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope specific mAb recognized recombinant PERV-B Env protein by immunoblot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,KRT1,IgG,,,"Source Antigen",Protein,"env protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1815519,http://www.iedb.org/reference/1021635,Literature,21228129,,"Yuki Nakaya; Shigeki Hoshino; Jiro Yasuda; Takayuki Miyazawa","J Gen Virol",2011,"Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.",http://www.iedb.org/epitope/141523,"Linear peptide",ALEPPHNLPVP,"PERV-B 251-261",,,251,261,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"env protein","recombinant PERV-B",,,http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,,,,,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960,";Freund's complete;",topical,"4 doses of 50 µg, administered at intervals of 2 weeks, and 1 dose of 25 µg was administered one week after the fourth immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing splenocytes from recombinant PERV-B immunized mice with P3U1 cells.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific mAb strongly reacted with the epitope by testing 12 overlapping peptides corresponding to the amino acid positions 241-275 of PERV-B SU Env protein.","Purified Immunoglobulin","Entire Antibody",Monoclonal,KRT1,IgG,,,Epitope,"Linear peptide",ALEPPHNLPVP,,251,261,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AAM29193.1,"Env protein",http://www.uniprot.org/uniprot/F6KPT7,"Porcine endogenous retrovirus B",http://purl.obolibrary.org/obo/NCBITaxon_194959,"Porcine type-C oncovirus",http://purl.obolibrary.org/obo/NCBITaxon_369960
http://www.iedb.org/assay/1815945,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,3,0,0,,Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Antigen",Protein,env,"HTLV-I gp46 glycoprotein",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1815946,http://www.iedb.org/reference/1008773,Literature,8083972,,"Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida","J Virol",1994,"Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.",http://www.iedb.org/epitope/141726,"Linear peptide",PTAPPLLPHS,"HTLV-1 peptide 185-194",,,185,194,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,F,,,"Administration in vivo",,,,Epitope,"Linear peptide",PTAPPLLPHS,,185,194,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"4 doses of 0.5 mg, administered on days 0, 14, 28, and 42.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Negative,,,4,0,0,"Rabbit antiserum to the epitope did not neutralize HTLV-I mediated syncytium formation at dilution of 1:2.",Serum,"Entire Antibody",Polyclonal-Monospecific,,IgG,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",HTLV-I,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1837747,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/102080,"Linear peptide",SPSSTPLLY,SPSSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope was bound as presented by HLA-B*3501.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Epitope,"Linear peptide",SPSSTPLLY,,249,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1837750,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/146012,"Linear peptide",SSPSTPLLY,SPPSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 3","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope was bound as presented by HLA-B*3501.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Epitope,"Linear peptide",SSPSTPLLY,,249,257,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1841680,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/102080,"Linear peptide",SPSSTPLLY,SPSSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 1","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb bound to HLA-B*51:01.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Other,Protein,"HLA class I histocompatibility antigen, B-51 alpha chain",HLA-B*51:01,,,http://www.ncbi.nlm.nih.gov/protein/P18464.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1841681,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/102080,"Linear peptide",SPSSTPLLY,SPSSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76485.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 1","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb bound to HLA-B*35:01. The epitope-specific mAb bound to HLA-B*53:01.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Other,Protein,"MHC class I antigen","HLA-B*35:01, HLA-B*53:01",,,http://www.ncbi.nlm.nih.gov/protein/AEJ08641.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1841689,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/146012,"Linear peptide",SSPSTPLLY,SPPSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 1","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb bound to HLA-B*51:01.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Other,Protein,"HLA class I histocompatibility antigen, B-51 alpha chain",HLA-B*51:01,,,http://www.ncbi.nlm.nih.gov/protein/P18464.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1841690,http://www.iedb.org/reference/1022249,Literature,9396861,,"T Sakaguchi; Y Takamiya; M Edidin; K Nokihara; K Miwa; C Schönbach; M Takiguchi",Immunogenetics,1998,"Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.",http://www.iedb.org/epitope/146012,"Linear peptide",SSPSTPLLY,SPPSTPLLY,,,249,257,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,,,"Administration in vivo",,,,Other,Protein,HLA-B35,,,,http://www.ncbi.nlm.nih.gov/protein/AAA19925.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,,intravenous,"3 doses of 5 x 106 cells on days 0,14 and 21.",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized both intravenously and intraperitoneally with 5 x 106 HUT 78 T cells on days 0, 14 and 21, as described previously in Hayes et al., Hum Immunol:4(273) 1982 [PMID:6181035].","Table 1","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb bound to HLA-B*35:01. The epitope-specific mAb bound to HLA-B*53:01.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4D12,,,,Other,Protein,"MHC class I antigen","HLA-B*35:01, HLA-B*53:01",,,http://www.ncbi.nlm.nih.gov/protein/AEJ08641.1,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/1853368,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 gp46 175",,,175,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,85,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853369,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2 and figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,85,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853370,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"HTLV-1 p19-100",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,85,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853372,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 gp46 175",,,175,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,14,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853373,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"HTLV-1 p19-100",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,14,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853374,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/16790,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,"HTLV-1 gp46 175",,,175,199,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,46,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FLNTEPSQLPPTAPPLLPHSNLDHI,,175,199,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853375,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/48871,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,"HTLV-1 p19-100",,,100,130,,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was from the cited reference: Washitani Y, 1992. J Clin Microbiol. 30: 287-90. [PMID: 1537894].",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,46,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPPPSSPTHDPPDSDPQIPPPYVEPTAPQVL,,100,130,,"Pr gag-pro-pol",http://www.ncbi.nlm.nih.gov/protein/AAD50663.1,"Gag-Pro-Pol polyprotein",http://www.uniprot.org/uniprot/P14078,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853376,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Table 2 and figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,46,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853380,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the epitope binding HAM/TSP patients' sera by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853381,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the epitope binding asymptomatic HTLV-1-infected carriers' sera by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853382,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/8544,"Linear peptide",DHILEPSIPWKSKLLTLVQL,"HTLV-1 gp46-197",,,197,216,,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited the epitope binding adult T-cell leukemia/lymphoma (ATLL) patients' sera by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DHILEPSIPWKSKLLTLVQL,,197,216,,gp46,http://www.ncbi.nlm.nih.gov/protein/AAF76481.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/1853383,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/150178,"Linear peptide",EHVLTPSTSWTTKILKFIQL,"HTLV-2 gp46-194",,,193,212,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope did not inhibit HAM/TSP patients' sera binding gp46-197 peptide (DHILEPSIPWKSKLLTLVQL) by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EHVLTPSTSWTTKILKFIQL,,193,212,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1853384,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/150178,"Linear peptide",EHVLTPSTSWTTKILKFIQL,"HTLV-2 gp46-194",,,193,212,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Chronic,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope did not inhibit asymptomatic HTLV-1-infected carriers' sera binding gp46-197 peptide (DHILEPSIPWKSKLLTLVQL) by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EHVLTPSTSWTTKILKFIQL,,193,212,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1853385,http://www.iedb.org/reference/548,Literature,15504252,,"Yasuko Sagara; Yukiko Inoue; Mitsushi Tsujimura; Eijiro Kojima; Hiroshi Shiraki; Seizaburo Kashiwagi","Cancer Sci",2004,"Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.",http://www.iedb.org/epitope/150178,"Linear peptide",EHVLTPSTSWTTKILKFIQL,"HTLV-2 gp46-194",,,193,212,,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Taxonomic Sibling",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,"Occurrence of cancer","adult T-cell leukemia/lymphoma",http://purl.obolibrary.org/obo/DOID_0050523,Chronic,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Negative,,,,,,"The epitope did not inhibit adult T-cell leukemia/lymphoma (ATLL) patients' sera binding gp46-197 peptide (DHILEPSIPWKSKLLTLVQL) by ELISA.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EHVLTPSTSWTTKILKFIQL,,193,212,,"env propeptide",http://www.ncbi.nlm.nih.gov/protein/NP_041006.1,"Envelope glycoprotein gp63",http://www.uniprot.org/uniprot/P03383,"Human T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_11909,"Primate T-lymphotropic virus 2",http://purl.obolibrary.org/obo/NCBITaxon_194441
http://www.iedb.org/assay/1943166,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb reacted with GST-tagged Jgp85 fusion protein.  The mAb epitope was identified by overlapping peptide studies.","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1943167,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The mAb epitope was identified by overlapping peptide studies.","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,Epitope,"Linear peptide",LPWDPQELDILG,,81,92,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1943168,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The mAb epitope was identified by overlapping peptide studies.  The epitope-specific mAb specifically reacts with virus-infected cells by indirect fluorescence assay (IFA).","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,"Taxonomic Sibling",Organism,"Avian leukosis virus strain NX0101","Infected DF-1 cells",,,,,,,,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1943278,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The mAb epitope was identified by overlapping peptide studies.  The epitope-specific mAb specifically reacts with virus-infected cells by indirect fluorescence assay (IFA).","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,"Taxonomic Sibling",Organism,"Avian leukosis virus isolate CAUGX01","Infected DF-1 cells",,,,,,,,"Avian leukosis virus isolate CAUGX01",https://ontology.iedb.org/taxon/10001966,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1943279,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The mAb epitope was identified by overlapping peptide studies.  The epitope-specific mAb specifically reacts with virus-infected cells by indirect fluorescence assay (IFA).","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,"Source Organism",Organism,"Avian leukosis virus isolate CAUHM01","Infected DF-1 cells",,,,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1943280,http://www.iedb.org/reference/1024564,Literature,22214862,,"Miao Sun; Duo Yu; Hongfei Mo; Hong Cao; Chen Chen; Fuyong Chen","J Vet Med Sci",2012,"Epitope mapping of a monoclonal antibody against the Gp85 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/173946,"Linear peptide",LPWDPQELDILG,"MAb 1E3 epitope",,,81,92,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/ontology/ONTIE_0001765,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"8 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus isolate CAUHM01",https://ontology.iedb.org/taxon/10001967,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 50 ug on day 0, 1 dose of 20 ug on day 21, 1 dose of 20 ug on day 28.",,,,,,,,,,,,,,,,,,,,,,,N,,"Splenocytes were taken from immunized mice and a hybridoma clone was created to generate epitope-specific mAb.","Figure 5","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The mAb epitope was identified by overlapping peptide studies.  The epitope-specific mAb specifically reacts with virus-infected cells by indirect fluorescence assay (IFA).","Ascitic Fluid","Entire Antibody",Monoclonal,1E3,IgG2b,,,"Taxonomic Sibling",Organism,"Avian leukosis virus isolate CAUSY01","Infected DF-1 cells",,,,,,,,"Avian leukosis virus isolate CAUSY01",https://ontology.iedb.org/taxon/10001968,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1964765,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb reacted with recombinant envelope protein (gp90) in Western-blot and indirect ELISA.","Culture Supernatant","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964766,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Figure 1","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb reacted with whole virus lysate in Western-blot and with infected chicken embryo fibroblasts in immunofluorescence assay.","Culture Supernatant","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,"Source Organism",Organism,"Reticuloendotheliosis virus strain HLJ07I",,,,,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964767,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Text, page 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb inhibited the infectivity of the virus on chicken embryo fibroblasts.","Ascitic Fluid","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,"Source Organism",Organism,"Reticuloendotheliosis virus strain HLJ07I",,,,,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964768,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb reacted with the epitope-GST fusion protein in Western-blot. Truncations of the epitope sequence abrogated the reactivity.","Purified Immunoglobulin","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,Epitope,"Linear peptide",SVQYHPL,,213,219,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964769,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,Unknown,,,,"Taxonomic Parent",Organism,"Reticuloendotheliosis virus (Avian reticuloendotheliosis virus)",,,,,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A REV-A positive chicken serum was used. Details of the immunization are not provided.","Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The REV-A positive chicken serum reacted with the epitope-GST fusion protein in Western-blot.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVQYHPL,,213,219,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964770,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb reacted with fragments of gp90 with extension of one to three residues to the N-terminus of the epitope in Western-blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,"Fragment of Source Antigen","Linear peptide",SVQYHPLA,,213,220,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/1964771,http://www.iedb.org/reference/1025328,Literature,23185456,,"Mei Xue; Xingming Shi; Jing Zhang; Yan Zhao; Hongyu Cui; Shunlei Hu; Hongbo Gao; Xianlan Cui; Yun-Feng Wang","PLoS One",2012,"Identification of a conserved B-cell epitope on reticuloendotheliosis virus envelope protein by screening a phage-displayed random peptide library.",http://www.iedb.org/epitope/177548,"Linear peptide",SVQYHPL,"gp90 213-219",,,213,219,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/ontology/ONTIE_0001796,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"The epitope sequence is conserved in the 32 REV-A strains, one REV-T strain, four spleen necrosis virus (SNV) strains and one chick syncytial virus (CSV) strain analyzed for conservancy.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein",gp90,,,http://www.ncbi.nlm.nih.gov/protein/ACT75575.1,,,,,"Reticuloendotheliosis virus strain HLJ07I",https://ontology.iedb.org/taxon/10001999,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 ug 2 weeks apart.",,,,,,,,,,,,,,,,,,,,,,,N,,"The first dose was in CFA, the others in IFA. Three days prior to fusion there was an i.p dose without adjuvant.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mAb reacted strongly with eight clones of a random peptide library that conformed the epitope consensus sequence SVQYHPL.","Purified Immunoglobulin","Entire Antibody",Monoclonal,A9E8,IgG2b,Kappa,,"Structurally Related","Linear peptide",SYLSVQYEPLLT,,,,,,,,,,,,
http://www.iedb.org/assay/1982664,http://www.iedb.org/reference/1026349,Literature,23750480,,"Guihua Wang; Xiaowei Wang; Qingqing Xu; Ziqiang Cheng","Monoclon Antib Immunodiagn Immunother",2013,"Polyclonal antibody against conserved peptide in transmembrane protein of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/187015,"Linear peptide",LQNRAAIDFLLLAQGHGCQDVEGMCCF,R73,,,376,402,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/ontology/ONTIE_0001763,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LQNRAAIDFLLLAQGHGCQDVEGMCCF,,376,402,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;",intramuscular,"200 ug three times",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Similar results were obtained with a Western blot assay. IFA results also showed that polyclonal antiserum binds ALV-J antigen in DF-1 cells.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",LQNRAAIDFLLLAQGHGCQDVEGMCCF,,376,402,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/1982666,http://www.iedb.org/reference/1026349,Literature,23750480,,"Guihua Wang; Xiaowei Wang; Qingqing Xu; Ziqiang Cheng","Monoclon Antib Immunodiagn Immunother",2013,"Polyclonal antibody against conserved peptide in transmembrane protein of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/187015,"Linear peptide",LQNRAAIDFLLLAQGHGCQDVEGMCCF,R73,,,376,402,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/ontology/ONTIE_0001763,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Oryctolagus cuniculus New Zealand White",https://ontology.iedb.org/ontology/ONTIE_0000126,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",LQNRAAIDFLLLAQGHGCQDVEGMCCF,,376,402,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;",intramuscular,"200 ug three times",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3 and 4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"RT-PCR results showed that 30 uL antiserum can completely inhibit ALV-J replication in vitro. The results of neutralization assays showed that neutralization titer of the antiserum was 1:16.",Serum,"Entire Antibody",Polyclonal,,,,,"Source Organism",Organism,"Avian leukosis virus strain NX0101",,,,,,,,,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2004917,http://www.iedb.org/reference/1026708,Literature,23955275,,"James T Koerber; Nathan D Thomsen; Brett T Hannigan; William F Degrado; James A Wells","Nat Biotechnol",2013,"Nature-inspired design of motif-specific antibody scaffolds.",http://www.iedb.org/epitope/192935,"Linear peptide","ERRPHFPQFSYSASGTA + PHOS(S10)","P8: Akt1 (S473)",S10,Phosphorylation|PHOS,485,501,,,"AKT kinase-transforming protein",http://www.ncbi.nlm.nih.gov/protein/P31748.1,,,"AKT8 murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11790,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A mouse Fab containing an anion-binding motif was used as a scaffold to design phospho-specific antibodies. The Fab was humanized and cloned into a phage display vector and phage display libraries with randomized CDR regions were selected for binding to pSer or pThr containing biologically relevant peptide targets.","Table 2 and Figure 4",ELISA,"dissociation constant KD",nM,http://purl.obolibrary.org/obo/OBI_0001728,Positive-Low,>,5000,,,,"The affinity of the phospho-epitope-specific scFv-Fc fusion protein for binding to the pSer containing epitope was determined by competition ELISA. Epitope-selected scFv bound specifically to the phosphorylated epitope and not to the unphosphorylated peptide or to other unrelated phosphopeptides.","Antibody construct",scFv,"Display Library",P8.H9,,,,Epitope,"Linear peptide","ERRPHFPQFSYSASGTA + PHOS(S10)",,485,501,,"AKT kinase-transforming protein",http://www.ncbi.nlm.nih.gov/protein/P31748.1,,,"AKT8 murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11790,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/2004920,http://www.iedb.org/reference/1026708,Literature,23955275,,"James T Koerber; Nathan D Thomsen; Brett T Hannigan; William F Degrado; James A Wells","Nat Biotechnol",2013,"Nature-inspired design of motif-specific antibody scaffolds.",http://www.iedb.org/epitope/192935,"Linear peptide","ERRPHFPQFSYSASGTA + PHOS(S10)","P8: Akt1 (S473)",S10,Phosphorylation|PHOS,485,501,,,"AKT kinase-transforming protein",http://www.ncbi.nlm.nih.gov/protein/P31748.1,,,"AKT8 murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11790,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A mouse Fab containing an anion-binding motif was used as a scaffold to design phospho-specific antibodies. The Fab was humanized and cloned into a phage display vector and phage display libraries with randomized CDR regions were selected for binding to pSer or pThr containing biologically relevant peptide targets.","Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The phospho-epitope-specific scFv bound to the phosphorylated AKT protein, but not to the dephosphorylated protein.","Antibody construct",scFv,"Display Library",P8.H9,,,,"Source Antigen",Protein,"AKT kinase-transforming protein",,,,http://www.ncbi.nlm.nih.gov/protein/P31748.1,,,,,"AKT8 murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11790,"Murine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11786
http://www.iedb.org/assay/2021414,http://www.iedb.org/reference/1027097,Literature,24365054,,"Raisa Perzova; Elliot Graziano; Swathi Sanghi; Caitlin Welch; Patricia Benz; Lynn Abbott; Danielle Lalone; Jordan Glaser; Thomas Loughran; William Sheremata; Bernard J Poiesz","Virol J",2013,"Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K10 Pol peptide",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Structurally Related",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"74 subjects infected with either HTLV-1 or HTLV-2 were tested.  Of these, 16 had myelopathy.","Figures 2, 3, Tables 1 and 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,74,21,28.4,"The HTLV myelopathy patients had a statistically significant increased prevalence of antibodies to the epitope as compared with large granular lymphocytic leukemia ( LGLL) patients, and the HTLV positive non-myelopathy subjects.",,,,,,,,Epitope,"Linear peptide",REPLENALTVFTD,,347,359,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/2022094,http://www.iedb.org/reference/1027097,Literature,24365054,,"Raisa Perzova; Elliot Graziano; Swathi Sanghi; Caitlin Welch; Patricia Benz; Lynn Abbott; Danielle Lalone; Jordan Glaser; Thomas Loughran; William Sheremata; Bernard J Poiesz","Virol J",2013,"Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.",http://www.iedb.org/epitope/194841,"Linear peptide",AYENANPECQ,"HERV-K10 Gag peptide",,,480,489,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/CAA76884.1,"Gag protein",http://www.uniprot.org/uniprot/Q96897,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Structurally Related",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"74 subjects infected with either HTLV-1 or HTLV-2 were tested.  Of these, 16 had myelopathy.","Figures 2, 3, Tables 1 and 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,74,18,24.3,"The HTLV myelopathy patients had a statistically significant increased prevalence of antibodies to the epitope as compared with large granular lymphocytic leukemia ( LGLL) patients, and the HTLV positive non-myelopathy subjects.",,,,,,,,Epitope,"Linear peptide",AYENANPECQ,,480,489,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/CAA76884.1,"Gag protein",http://www.uniprot.org/uniprot/Q96897,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/2110254,http://www.iedb.org/reference/1027958,Literature,24916842,,"Katia Forti; Giorgia Rizzo; Monica Cagiola; Giovanna Ferrante; Carla Marini; Francesco Feliziani; Giovanni Pezzotti; Antonio De Giuseppe","Vet Microbiol",2014,"Identification of a novel overlapping sequential E epitope (E') on the bovine leukaemia virus SU glycoprotein and analysis of immunological data.",http://www.iedb.org/epitope/227838,"Linear peptide",SDWVPSVRSWA,"gp51 (189-199)",,,189,199,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"The epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of BLV particles: 2 at 2-weeks intervals; 2 at 1-week interval",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously with purified BLV particles as antigen (50ug/mouse) in Freund’s complete adjuvant. Two weeks later, the same amount of antigen without the adjuvant was injected intraperitoneally. Two other injections were performed at one-week intervals. Three days after the final injection, spleen cells were fused with P3/NS0 myeloma cells.","Figures 2, 3, 4, 5 and 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mAb 2G7 was shown to bind the native recombinant protein. Fine mapping using deleted forms of the protein showed that the epitope was at the C-terminus of the surface envelope glycoprotein subunit (SU), residues 189-199. This was also shown by western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2G7,,,,"Source Antigen",Protein,"envelope polyprotein",rSU-H6,,,http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2110268,http://www.iedb.org/reference/1027958,Literature,24916842,,"Katia Forti; Giorgia Rizzo; Monica Cagiola; Giovanna Ferrante; Carla Marini; Francesco Feliziani; Giovanni Pezzotti; Antonio De Giuseppe","Vet Microbiol",2014,"Identification of a novel overlapping sequential E epitope (E') on the bovine leukaemia virus SU glycoprotein and analysis of immunological data.",http://www.iedb.org/epitope/227838,"Linear peptide",SDWVPSVRSWA,"gp51 (189-199)",,,189,199,,,"envelope polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA42786.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"The epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Freund's complete;",subcutaneous,"4 doses of BLV particles: 2 at 2-weeks intervals; 2 at 1-week interval",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously with purified BLV particles as antigen (50ug/mouse) in Freund’s complete adjuvant. Two weeks later, the same amount of antigen without the adjuvant was injected intraperitoneally. Two other injections were performed at one-week intervals. Three days after the final injection, spleen cells were fused with P3/NS0 myeloma cells.","Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,,,,"The epitope-specific mAb 2G7 was shown not to bind BLV particles.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2G7,,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","BLV particles",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2383106,http://www.iedb.org/reference/1028687,Literature,24524420,,"Yuetsu Tanaka; Yoshiaki Takahashi; Reiko Tanaka; Akira Kodama; Hideki Fujii; Atsuhiko Hasegawa; Mari Kannagi; Aftab A Ansari; Mineki Saito","AIDS Res Hum Retroviruses",2014,"Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in Tanaka et al. J Immunol. 1991 Jul 1;147(1):354-60. [PMID:1711082].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"1 dose of 5 x 10E6 W7KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 10 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in Tanaka et al. (1991) [PMID: 1711082].","Figures 1, 3, 4, 5, and 6 and Supplementary Figures S3 and S4","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The epitope-specific mAb blocked syncytium formation of IL-2-dependent CD4-CD8+ ILTM1 cells derived from an HTLV-1-associated myelopathy/tropical spastic paraparesis HAM/TSP patient and Jurkat cells. The mAb also blocked HTLV-1-mediated T cell immortalization in vitro. The mAb also reduced the number of Tax-expressing cells in in vitro cultures of PBMCs from HAM patients.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG2b,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/2383138,http://www.iedb.org/reference/1028687,Literature,24524420,,"Yuetsu Tanaka; Yoshiaki Takahashi; Reiko Tanaka; Akira Kodama; Hideki Fujii; Atsuhiko Hasegawa; Mari Kannagi; Aftab A Ansari; Mineki Saito","AIDS Res Hum Retroviruses",2014,"Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in Tanaka et al. J Immunol. 1991 Jul 1;147(1):354-60. [PMID:1711082].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"1 dose of 5 x 10E6 W7KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 10 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in Tanaka et al. (1991) [PMID: 1711082].","Figure 7","biological activity","antibody-dependent cellular cytotoxicity",,http://purl.obolibrary.org/obo/OBI_0001642,Positive,,,,,,"The epitope-specific mAb induced significant antibody-dependent cellular cytotoxicity (ADCC) against HTLV-1-infected cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG2b,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/2383139,http://www.iedb.org/reference/1028687,Literature,24524420,,"Yuetsu Tanaka; Yoshiaki Takahashi; Reiko Tanaka; Akira Kodama; Hideki Fujii; Atsuhiko Hasegawa; Mari Kannagi; Aftab A Ansari; Mineki Saito","AIDS Res Hum Retroviruses",2014,"Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"gp 46 191-196",,,191,196,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in Tanaka et al. J Immunol. 1991 Jul 1;147(1):354-60. [PMID:1711082].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein","HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAL05536.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,intraperitoneal,"1 dose of 5 x 10E6 W7KSV cells infected previously with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 10 µg gp46 glycoprotein two months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in Tanaka et al. (1991) [PMID: 1711082].","Supplementary Figure S1","flow cytometry","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001659,Positive,,,,,,"The epitope-specific mAb bound HTLV-1-positive MT-2 cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,LAT-27,IgG2b,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/2402490,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2, text page 998",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific mAb recognized the protein in western blot, ELISA, and IFA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4A3,IgG1,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402491,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb stained virus-infected DF1 cells.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4A3,IgG1,,,"Source Organism",Organism,"Avian leukosis virus HPRS103",,,,,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402492,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb stained virus-infected DF1 cells. The mAb recognized several ALV-J strains: ADOL-Hc1 and ADOL-7501 (American strains), NX0101 (early Chinese broiler strain), and HuB09JY03, JL08CH3-1, SD09DP04, HLJ09SH01, and LN08SY10 (recent Chinese layer strains).","Purified Immunoglobulin","Entire Antibody",Monoclonal,4A3,IgG1,,,"Taxonomic Sibling",Organism,"Avian leukosis virus strain NX0101","ALV-J strains",,,,,,,,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402493,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3, 4 and Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb recognized overlapping peptide fragments containing the epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4A3,IgG1,,,"Fragment of Source Antigen","Linear peptide",DGNFNGTGGAEAELRDFIEK,,125,144,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402494,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"4 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope was identified by study of overlapping peptides.","Purified Immunoglobulin","Entire Antibody",Monoclonal,4A3,IgG1,,,Epitope,"Linear peptide",AEAELRDFI,,134,142,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402495,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Avian leukosis virus HPRS103",,,,,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AEAELRDFI,,134,142,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2402496,http://www.iedb.org/reference/1028823,Literature,25655260,,"Xiaofei Li; Haibo Zhu; Qi Wang; Jiashan Sun; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2015,"Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.",http://www.iedb.org/epitope/243862,"Linear peptide",AEAELRDFI,"ALV-J gp85 (134-142)",,,134,142,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 µg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AEAELRDFI,,134,142,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2606530,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489665,"Linear peptide",MGNSPSYNPPAGISP,P15-1,,,1,15,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MGNSPSYNPPAGISP,,1,15,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606531,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489719,"Linear peptide",PSYNPPAGISPSDWL,P15-2,,,5,19,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSYNPPAGISPSDWL,,5,19,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606532,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489707,"Linear peptide",PPAGISPSDWLNLVQ,P15-3,,,9,23,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPAGISPSDWLNLVQ,,9,23,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606533,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489595,"Linear peptide",ISPSDWLNLVQSAQR,P15-4,,,13,27,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISPSDWLNLVQSAQR,,13,27,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606534,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489512,"Linear peptide",DWLNLVQSAQRLNPR,P15-5,,,17,31,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DWLNLVQSAQRLNPR,,17,31,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606535,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489663,"Linear peptide",LVQSAQRLNPRPSPS,P15-6,,,21,35,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVQSAQRLNPRPSPS,,21,35,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606536,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489475,"Linear peptide",AQRLNPRPSPSDFTD,P15-7,,,25,39,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AQRLNPRPSPSDFTD,,25,39,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606537,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489682,"Linear peptide",NPRPSPSDFTDLKNY,P15-8,,,29,43,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NPRPSPSDFTDLKNY,,29,43,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606538,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489780,"Linear peptide",SPSDFTDLKNYIHWF,P15-9,,,33,47,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPSDFTDLKNYIHWF,,33,47,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606539,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489544,"Linear peptide",FTDLKNYIHWFHKTQ,P15-10,,,37,51,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FTDLKNYIHWFHKTQ,,37,51,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606540,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489617,"Linear peptide",KNYIHWFHKTQKKPW,P15-11,,,41,55,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KNYIHWFHKTQKKPW,,41,55,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606541,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489579,"Linear peptide",HWFHKTQKKPWTFTS,P15-12,,,45,59,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HWFHKTQKKPWTFTS,,45,59,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606542,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489625,"Linear peptide",KTQKKPWTFTSGGPT,P15-13,,,49,63,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KTQKKPWTFTSGGPT,,49,63,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606543,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489621,"Linear peptide",KPWTFTSGGPTSCPP,P15-14,,,53,67,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KPWTFTSGGPTSCPP,,53,67,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606544,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489545,"Linear peptide",FTSGGPTSCPPGRFG,P15-15,,,57,71,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FTSGGPTSCPPGRFG,,57,71,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606545,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489561,"Linear peptide",GPTSCPPGRFGRVPL,P15-16,,,61,75,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPTSCPPGRFGRVPL,,61,75,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606546,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489492,"Linear peptide",CPPGRFGRVPLVLAT,P15-17,,,65,79,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPPGRFGRVPLVLAT,,65,79,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606547,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489752,"Linear peptide",RFGRVPLVLATLNEV,P15-18,,,69,83,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RFGRVPLVLATLNEV,,69,83,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606548,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489838,"Linear peptide",VPLVLATLNEVLSNE,P15-19,,,73,87,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VPLVLATLNEVLSNE,,73,87,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606549,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489630,"Linear peptide",LATLNEVLSNEGGAP,P15-20,,,77,91,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LATLNEVLSNEGGAP,,77,91,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606550,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489674,"Linear peptide",NEVLSNEGGAPGASA,P15-21,,,81,95,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NEVLSNEGGAPGASA,,81,95,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606551,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489777,"Linear peptide",SNEGGAPGASAPEEQ,P15-22,,,85,99,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SNEGGAPGASAPEEQ,,85,99,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606552,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489546,"Linear peptide",GAPGASAPEEQPPPY,P15-23,,,89,103,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GAPGASAPEEQPPPY,,89,103,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606553,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489478,"Linear peptide",ASAPEEQPPPYDPPA,P15-24,,,93,107,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ASAPEEQPPPYDPPA,,93,107,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606554,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489518,"Linear peptide",EEQPPPYDPPAI,P15-25,,,97,108,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EEQPPPYDPPAI,,97,108,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606555,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489649,"Linear peptide",LPIISEGNRNRHRAW,p24-1,,,109,123,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPIISEGNRNRHRAW,,109,123,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606556,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489769,"Linear peptide",SEGNRNRHRAWALRE,p24-2,,,113,127,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SEGNRNRHRAWALRE,,113,127,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606557,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489755,"Linear peptide",RNRHRAWALRELQDI,p24-3,,,117,131,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RNRHRAWALRELQDI,,117,131,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606558,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489749,"Linear peptide",RAWALRELQDIKKEI,p24-4,,,121,135,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RAWALRELQDIKKEI,,121,135,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606559,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/85751,"Linear peptide",LRELQDIKKEIENKA,p24-5,,,125,139,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRELQDIKKEIENKA,,125,139,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606560,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489730,"Linear peptide",QDIKKEIENKAPGSQ,p24-6,,,129,143,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QDIKKEIENKAPGSQ,,129,143,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606561,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489612,"Linear peptide",KEIENKAPGSQVWIQ,p24-7,,,133,147,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KEIENKAPGSQVWIQ,,133,147,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606562,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489678,"Linear peptide",NKAPGSQVWIQTLRL,p24-8,,,137,151,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKAPGSQVWIQTLRL,,137,151,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606563,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489569,"Linear peptide",GSQVWIQTLRLAILQ,p24-9,,,141,155,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GSQVWIQTLRLAILQ,,141,155,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606564,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/90574,"Linear peptide",WIQTLRLAILQADPT,p24-10,,,145,159,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WIQTLRLAILQADPT,,145,159,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606565,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489656,"Linear peptide",LRLAILQADPTPADL,p24-11,,,149,163,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRLAILQADPTPADL,,149,163,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606566,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489587,"Linear peptide",ILQADPTPADLEQLC,p24-12,,,153,167,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ILQADPTPADLEQLC,,153,167,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606567,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489508,"Linear peptide",DPTPADLEQLCQYIA,p24-13,,,157,171,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DPTPADLEQLCQYIA,,157,171,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606568,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489447,"Linear peptide",ADLEQLCQYIASPVD,p24-14,,,161,175,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ADLEQLCQYIASPVD,,161,175,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606569,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489739,"Linear peptide",QLCQYIASPVDQTAH,p24-15,,,165,179,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QLCQYIASPVDQTAH,,165,179,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606570,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489856,"Linear peptide",YIASPVDQTAHMTSL,p24-16,,,169,183,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YIASPVDQTAHMTSL,,169,183,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606571,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489720,"Linear peptide",PVDQTAHMTSLTAAI,p24-17,,,173,187,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PVDQTAHMTSLTAAI,,173,187,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606572,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489801,"Linear peptide",TAHMTSLTAAIAAAE,p24-18,,,177,191,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TAHMTSLTAAIAAAE,,177,191,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606573,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489821,"Linear peptide",TSLTAAIAAAEAANT,p24-19,,,181,195,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSLTAAIAAAEAANT,,181,195,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606574,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/80132,"Linear peptide",AAIAAAEAANTLQGF,p24-20,,,185,199,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AAIAAAEAANTLQGF,,185,199,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606575,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489440,"Linear peptide",AAEAANTLQGFNPQN,p24-21,,,189,203,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AAEAANTLQGFNPQN,,189,203,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606576,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489472,"Linear peptide",ANTLQGFNPQNGTLT,p24-22,,,193,207,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ANTLQGFNPQNGTLT,,193,207,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606577,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489735,"Linear peptide",QGFNPQNGTLTQQSA,p24-23,,,197,211,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QGFNPQNGTLTQQSA,,197,211,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606578,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489713,"Linear peptide",PQNGTLTQQSAQPNA,p24-24,,,201,215,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PQNGTLTQQSAQPNA,,201,215,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606579,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/89577,"Linear peptide",TLTQQSAQPNAGDLR,p24-25,,,205,219,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLTQQSAQPNAGDLR,,205,219,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606580,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489744,"Linear peptide",QSAQPNAGDLRSQYQ,p24-26,,,209,223,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QSAQPNAGDLRSQYQ,,209,223,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606581,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489706,"Linear peptide",PNAGDLRSQYQNLWL,p24-27,,,213,227,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PNAGDLRSQYQNLWL,,213,227,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606582,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489505,"Linear peptide",DLRSQYQNLWLQAWK,p24-28,,,217,231,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DLRSQYQNLWLQAWK,,217,231,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606583,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489748,"Linear peptide",QYQNLWLQAWKNLPT,p24-29,,,221,235,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QYQNLWLQAWKNLPT,,221,235,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606584,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/86096,"Linear peptide",LWLQAWKNLPTRPSV,p24-30,,,225,239,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LWLQAWKNLPTRPSV,,225,239,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606585,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489487,"Linear peptide",AWKNLPTRPSVQPWS,p24-31,,,229,243,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AWKNLPTRPSVQPWS,,229,243,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606586,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489653,"Linear peptide",LPTRPSVQPWSTIVQ,p24-32,,,233,247,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPTRPSVQPWSTIVQ,,233,247,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606587,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489717,"Linear peptide",PSVQPWSTIVQGPAE,p24-33,,,237,251,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSVQPWSTIVQGPAE,,237,251,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606588,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489725,"Linear peptide",PWSTIVQGPAESYVE,p24-34,,,241,255,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PWSTIVQGPAESYVE,,241,255,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606589,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/84102,"Linear peptide",IVQGPAESYVEFVNR,p24-35,,,245,259,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IVQGPAESYVEFVNR,,245,259,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606590,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489687,"Linear peptide",PAESYVEFVNRLQIS,p24-36,,,249,263,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PAESYVEFVNRLQIS,,249,263,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606591,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489864,"Linear peptide",YVEFVNRLQISLADN,p24-37,,,253,267,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YVEFVNRLQISLADN,,253,267,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606592,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489836,"Linear peptide",VNRLQISLADNLPDG,p24-38,,,257,271,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VNRLQISLADNLPDG,,257,271,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606593,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489737,"Linear peptide",QISLADNLPDGVPKE,p24-39,,,261,275,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QISLADNLPDGVPKE,,261,275,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606594,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/80192,"Linear peptide",ADNLPDGVPKEPIID,p24-40,,,265,279,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ADNLPDGVPKEPIID,,265,279,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606595,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489688,"Linear peptide",PDGVPKEPIIDSLSY,p24-41,,,269,283,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDGVPKEPIIDSLSY,,269,283,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606596,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489701,"Linear peptide",PKEPIIDSLSYANAN,p24-42,,,273,287,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PKEPIIDSLSYANAN,,273,287,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606597,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489584,"Linear peptide",IIDSLSYANANKECQ,p24-43,,,277,291,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IIDSLSYANANKECQ,,277,291,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606598,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489659,"Linear peptide",LSYANANKECQQILQ,p24-44,,,281,295,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LSYANANKECQQILQ,,281,295,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606599,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/86642,"Linear peptide",NANKECQQILQGRGL,p24-45,,,285,299,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NANKECQQILQGRGL,,285,299,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606600,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489515,"Linear peptide",ECQQILQGRGLVAAP,p24-46,,,289,303,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ECQQILQGRGLVAAP,,289,303,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606601,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489588,"Linear peptide",ILQGRGLVAAPVGQK,p24-47,,,293,307,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ILQGRGLVAAPVGQK,,293,307,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606602,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489753,"Linear peptide",RGLVAAPVGQKLQAC,p24-48,,,297,311,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RGLVAAPVGQKLQAC,,297,311,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606603,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489442,"Linear peptide",AAPVGQKLQACAHWA,p24-49,,,301,315,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AAPVGQKLQACAHWA,,301,315,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606604,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489564,"Linear peptide",GQKLQACAHWAPKMK,p24-50,,,305,319,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GQKLQACAHWAPKMK,,305,319,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606605,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489727,"Linear peptide",QACAHWAPKMKQPAI,p24-51,,,309,323,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QACAHWAPKMKQPAI,,309,323,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606606,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489578,"Linear peptide",HWAPKMKQPAIL,p24-52,,,313,324,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HWAPKMKQPAIL,,313,324,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606607,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489831,"Linear peptide",VHTPGPKMPGPRQPA,p12-1,,,325,339,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VHTPGPKMPGPRQPA,,325,339,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606608,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489558,"Linear peptide",GPKMPGPRQPAPKRP,p12-2,,,329,343,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPKMPGPRQPAPKRP,,329,343,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606609,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489696,"Linear peptide",PGPRQPAPKRPPPGP,p12-3,,,333,347,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PGPRQPAPKRPPPGP,,333,347,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606610,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489740,"Linear peptide",QPAPKRPPPGPCYRC,p12-4,,,337,351,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QPAPKRPPPGPCYRC,,337,351,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606611,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489622,"Linear peptide",KRPPPGPCYRCLKEG,p12-5,,,341,355,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KRPPPGPCYRCLKEG,,341,355,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606612,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489694,"Linear peptide",PGPCYRCLKEGHWAR,p12-6,,,345,359,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PGPCYRCLKEGHWAR,,345,359,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606613,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489860,"Linear peptide",YRCLKEGHWARDCPT,p12-7,,,349,363,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YRCLKEGHWARDCPT,,349,363,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606614,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489611,"Linear peptide",KEGHWARDCPTKATG,p12-8,,,353,367,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KEGHWARDCPTKATG,,353,367,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606615,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489847,"Linear peptide",WARDCPTKATGPPPG,p12-9,,,357,371,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WARDCPTKATGPPPG,,357,371,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606616,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489493,"Linear peptide",CPTKATGPPPGPCPI,p12-10,,,361,375,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPTKATGPPPGPCPI,,361,375,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606617,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489481,"Linear peptide",ATGPPPGPCPICKDP,p12-11,,,365,379,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ATGPPPGPCPICKDP,,365,379,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606618,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489708,"Linear peptide",PPGPCPICKDPSHWK,p12-12,,,369,383,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPGPCPICKDPSHWK,,369,383,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606619,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489491,"Linear peptide",CPICKDPSHWKRDCP,p12-13,,,373,387,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",CPICKDPSHWKRDCP,,373,387,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606620,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489609,"Linear peptide",KDPSHWKRDCPTLKS,p12-14,,,377,391,,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KDPSHWKRDCPTLKS,,377,391,,"gag polyprotein precursor, partial",http://www.ncbi.nlm.nih.gov/protein/BAR88278.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q85490,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606621,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489824,"Linear peptide",TWRCSLSLGNQQWMT,gp51-1,,,33,47,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TWRCSLSLGNQQWMT,,33,47,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606622,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489774,"Linear peptide",SLSLGNQQWMTAYNQ,gp51-2,,,37,51,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SLSLGNQQWMTAYNQ,,37,51,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606623,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489556,"Linear peptide",GNQQWMTAYNQEAKF,gp51-3,,,41,55,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GNQQWMTAYNQEAKF,,41,55,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606624,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489850,"Linear peptide",WMTAYNQEAKFSISI,gp51-4,,,45,59,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WMTAYNQEAKFSISI,,45,59,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606625,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489858,"Linear peptide",YNQEAKFSISIDQIL,gp51-5,,,49,63,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YNQEAKFSISIDQIL,,49,63,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606626,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489463,"Linear peptide",AKFSISIDQILEAHN,gp51-6,,,53,67,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AKFSISIDQILEAHN,,53,67,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606627,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489594,"Linear peptide",ISIDQILEAHNQSPF,gp51-7,,,57,71,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISIDQILEAHNQSPF,,57,71,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606628,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489736,"Linear peptide",QILEAHNQSPFCAKS,gp51-8,,,61,75,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QILEAHNQSPFCAKS,,61,75,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606629,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489459,"Linear peptide",AHNQSPFCAKSPRYT,gp51-9,,,65,79,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AHNQSPFCAKSPRYT,,65,79,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606630,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489778,"Linear peptide",SPFCAKSPRYTLDSV,gp51-10,,,69,83,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SPFCAKSPRYTLDSV,,69,83,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606631,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489464,"Linear peptide",AKSPRYTLDSVNGYP,gp51-11,,,73,87,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AKSPRYTLDSVNGYP,,73,87,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606632,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489763,"Linear peptide",RYTLDSVNGYPKIYW,gp51-12,,,77,91,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RYTLDSVNGYPKIYW,,77,91,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606633,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489511,"Linear peptide",DSVNGYPKIYWPPPQ,gp51-13,,,81,95,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DSVNGYPKIYWPPPQ,,81,95,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606634,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489572,"Linear peptide",GYPKIYWPPPQGRRR,gp51-14,,,85,99,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GYPKIYWPPPQGRRR,,85,99,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606635,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489601,"Linear peptide",IYWPPPQGRRRFGAR,gp51-15,,,89,103,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IYWPPPQGRRRFGAR,,89,103,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606636,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489710,"Linear peptide",PPQGRRRFGARAMVT,gp51-16,,,93,107,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,4,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPQGRRRFGARAMVT,,93,107,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606637,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489760,"Linear peptide",RRRFGARAMVTYDCE,gp51-17,,,97,111,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,3,75,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RRRFGARAMVTYDCE,,97,111,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606638,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489547,"Linear peptide",GARAMVTYDCEPRCP,gp51-18,,,101,115,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GARAMVTYDCEPRCP,,101,115,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606639,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489669,"Linear peptide",MVTYDCEPRCPYVGA,gp51-19,,,105,119,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MVTYDCEPRCPYVGA,,105,119,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606640,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489495,"Linear peptide",DCEPRCPYVGADRFD,gp51-20,,,109,123,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DCEPRCPYVGADRFD,,109,123,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606641,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489750,"Linear peptide",RCPYVGADRFDCPHW,gp51-21,,,113,127,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RCPYVGADRFDCPHW,,113,127,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606642,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489830,"Linear peptide",VGADRFDCPHWDNAS,gp51-22,,,117,131,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VGADRFDCPHWDNAS,,117,131,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606643,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489751,"Linear peptide",RFDCPHWDNASQADQ,gp51-23,,,121,135,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RFDCPHWDNASQADQ,,121,135,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606644,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489699,"Linear peptide",PHWDNASQADQGSFY,gp51-24,,,125,139,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PHWDNASQADQGSFY,,125,139,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606645,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489671,"Linear peptide",NASQADQGSFYVNHQ,gp51-25,,,129,143,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NASQADQGSFYVNHQ,,129,143,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606646,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489451,"Linear peptide",ADQGSFYVNHQILFL,gp51-26,,,133,147,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ADQGSFYVNHQILFL,,133,147,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606647,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489771,"Linear peptide",SFYVNHQILFLHLKQ,gp51-27,,,137,151,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SFYVNHQILFLHLKQ,,137,151,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606648,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489677,"Linear peptide",NHQILFLHLKQCHGI,gp51-28,,,141,155,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NHQILFLHLKQCHGI,,141,155,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606649,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489638,"Linear peptide",LFLHLKQCHGIFTLT,gp51-29,,,145,159,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LFLHLKQCHGIFTLT,,145,159,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606650,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489646,"Linear peptide",LKQCHGIFTLTWEIW,gp51-30,,,149,163,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LKQCHGIFTLTWEIW,,149,163,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606651,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489575,"Linear peptide",HGIFTLTWEIWGYDP,gp51-31,,,153,167,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HGIFTLTWEIWGYDP,,153,167,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606652,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489811,"Linear peptide",TLTWEIWGYDPLITF,gp51-32,,,157,171,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TLTWEIWGYDPLITF,,157,171,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606653,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489521,"Linear peptide",EIWGYDPLITFSLHK,gp51-33,,,161,175,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EIWGYDPLITFSLHK,,161,175,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606654,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489854,"Linear peptide",YDPLITFSLHKIPDP,gp51-34,,,165,179,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YDPLITFSLHKIPDP,,165,179,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606655,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489599,"Linear peptide",ITFSLHKIPDPPQPD,gp51-35,,,169,183,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ITFSLHKIPDPPQPD,,169,183,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606656,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489643,"Linear peptide",LHKIPDPPQPDFPQL,gp51-36,,,173,187,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LHKIPDPPQPDFPQL,,173,187,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606657,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489690,"Linear peptide",PDPPQPDFPQLNSDW,gp51-37,,,177,191,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDPPQPDFPQLNSDW,,177,191,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606658,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489741,"Linear peptide",QPDFPQLNSDWVPSV,gp51-38,,,181,195,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QPDFPQLNSDWVPSV,,181,195,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606659,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489712,"Linear peptide",PQLNSDWVPSVRSWA,gp51-39,,,185,199,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PQLNSDWVPSVRSWA,,185,199,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606660,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489768,"Linear peptide",SDWVPSVRSWALLLN,gp51-40,,,189,203,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,2,50,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SDWVPSVRSWALLLN,,189,203,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606661,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489718,"Linear peptide",PSVRSWALLLNQTAR,gp51-41,,,193,207,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSVRSWALLLNQTAR,,193,207,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606662,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489797,"Linear peptide",SWALLLNQTARAFPD,gp51-42,,,197,211,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SWALLLNQTARAFPD,,197,211,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606663,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489647,"Linear peptide",LLNQTARAFPDCAIC,gp51-43,,,201,215,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LLNQTARAFPDCAIC,,201,215,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606664,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489802,"Linear peptide",TARAFPDCAICWEPS,gp51-44,,,205,219,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TARAFPDCAICWEPS,,205,219,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606665,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489539,"Linear peptide",FPDCAICWEPSPPWA,gp51-45,,,209,223,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",FPDCAICWEPSPPWA,,209,223,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606666,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489461,"Linear peptide",AICWEPSPPWAPEIL,gp51-46,,,213,227,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AICWEPSPPWAPEIL,,213,227,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606667,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489527,"Linear peptide",EPSPPWAPEILVYNK,gp51-47,,,217,231,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EPSPPWAPEILVYNK,,217,231,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606668,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489723,"Linear peptide",PWAPEILVYNKTISS,gp51-48,,,221,235,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PWAPEILVYNKTISS,,221,235,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606669,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489519,"Linear peptide",EILVYNKTISSSGPG,gp51-49,,,225,239,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EILVYNKTISSSGPG,,225,239,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606670,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489857,"Linear peptide",YNKTISSSGPGLALP,gp51-50,,,229,243,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YNKTISSSGPGLALP,,229,243,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606671,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489596,"Linear peptide",ISSSGPGLALPDAQI,gp51-51,,,233,247,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ISSSGPGLALPDAQI,,233,247,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606672,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489557,"Linear peptide",GPGLALPDAQIFWVN,gp51-52,,,237,251,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GPGLALPDAQIFWVN,,237,251,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606673,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489469,"Linear peptide",ALPDAQIFWVNTSSF,gp51-53,,,241,255,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ALPDAQIFWVNTSSF,,241,255,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606674,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489474,"Linear peptide",AQIFWVNTSSFNTTQ,gp51-54,,,245,259,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AQIFWVNTSSFNTTQ,,245,259,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606675,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489853,"Linear peptide",WVNTSSFNTTQGWHH,gp51-55,,,249,263,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WVNTSSFNTTQGWHH,,249,263,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606676,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489789,"Linear peptide",SSFNTTQGWHHPSQR,gp51-56,,,253,267,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSFNTTQGWHHPSQR,,253,267,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606677,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489823,"Linear peptide",TTQGWHHPSQRLLFN,gp51-57,,,257,271,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TTQGWHHPSQRLLFN,,257,271,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606678,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489848,"Linear peptide",WHHPSQRLLFNVSQG,gp51-58,,,261,275,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WHHPSQRLLFNVSQG,,261,275,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606679,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489783,"Linear peptide",SQRLLFNVSQGNALL,gp51-59,,,265,279,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SQRLLFNVSQGNALL,,265,279,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606680,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489640,"Linear peptide",LFNVSQGNALLLPPI,gp51-60,,,269,283,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LFNVSQGNALLLPPI,,269,283,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606681,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489782,"Linear peptide",SQGNALLLPPISLVN,gp51-61,,,273,287,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SQGNALLLPPISLVN,,273,287,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606682,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489468,"Linear peptide",ALLLPPISLVNLSTA,gp51-62,,,277,291,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ALLLPPISLVNLSTA,,277,291,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606683,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489709,"Linear peptide",PPISLVNLSTASSAP,gp51-63,,,281,295,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PPISLVNLSTASSAP,,281,295,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606684,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489662,"Linear peptide",LVNLSTASSAPPTRV,gp51-64,,,285,299,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,4,1,25,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LVNLSTASSAPPTRV,,285,299,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606685,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489792,"Linear peptide",STASSAPPTRVRR,gp51-65,,,289,301,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,intravenous,"1 dose of 4 x 10E7 proviral copies",,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were experimentally infected with white blood cells containing  4 x 10E7 proviral copies.","Table 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Negative,,,4,0,0,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",STASSAPPTRVRR,,289,301,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2606686,http://www.iedb.org/reference/1029778,Literature,26715158,,"Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida",Retrovirology,2015,"Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.",http://www.iedb.org/epitope/489852,"Linear peptide",WPPPQGRRRFGARAMVTYDC,gp51p16-C,,,91,110,,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus Japanese Black",https://ontology.iedb.org/ontology/ONTIE_0001958,,,,"6 to 8 months",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Unknown,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were taken from 647 cattle naturally infected with Bovine leukemia virus and 4 cows experimentally infected.","Figures 1 and 2 and Table 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,651,594,91.2,"Amino acids W1, G6, R7, R9, F10, M15, V16, T17, and Y18 were identified as critical residues using alanine scan. All experimentally infected cows were positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WPPPQGRRRFGARAMVTYDC,,91,110,,"envelope precursor",http://www.ncbi.nlm.nih.gov/protein/ABS11217.1,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/2691723,http://www.iedb.org/reference/1029909,Literature,26848684,,"Hideki Fujii; Mamoru Shimizu; Takuya Miyagi; Marie Kunihiro; Reiko Tanaka; Yoshiaki Takahashi; Yuetsu Tanaka",Viruses,2016,"A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in Tanaka et al., J Virol. 1994 Oct;68(10):6323-31. [PMID:8083972].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,adult,,"Administration in vivo",,,,"Source Antigen",Protein,env,,,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10 MOI followed by 1 dose of 50 µg gp46 2 months later.",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in Tanaka et al., J Virol. 1994 Oct;68(10):6323-31. [PMID:8083972]. Animals were initially inoculated with L8KSV cells infected with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.","Figure 3","biological activity",neutralization,,http://purl.obolibrary.org/obo/OBI_0001643,Positive,,,,,,"The humanized epitope-specific mAb blocked syncytium formation of IL-2-dependent CD4-CD8+ ILTM1 cells derived from a HTLV-1-associated myelopathy/tropical spastic paraparesis HAM/TSP patient. The original mAb, LAT-27 (IgG2b) showed similar neutralization activity.","Purified Immunoglobulin","Entire Antibody",Monoclonal,huLAT-27,IgG1,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/2691727,http://www.iedb.org/reference/1029909,Literature,26848684,,"Hideki Fujii; Mamoru Shimizu; Takuya Miyagi; Marie Kunihiro; Reiko Tanaka; Yoshiaki Takahashi; Yuetsu Tanaka",Viruses,2016,"A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.",http://www.iedb.org/epitope/38522,"Linear peptide",LPHSNL,"HTLV-1 peptide 191-196",,,191,196,,,env,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,"The epitope sequence was cited in Tanaka et al., J Virol. 1994 Oct;68(10):6323-31. [PMID:8083972].",,,,,,,,,,,,,,,,"Rattus norvegicus WKAH",https://ontology.iedb.org/ontology/ONTIE_0000867,,,F,adult,,"Administration in vivo",,,,"Source Antigen",Protein,env,"HTLV-I env-vac",,,http://www.ncbi.nlm.nih.gov/protein/AAA96674.1,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,subcutaneous,"1 dose of 10 MOI followed by 1 dose of 50 µg gp46 2 months later.",,,,,,,,,,,,,,,,,,,,,,,Y,"Rattus norvegicus Sprague-Dawley were adoptively transferred with Purified Immunoglobulin.","Generation of the monoclonal antibody was previously described in Tanaka et al., J Virol. 1994 Oct;68(10):6323-31. [PMID:8083972]. Animals were initially inoculated with L8KSV cells infected with WR-proenv1 at a multiplicity of infection of 10, and 1 dose of 50 µg gp46 glycoprotein two months later.","Figures 2 and 4","in vivo assay","pathogen burden after challenge after adoptive transfer",,http://purl.obolibrary.org/obo/OBI_0002640,Positive,,,11,11,100,"Immunization with the humanized epitope-specific mAb protected mice from challenge with the virus. Complete protection (9/9) was also seen in the offspring of mice that received the mAb during pregnancy. In addition, humanized immunodeficient hu-PBL-NOG mice pre-infused intravenously with the epitope specific mAb were protected from HTLV-I infection.",,,,,,,,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/2707392,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509274,"Linear peptide",LRDFIAKWKSDDLLIRPYVNQS,"ALV gp85 (137-158)",,,138,159,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figures 3, 4, and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,"The minimal epitope was identified by study of deletion mutants and overlapping peptides by Western blot and ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,Epitope,"Linear peptide",LRDFIAKWKSDDLLIRPYVNQS,,138,159,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710021,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509274,"Linear peptide",LRDFIAKWKSDDLLIRPYVNQS,"ALV gp85 (137-158)",,,138,159,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,China,http://purl.obolibrary.org/obo/GAZ_00002845,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-ALV-J sera (56 samples) were collected in various flocks.","Figure 5 and Supplementary Table S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,56,49,87.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRDFIAKWKSDDLLIRPYVNQS,,138,159,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710022,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509277,"Linear peptide",LRDFIEKWKSDDLLIRPYVNQS,"ALV gp85 A142E (137-158)",,,137,158,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figures 3 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,Epitope,"Linear peptide",LRDFIEKWKSDDLLIRPYVNQS,,137,158,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710023,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509277,"Linear peptide",LRDFIEKWKSDDLLIRPYVNQS,"ALV gp85 A142E (137-158)",,,137,158,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,China,http://purl.obolibrary.org/obo/GAZ_00002845,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-ALV-J sera (56 samples) were collected in various flocks.","Figure 5 and Supplementary Table S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,56,49,87.5,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRDFIEKWKSDDLLIRPYVNQS,,137,158,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710024,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509276,"Linear peptide",LRDFIEKWKSDDHLIRPYVNQS,"ALV gp85 A142E-L150H (137-158)",,,137,158,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,China,http://purl.obolibrary.org/obo/GAZ_00002845,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-ALV-J sera (56 samples) were collected in various flocks.","Figure 5 and Supplementary Table S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,56,55,98.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRDFIEKWKSDDHLIRPYVNQS,,137,158,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710025,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509276,"Linear peptide",LRDFIEKWKSDDHLIRPYVNQS,"ALV gp85 A142E-L150H (137-158)",,,137,158,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figures 3 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,Epitope,"Linear peptide",LRDFIEKWKSDDHLIRPYVNQS,,137,158,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710026,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509275,"Linear peptide",LRDFIEKWKGDDHLIRPYVNQS,"ALV gp85 A142E-S147G-L150H (137-158)",,,138,159,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,China,http://purl.obolibrary.org/obo/GAZ_00002845,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-ALV-J sera (56 samples) were collected in various flocks.","Figure 5 and Supplementary Table S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,56,55,98.2,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRDFIEKWKGDDHLIRPYVNQS,,138,159,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710027,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509275,"Linear peptide",LRDFIEKWKGDDHLIRPYVNQS,"ALV gp85 A142E-S147G-L150H (137-158)",,,138,159,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figures 3 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,Epitope,"Linear peptide",LRDFIEKWKGDDHLIRPYVNQS,,138,159,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710028,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509278,"Linear peptide",LRDFITKWKGDDHLIRPYVNQS,"ALV gp85 A142T-S147G-L150H (137-158)",,,137,158,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,China,http://purl.obolibrary.org/obo/GAZ_00002845,,,,"Exposure with existing immune reactivity without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Anti-ALV-J sera (56 samples) were collected in various flocks.","Figure 5 and Supplementary Table S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-High,,,56,54,96.4,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LRDFITKWKGDDHLIRPYVNQS,,137,158,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2710029,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509278,"Linear peptide",LRDFITKWKGDDHLIRPYVNQS,"ALV gp85 A142T-S147G-L150H (137-158)",,,137,158,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figures 3 and 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,Epitope,"Linear peptide",LRDFITKWKGDDHLIRPYVNQS,,137,158,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2723600,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509274,"Linear peptide",LRDFIAKWKSDDLLIRPYVNQS,"ALV gp85 (137-158)",,,138,159,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound the protein in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/ABR57239.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2723601,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509277,"Linear peptide",LRDFIEKWKSDDLLIRPYVNQS,"ALV gp85 A142E (137-158)",,,137,158,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound the protein in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,"Source Antigen",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2723602,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509276,"Linear peptide",LRDFIEKWKSDDHLIRPYVNQS,"ALV gp85 A142E-L150H (137-158)",,,137,158,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound the protein in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,"Source Antigen",Protein,"surface glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2723603,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509275,"Linear peptide",LRDFIEKWKGDDHLIRPYVNQS,"ALV gp85 A142E-S147G-L150H (137-158)",,,138,159,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound the protein in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,"Source Antigen",Protein,"surface glycoprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2723604,http://www.iedb.org/reference/1029971,Literature,26850757,,"Minbo Hou; Defang Zhou; Gen Li; Huijun Guo; Jianzhu Liu; Guihua Wang; Qiankun Zheng; Ziqiang Cheng",Vaccine,2016,"Identification of a variant antigenic neutralizing epitope in hypervariable region 1 of avian leukosis virus subgroup J.",http://www.iedb.org/epitope/509278,"Linear peptide",LRDFITKWKGDDHLIRPYVNQS,"ALV gp85 A142T-S147G-L150H (137-158)",,,137,158,,,"envelope glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound the protein in Western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,2D5,IgG,,,"Source Antigen",Protein,"envelope glycoprotein, partial",,,,http://www.ncbi.nlm.nih.gov/protein/AEU12421.1,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858627,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Six-week-old female BALB/c mice were immunized with purified P27 protein to produce monoclonal antibodies. After cell fusion, the hybridoma cells were sub-cloned by limiting dilution three times.","Figure 1B","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb 3A9 was shown to bind recombinant P27 by western blot.","Culture Supernatant","Entire Antibody",Monoclonal,3A9,IgG1,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858628,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Six-week-old female BALB/c mice were immunized with purified P27 protein to produce monoclonal antibodies. After cell fusion, the hybridoma cells were sub-cloned by limiting dilution three times.","Figure 1C","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb 3A9 was shown to react with the British prototype strains RAV-1, RAV-2 and HPRS-103, the early Chinese broiler strain NX0101, the American strains ADOL-Hc1 and ADOL-7501, and the recent Chinese layer  strains  HuB09JY03, HLJ09SH01,  JL08CH3-1, LN08SY10 and  SD09DP04.","Culture Supernatant","Entire Antibody",Monoclonal,3A9,IgG1,,,"Taxonomic Child",Organism,"Avian leukosis virus strain NX0101","ALV strain NX0101",,,,,,,,"Avian leukosis virus strain NX0101",https://ontology.iedb.org/taxon/10001965,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858629,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Six-week-old female BALB/c mice were immunized with purified P27 protein to produce monoclonal antibodies. After cell fusion, the hybridoma cells were sub-cloned by limiting dilution three times.","Figure 1C","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific mAb 3A9 was shown to react with the British prototype strains RAV-1, RAV-2 and HPRS-103, the early Chinese broiler strain NX0101, the American strains ADOL-Hc1 and ADOL-7501, and the recent Chinese layer  strains  HuB09JY03, HLJ09SH01,  JL08CH3-1, LN08SY10 and  SD09DP04.","Culture Supernatant","Entire Antibody",Monoclonal,3A9,IgG1,,,"Taxonomic Child",Organism,"Avian leukosis virus HPRS103","ALV strain HPRS103",,,,,,,,"Avian leukosis virus HPRS103",http://purl.obolibrary.org/obo/NCBITaxon_363020,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858630,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Six-week-old female BALB/c mice were immunized with purified P27 protein to produce monoclonal antibodies. After cell fusion, the hybridoma cells were sub-cloned by limiting dilution three times.","Figure 2C","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope of mAb 3A9 was mapped using GST-fusion fragments spanning 181-197 of the P27 protein.","Culture Supernatant","Entire Antibody",Monoclonal,3A9,IgG1,,,Epitope,"Linear peptide",PPSAR,,423,427,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858631,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Six-week-old female BALB/c mice were immunized with purified P27 protein to produce monoclonal antibodies. After cell fusion, the hybridoma cells were sub-cloned by limiting dilution three times.","Figure 2C","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope of mAb 3A9 was mapped using GST-fusion fragments spanning 181-197 of the P27 protein. MAb 3A9 was shown to recognize the long fragment 180-197.","Culture Supernatant","Entire Antibody",Monoclonal,3A9,IgG1,,,"Fragment of Source Antigen","Linear peptide",LPPSARAPVIIDCFRQKS,"pep8 (180-197)",422,439,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858633,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with recombinant P27 protein.","Figure 3A",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Mouse anti-ALV P27 sera were shown to recognize the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSAR,,423,427,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/2858634,http://www.iedb.org/reference/1030701,Literature,27438076,,"Xiaofei Li; Liting Qin; Haibo Zhu; Yingjun Sun; Xuezhi Cui; Yadong Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang","Arch Virol",2016,"Identification of a linear B-cell epitope on the avian leukosis virus P27 protein using monoclonal antibodies.",http://www.iedb.org/epitope/549207,"Linear peptide",PPSAR,"mAb 3A9 (P27 181-185)",,,423,427,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Avian leukosis virus (Avian leukosis viruses)",,,,,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Chickens were infected with different avian leukosis virus strains: ALV-A, ALV-B and ALV-J strains (HLJ09SH01).","Figure 3B",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Sera from chickens infected with different avian leukosis virus strains (ALV-A, ALV-B and ALV-J) were shown to recognize the epitope.",Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",PPSAR,,423,427,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/ABC94885.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/3064587,http://www.iedb.org/reference/1030809,Literature,27706644,,"Y Liu; Y F Zhang; X L Sun; S Y Liu","Genet Mol Res",2016,"Detection of Jaagsiekte sheep retrovirus in the peripheral blood during the pre-clinical period of ovine pulmonary adenomatosis.",http://www.iedb.org/epitope/569701,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,"JSRV- Env(572-615)",,,572,615,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"5 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,,572,615,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"Four doses of 100 ug, administered at 2-week intervals..",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously with the peptide emulsified with isopycnic complete Freund’s adjuvant in the first immunization. The incomplete Freund’s adjuvant was used in the two subsequent booster shots at 2-week intervals. A final tail intravenous immunization with the peptide alone was administered 3 days before cell fusion. Splenocytes were used to create the epitope-specific hybridomas.","Figures 2 and 5","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The eptiope-specific hybridoma reacted with the JSRV Env protein and total protein from lung tissues of OPA-affected sheep.","Ascitic Fluid","Entire Antibody",Monoclonal,8E5,IgG2a,Kappa,,"Source Antigen",Protein,"env protein",,,,http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,,,,,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746
http://www.iedb.org/assay/3064588,http://www.iedb.org/reference/1030809,Literature,27706644,,"Y Liu; Y F Zhang; X L Sun; S Y Liu","Genet Mol Res",2016,"Detection of Jaagsiekte sheep retrovirus in the peripheral blood during the pre-clinical period of ovine pulmonary adenomatosis.",http://www.iedb.org/epitope/569701,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,"JSRV- Env(572-615)",,,572,615,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"5 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,,572,615,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"Four doses of 100 ug, administered at 2-week intervals..",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously with the peptide emulsified with isopycnic complete Freund’s adjuvant in the first immunization. The incomplete Freund’s adjuvant was used in the two subsequent booster shots at 2-week intervals. A final tail intravenous immunization with the peptide alone was administered 3 days before cell fusion. Splenocytes were used to create the epitope-specific hybridomas.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The eptiope-specific hybridoma reacted with the antigen.","Ascitic Fluid","Entire Antibody",Monoclonal,8E5,IgG2a,Kappa,,Epitope,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,,572,615,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746
http://www.iedb.org/assay/3064589,http://www.iedb.org/reference/1030809,Literature,27706644,,"Y Liu; Y F Zhang; X L Sun; S Y Liu","Genet Mol Res",2016,"Detection of Jaagsiekte sheep retrovirus in the peripheral blood during the pre-clinical period of ovine pulmonary adenomatosis.",http://www.iedb.org/epitope/569701,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,"JSRV- Env(572-615)",,,572,615,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"5 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGDDP,,572,615,,"env protein",http://www.ncbi.nlm.nih.gov/protein/AKE78834.1,"Env polyprotein",http://www.uniprot.org/uniprot/A0A0F6UUH9,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"Four doses of 100 ug, administered at 2-week intervals..",,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were injected subcutaneously with the peptide emulsified with isopycnic complete Freund’s adjuvant in the first immunization. The incomplete Freund’s adjuvant was used in the two subsequent booster shots at 2-week intervals. A final tail intravenous immunization with the peptide alone was administered 3 days before cell fusion. Splenocytes were used to create the epitope-specific hybridomas.","Figures 4 and 6",immunohistochemistry,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001998,Positive,,,,,,"The epitope specific hybridoma reacted with the JSRV infected sheep lung tissues.","Ascitic Fluid","Entire Antibody",Monoclonal,8E5,IgG2a,Kappa,,"Source Organism",Organism,"Jaagsiekte sheep retrovirus (Endogenous Jaagziekte retrovirus)",,,,,,,,,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746,"Jaagsiekte sheep retrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11746
http://www.iedb.org/assay/3264592,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606856,"Linear peptide",NMPRAVLLLNK,"Env (381-391)",,,381,391,,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Rattus norvegicus Wistar",https://ontology.iedb.org/ontology/ONTIE_0000905,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,Env,pBC-Env,,,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Rats were immunized with the CMV immediate early promoter-driven expression plasmid pBCEnv, encoding the full-length Env protein of the FFV FUV serotype. The plasmid DNA was coated on gold particles (3ug DNA/mg gold) and used for three successive ballistic immunizations (3X 1ug DNA per treatment). Booster immunizations were performed at a 3-week interval and final antisera were obtained 21 days after the last injection.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from rats immunized with pDNA encoding the whole protein.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NMPRAVLLLNK,,381,391,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264593,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606779,"Linear peptide",IWKKNYTLSSVLAEC,"Env (485-499)",,,485,499,,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IWKKNYTLSSVLAEC,,485,499,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264595,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606655,"Linear peptide",EDIHLVPEKVPLKMRMRYRCYTL,"Env (36-59)",,,37,59,,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus. The epitope was also recognized by sera from free-ranging North American pumas naturally infected with the FFVpc, which is highly related to FFV from domestic cats.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EDIHLVPEKVPLKMRMRYRCYTL,,37,59,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264596,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606998,"Linear peptide",WKEAITHPGPVLSWQVTNSHVTMGGNT,"Env (92-119)",,,93,119,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAD92801.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus. The epitope was recognized by sera from cats naturally-infected with the virus. The epitope was also recognized by sera from free-ranging North American pumas naturally infected with the FFVpc, which is highly related to FFV from domestic cats.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WKEAITHPGPVLSWQVTNSHVTMGGNT,,93,119,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAD92801.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264597,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606842,"Linear peptide",MKVIRKTARCIPYNVKQTRNLNT,"Env (668-691)",,,667,689,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAD92801.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",MKVIRKTARCIPYNVKQTRNLNT,,667,689,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/CAD92801.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264598,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606597,"Linear peptide",ARAKAELLRLDLHEGDYPEWLQLLGEATKDVWPTISNFVSGIG,"Env (888-930)",,,888,930,,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus. This epitope was also weakly recognized by sera from free-ranging pumas naturally-infected with FFVpc, which is closely related to FFV.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ARAKAELLRLDLHEGDYPEWLQLLGEATKDVWPTISNFVSGIG,,888,930,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264599,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606597,"Linear peptide",ARAKAELLRLDLHEGDYPEWLQLLGEATKDVWPTISNFVSGIG,"Env (888-930)",,,888,930,,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cat 8014 was experimentally infected with FFV serotype FUV.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from an experimentally FFV (FUV)-infected (positive control) cat.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ARAKAELLRLDLHEGDYPEWLQLLGEATKDVWPTISNFVSGIG,,888,930,,"hypothetical protein FFV_gp1",http://www.ncbi.nlm.nih.gov/protein/NP_056915.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3264600,http://www.iedb.org/reference/1031655,Literature,28355125,,"Michael Mühle; Anne Bleiholder; Martin Löchelt; Joachim Denner","Viral Immunol",2017,"Epitope Mapping of the Antibody Response Against the Envelope Proteins of the Feline Foamy Virus.",http://www.iedb.org/epitope/606945,"Linear peptide",SVQCYNNDMCYYRPLYDGTENTE,"Env (441-463)",,,441,463,,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Feline foamy virus (Feline syncytial virus)",,,,,,,,,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera were from 23 well-characterized naturally FFV-infected cats, previously tested positive by PCR, and ELISA-based screening for antibodies using recombinant Gag, Bet, and TM proteins or western blot analysis using FFV-infected cells as antigen.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The epitope was recognized by sera from cats naturally-infected with the virus. A significant correlation was found between binding reactivity to individual peptides and FFV-FUV neutralization activity.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SVQCYNNDMCYYRPLYDGTENTE,,441,463,,Env,http://www.ncbi.nlm.nih.gov/protein/AGC11914.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/O56861,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182,"Feline foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_53182
http://www.iedb.org/assay/3466827,http://www.iedb.org/reference/1031978,Literature,28698047,,"Wiaam O A Khairy; Lin Wang; Xue Tian; Jianqiang Ye; Kun Qian; Hongxia Shao; Aijian Qin","Virus Res",2017,"Identification of a novel linear B-cell epitope in the p27 of Avian leukosis virus.",http://www.iedb.org/epitope/657081,"Linear peptide",CFRQKSQPDI,"ALV-p27 (193-202)",,,431,440,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"The epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSESFVDFANRLIKAVEGSDLPPSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKTAPLTDQGIAAA,p27,399,478,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,intraperitoneal,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with recombinant ALV p27 protein. Spleen cells were fused with SP2/0 myeloma cells to generate hybridomas, which were screen by IFA and indirect ELISA.","Figures 2 and 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope recognized by mAb 5D3 was determined by analysis of binding to overlapping peptides from p27. The epitope was determined to be the minimal peptide bound by mAb 5D3. Deletion of the N-terminal Cys or C-terminal Ile residues abrogated binding by the mAb.","Purified Immunoglobulin","Entire Antibody",Monoclonal,5D3,IgG1,,,Epitope,"Linear peptide",CFRQKSQPDI,,431,440,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/3466828,http://www.iedb.org/reference/1031978,Literature,28698047,,"Wiaam O A Khairy; Lin Wang; Xue Tian; Jianqiang Ye; Kun Qian; Hongxia Shao; Aijian Qin","Virus Res",2017,"Identification of a novel linear B-cell epitope in the p27 of Avian leukosis virus.",http://www.iedb.org/epitope/657081,"Linear peptide",CFRQKSQPDI,"ALV-p27 (193-202)",,,431,440,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"The epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSESFVDFANRLIKAVEGSDLPPSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKTAPLTDQGIAAA,p27,399,478,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,intraperitoneal,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with recombinant ALV p27 protein. Spleen cells were fused with SP2/0 myeloma cells to generate hybridomas, which were screen by IFA and indirect ELISA.","Figure 1","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb 5D3 recognized ALV-p27 on Western blots.","Purified Immunoglobulin","Entire Antibody",Monoclonal,5D3,IgG1,,,"Fragment of Source Antigen","Linear peptide",MPVVIKTEGPAWTPLEPKLITRLADTVRTKGLRSPITMAEVEALMSSPLLPHDVTNLMRVILGPAPYALWMDAWGVQLQTVIAAATRDPRHPANGQGRGERTNLDRLKGLADGMVGNPQGQAALLRPGELVAITASALQAFREVARLAEPAGPWADITQGPSESFVDFANRLIKAVEGSDLPPSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKTAPLTDQGIAAA,p27,239,478,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/3466829,http://www.iedb.org/reference/1031978,Literature,28698047,,"Wiaam O A Khairy; Lin Wang; Xue Tian; Jianqiang Ye; Kun Qian; Hongxia Shao; Aijian Qin","Virus Res",2017,"Identification of a novel linear B-cell epitope in the p27 of Avian leukosis virus.",http://www.iedb.org/epitope/657081,"Linear peptide",CFRQKSQPDI,"ALV-p27 (193-202)",,,431,440,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"The epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",PSESFVDFANRLIKAVEGSDLPPSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKTAPLTDQGIAAA,p27,399,478,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,intraperitoneal,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with recombinant ALV p27 protein. Spleen cells were fused with SP2/0 myeloma cells to generate hybridomas, which were screen by IFA and indirect ELISA.","Figures 1, 3, S1 and S2","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb 5D3 recognized fragment 173-240 of ALV-p27 on Western blots. The epitope region recognized by mAb 5D3 was determined by first showing the mAb recognized the C-terminal fragment (residues 97-240) and then further refining the reactivity on Western blots to fragment 173-240.","Purified Immunoglobulin","Entire Antibody",Monoclonal,5D3,IgG1,,,"Fragment of Source Antigen","Linear peptide",IKAVEGSDLPPSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKTAPLTDQGIAAA,"p27 (173-240)",411,478,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/3466852,http://www.iedb.org/reference/1031984,Literature,28539445,,"Guiqing Hu; Jun Liu; Kenneth H Roux; Kenneth A Taylor","J Virol",2017,"Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.",http://www.iedb.org/epitope/693629,"Discontinuous peptide","G322, D323, I324, R325, H328","Epitope of mAb 36D5 on SIV Env",,,,,,,"gp160 envelope glycoprotein [Simian-Human immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ANG65466.1,,,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667,"The epitope residues were calculated from [PDB: 3JCB] as the antigen residues at 4Å atomic distance from the antibody.",,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gp160 envelope glycoprotein [Simian-Human immunodeficiency virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ANG65466.1,,,,,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667,";Freund's complete;Freund's incomplete (IFA);",intradermal,"3 doses of 50 µg at 4-week intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the monoclonal antibody was previously described in the cited reference: Edinger et al. (2000) J Virol 74(17): 7922-7935 [PMID: 10933700]. Mice were immunized intradermally with 50 μg of SIV CP-MAC soluble gp140 oligomers three times at 4-week intervals, with a final boost 4 days before hybridoma fusion. The first immunization was done in Freund's complete adjuvant; incomplete Freund's adjuvant was used for subsequent immunizations. Splenocytes from a one animal were harvested and cells were fused with SP2 myeloma cells. Hybridomas were screened for reactivity with sgp140 by ELISA. The Env protein of CP-MAC, a lab-adapted variant of SIVmacBK28, was chosen because of its highly stable gp120/gp41 association.","Figures 2, 3, 4 and PDB 3JCB","electron microscopy","3D structure",,http://purl.obolibrary.org/obo/OBI_0001646,Positive,,,,,,"The epitope of mAb 36D5 on the human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus (SIV) envelope spike (Env) was determined by cryo-electron tomography analysis of the complex.","Purified Immunoglobulin","Entire Antibody",Monoclonal,36D5,,,3JCB,"Source Antigen",Protein,"gp160 envelope glycoprotein [Simian-Human immunodeficiency virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ANG65466.1,,,,,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667,"Simian-Human immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_57667
http://www.iedb.org/assay/3786317,http://www.iedb.org/reference/1032428,Literature,29102104,,"Wiaam O A Khairy; Kun Qian; Hongxia Shao; Jianqiang Ye; Aijian Qin","Vet Microbiol",2017,"Identification of two conserved B-cell epitopes in the gp90 of reticuloendothelial virus using peptide microarray.",http://www.iedb.org/epitope/732771,"Linear peptide",YHPLA,"REV gp90 (216-220)",,,216,220,,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein [Reticuloendotheliosis virus]","REV-HA1101 gp90",,,http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 1",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The mAb bound overlapping peptides to map its epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,6C12,IgG1,,,"Other Structure from Source Organism","Linear peptide",EEIIRHSYPSVQYHP,,204,218,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/3786318,http://www.iedb.org/reference/1032428,Literature,29102104,,"Wiaam O A Khairy; Kun Qian; Hongxia Shao; Jianqiang Ye; Aijian Qin","Vet Microbiol",2017,"Identification of two conserved B-cell epitopes in the gp90 of reticuloendothelial virus using peptide microarray.",http://www.iedb.org/epitope/700883,"Linear peptide",DPQTSDILEA,"REV gp90 (230-239)",,,230,239,,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein [Reticuloendotheliosis virus]","REV-HA1101 gp90",,,http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive,,,,,,"The mAb bound overlapping peptides to map its epitope.","Purified Immunoglobulin","Entire Antibody",Monoclonal,09980,IgG1,,,"Other Structure from Source Organism","Linear peptide",QTSDILEATHQVLNA,,232,246,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/3786320,http://www.iedb.org/reference/1032428,Literature,29102104,,"Wiaam O A Khairy; Kun Qian; Hongxia Shao; Jianqiang Ye; Aijian Qin","Vet Microbiol",2017,"Identification of two conserved B-cell epitopes in the gp90 of reticuloendothelial virus using peptide microarray.",http://www.iedb.org/epitope/732771,"Linear peptide",YHPLA,"REV gp90 (216-220)",,,216,220,,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein [Reticuloendotheliosis virus]","REV-HA1101 gp90",,,http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,6C12,IgG1,,,Epitope,"Linear peptide",YHPLA,,216,220,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/3786321,http://www.iedb.org/reference/1032428,Literature,29102104,,"Wiaam O A Khairy; Kun Qian; Hongxia Shao; Jianqiang Ye; Aijian Qin","Vet Microbiol",2017,"Identification of two conserved B-cell epitopes in the gp90 of reticuloendothelial virus using peptide microarray.",http://www.iedb.org/epitope/700883,"Linear peptide",DPQTSDILEA,"REV gp90 (230-239)",,,230,239,,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"env protein [Reticuloendotheliosis virus]","REV-HA1101 gp90",,,http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,,,,,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Purified Immunoglobulin","Entire Antibody",Monoclonal,09980,IgG1,,,Epitope,"Linear peptide",DPQTSDILEA,,230,239,,"env protein [Reticuloendotheliosis virus]",http://www.ncbi.nlm.nih.gov/protein/AGS83376.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/B7U6K9,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636,"Reticuloendotheliosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11636
http://www.iedb.org/assay/3924431,http://www.iedb.org/reference/1033208,Literature,29757587,,"Parvin Mosadeghi; Hafez Heydari-Zarnagh","Iran J Allergy Asthma Immunol",2018,"Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.",http://www.iedb.org/epitope/767118,"Linear peptide",AAQNRRGLDLLFWEQGGLCKALQEQC,H1,,,375,400,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Iran,http://purl.obolibrary.org/obo/GAZ_00004474,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Sera from pooled human T-lymphotropic virus type I (HTLV-I) positive sera bound the chimeric peptide in ELISA. The peptide alone was also positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AAQNRRGLDLLFWEQGGLCKALQEQC,H1-GSGGSG-H2,375,400,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/3924432,http://www.iedb.org/reference/1033208,Literature,29757587,,"Parvin Mosadeghi; Hafez Heydari-Zarnagh","Iran J Allergy Asthma Immunol",2018,"Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.",http://www.iedb.org/epitope/767252,"Linear peptide",IWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWK,H2,,,173,207,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Iran,http://purl.obolibrary.org/obo/GAZ_00004474,,,,"Occurrence of infectious disease","human T-lymphotropic virus 1 carrier",https://ontology.iedb.org/ontology/ONTIE_0003426,Unknown,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)",,,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"Sera from pooled human T-lymphotropic virus type I (HTLV-I) positive sera bound the chimeric peptide in ELISA. The peptide alone was also positive.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IWFLNTEPSQLPPTAPPLLPHSNLDHILEPSIPWK,H2-GSGGSG-H1,173,207,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAU04921.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/4570863,http://www.iedb.org/reference/1033780,Literature,30257680,,"Kun Qian; Xue Tian; Hongxia Shao; Jianqiang Ye; Yongxiu Yao; Venugopal Nair; Aijian Qin","BMC Vet Res",2018,"Identification of novel B-cell epitope in gp85 of subgroup J avian leukosis virus and its application in diagnosis of disease.",http://www.iedb.org/epitope/841271,"Linear peptide",WDPQEL,"mAb JE9",,,83,88,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Epitope was deduced.",,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein",,,,http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The mAb was generated by fusing NS1 myeloma cells and spleen cells from mice immunized with the recombinant baculoviruses expressing gp85. Details were not provided.","Figure 1, Tables 1, 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The mAb JE9 was tested in western blot against truncated versions of peptides spanning the protein, and then the epitope was deduced from the binding analysis against 11- to 20-mers by ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,JE9,IgG,,,"Fragment of Source Antigen","Linear peptide",WDPQELDILGSQ,3p-2-2,83,94,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAG24904.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/4570867,http://www.iedb.org/reference/1033780,Literature,30257680,,"Kun Qian; Xue Tian; Hongxia Shao; Jianqiang Ye; Yongxiu Yao; Venugopal Nair; Aijian Qin","BMC Vet Res",2018,"Identification of novel B-cell epitope in gp85 of subgroup J avian leukosis virus and its application in diagnosis of disease.",http://www.iedb.org/epitope/841175,"Linear peptide",QALNTTLPWDPQELDILGSQ,"ALV gp85 (75-94)",,,75,94,,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,"Environmental exposure to endemic/ubiquitous agent without evidence for disease",,,,"Source Organism",Organism,"Avian leukosis virus (Avian leukosis viruses)",,,,,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Sera from different chicken farms with the eradication program of ALV being conducted in Jiangsu and Shandong Province in China were used to evaluate the diagnostic ELISA.","Table 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,240,49,20.4,"Chicken sera were tested for reactivity against the peptide ELISA. This epitope-based ELISA was more sensitive for ALV-J antibody than current serological method for ALV-J in IDEXX ELISA.",Serum,"Entire Antibody",Polyclonal,,IgY,,,Epitope,"Linear peptide",QALNTTLPWDPQELDILGSQ,,75,94,,"surface glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ADM72957.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/5045255,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/64602,"Linear peptide",TKKPNRNGGGYYSASYSDPCSL,"gp46 (89-110)",,,89,110,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,38,41.8,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045257,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/38346,"Linear peptide",LNTEPSQLPPTAPPLLPHSNLDHI,"gp46 (176-199)",,,176,199,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,71,73.2,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045258,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/37660,"Linear peptide",LLPHSNLDHILEPSIPWKSK,"gp46 (190-209)",,,190,209,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,39,42.9,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045259,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/37661,"Linear peptide",LLPHSNLDHILEPSIPWKSKLLT,"gp46 (190-212)",,,190,212,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,84,86.6,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045260,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/58884,"Linear peptide",SKLLTLVQLTLQSTNYTCIVCID,"gp46 (209-231)",,,208,230,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,67,32,47.8,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045261,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/94590,"Linear peptide",LLTLVQLTLQSTNYTCIVCIDRA,"gp46 (211-233)",,,210,232,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,33,6,18.2,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045262,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/75984,"Linear peptide",YTCIVCIDRASLSTWHVLYSP,"gp46 (224-244)",,,223,243,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,79,81.4,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045263,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/39726,"Linear peptide",LSTWHVLYSPNVSVPSSSSTPLL,"gp46 (235-257)",,,234,256,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,33,8,24.2,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045264,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/69909,"Linear peptide",VLYSPNVSVPSSSSTPLLYPSLA,"gp46 (240-262)",,,239,261,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,81,89,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045265,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/73133,"Linear peptide",WTHCFDPQIQAIVSSPCHNSLIL,"gp46 (274-296)",,,273,295,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,54,55.7,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045266,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/61260,"Linear peptide",SSPCHNSLILPPFSLSPVPTLGSRS,"gp46 (287-311)",,,286,310,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,33,9,27.3,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045267,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/45894,"Linear peptide",NSLILPPFSLSPVPTLGSRSRRA,"gp46 (292-314)",,,291,313,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,76,78.4,,Serum,"Entire Antibody",Polyclonal,,,,,"Fragment of Source Antigen","Linear peptide",TKKPNRNGGGYYSASYSDPCSL,,89,110,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045449,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/94690,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,"gp21 (346-368)",,,345,367,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,81,30,37,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",SLLHEVDKDISQLTQAIVKNHKN,,345,367,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045450,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/94530,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,"gp21 (382-404)",,,381,404,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,97,57,58.8,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",GLDLLFWEQGGLCKALQEQCRFPN,,381,404,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5045451,http://www.iedb.org/reference/1006804,Literature,1712105,,"P Horal; W W Hall; B Svennerholm; J Lycke; S Jeansson; L Rymo; M H Kaplan; A Vahlne","Proc Natl Acad Sci U S A",1991,"Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.",http://www.iedb.org/epitope/94658,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,"gp21 (467-489)",,,466,488,,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of infectious disease","tropical spastic paraparesis",http://purl.obolibrary.org/obo/DOID_321,Chronic,"Source Organism",Organism,"Human T-cell leukemia virus type I (Human T cell leukemia virus type 1)","Human T-lymphotropic virus 1",,,,,,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"HTLV-1 sera were included in a collection of 97 samples from different geographic areas and included samples from patients with adult T-cell leukemia (n= 25) and HTLV-1-associated myelopathy/tropical spastic paraparesis (n=46) and asymptomatic carriers (n=26).","Table 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,91,65,71.4,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",QLRHLPSRVRYPHYSLIKPESSL,,466,488,,"Envelope glycoprotein gp62 precursor",http://www.ncbi.nlm.nih.gov/protein/P03381.1,"Envelope glycoprotein gp62",http://www.uniprot.org/uniprot/P14075,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/5566965,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,N96-V110,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 1, 2, 3, 6, 7, and 8 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,16,84.2,"Amino acids D3, I4, G8, V10, I11, and W13 were identified as critical residues by alanine scan and deletion mutants.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566966,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,S91-V105,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 60 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566967,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,V110-V115,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 60 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566975,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,N96-V110,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566976,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,N96-V110,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,4,66.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566987,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922932,"Linear peptide",NRDIQVLGPVIDWNV,"chimpanzee SFVpve",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 6 abd Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDIQVLGPVIDWNV,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566988,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922932,"Linear peptide",NRDIQVLGPVIDWNV,"chimpanzee SFVpve",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,7,87.5,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDIQVLGPVIDWNV,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566989,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922932,"Linear peptide",NRDIQVLGPVIDWNV,"chimpanzee SFVpve",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,2,33.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDIQVLGPVIDWNV,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/NP_056804.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566990,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922920,"Linear peptide",NKDIQVLGPVIDWNA,"gorilla SFV ggo_huBAK82",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNA,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566991,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922920,"Linear peptide",NKDIQVLGPVIDWNA,"gorilla SFV ggo_huBAK82",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNA,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566992,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922920,"Linear peptide",NKDIQVLGPVIDWNA,"gorilla SFV ggo_huBAK82",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,4,66.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNA,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566993,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922927,"Linear peptide",NQDIQVYGPVIDWNI,"Orangutan SFV ppy",,,96,110,,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figure 5 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NQDIQVYGPVIDWNI,,96,110,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193
http://www.iedb.org/assay/5566994,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922927,"Linear peptide",NQDIQVYGPVIDWNI,"Orangutan SFV ppy",,,96,110,,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NQDIQVYGPVIDWNI,,96,110,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193
http://www.iedb.org/assay/5566995,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922927,"Linear peptide",NQDIQVYGPVIDWNI,"Orangutan SFV ppy",,,96,110,,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,3,50,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NQDIQVYGPVIDWNI,,96,110,,"envelope glycoprotein [Simian foamy virus Pongo pygmaeus pygmaeus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508889.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/Q7SIS5,"Simian foamy virus Pongo pygmaeus pygmaeus",http://purl.obolibrary.org/obo/NCBITaxon_221703,"Bornean orangutan simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170193
http://www.iedb.org/assay/5566996,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922923,"Linear peptide",NKDITVLGPVIDWNV,"Mandril SFV msp",,,96,110,,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5, 6, and 7 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,13,68.4,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVLGPVIDWNV,,96,110,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566997,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922923,"Linear peptide",NKDITVLGPVIDWNV,"Mandril SFV msp",,,96,110,,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVLGPVIDWNV,,96,110,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566998,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922923,"Linear peptide",NKDITVLGPVIDWNV,"Mandril SFV msp",,,96,110,,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,3,50,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVLGPVIDWNV,,96,110,,"Env [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AZS32943.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Mandrillus leucophaeus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_288118,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5566999,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922915,"Linear peptide",NKDIAVFGPVIDWNV,"Orangutan SFV mcy_FV21",,,92,106,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figure 5 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIAVFGPVIDWNV,,92,106,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5567000,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922915,"Linear peptide",NKDIAVFGPVIDWNV,"Orangutan SFV mcy_FV21",,,92,106,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIAVFGPVIDWNV,,92,106,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5567001,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922915,"Linear peptide",NKDIAVFGPVIDWNV,"Orangutan SFV mcy_FV21",,,92,106,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,4,66.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIAVFGPVIDWNV,,92,106,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AAA47794.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5567002,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922924,"Linear peptide",NKDIVTLGPVIDWNV,"Ceropithecus SFV cni_huAG16",,,96,110,,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIVTLGPVIDWNV,,96,110,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197
http://www.iedb.org/assay/5567003,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922924,"Linear peptide",NKDIVTLGPVIDWNV,"Ceropithecus SFV cni_huAG16",,,96,110,,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,7,87.5,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIVTLGPVIDWNV,,96,110,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197
http://www.iedb.org/assay/5567004,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922924,"Linear peptide",NKDIVTLGPVIDWNV,"Ceropithecus SFV cni_huAG16",,,96,110,,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,1,16.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIVTLGPVIDWNV,,96,110,,"env protein [Guenon simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98100.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/K7YEX3,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197,"Guenon simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170197
http://www.iedb.org/assay/5567005,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922922,"Linear peptide",NKDITVFGPVIDWNV,"Chlorocebus SFV cae_Hu1",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figure 5 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,8,88.9,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567006,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922922,"Linear peptide",NKDITVFGPVIDWNV,"Chlorocebus SFV cae_Hu1",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567007,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922922,"Linear peptide",NKDITVFGPVIDWNV,"Chlorocebus SFV cae_Hu1",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,3,50,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDITVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567008,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922930,"Linear peptide",NRDINVFGPVIDWNV,"Chlorocebus SFV cae_LK3",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5, 6, and 7 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,13,68.4,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567009,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922930,"Linear peptide",NRDINVFGPVIDWNV,"Chlorocebus SFV cae_LK3",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567010,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922930,"Linear peptide",NRDINVFGPVIDWNV,"Chlorocebus SFV cae_LK3",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,3,50,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDWNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567011,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922929,"Linear peptide",NRDINVFGPVIDRNV,"Chlorocebus SFV cae_agm22",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,2,10.5,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDRNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567012,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922929,"Linear peptide",NRDINVFGPVIDRNV,"Chlorocebus SFV cae_agm22",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDRNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567013,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922929,"Linear peptide",NRDINVFGPVIDRNV,"Chlorocebus SFV cae_agm22",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIDRNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5567014,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922866,"Linear peptide",KQAIITHGAVIDWNQ,"Chlorocebus SFV axx",,,98,112,,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,5,26.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KQAIITHGAVIDWNQ,,98,112,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200
http://www.iedb.org/assay/5567015,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922866,"Linear peptide",KQAIITHGAVIDWNQ,"Chlorocebus SFV axx",,,98,112,,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,8,2,25,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KQAIITHGAVIDWNQ,,98,112,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200
http://www.iedb.org/assay/5567016,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922866,"Linear peptide",KQAIITHGAVIDWNQ,"Chlorocebus SFV axx",,,98,112,,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KQAIITHGAVIDWNQ,,98,112,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200
http://www.iedb.org/assay/5567017,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922960,"Linear peptide",RHAIITPGPVIDWNS,"Chlorocebus SFV cja/sxa",,,98,112,,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 7 and Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,19,7,36.8,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RHAIITPGPVIDWNS,,98,112,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206
http://www.iedb.org/assay/5567018,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922960,"Linear peptide",RHAIITPGPVIDWNS,"Chlorocebus SFV cja/sxa",,,98,112,,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,8,2,25,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RHAIITPGPVIDWNS,,98,112,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206
http://www.iedb.org/assay/5567019,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922960,"Linear peptide",RHAIITPGPVIDWNS,"Chlorocebus SFV cja/sxa",,,98,112,,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,6,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RHAIITPGPVIDWNS,,98,112,,"env protein [Yellow-breasted capuchin simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508583.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A0G3Y5C1,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206,"Yellow-breasted capuchin simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170206
http://www.iedb.org/assay/5567020,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922968,"Linear peptide",RNAITVPGIILDWNS,"Chlorocebus SFV ssc_124",,,97,111,,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Figures 5 and 6 abd Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,9,3,33.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RNAITVPGIILDWNS,,97,111,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201
http://www.iedb.org/assay/5567021,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922968,"Linear peptide",RNAITVPGIILDWNS,"Chlorocebus SFV ssc_124",,,97,111,,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"33 to 71 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Pan troglodytes foamy virus","Chimpanzee simian foamy virus",,,,,,,,"Pan troglodytes foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_298339,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with gorilla chimpanzee foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,8,4,50,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RNAITVPGIILDWNS,,97,111,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201
http://www.iedb.org/assay/5567022,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922968,"Linear peptide",RNAITVPGIILDWNS,"Chlorocebus SFV ssc_124",,,97,111,,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,,"29 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Cercopithecus foamy virus","Cercopithecus foamy virus",,,,,,,,"Cercopithecus foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_399495,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients from Cameroon and Gabon with Cercopithecus simian foamy virus infection.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,6,1,16.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RNAITVPGIILDWNS,,97,111,,"env [Squirrel monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508567.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/D5JWU7,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201,"Squirrel monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170201
http://www.iedb.org/assay/5645284,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922849,"Linear peptide",IQVLGPVIDWNV,I99-V110,,,99,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IQVLGPVIDWNV,,99,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645288,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922949,"Linear peptide",QVLGPVIDWNV,Q100-V110,,,100,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QVLGPVIDWNV,,100,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645289,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922919,"Linear peptide",NKDIQVLGPVID,N96-D107,,,96,107,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVID,,96,107,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645290,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922918,"Linear peptide",NKDIQVLGPVI,N96-I106,,,96,106,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVI,,96,106,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645291,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922917,"Linear peptide",NKDIQVLGPV,N96-V105,,,96,105,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPV,,96,105,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645292,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922920,"Linear peptide",NKDIQVLGPVIDWNA,"N96-A110-ggo huBAK82",,,96,110,,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,9,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNA,,96,110,,"envelope protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/ALJ11194.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/5645293,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922916,"Linear peptide",NKDIAVLGPVIDWNV,N96-A110-mac/N96-A100-V110,,,96,110,,,"env protein [Macaque simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AGM61339.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/R9RWZ9,"Macaque simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338478,"Macaque simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338478,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,9,9,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIAVLGPVIDWNV,,96,110,,"env protein [Macaque simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AGM61339.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/R9RWZ9,"Macaque simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338478,"Macaque simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338478
http://www.iedb.org/assay/5645294,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922931,"Linear peptide",NRDINVFGPVIVRNV,"N96-V100-cae agm22",,,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,9,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NRDINVFGPVIVRNV,,,,,"env protein ",,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P27399,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079,"African green monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_338079
http://www.iedb.org/assay/5645295,http://www.iedb.org/reference/1035034,Literature,30894477,,"Caroline Lambert; Damien Batalie; Thomas Montange; Edouard Betsem; Augustin Mouinga-Ondeme; Richard Njouom; Antoine Gessain; Florence Buseyne","J Virol",2019,"An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.",http://www.iedb.org/epitope/922866,"Linear peptide",KQAIITHGAVIDWNQ,N96-V110-axx,,,98,112,,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Cameroon [ID: GAZ_00001093]",http://purl.obolibrary.org/obo/GAZ_00001093,M,"31 to 73 years",,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)","Gorilla simian foamy virus",,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma was taken from patients with gorilla simian foamy virus infection.","Table 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,9,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KQAIITHGAVIDWNQ,,98,112,,"env [Spider monkey simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/YP_009508562.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A8HC79,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200,"Spider monkey simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170200
http://www.iedb.org/assay/8116010,http://www.iedb.org/reference/1036921,Literature,31759029,,"Ze-Yi Yan; Hong-Mei Li; Cheng-Cheng Wang; Jianhua Qiu; Yao Pan; Dandan Zhang; Weiguo Hu; Hui-Jun Guo","Int J Biol Macromol",2020,"Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope.",http://www.iedb.org/epitope/1074743,"Linear peptide",ATRFLLR,E3,,,219,225,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 0.2 mg followed by boosters at 3, 5, and 7 weeks after the initial immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,"Ascitic Fluid","Entire Antibody",Monoclonal,A18GH,IgG,"Light Isotype n/s",,Epitope,"Linear peptide",ATRFLLR,,219,225,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/8116076,http://www.iedb.org/reference/1036921,Literature,31759029,,"Ze-Yi Yan; Hong-Mei Li; Cheng-Cheng Wang; Jianhua Qiu; Yao Pan; Dandan Zhang; Weiguo Hu; Hui-Jun Guo","Int J Biol Macromol",2020,"Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope.",http://www.iedb.org/epitope/1074743,"Linear peptide",ATRFLLR,E3,,,219,225,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 0.2 mg followed by boosters at 3, 5, and 7 weeks after the initial immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope-specific monoclonal antibody, A18GH, recognized the epitope in cells infected with the ALV-A/K strains, but not in cells infected with the ALV-B/J strains.","Ascitic Fluid","Entire Antibody",Monoclonal,A18GH,IgG,"Light Isotype n/s",,"Source Organism",Organism,"Avian leukosis virus (Avian leukosis viruses)",,,,,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/8116077,http://www.iedb.org/reference/1036921,Literature,31759029,,"Ze-Yi Yan; Hong-Mei Li; Cheng-Cheng Wang; Jianhua Qiu; Yao Pan; Dandan Zhang; Weiguo Hu; Hui-Jun Guo","Int J Biol Macromol",2020,"Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope.",http://www.iedb.org/epitope/1074743,"Linear peptide",ATRFLLR,E3,,,219,225,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"1 dose of 0.2 mg followed by boosters at 3, 5, and 7 weeks after the initial immunization.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific monoclonal antibody, A18GH, bound epitope-containing peptide fragments from the ALV gp85 envelope polyprotein.","Ascitic Fluid","Entire Antibody",Monoclonal,A18GH,IgG,"Light Isotype n/s",,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO34844.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/13846982,http://www.iedb.org/reference/1038772,Literature,33129191,,"Xueyang Chen; Houkun Wang; Xiaowei Fang; Keli Gao; Chun Fang; Yufang Gu; Yulong Gao; Xiaomei Wang; Hongsheng Huang; Xiongyan Liang; Yuying Yang","Vet Immunol Immunopathol",2020,"Identification of a novel epitope specific for Gp85 protein of avian leukosis virus subgroup K.",http://www.iedb.org/epitope/1394295,"Linear peptide",AFGPRSIDTLSDWSRPQ,"Km3 epitope",,,194,210,,,"envelope protein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain HB2018003",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,,,,,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses at 2 week intervals with a final boost of 50 µg intraperitoneally.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope specific mAb recognized DF-1 cells infected with ALV-K strains HB2015032 and HB2018003, but not cells infected with ALV-A or ALV-J.","Purified Immunoglobulin","Entire Antibody",Monoclonal,Km3,IgG1,,,"Source Organism",Organism,"Avian leukosis virus strain HB2018003",,,,,,,,,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/13847018,http://www.iedb.org/reference/1038772,Literature,33129191,,"Xueyang Chen; Houkun Wang; Xiaowei Fang; Keli Gao; Chun Fang; Yufang Gu; Yulong Gao; Xiaomei Wang; Hongsheng Huang; Xiongyan Liang; Yuying Yang","Vet Immunol Immunopathol",2020,"Identification of a novel epitope specific for Gp85 protein of avian leukosis virus subgroup K.",http://www.iedb.org/epitope/1394295,"Linear peptide",AFGPRSIDTLSDWSRPQ,"Km3 epitope",,,194,210,,,"envelope protein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain HB2018003",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,,,,,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses at 2 week intervals with a final boost of 50 µg intraperitoneally.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope specific mAb recognized Gp85 from ALV-K.","Purified Immunoglobulin","Entire Antibody",Monoclonal,Km3,IgG1,,,"Source Antigen",Protein,"envelope protein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,,,,,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/13847019,http://www.iedb.org/reference/1038772,Literature,33129191,,"Xueyang Chen; Houkun Wang; Xiaowei Fang; Keli Gao; Chun Fang; Yufang Gu; Yulong Gao; Xiaomei Wang; Hongsheng Huang; Xiongyan Liang; Yuying Yang","Vet Immunol Immunopathol",2020,"Identification of a novel epitope specific for Gp85 protein of avian leukosis virus subgroup K.",http://www.iedb.org/epitope/1394295,"Linear peptide",AFGPRSIDTLSDWSRPQ,"Km3 epitope",,,194,210,,,"envelope protein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain HB2018003",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope protein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,,,,,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses at 2 week intervals with a final boost of 50 µg intraperitoneally.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope specific mAb recognized the epitope in Gp85 from ALV-K.","Purified Immunoglobulin","Entire Antibody",Monoclonal,Km3,IgG1,,,Epitope,"Linear peptide",AFGPRSIDTLSDWSRPQ,,194,210,,"envelope protein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AKP18449.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus strain HB2018003",https://ontology.iedb.org/taxon/10002414,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/15012842,http://www.iedb.org/reference/1038929,Literature,34116348,,"Houkun Wang; Xueyang Chen; Lilin Zhu; Xiaowei Fang; Keli Gao; Chun Fang; Jing Liu; Yufang Gu; Xiongyan Liang; Yuying Yang","Poult Sci",2021,"Preparation of a novel monoclonal antibody against Avian leukosis virus subgroup J Gp85 protein and identification of its epitope.",http://www.iedb.org/epitope/1397362,"Linear peptide",LIRPYVNQ,"Peptide E",,,150,157,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",WDPQELDILGSQMIKNGTTRTCVTFGSVCYTGNNNSRVCHIFDGNFNGTGGAEAELRDFIEKWKSDDHLIRPYVNQSWTMVSPINIESFSISSRYCGFTSNKTRYFQGNESSWCGSKGGNWSAAYSNGTACSSNTTGCGGNCTAEWNYYAYGFTFRNKSEILWNNGTAK,,82,250,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 µg at a 2 week interval followed by a final booster of 50 µg  without adjuvant 3 days before hybridoma production.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope specific mAb recognized the antigen by western blot.","Ascitic Fluid","Entire Antibody",Monoclonal,J16,IgG1,,,"Fragment of Source Antigen","Linear peptide",LIRPYVNQSWTMVSPINIESFSISSRYCGFTSNKTRYFQGNESSW,,150,194,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/15012843,http://www.iedb.org/reference/1038929,Literature,34116348,,"Houkun Wang; Xueyang Chen; Lilin Zhu; Xiaowei Fang; Keli Gao; Chun Fang; Jing Liu; Yufang Gu; Xiongyan Liang; Yuying Yang","Poult Sci",2021,"Preparation of a novel monoclonal antibody against Avian leukosis virus subgroup J Gp85 protein and identification of its epitope.",http://www.iedb.org/epitope/1397362,"Linear peptide",LIRPYVNQ,"Peptide E",,,150,157,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",WDPQELDILGSQMIKNGTTRTCVTFGSVCYTGNNNSRVCHIFDGNFNGTGGAEAELRDFIEKWKSDDHLIRPYVNQSWTMVSPINIESFSISSRYCGFTSNKTRYFQGNESSWCGSKGGNWSAAYSNGTACSSNTTGCGGNCTAEWNYYAYGFTFRNKSEILWNNGTAK,,82,250,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 µg at a 2 week interval followed by a final booster of 50 µg  without adjuvant 3 days before hybridoma production.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope specific mAb recognized the epitope by western blot.","Ascitic Fluid","Entire Antibody",Monoclonal,J16,IgG1,,,Epitope,"Linear peptide",LIRPYVNQ,,150,157,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/15012844,http://www.iedb.org/reference/1038929,Literature,34116348,,"Houkun Wang; Xueyang Chen; Lilin Zhu; Xiaowei Fang; Keli Gao; Chun Fang; Jing Liu; Yufang Gu; Xiongyan Liang; Yuying Yang","Poult Sci",2021,"Preparation of a novel monoclonal antibody against Avian leukosis virus subgroup J Gp85 protein and identification of its epitope.",http://www.iedb.org/epitope/1397362,"Linear peptide",LIRPYVNQ,"Peptide E",,,150,157,,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",WDPQELDILGSQMIKNGTTRTCVTFGSVCYTGNNNSRVCHIFDGNFNGTGGAEAELRDFIEKWKSDDHLIRPYVNQSWTMVSPINIESFSISSRYCGFTSNKTRYFQGNESSWCGSKGGNWSAAYSNGTACSSNTTGCGGNCTAEWNYYAYGFTFRNKSEILWNNGTAK,,82,250,,"surface glycoprotein, partial",http://www.ncbi.nlm.nih.gov/protein/AIC77142.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",subcutaneous,"3 doses of 100 µg at a 2 week interval followed by a final booster of 50 µg  without adjuvant 3 days before hybridoma production.",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope specific mAb recognized DF-1 cells infected with ALV-J strains HB2015029 and HB2010001, but not cells infected with ALV-A or ALV-K subgroups by immunofluorescence.","Ascitic Fluid","Entire Antibody",Monoclonal,J16,IgG1,,,"Source Organism",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/18917896,http://www.iedb.org/reference/1040594,Literature,35482583,,"Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang","ACS Infect Dis",2022,"Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Q&beta; Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"gp51 peptide 1",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Bos taurus (bovine)",http://purl.obolibrary.org/obo/NCBITaxon_9913,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)","Bovine Leukemia Virus",,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,,Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,,177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/18917897,http://www.iedb.org/reference/1040594,Literature,35482583,,"Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang","ACS Infect Dis",2022,"Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Q&beta; Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"gp51 peptide 1",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"7-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"mQβ-gp51 conjugate 4",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Monophosphoryl lipid A;",subcutaneous,"3 doses of 3 ug at 14 day intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Multiple immunogens were studied all of which had the epitope conjugated to different carriers. The three investigated carriers were: a mutant bacteriophage Qβ-carrier conjugated with an N-terminus homo-bifunctional dinitrophenyl adipate linker (NPL), a mutant bacteriophage Qβ-carrier conjugated with an N-terminus isothiocyanate group (NCS), or the epitope conjugated to keyhole limpet hemocyanin.","Figure 2, 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,5,5,100,"Both mutant bacteriophage Qβ- conjugates had similar results. KHL showed a slightly lower IgG titer. IgG1, IgG2b, IgG2c, IgG3 all had similar titers. The epitope with no carriers or conjugation had IgG titers no different from negative contols. The epitope conjugated to NCS showed the strongest IgG titer at day 539 post-immunization.",Serum,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,,177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/18917898,http://www.iedb.org/reference/1040594,Literature,35482583,,"Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang","ACS Infect Dis",2022,"Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Q&beta; Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"gp51 peptide 1",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"7-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"mQβ-gp51 conjugate 4",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Monophosphoryl lipid A;",subcutaneous,"3 doses of 3 ug at 14 day intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"Multiple immunogens were studied all of which had the epitope conjugated to different carriers. The three investigated carriers were: a mutant bacteriophage Qβ-carrier conjugated with an N-terminus homo-bifunctional dinitrophenyl adipate linker (NPL), a mutant bacteriophage Qβ-carrier conjugated with an N-terminus isothiocyanate group (NCS), or the epitope conjugated to keyhole limpet hemocyanin.","Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,5,0,0,,Serum,"Entire Antibody",Polyclonal,,IgM,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,,177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/18917899,http://www.iedb.org/reference/1040594,Literature,35482583,,"Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang","ACS Infect Dis",2022,"Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Q&beta; Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"gp51 peptide 1",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"7-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"mQβ-gp51 conjugate 4",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Monophosphoryl lipid A;",subcutaneous,"3 doses of 3 ug at 14 day intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was the epitope conjugated to a mutant bacteriophage Qβ-carrier conjugated with an N-terminus isothiocyanate group (NCS).","Figure 4",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Antigen",Protein,"envelope glycoprotein gp51",,,,http://www.ncbi.nlm.nih.gov/protein/1506533A,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/18917902,http://www.iedb.org/reference/1040594,Literature,35482583,,"Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang","ACS Infect Dis",2022,"Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Q&beta; Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.",http://www.iedb.org/epitope/47063,"Linear peptide",PDCAICWEPSPPWAPE,"gp51 peptide 1",,,177,192,,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"7-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",PDCAICWEPSPPWAPE,"mQβ-gp51 conjugate 4",177,192,,"envelope glycoprotein gp51",http://www.ncbi.nlm.nih.gov/protein/1506533A,"Env polyprotein",http://www.uniprot.org/uniprot/Q77YG2,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,";Monophosphoryl lipid A;",subcutaneous,"3 doses of 3 ug at 14 day intervals",,,,,,,,,,,,,,,,,,,,,,,N,,"The immunogen was the epitope conjugated to a mutant bacteriophage Qβ-carrier conjugated with an N-terminus isothiocyanate group (NCS).","Figure 5 and S10","biological activity","secondary in vitro activity",,http://purl.obolibrary.org/obo/OBI_0001704,Positive,,,,,,"The BLV virus was mixed with serum and then added to cell culture of a feline kidney cell line (CC81). Each multinucleated fused cell with more than five nuclei was counted as synctium. Serum from epitope-immunized mice was able to inhibit syncytium compared to serum from non-immunized mice.",Serum,"Entire Antibody",Polyclonal,,IgG,,,"Source Organism",Organism,"Bovine leukemia virus (bovine leukemia virus BLV)",,,,,,,,,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901,"Bovine leukemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11901
http://www.iedb.org/assay/22330254,http://www.iedb.org/reference/1041838,Literature,36643488,,"Xiaochen Zhang; Hongmei Li; Chengcheng Wang; Yixuan Du; Yuying Li; Liwei Zhang; Mengjie Huang; Jianhua Qiu; Huijun Guo","ACS Omega",2023,"Preparation and Biochemical Characteristics of a New IgG-Type Monoclonal Antibody against K Subgroup Avian Leukosis Virus.",http://www.iedb.org/epitope/2157552,"Linear peptide",RRNYT,"Epitope of mAb 30B9",,,217,221,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]","ALV-K gp85",,,http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 200μg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"6-week-old Balb/c mice were injected intraperitoneally with 200μg ALV-K gp85, with complete Freund's adjuvant, followed by booster immunizations every other week for a total of three immunizations.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific antibody 30B9 bound Avian leukosis virus strain K envelope protein (gp85) as shown by ELISA and western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,30B9,IgG2b,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]","ALV-k gp85",,,http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22330257,http://www.iedb.org/reference/1041838,Literature,36643488,,"Xiaochen Zhang; Hongmei Li; Chengcheng Wang; Yixuan Du; Yuying Li; Liwei Zhang; Mengjie Huang; Jianhua Qiu; Huijun Guo","ACS Omega",2023,"Preparation and Biochemical Characteristics of a New IgG-Type Monoclonal Antibody against K Subgroup Avian Leukosis Virus.",http://www.iedb.org/epitope/2157552,"Linear peptide",RRNYT,"Epitope of mAb 30B9",,,217,221,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]","ALV-K gp85",,,http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 200μg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"6-week-old Balb/c mice were injected intraperitoneally with 200μg ALV-K gp85, with complete Freund's adjuvant, followed by booster immunizations every other week for a total of three immunizations.","Figures  5 and 6",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope specific antibody 30B9 bound fragment 217-221 (and larger overlapping fragments), of Avian leukosis virus strain K envelope protein (gp85), as shown by ELISA and western blot.","Purified Immunoglobulin","Entire Antibody",Monoclonal,30B9,IgG2b,,,Epitope,"Linear peptide",RRNYT,gp85-3-7,217,221,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22330260,http://www.iedb.org/reference/1041838,Literature,36643488,,"Xiaochen Zhang; Hongmei Li; Chengcheng Wang; Yixuan Du; Yuying Li; Liwei Zhang; Mengjie Huang; Jianhua Qiu; Huijun Guo","ACS Omega",2023,"Preparation and Biochemical Characteristics of a New IgG-Type Monoclonal Antibody against K Subgroup Avian Leukosis Virus.",http://www.iedb.org/epitope/2157552,"Linear peptide",RRNYT,"Epitope of mAb 30B9",,,217,221,,,"envelope polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,"Envelope glycoprotein gp95",http://www.uniprot.org/uniprot/P0DTM4,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,,"6 weeks",,"Administration in vivo",,,,"Source Antigen",Protein,"envelope polyprotein [Avian leukosis virus]","ALV-K gp85",,,http://www.ncbi.nlm.nih.gov/protein/AIL52056.1,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,";Freund's complete;Freund's incomplete (IFA);",intraperitoneal,"3 doses of 200μg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,N,,"6-week-old Balb/c mice were injected intraperitoneally with 200μg ALV-K gp85, with complete Freund's adjuvant, followed by booster immunizations every other week for a total of three immunizations.","Figure 4","immuno staining","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001652,Positive,,,,,,"The epitope specific antibody 30B9 bound Avian leukosis virus strain K isolate JS11c1 but did not bind ALV of other strains, including ALV-A (SDAU09C1 strain), ALV-B (SDAU09C2 strain), or ALV-J (NX0101 strain).","Purified Immunoglobulin","Entire Antibody",Monoclonal,30B9,IgG2b,,,"Source Organism",Organism,"Avian leukosis virus (Avian leukosis viruses)","ALV-K-JS11c1 strain",,,,,,,,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22464528,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218545,"Linear peptide",PSEELIADQCPLPGYHAGVEYTTQ,BAD468-247,,,247,270,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,"Positive plasma was from an individual infected with GI and GII.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PSEELIADQCPLPGYHAGVEYTTQ,,247,270,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464529,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218587,"Linear peptide",YTTQAIWDYYIKVEITRP,BAD468-267,,,267,284,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YTTQAIWDYYIKVEITRP,,267,284,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464530,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218482,"Linear peptide",EITRPKNWTSYAQYGNARLGS,BAD468-280,,,280,300,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EITRPKNWTSYAQYGNARLGS,,280,300,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464531,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218552,"Linear peptide",RKNFTHVLFCSDQLYAKWYNIENTLLKNEE,BAD468-308,,,308,337,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RKNFTHVLFCSDQLYAKWYNIENTLLKNEE,,308,337,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464532,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218486,"Linear peptide",ENTLLKNEELLQKK,BAD468-329,,,329,342,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ENTLLKNEELLQKK,,329,342,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464533,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218532,"Linear peptide",LQKKLNNLTELTSLLKKR,BAD468-340,,,339,356,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LQKKLNNLTELTSLLKKR,,339,356,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464534,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218574,"Linear peptide",TSLLKKRALPRTWTTQGKNNLFRNI,BAD468-350,,,350,374,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",TSLLKKRALPRTWTTQGKNNLFRNI,,350,374,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464535,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218580,"Linear peptide",WEGDCNYTKDKISEIVPQCK,BAD468-399,,,399,418,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,"Positive plasma was from an individual infected with GI.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WEGDCNYTKDKISEIVPQCK,,399,418,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464536,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218559,"Linear peptide",SEIVPQCKGFYNNSKWMHMHPY,BAD468-411,,,411,432,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SEIVPQCKGFYNNSKWMHMHPY,,411,432,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464537,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218563,"Linear peptide",SKWMHMHPYACRFWRNKNEKE,BAD468-425,,,424,444,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SKWMHMHPYACRFWRNKNEKE,,424,444,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464538,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218551,"Linear peptide",RFWRNKNEKEETKCDGRDDN,BAD468-435,,,435,454,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RFWRNKNEKEETKCDGRDDN,,435,454,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464539,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218540,"Linear peptide",NEKEETKCDGRDDNKCLYYP,BAD468-441,,,441,460,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,3,17.6,"Positive plasma was from an individual infected with GII and two individuals infected with GI and GII.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NEKEETKCDGRDDNKCLYYP,,441,460,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464540,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218498,"Linear peptide",GRDDNKCLYYPLWDSPEATYDFG,BAD468-450,,,450,472,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GRDDNKCLYYPLWDSPEATYDFG,,450,472,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464541,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218567,"Linear peptide",SSKQIRQQDYEVYSIYQECKLASRIH,BAD468-487,,,487,512,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,"Positive plasma was from an individual infected with GI.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SSKQIRQQDYEVYSIYQECKLASRIH,,487,512,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464542,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218544,"Linear peptide",PNEGLIADQCPLPGLADVSFYPYQ,BAK74-247,,,247,270,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PNEGLIADQCPLPGLADVSFYPYQ,,247,270,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464543,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218586,"Linear peptide",YPYQAIWDYYAKIENIRP,BAK74-267,,,267,284,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",YPYQAIWDYYAKIENIRP,,267,284,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464544,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218485,"Linear peptide",ENIRPANWTSSKLYGKARMGS,BAK74-280,,,280,300,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ENIRPANWTSSKLYGKARMGS,,280,300,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464545,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218556,"Linear peptide",RNINNTHILFCSDVLYSKWYNLQNSILQNEN,BAK74-308,,,308,338,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RNINNTHILFCSDVLYSKWYNLQNSILQNEN,,308,338,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464546,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218547,"Linear peptide",QNSILQNENELTKRLSNLT,BAK74-330,,,330,348,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",QNSILQNENELTKRLSNLT,,330,348,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464547,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218483,"Linear peptide",ELTKRLSNLTIGNKLKN,BAK74-339,,,339,355,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ELTKRLSNLTIGNKLKN,,339,355,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464548,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218497,"Linear peptide",GNKLKNRALPYEWAKGGLNRLFRNI,BAK74-350,,,350,374,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",GNKLKNRALPYEWAKGGLNRLFRNI,,350,374,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464549,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218579,"Linear peptide",WEGDCNITRYNVNETVPECK,BAK74-399,,,399,418,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,2,11.8,"Positive plasma were from individuals infected with GI.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",WEGDCNITRYNVNETVPECK,,399,418,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464550,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218541,"Linear peptide",NETVPECKDFPHRRFNDHPY,BAK74-411,,,411,430,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NETVPECKDFPHRRFNDHPY,,411,430,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464551,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218557,"Linear peptide",RRFNDHPYSCRLWRYREGKE,BAK74-425,,,423,442,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RRFNDHPYSCRLWRYREGKE,,423,442,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464552,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218554,"Linear peptide",RLWRYREGKEEVKCLTSDHTR,BAK74-435,,,433,453,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RLWRYREGKEEVKCLTSDHTR,,433,453,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464553,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218550,"Linear peptide",REGKEEVKCLTSDHTRCLYYP,BAK74-441,,,438,458,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",REGKEEVKCLTSDHTRCLYYP,,438,458,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464554,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218558,"Linear peptide",SDHTRCLYYPEYSNPEALFDFG,BAK74-449,,,449,470,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SDHTRCLYYPEYSNPEALFDFG,,449,470,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464555,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218488,"Linear peptide",ESTSIRQQDYEVYSIYQECKLASKTY,BAK74-485,,,485,510,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,"Positive plasma was from an individual infected with GI.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ESTSIRQQDYEVYSIYQECKLASKTY,,485,510,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464556,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218522,"Linear peptide",LIADQCPLPGYHAGL,PFV-37,,,251,265,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LIADQCPLPGYHAGL,,251,265,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464557,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218562,"Linear peptide",SIWDYYIKVESIRPA,PFV-41,,,271,285,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SIWDYYIKVESIRPA,,271,285,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464558,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218475,"Linear peptide",ARLGSFYIPSSLRQI,PFV-46,,,296,310,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",ARLGSFYIPSSLRQI,,296,310,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464559,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218529,"Linear peptide",LNKLNNLTSGTSVLK,PFV-55,,,341,355,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LNKLNNLTSGTSVLK,,341,355,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464560,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218542,"Linear peptide",NTSYYSFSLWEGDCN,PFV-65,,,391,405,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NTSYYSFSLWEGDCN,,391,405,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464561,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218561,"Linear peptide",SFSLWEGDCNFTKDM,PFV-66,,,396,410,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SFSLWEGDCNFTKDM,,396,410,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464562,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218543,"Linear peptide",PESTYDFGYLAYQKN,PFV-80,,,466,480,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",PESTYDFGYLAYQKN,,466,480,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464563,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218479,"Linear peptide",DFGYLAYQKNFPSPI,PFV-81,,,471,485,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,17,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",DFGYLAYQKNFPSPI,,471,485,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464564,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218476,"Linear peptide",AYQKNFPSPICIEQQ,PFV-82,,,476,490,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=7) or GII (n=2), or GI+GII (n=8).","Figure S7",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,17,1,5.9,"Positive plasma was from an individual infected with GI.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",AYQKNFPSPICIEQQ,,476,490,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464565,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218531,"Linear peptide",LPGYHAGVEYTT,L1-GI,,,258,269,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPGYHAGVEYTT,,258,269,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464566,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218530,"Linear peptide",LPGLADVSFYPY,L1-GII,,,258,269,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",LPGLADVSFYPY,,258,269,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464567,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218576,"Linear peptide",VEITRPKNWT,L2-GI,,,279,288,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VEITRPKNWT,,279,288,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464568,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218500,"Linear peptide",IENIRPANWT,L2-GII,,,279,288,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",IENIRPANWT,,279,288,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464569,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218560,"Linear peptide",SEIVPQCKGFYNNSKWMHMHPYACR,L3-GI,,,411,435,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SEIVPQCKGFYNNSKWMHMHPYACR,,411,435,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464570,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218578,"Linear peptide",VNETVPECKDFPHRRFNDHPYSCR,L3-GII,,,410,433,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VNETVPECKDFPHRRFNDHPYSCR,,410,433,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464571,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218508,"Linear peptide",KCDGRDDNKCL,L4-GI,,,447,457,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KCDGRDDNKCL,,447,457,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98095.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAD468",https://ontology.iedb.org/taxon/10002863,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464572,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218509,"Linear peptide",KCLTSDHTRCL,L4-GII,,,445,455,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,8,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",KCLTSDHTRCL,,445,455,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464573,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/922921,"Linear peptide",NKDIQVLGPVIDWNV,ENV6,,,96,110,,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Sibling",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GI (n=3) or GII (n=4), or GI+GII (n=1).","Figure 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,8,8,100,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NKDIQVLGPVIDWNV,,96,110,,"envelope protein [Human spumaretrovirus]",http://www.ncbi.nlm.nih.gov/protein/AAB48113.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Human spumaretrovirus",http://purl.obolibrary.org/obo/NCBITaxon_11963,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464588,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218512,"Linear peptide",KIENIRPANWTSSKLY,"GII SUvar RBD apex L2",,,278,293,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 4 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,3,42.9,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 2 GII infected individuals and 1 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464604,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218578,"Linear peptide",VNETVPECKDFPHRRFNDHPYSCR,"GII SUvar RBD apex L3",,,410,433,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 4 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,6,85.7,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 4 GII infected individuals and 2 GI+GII infected individuals.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464605,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218481,"Linear peptide",EEVKCLTSDHTRCLYYP,"GII SUvar RBD apex L4",,,442,458,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 4 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,5,71.4,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 4 GII infected individuals and 1 GI+GII infected individuals.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464608,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218604,"Discontinuous peptide",N373,"GII SUvar N8 region N7'",,,,,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 3 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,5,71.4,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 4 GII infected individuals and 1 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464611,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218566,"Linear peptide",SNLTIGN,"GII SUvar 345-351 loop",,,345,351,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 5, 6, and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,6,85.7,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 5 GII infected individuals and 1 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464613,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218602,"Discontinuous peptide",E502,"GII SUvar E502",,,,,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=4).","Figures 5 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,4,3,75,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464614,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218603,"Discontinuous peptide",L505,"GII SUvar L505",,,,,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=4).","Figures 5 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,4,4,100,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22464669,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218517,"Linear peptide",KVESIRPANWTTKSKY,"CI SUvar RBD apex L2",,,278,293,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GI+GII (n=3).","Figures 7 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,6,3,50,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV). Positive samples were from 2 GI infected individuals and 1 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLRMQHPVPKYVEVNMTSIPQGVYYEPHPEPIVVKERVLGLSQILMINSENIANNANLTQEVKKLLTEMVNEEMQSLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFANCYLVKYKEPKPWPKEGLIADQCPLPGYHAGLTYNRQSIWDYYIKVESIRPANWTTKSKYGQARLGSFYIPSSLRQINVSHVLFCSDQLYSKWYNIENTIEQNERFLLNKLNNLTSGTSVLKKRALPKDWSSQGKNALFREINVLDICSKPESVILLNTSYYSFSLWEGDCNFTKDMISQLVPECDGFYNNSKWMHMHPYACRFWRSKNEKEETKCRDGETKRCLYYPLWDSPESTYDFGYLAYQKNFPSPICIEQQKIRDQDYEVYSLYQECKIASKAYGIDTVLFSLKNFLNYTGTPVNEMPNARAFVGLIDPKFPPSYPNVTREHYTSCNN,,127,567,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464670,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218505,"Linear peptide",ISQLVPECDGFYNNSKWMHMHPYACR,"CI SUvar RBD apex L3",,,411,436,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GI+GII (n=3).","Figures 7 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,6,6,100,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLRMQHPVPKYVEVNMTSIPQGVYYEPHPEPIVVKERVLGLSQILMINSENIANNANLTQEVKKLLTEMVNEEMQSLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFANCYLVKYKEPKPWPKEGLIADQCPLPGYHAGLTYNRQSIWDYYIKVESIRPANWTTKSKYGQARLGSFYIPSSLRQINVSHVLFCSDQLYSKWYNIENTIEQNERFLLNKLNNLTSGTSVLKKRALPKDWSSQGKNALFREINVLDICSKPESVILLNTSYYSFSLWEGDCNFTKDMISQLVPECDGFYNNSKWMHMHPYACRFWRSKNEKEETKCRDGETKRCLYYPLWDSPESTYDFGYLAYQKNFPSPICIEQQKIRDQDYEVYSLYQECKIASKAYGIDTVLFSLKNFLNYTGTPVNEMPNARAFVGLIDPKFPPSYPNVTREHYTSCNN,,127,567,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22464671,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218480,"Linear peptide",EETKCRDGETKRCLYYP,"CI SUvar RBD apex L4",,,445,461,,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195,"The epitope was deduced.",,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar. Samples were from patients infected with only GI (n=3) or GI+GII (n=3).","Figures 7 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,6,3,50,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV). Positive samples were from 2 GI infected individuals and 1 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",SLRMQHPVPKYVEVNMTSIPQGVYYEPHPEPIVVKERVLGLSQILMINSENIANNANLTQEVKKLLTEMVNEEMQSLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFANCYLVKYKEPKPWPKEGLIADQCPLPGYHAGLTYNRQSIWDYYIKVESIRPANWTTKSKYGQARLGSFYIPSSLRQINVSHVLFCSDQLYSKWYNIENTIEQNERFLLNKLNNLTSGTSVLKKRALPKDWSSQGKNALFREINVLDICSKPESVILLNTSYYSFSLWEGDCNFTKDMISQLVPECDGFYNNSKWMHMHPYACRFWRSKNEKEETKCRDGETKRCLYYPLWDSPESTYDFGYLAYQKNFPSPICIEQQKIRDQDYEVYSLYQECKIASKAYGIDTVLFSLKNFLNYTGTPVNEMPNARAFVGLIDPKFPPSYPNVTREHYTSCNN,,127,567,,"envelope protein [Eastern chimpanzee simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AQM52259.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/A0A1Q1N9U9,"Eastern chimpanzee simian foamy virus pHSRV13",https://ontology.iedb.org/taxon/10002865,"Eastern chimpanzee simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_2170195
http://www.iedb.org/assay/22502924,http://www.iedb.org/reference/1042400,Literature,37093892,,"Lasse Toftdal Dynesen; Ignacio Fernandez; Youna Coquin; Manon Delaplace; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Félix A Rey; Antoine Gessain; Marija Backovic; Florence Buseyne","PLoS Pathog",2023,"Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus.",http://www.iedb.org/epitope/2218601,"Discontinuous peptide",E485,"GII SUvar N8 region E485",,,,,,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,Africa,http://purl.obolibrary.org/obo/GAZ_00000457,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,Chronic,"Taxonomic Parent",Organism,"Simian foamy virus-gorilla (Gorilla gorilla foamy virus)",,,,,,,,,"Simian foamy virus-gorilla",http://purl.obolibrary.org/obo/NCBITaxon_41858,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Plasma samples were collected from patients infected with a gorilla SFV of which the genotype was defined by PCR using primers located within SUvar.  Samples were from patients infected with only GII (n=5) or GI+GII (n=2).","Figures 4 and 10","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,7,6,85.7,"Patient plasma adsorbed with the SUvar formatted as an immunoadhesin with mutation/deletion of the epitope displayed reduced neutralization and/or increased infectivity of foamy virus particles (FVV).  Positive samples were from 4 GII infected individuals and 2 GI+GII infected individual.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,"Fragment of Source Antigen","Linear peptide",ALRAQHPVPKYVEVNMTSIPQGVFYQPHPEPIIHTERVLGLSQVLMINSENVANSANLSQETKALLTEMVNEEMQGLSDVMIDFEIPLGDPRDQEQYIHRKCYQEFAHCYLVKYKTPQPWPNEGLIADQCPLPGLADVSFYPYQAIWDYYAKIENIRPANWTSSKLYGKARMGSYYIPKRLRNINNTHILFCSDVLYSKWYNLQNSILQNENELTKRLSNLTIGNKLKNRALPYEWAKGGLNRLFRNISVLDVCSRPEMVLLLNKTYYTFSLWEGDCNITRYNVNETVPECKDFPHRRFNDHPYSCRLWRYREGKEEVKCLTSDHTRCLYYPEYSNPEALFDFGFLSYMRNFPGPQCIESTSIRQQDYEVYSIYQECKLASKTYGIDSVLFSLKNFLNYTGKPVNEMPNARAFVGLIDPKFPPTYPNITRDQYQGCNINQR,,127,567,,"env protein [Simian foamy virus]",http://www.ncbi.nlm.nih.gov/protein/AFX98090.1,"Envelope glycoprotein gp130",http://www.uniprot.org/uniprot/P14351,"Simian foamy virus BAK74",https://ontology.iedb.org/taxon/10002864,"Simian foamy virus",http://purl.obolibrary.org/obo/NCBITaxon_11642
http://www.iedb.org/assay/22746577,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/1711669,"Linear peptide",VWVPGPTDDRCPAKPEEEG,"HERV-K-env-su (19–37)",,,19,37,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,14,29.8,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VWVPGPTDDRCPAKPEEEG,,19,37,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746578,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/1711669,"Linear peptide",VWVPGPTDDRCPAKPEEEG,"HERV-K-env-su (19–37)",,,19,37,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,4,10.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VWVPGPTDDRCPAKPEEEG,,19,37,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746579,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/1863649,"Linear peptide",RPKGKTCPKEIPKGSKNT,"HERV-K-env-su (109–126)",,,110,127,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,28,59.6,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RPKGKTCPKEIPKGSKNT,,110,127,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746580,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/1863649,"Linear peptide",RPKGKTCPKEIPKGSKNT,"HERV-K-env-su (109–126)",,,110,127,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Negative,,,39,0,0,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",RPKGKTCPKEIPKGSKNT,,110,127,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746581,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/2257982,"Linear peptide",SGQTQSCPSAQVSPAVDSDLTES,"HERV-K-env-su (164–186)",,,164,186,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,16,34,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SGQTQSCPSAQVSPAVDSDLTES,,164,186,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746582,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/2257982,"Linear peptide",SGQTQSCPSAQVSPAVDSDLTES,"HERV-K-env-su (164–186)",,,164,186,,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,4,10.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",SGQTQSCPSAQVSPAVDSDLTES,,164,186,,"envelope surface protein",http://www.ncbi.nlm.nih.gov/protein/ACA34118.1,"Envelope polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q27VB7,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746583,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/2257805,"Linear peptide",EKGISTPRPKIISPVSGPEHPE,"HERV-K-env-su (205–226)",,,206,227,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,47,11,23.4,"Reactivity was not significantly higher than in healthy controls.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EKGISTPRPKIISPVSGPEHPE,,206,227,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746584,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/2257805,"Linear peptide",EKGISTPRPKIISPVSGPEHPE,"HERV-K-env-su (205–226)",,,206,227,,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,3,7.7,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",EKGISTPRPKIISPVSGPEHPE,,206,227,,"env protein",http://www.ncbi.nlm.nih.gov/protein/CAB56604.1,Env,http://www.uniprot.org/uniprot/A0AAQ5KSX2,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22746585,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243823,"Linear peptide",NPSCPGGLGVTVCWTY,"HERV-W-env (93–108)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,19,40.4,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NPSCPGGLGVTVCWTY,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746586,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243823,"Linear peptide",NPSCPGGLGVTVCWTY,"HERV-W-env (93–108)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,4,10.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NPSCPGGLGVTVCWTY,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746587,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243844,"Linear peptide",VKEVISQLTRVHGTS,"HERV-W-env (129–143)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,15,31.9,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VKEVISQLTRVHGTS,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746588,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243844,"Linear peptide",VKEVISQLTRVHGTS,"HERV-W-env (129–143)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,4,10.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",VKEVISQLTRVHGTS,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746589,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243807,"Linear peptide",HTRLVSLFNTTLTGLHEVSA,"HERV-W-env (161–180)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,47,6,12.8,"Reactivity was not significantly higher than in healthy controls.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HTRLVSLFNTTLTGLHEVSA,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746590,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243807,"Linear peptide",HTRLVSLFNTTLTGLHEVSA,"HERV-W-env (161–180)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,4,10.3,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",HTRLVSLFNTTLTGLHEVSA,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746591,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243824,"Linear peptide",NSQCIRWVTPPTQIV,"HERV-W-env (248–262)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of autoimmune disease","myasthenia gravis",http://purl.obolibrary.org/obo/DOID_437,Chronic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,47,19,40.4,"Reactivity was significantly higher in Myasthenia Gravis patients compared to healthy controls. These results remained highly significant even when patients were subdivided into acetylcholine receptor Ab+ (MG-AchR Ab+) and double seronegative patients (MG-DSN) subgroups.",Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NSQCIRWVTPPTQIV,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22746592,http://www.iedb.org/reference/1043424,Literature,38203616,,"Elena Rita Simula; Ignazio Roberto Zarbo; Giannina Arru; Elia Sechi; Rossella Meloni; Giovanni Andrea Deiana; Paolo Solla; Leonardo Antonio Sechi","Int J Mol Sci",2023,"Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.",http://www.iedb.org/epitope/243824,"Linear peptide",NSQCIRWVTPPTQIV,"HERV-W-env (248–262)",,,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"No immunization",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 1, 2, 3, 4, 5, S1, S2, S3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive-Low,,,39,6,15.4,,Plasma,"Entire Antibody",Polyclonal,,IgG,,,Epitope,"Linear peptide",NSQCIRWVTPPTQIV,,,,,"Env protein",https://ontology.iedb.org/ontology/ONTIE_0002507,,,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786,"Human endogenous retrovirus W",http://purl.obolibrary.org/obo/NCBITaxon_87786
http://www.iedb.org/assay/22909827,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody bound P27 from ALV-J strain SX-18-01, as shown by ELISA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909834,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3. 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody recognized ALV-J strain SX-18-01 in infected DF1 cells, as shown by IFA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,"Source Organism",Organism,"Avian leukemia virus J SX-18-01",,,,,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909835,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3. 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody recognized ALV-A strain XTM-21-01 in infected DF1 cells, as shown by IFA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,"Taxonomic Sibling",Organism,"Avian leukemia virus A XTM-21-01",ALV-A,,,,,,,,"Avian leukemia virus A XTM-21-01",https://ontology.iedb.org/taxon/10003169,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909836,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3. 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody recognized ALV-B strain SZ-19-01 in infected DF1 cells, as shown by IFA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,"Taxonomic Sibling",Organism,"Avian leukemia virus B SZ-19-01",ALV-B,,,,,,,,"Avian leukemia virus B SZ-19-01",https://ontology.iedb.org/taxon/10003170,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909837,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3. 8",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody recognized ALV-K strain SH-20-01 in infected DF1 cells, as shown by IFA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,"Taxonomic Sibling",Organism,"Avian leukemia virus K SH-20-01",ALV-K,,,,,,,,"Avian leukemia virus K SH-20-01",https://ontology.iedb.org/taxon/10003171,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909845,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"6 weeks old",,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein [Avian leukosis virus]",,,,http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,,,,,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,subcutaneous,"3 doses of 50 micrograms at intervals of 2 weeis",,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4, 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The epitope-specific antibody bound the epitope, a fragment of P27 from ALV-J strain SX-18-01, as well as larger overlapping fragments, as shown by ELISA and western blotting.","Purified Immunoglobulin","Entire Antibody",Monoclonal,IF8,IgG1,Kappa,,Epitope,"Linear peptide",IIKYVLDRQK,,457,466,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909846,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,Unknown,,,,"Taxonomic Sibling",Organism,"Avian leukosis virus - RSA",ALV-A,,,,,,,,"Avian leukosis virus - RSA",http://purl.obolibrary.org/obo/NCBITaxon_363745,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Serum was obtained from chickens seropositive for exposure to ALV-A/B. The details of the immunization procedure were not described.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IIKYVLDRQK,,457,466,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22909847,http://www.iedb.org/reference/1044374,Literature,38921021,,"Zui Wang; Lina Liu; Junfeng Dou; Li Li; Qin Lu; Xinxin Jin; Huabin Shao; Zhengyu Cheng; Tengfei Zhang; Qingping Luo; Weicheng Bei","Curr Issues Mol Biol",2024,"Identification of a New B-Cell Epitope on the Capsid Protein of Avian Leukosis Virus and Its Application.",http://www.iedb.org/epitope/2265734,"Linear peptide",IIKYVLDRQK,"Epitope of mAb 1F8",,,457,466,,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,"Gallus gallus (chicken)",http://purl.obolibrary.org/obo/NCBITaxon_9031,,,,,,Unknown,,,,"Taxonomic Parent",Organism,"Avian leukosis virus ev/J (Avian leukosis virus J)",ALV-J,,,,,,,,"Avian leukosis virus ev/J",http://purl.obolibrary.org/obo/NCBITaxon_1401444,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Figure 5",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,,Serum,"Entire Antibody",Polyclonal,,,,,Epitope,"Linear peptide",IIKYVLDRQK,,457,466,,"gag polyprotein [Avian leukosis virus]",http://www.ncbi.nlm.nih.gov/protein/ADO00990.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P0C776,"Avian leukemia virus J SX-18-01",https://ontology.iedb.org/taxon/10003168,"Avian leukosis virus",http://purl.obolibrary.org/obo/NCBITaxon_11864
http://www.iedb.org/assay/22922069,http://www.iedb.org/reference/1043985,Literature,7905605,,"J K Wu; J K Wang","Neurol Res",1993,"Increased expression in human astrocytomas of a 100 kDa protein with sequence homology to the ros tyrosine kinase domain.",http://www.iedb.org/epitope/2266727,"Linear peptide",VWETLTLGQQPYPGLSNIEVL,"v-ros 455-475",,,455,475,,,"P68 protein [UR2 sarcoma virus]",http://www.ncbi.nlm.nih.gov/protein/NP_042289.1,"Tyrosine-protein kinase transforming protein ros",http://www.uniprot.org/uniprot/P00529,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VWETLTLGQQPYPGLSNIEVL,,455,475,,"P68 protein [UR2 sarcoma virus]",http://www.ncbi.nlm.nih.gov/protein/NP_042289.1,"Tyrosine-protein kinase transforming protein ros",http://www.uniprot.org/uniprot/P00529,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described. The mAb was purchased from Microbiological Associates, Bethesda, MD.","Figure 1","inhibition by antigen","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001701,Positive,,,,,,"The epitope inhibited binding of the epitope-specififc mAb to U-242MG glioblastoma cells measured by Western blot.",,"Entire Antibody",Monoclonal,"v-ros antibody",,,,Epitope,"Linear peptide",VWETLTLGQQPYPGLSNIEVL,,455,475,,"P68 protein [UR2 sarcoma virus]",http://www.ncbi.nlm.nih.gov/protein/NP_042289.1,"Tyrosine-protein kinase transforming protein ros",http://www.uniprot.org/uniprot/P00529,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090
http://www.iedb.org/assay/22922075,http://www.iedb.org/reference/1043985,Literature,7905605,,"J K Wu; J K Wang","Neurol Res",1993,"Increased expression in human astrocytomas of a 100 kDa protein with sequence homology to the ros tyrosine kinase domain.",http://www.iedb.org/epitope/2266727,"Linear peptide",VWETLTLGQQPYPGLSNIEVL,"v-ros 455-475",,,455,475,,,"P68 protein [UR2 sarcoma virus]",http://www.ncbi.nlm.nih.gov/protein/NP_042289.1,"Tyrosine-protein kinase transforming protein ros",http://www.uniprot.org/uniprot/P00529,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,,,,,,,,,,,,,,,,,"Mus musculus (mouse)",http://purl.obolibrary.org/obo/NCBITaxon_10090,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",VWETLTLGQQPYPGLSNIEVL,,455,475,,"P68 protein [UR2 sarcoma virus]",http://www.ncbi.nlm.nih.gov/protein/NP_042289.1,"Tyrosine-protein kinase transforming protein ros",http://www.uniprot.org/uniprot/P00529,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,"UR2 sarcoma virus",http://purl.obolibrary.org/obo/NCBITaxon_354090,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described. The mAb was purchased from Microbiological Associates, Bethesda, MD.","Figure 1, 2, 3, 4","western blot","qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001650,Positive,,,,,,"The epitope-specific mAb bound a protein of U-242MG glioblastoma cells measured by Western blot. In addition, high levels of a 100 kDa protein were detected in many primary brain tumors. In contrast, low levels of this 100 kDa protein were consistently found in the non-tumor brain control samples. This protein is probably not the c-ros protein but may be a novel cytosolic protein-tyrosine kinase and a marker for early transformation of astrocytomas.",,"Entire Antibody",Monoclonal,"v-ros antibody",,,,Other,"Tumor Cell","Other from Brain (Homo sapiens (human))","brain tumor cells",,,,,,,,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/22960766,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-CFH mAb GT103 bound the antigen which contained the core binding motif.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",GPPPPIDNGDITSFP,"CFH peptide",1110,1124,,"Complement factor H",https://www.uniprot.org/uniprot/P08603.4,"Complement factor H",http://www.uniprot.org/uniprot/P08603,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/22960767,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TSTIPIDNPDITPNS,"HMPV peptide",82,96,,"glycoprotein [human metapneumovirus]",http://www.ncbi.nlm.nih.gov/protein/WAB07545.1,"Major surface glycoprotein G",http://www.uniprot.org/uniprot/Q6WB94,"human metapneumovirus",http://purl.obolibrary.org/obo/NCBITaxon_162145,"human metapneumovirus",http://purl.obolibrary.org/obo/NCBITaxon_162145
http://www.iedb.org/assay/22960768,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figures 2 and 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-High,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  Binding to the antigen was also demonstrated by ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,Epitope,"Linear peptide",REPLENALTVFTD,"HERV-K pol",347,359,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22960769,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figures 2 and 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-High,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  Weak binding to the antigen was also demonstrated by ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",HMTNYLEQPVSNDLS,"Measles HA",271,285,,hemagglutinin,http://www.ncbi.nlm.nih.gov/protein/BAJ23068.1,"Hemagglutinin glycoprotein",http://www.uniprot.org/uniprot/Q786F2,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234
http://www.iedb.org/assay/22960770,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound P30 peptide SDPPLVANQVVTCPD.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",STAAVILTPTENHFT,"T. gondii P30",65,79,,"Major surface antigen p30 precursor",http://www.ncbi.nlm.nih.gov/protein/P13664.1,"SAG-related sequence SRS29B",http://www.uniprot.org/uniprot/V4Z6M2,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811
http://www.iedb.org/assay/22960771,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RVEAQLHVWIPPLN,"HepC 1a",852,865,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/AAF81759.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"hepatitis C virus genotype 1a",http://purl.obolibrary.org/obo/NCBITaxon_2847144,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22960772,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TAAVILTPTENHFTL,"T. gondii ME49 P30",66,80,,"Major surface antigen p30 precursor",http://www.ncbi.nlm.nih.gov/protein/P13664.1,"SAG-related sequence SRS29B",http://www.uniprot.org/uniprot/V4Z6M2,"Toxoplasma gondii ME49",http://purl.obolibrary.org/obo/NCBITaxon_508771,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811
http://www.iedb.org/assay/22960773,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HA peptides TIRGQFSNMSLSLLD and KFLNPDREYDFRDLT.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TNYLEQPVSNDLSNC,"Measles Edmonston HA",273,287,,"Hemagglutinin glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08362.1,"Hemagglutinin glycoprotein",http://www.uniprot.org/uniprot/Q786F2,"Measles virus strain Edmonston",http://purl.obolibrary.org/obo/NCBITaxon_11235,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234
http://www.iedb.org/assay/22960774,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound spike peptide NFSISI.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",CTPPALNCYWPLNDY,"SARS-CoV1 S",467,481,,"Spike glycoprotein",https://www.uniprot.org/uniprot/P59594.1,"Spike glycoprotein",http://www.uniprot.org/uniprot/P59594,"Severe acute respiratory syndrome coronavirus",http://purl.obolibrary.org/obo/NCBITaxon_2901879,"Severe acute respiratory syndrome-related coronavirus",http://purl.obolibrary.org/obo/NCBITaxon_694009
http://www.iedb.org/assay/22960775,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RIEDPPFNSLL,"EBV B95-8 LMP2",199,209,,"Latent membrane protein 2",https://www.uniprot.org/uniprot/P13285.1,"Latent membrane protein 2",http://www.uniprot.org/uniprot/P13285,"Human herpesvirus 4 strain B95-8",http://purl.obolibrary.org/obo/NCBITaxon_10377,"human gammaherpesvirus 4",http://purl.obolibrary.org/obo/NCBITaxon_10376
http://www.iedb.org/assay/22960776,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound E7 peptide DLYCYEQLNDSSEE.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",YEQLNDSSEEEDEIDG,"HPV16 E7",25,40,,"Protein E7",http://www.ncbi.nlm.nih.gov/protein/P03129.1,"Protein E7",http://www.uniprot.org/uniprot/P03129,"Human papillomavirus 16",http://purl.obolibrary.org/obo/NCBITaxon_333760,"Alphapapillomavirus 9",http://purl.obolibrary.org/obo/NCBITaxon_337041
http://www.iedb.org/assay/22960777,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound E2 peptides CYGVSATKLNDLCFS, VLSFELLNAPATVCG, GVSATKLNDLCFSNV, and EDLLFNKVTLADAGF.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",PPALNCYWPLNDYGF,"SARS-CoV1 Tor2 E2",469,483,,"spike glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAP41037.1,"Spike glycoprotein",http://www.uniprot.org/uniprot/P59594,"SARS coronavirus Tor2",http://purl.obolibrary.org/obo/NCBITaxon_227984,SARS-CoV1,https://ontology.iedb.org/taxon/10002316
http://www.iedb.org/assay/22960778,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HepC 2b peptide IGRLHLNDR.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",GRLHLNDRV,"HepC 2b",1688,1696,,"polyprotein [Hepatitis C virus subtype 2b]",http://www.ncbi.nlm.nih.gov/protein/BAK61655.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus subtype 2b",http://purl.obolibrary.org/obo/NCBITaxon_31650,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22960779,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HepC 1b peptides GPLTNS and GGPLTN.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TWGENETDVLLLNNT,"HepC 1b",528,542,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/ACE82411.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus subtype 1b",http://purl.obolibrary.org/obo/NCBITaxon_31647,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22960780,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RISNLND,"B. pertussis Fim2",114,120,,Fim2,http://www.ncbi.nlm.nih.gov/protein/ACI16083.1,"Serotype 2 fimbrial subunit",http://www.uniprot.org/uniprot/P05788,"Bordetella pertussis",http://purl.obolibrary.org/obo/NCBITaxon_520,"Bordetella pertussis",http://purl.obolibrary.org/obo/NCBITaxon_520
http://www.iedb.org/assay/22960781,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also weakly bound gp peptide VLNRDVSFQDLSD.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RDHVNLVLNRDVS,"Andes virus Chi-7913 gp",45,57,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/Q5MJZ9,"Envelopment polyprotein",http://www.uniprot.org/uniprot/O55346,"Andes virus CHI-7913",https://ontology.iedb.org/taxon/10000553,"Orthohantavirus andesense",http://purl.obolibrary.org/obo/NCBITaxon_1980456
http://www.iedb.org/assay/22960782,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SKLPINPLSNSLLRH,HepC,2442,2456,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/BAB18810.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22960783,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound Vp4-Vp2 peptide VMIKSLPALNSPTVE.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",IKSLPALNSPTVEEC,"Coxsackie B4 Vp4-Vp2",55,69,,VP4-VP2,http://www.ncbi.nlm.nih.gov/protein/AAR16005.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P08292,"Coxsackievirus B4",http://purl.obolibrary.org/obo/NCBITaxon_12073,"Enterovirus B",http://purl.obolibrary.org/obo/NCBITaxon_138949
http://www.iedb.org/assay/22960784,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",EDTLNKVD,"M. tuberculosis DNAK",538,545,,"Chaperone protein DnaK",http://www.ncbi.nlm.nih.gov/protein/P9WMJ8.1,"Chaperone protein DnaK",http://www.uniprot.org/uniprot/P9WMJ9,"Mycobacterium tuberculosis",http://purl.obolibrary.org/obo/NCBITaxon_1773,"Mycobacterium tuberculosis",http://purl.obolibrary.org/obo/NCBITaxon_1773
http://www.iedb.org/assay/22960785,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",LNDITKEYEKLLNEI,"P. falciparum MSP1",475,489,,"merozoite surface protein-1 [Plasmodium falciparum]",http://www.ncbi.nlm.nih.gov/protein/BAF62271.1,"Merozoite surface protein 1",http://www.uniprot.org/uniprot/Q8I0U8,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833
http://www.iedb.org/assay/22960786,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RDEVDFCVGLNSFV,"HepC 2a",,,,"Genome polyprotein",,,,"Hepatitis C virus subtype 2a",http://purl.obolibrary.org/obo/NCBITaxon_31649,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22960787,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound Dengue 2 peptide SLNEEQ.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",LNEEQD,"Dengue 2 Jamaica",362,367,,"Genome polyprotein",http://www.ncbi.nlm.nih.gov/protein/P07564.2,"Genome polyprotein",http://www.uniprot.org/uniprot/P17763,"Dengue virus 2 Jamaica/1409/1983",http://purl.obolibrary.org/obo/NCBITaxon_11064,"Dengue virus",http://purl.obolibrary.org/obo/NCBITaxon_12637
http://www.iedb.org/assay/22960788,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",QPESPARLASAILNA,"Dengue 4",35,49,,"Non-structural protein 1",https://www.uniprot.org/uniprot/Q6TFL5.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P17763,"dengue virus type 4",http://purl.obolibrary.org/obo/NCBITaxon_11070,"Dengue virus",http://purl.obolibrary.org/obo/NCBITaxon_12637
http://www.iedb.org/assay/22960789,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",DNSNPVVQAEQLNWL,"S. mutans GTF",427,441,,"Glucosyltransferase-S precursor (GTF-S) (Dextransucrase) (Sucrose 6-glucosyltransferase)",http://www.ncbi.nlm.nih.gov/protein/P49331.3,Glucosyltransferase-S,http://www.uniprot.org/uniprot/P49331,"Streptococcus mutans",http://purl.obolibrary.org/obo/NCBITaxon_1309,"Streptococcus mutans",http://purl.obolibrary.org/obo/NCBITaxon_1309
http://www.iedb.org/assay/22960790,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/22960791,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SGSVQYALNDNA,"N. meningitidis OMP",158,169,,"Serotype 15 outer membrane protein",http://www.ncbi.nlm.nih.gov/protein/Q51271,"Major outer membrane protein P.IB",http://www.uniprot.org/uniprot/P30690,"Neisseria meningitidis",http://purl.obolibrary.org/obo/NCBITaxon_487,"Neisseria meningitidis",http://purl.obolibrary.org/obo/NCBITaxon_487
http://www.iedb.org/assay/22960792,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/194870,"Linear peptide",REPLENALTVFTD,"HERV-K pol",,,347,359,,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SGVLPTSFGNTITC,"HepC 3",2711,2724,,"polyprotein [Hepatitis C virus genotype 3]",http://www.ncbi.nlm.nih.gov/protein/AEV46286.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus genotype 3",http://purl.obolibrary.org/obo/NCBITaxon_356114,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961561,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-CFH mAb GT103 bound the antigen which contained the core binding motif.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",GPPPPIDNGDITSFP,"CFH peptide",1110,1124,,"Complement factor H",https://www.uniprot.org/uniprot/P08603.4,"Complement factor H",http://www.uniprot.org/uniprot/P08603,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606,"Homo sapiens",http://purl.obolibrary.org/obo/NCBITaxon_9606
http://www.iedb.org/assay/22961562,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 3",ELISA,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0001657,Positive,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TSTIPIDNPDITPNS,"HMPV peptide",82,96,,"glycoprotein [human metapneumovirus]",http://www.ncbi.nlm.nih.gov/protein/WAB07545.1,"Major surface glycoprotein G",http://www.uniprot.org/uniprot/Q6WB94,"human metapneumovirus",http://purl.obolibrary.org/obo/NCBITaxon_162145,"human metapneumovirus",http://purl.obolibrary.org/obo/NCBITaxon_162145
http://www.iedb.org/assay/22961563,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figures 2 and 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-High,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  Binding to the antigen was also demonstrated by ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",REPLENALTVFTD,"HERV-K pol",347,359,,"pol protein",http://www.ncbi.nlm.nih.gov/protein/CAB56603.1,"Polymerase (Fragment)",http://www.uniprot.org/uniprot/O71089,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617,"Human endogenous retrovirus K",http://purl.obolibrary.org/obo/NCBITaxon_45617
http://www.iedb.org/assay/22961564,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figures 2 and 3",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-High,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  Weak binding to the antigen was also demonstrated by ELISA.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",HMTNYLEQPVSNDLS,"Measles HA",271,285,,hemagglutinin,http://www.ncbi.nlm.nih.gov/protein/BAJ23068.1,"Hemagglutinin glycoprotein",http://www.uniprot.org/uniprot/Q786F2,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234
http://www.iedb.org/assay/22961565,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound P30 peptide SDPPLVANQVVTCPD.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",STAAVILTPTENHFT,"T. gondii P30",65,79,,"Major surface antigen p30 precursor",http://www.ncbi.nlm.nih.gov/protein/P13664.1,"SAG-related sequence SRS29B",http://www.uniprot.org/uniprot/V4Z6M2,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811
http://www.iedb.org/assay/22961566,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RVEAQLHVWIPPLN,"HepC 1a",852,865,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/AAF81759.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"hepatitis C virus genotype 1a",http://purl.obolibrary.org/obo/NCBITaxon_2847144,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961567,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TAAVILTPTENHFTL,"T. gondii ME49 P30",66,80,,"Major surface antigen p30 precursor",http://www.ncbi.nlm.nih.gov/protein/P13664.1,"SAG-related sequence SRS29B",http://www.uniprot.org/uniprot/V4Z6M2,"Toxoplasma gondii ME49",http://purl.obolibrary.org/obo/NCBITaxon_508771,"Toxoplasma gondii",http://purl.obolibrary.org/obo/NCBITaxon_5811
http://www.iedb.org/assay/22961568,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Intermediate,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HA peptides TIRGQFSNMSLSLLD and KFLNPDREYDFRDLT.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TNYLEQPVSNDLSNC,"Measles Edmonston HA",273,287,,"Hemagglutinin glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P08362.1,"Hemagglutinin glycoprotein",http://www.uniprot.org/uniprot/Q786F2,"Measles virus strain Edmonston",http://purl.obolibrary.org/obo/NCBITaxon_11235,"Measles morbillivirus",http://purl.obolibrary.org/obo/NCBITaxon_11234
http://www.iedb.org/assay/22961569,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound spike peptide NFSISI.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",CTPPALNCYWPLNDY,"SARS-CoV1 S",467,481,,"Spike glycoprotein",https://www.uniprot.org/uniprot/P59594.1,"Spike glycoprotein",http://www.uniprot.org/uniprot/P59594,"Severe acute respiratory syndrome coronavirus",http://purl.obolibrary.org/obo/NCBITaxon_2901879,"Severe acute respiratory syndrome-related coronavirus",http://purl.obolibrary.org/obo/NCBITaxon_694009
http://www.iedb.org/assay/22961570,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RIEDPPFNSLL,"EBV B95-8 LMP2",199,209,,"Latent membrane protein 2",https://www.uniprot.org/uniprot/P13285.1,"Latent membrane protein 2",http://www.uniprot.org/uniprot/P13285,"Human herpesvirus 4 strain B95-8",http://purl.obolibrary.org/obo/NCBITaxon_10377,"human gammaherpesvirus 4",http://purl.obolibrary.org/obo/NCBITaxon_10376
http://www.iedb.org/assay/22961571,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound E7 peptide DLYCYEQLNDSSEE.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",YEQLNDSSEEEDEIDG,"HPV16 E7",25,40,,"Protein E7",http://www.ncbi.nlm.nih.gov/protein/P03129.1,"Protein E7",http://www.uniprot.org/uniprot/P03129,"Human papillomavirus 16",http://purl.obolibrary.org/obo/NCBITaxon_333760,"Alphapapillomavirus 9",http://purl.obolibrary.org/obo/NCBITaxon_337041
http://www.iedb.org/assay/22961572,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound E2 peptides CYGVSATKLNDLCFS, VLSFELLNAPATVCG, GVSATKLNDLCFSNV, and EDLLFNKVTLADAGF.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",PPALNCYWPLNDYGF,"SARS-CoV1 Tor2 E2",469,483,,"spike glycoprotein",http://www.ncbi.nlm.nih.gov/protein/AAP41037.1,"Spike glycoprotein",http://www.uniprot.org/uniprot/P59594,"SARS coronavirus Tor2",http://purl.obolibrary.org/obo/NCBITaxon_227984,SARS-CoV1,https://ontology.iedb.org/taxon/10002316
http://www.iedb.org/assay/22961573,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HepC 2b peptide IGRLHLNDR.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",GRLHLNDRV,"HepC 2b",1688,1696,,"polyprotein [Hepatitis C virus subtype 2b]",http://www.ncbi.nlm.nih.gov/protein/BAK61655.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus subtype 2b",http://purl.obolibrary.org/obo/NCBITaxon_31650,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961574,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound HepC 1b peptides GPLTNS and GGPLTN.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",TWGENETDVLLLNNT,"HepC 1b",528,542,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/ACE82411.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus subtype 1b",http://purl.obolibrary.org/obo/NCBITaxon_31647,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961575,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RISNLND,"B. pertussis Fim2",114,120,,Fim2,http://www.ncbi.nlm.nih.gov/protein/ACI16083.1,"Serotype 2 fimbrial subunit",http://www.uniprot.org/uniprot/P05788,"Bordetella pertussis",http://purl.obolibrary.org/obo/NCBITaxon_520,"Bordetella pertussis",http://purl.obolibrary.org/obo/NCBITaxon_520
http://www.iedb.org/assay/22961576,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also weakly bound gp peptide VLNRDVSFQDLSD.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RDHVNLVLNRDVS,"Andes virus Chi-7913 gp",45,57,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/Q5MJZ9,"Envelopment polyprotein",http://www.uniprot.org/uniprot/O55346,"Andes virus CHI-7913",https://ontology.iedb.org/taxon/10000553,"Orthohantavirus andesense",http://purl.obolibrary.org/obo/NCBITaxon_1980456
http://www.iedb.org/assay/22961577,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SKLPINPLSNSLLRH,HepC,2442,2456,,polyprotein,http://www.ncbi.nlm.nih.gov/protein/BAB18810.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961578,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound Vp4-Vp2 peptide VMIKSLPALNSPTVE.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",IKSLPALNSPTVEEC,"Coxsackie B4 Vp4-Vp2",55,69,,VP4-VP2,http://www.ncbi.nlm.nih.gov/protein/AAR16005.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P08292,"Coxsackievirus B4",http://purl.obolibrary.org/obo/NCBITaxon_12073,"Enterovirus B",http://purl.obolibrary.org/obo/NCBITaxon_138949
http://www.iedb.org/assay/22961579,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",EDTLNKVD,"M. tuberculosis DNAK",538,545,,"Chaperone protein DnaK",http://www.ncbi.nlm.nih.gov/protein/P9WMJ8.1,"Chaperone protein DnaK",http://www.uniprot.org/uniprot/P9WMJ9,"Mycobacterium tuberculosis",http://purl.obolibrary.org/obo/NCBITaxon_1773,"Mycobacterium tuberculosis",http://purl.obolibrary.org/obo/NCBITaxon_1773
http://www.iedb.org/assay/22961580,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",LNDITKEYEKLLNEI,"P. falciparum MSP1",475,489,,"merozoite surface protein-1 [Plasmodium falciparum]",http://www.ncbi.nlm.nih.gov/protein/BAF62271.1,"Merozoite surface protein 1",http://www.uniprot.org/uniprot/Q8I0U8,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833,"Plasmodium falciparum",http://purl.obolibrary.org/obo/NCBITaxon_5833
http://www.iedb.org/assay/22961581,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",RDEVDFCVGLNSFV,"HepC 2a",,,,"Genome polyprotein",,,,"Hepatitis C virus subtype 2a",http://purl.obolibrary.org/obo/NCBITaxon_31649,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
http://www.iedb.org/assay/22961582,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.  The mAb also bound Dengue 2 peptide SLNEEQ.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",LNEEQD,"Dengue 2 Jamaica",362,367,,"Genome polyprotein",http://www.ncbi.nlm.nih.gov/protein/P07564.2,"Genome polyprotein",http://www.uniprot.org/uniprot/P17763,"Dengue virus 2 Jamaica/1409/1983",http://purl.obolibrary.org/obo/NCBITaxon_11064,"Dengue virus",http://purl.obolibrary.org/obo/NCBITaxon_12637
http://www.iedb.org/assay/22961583,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",QPESPARLASAILNA,"Dengue 4",35,49,,"Non-structural protein 1",https://www.uniprot.org/uniprot/Q6TFL5.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P17763,"dengue virus type 4",http://purl.obolibrary.org/obo/NCBITaxon_11070,"Dengue virus",http://purl.obolibrary.org/obo/NCBITaxon_12637
http://www.iedb.org/assay/22961584,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",DNSNPVVQAEQLNWL,"S. mutans GTF",427,441,,"Glucosyltransferase-S precursor (GTF-S) (Dextransucrase) (Sucrose 6-glucosyltransferase)",http://www.ncbi.nlm.nih.gov/protein/P49331.3,Glucosyltransferase-S,http://www.uniprot.org/uniprot/P49331,"Streptococcus mutans",http://purl.obolibrary.org/obo/NCBITaxon_1309,"Streptococcus mutans",http://purl.obolibrary.org/obo/NCBITaxon_1309
http://www.iedb.org/assay/22961585,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,Epitope,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440
http://www.iedb.org/assay/22961586,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SGSVQYALNDNA,"N. meningitidis OMP",158,169,,"Serotype 15 outer membrane protein",http://www.ncbi.nlm.nih.gov/protein/Q51271,"Major outer membrane protein P.IB",http://www.uniprot.org/uniprot/P30690,"Neisseria meningitidis",http://purl.obolibrary.org/obo/NCBITaxon_487,"Neisseria meningitidis",http://purl.obolibrary.org/obo/NCBITaxon_487
http://www.iedb.org/assay/22961587,http://www.iedb.org/reference/1045775,Literature,40009215,,"Michael J Campa; Elizabeth B Gottlin; Kevin Wiehe; Edward F Patz Jr","Cancer Immunol Immunother",2025,"A tumor-binding antibody with cross-reactivity to viral antigens.",http://www.iedb.org/epitope/2275221,"Linear peptide",LPHSLNDHILEPSIP,"HTLV1 gp68",,,,,,,"Envelope glycoprotein 68",,,,"Human T-cell leukemia virus type I",http://purl.obolibrary.org/obo/NCBITaxon_11908,"Primate T-lymphotropic virus 1",http://purl.obolibrary.org/obo/NCBITaxon_194440,,,,,,,,,,,,,,,,,"Homo sapiens (human)",http://purl.obolibrary.org/obo/NCBITaxon_9606,,,,,,"Occurrence of cancer","lung non-small cell carcinoma",http://purl.obolibrary.org/obo/DOID_3908,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Generation of the parent mAb 7968 was described in cited reference [PMID: 27160908] and patent application NCT04314089. PBMCs of 11 patients diagnosed with non-small cell lung cancer (NSCLC), and who were shown by immunoblot to express CFH autoantibody, were pooled. Memory B cells were sorted from the pooled PBMCs using a biotinylated CFH 15-mer peptide containing the epitope as bait. Ig VH and VL gene pairs were isolated for expression. GT103 is the IgG3 version of mAb 7968.","Figure 2",microarray,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_0002053,Positive-Low,,,,,,"The anti-CFH mAb GT103 cross reacted with the antigen.","Purified Immunoglobulin","Entire Antibody",Monoclonal,GT103,IgG3,Kappa,,"Structurally Related","Linear peptide",SGVLPTSFGNTITC,"HepC 3",2711,2724,,"polyprotein [Hepatitis C virus genotype 3]",http://www.ncbi.nlm.nih.gov/protein/AEV46286.1,"Genome polyprotein",http://www.uniprot.org/uniprot/P27958,"Hepatitis C virus genotype 3",http://purl.obolibrary.org/obo/NCBITaxon_356114,"Hepacivirus hominis",http://purl.obolibrary.org/obo/NCBITaxon_3052230
